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PART 1 
 
Chapter 1 : Introduction 
 
The discovery and exploitation of polymer-supported chemistry  
In 1963, Merrifield took the first step towards introducing polymer-supported chemistry to 
the wider world of synthesis with the publication of his “solid phase” peptide synthesis 
methodology.1) 
However a more widespread appreciation of the advantages that polymers have to offer to 
synthesis has only really occurred in the last ten years or so, with the explosion in the use of 
solid phase combinatorial synthetic methodologies, spurred on by the need for rapid synthesis 
and screening of potential lead compounds in drug discovery within the pharmaceutical industry. 
Increasing familiarity with the use of polymer resins in solid phase synthesis has stimulated even 
mainstream organic synthetic groups to investigate the prospects of employing polymers as 
catalyst supports for use, for example, in solution phase combinatorial synthesis.  
In most cases, the development of new synthetic sequences on polymer supports is regarded 
as the key for successfully generating these libraries. Solid phase synthesis was first applied to 
the construction of peptides, and methods have since been developed for the synthesis of 
oligonucleotides and oligosaccharides. Application of polymer supports to organic synthesis is 
basically classified into four methods as shown in Scheme 1-1.2) 
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AA A-B A-B
B
linker
Method A: Solid phase synthesis
Method B: Polymer-bound reagents and catalysts
D E
A B C
Method D: Capture-release method
B-A
B
A A-C
C
Method C: Polymer-bound scavenging reagents
D-C + B
D
A
C (excess)
B + C
B + C-E
("Tagging" reagents)
E
F-E-C + B
F
 
Scheme 1-1. Various uses of polymer supports in organic chemistry 
 
These techniques have various advantages over conventional solution phase chemistry as 
follows. 
(1) The ease of chemistry. Thus, reaction can be accomplished in only three steps: addition of 
reagents, filtering, and washing the resin. 
(2) Reuse of a catalyst or a supported reagent after regeneration. 
(3) The ease of adaptation to continuous-flow processes and hence use in automated synthesis. 
(4) The reduced toxicity and odour of supported species compared with low molecular weight 
unsupported analogues. 
(5) Chemical differences, such as prolonged activity or altered selectivity of a catalyst in 
supported form compared with its soluble analogue. 
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A discussion on functionalized polymers should also include obstacles associated with  
their use, particular in comparison to their soluble analogues. 
(1) Higher costs 
(2) Lower reactivities because of diffusion limitations 
(3) Difficulty in structural analysis of the supported species 
(4) The inability to separate polymer-bound impurities 
(5) Excess use of reagent to drive the reaction to completion. 
 
Polymer-supported reagents and catalysts 
The preparation of novel heterogeneous reagents and catalysts is a continuously growing 
field. This is based on the fact that heterogeneous reagents and catalysts are, in principle, best 
suited for industrial applications. Polymeric supports have been mainly used to immobilize 
substrates, reagents and catalysts. Insoluble polymeric matrices allow to fully exploit the ease of 
solid-liquid separation by filtration. In addition, certain soluble polymers were examined which 
can be easily precipitated. The polymers which were used can be divided in the following 
classes. 
? Crosslinked organic polymers:  
- insoluble in organic solvents [e.g., polystyrene-divinylbenzene and poly(4-vinylpyridine)]  
? Linear organic polymers:  
- usually soluble in organic solvents and can be precipitated in certain cases [e.g., 
polyethylene glycol (PEG) and polystyrene] 
? Dendrimers:  
- solubility depends on size and shape 
? Inorganic supports: 
- such as porous glass, SiO2, Al2O3, graphite, and clays 
Different supports have been used, for this purpose, but polystyrene-divinylbenzene (PS-DVB) 
and related resins continue being one of the most popular supporting materials. Their use has 
even increase in recent years because of the important advances made in the preparation and 
modification of materials of this class for their use in solid-phase combinatorial chemistry. 
 
Resins withstand a wide range of reaction condition, but some limitations can be observed. 
 Prolonged use of mechanical stirring can cause mechanical damage of the resin. Mixing is 
achieved by vortexing by employing orbital shakers, ultrasonic or magnetic stirrers or by 
bubbling gas through the suspension. 
 The large interior surface area of the resin is easily accessible for solvents and reagents.       
Extensive washing procedures are required in order to remove excess reagents and high 
boiling solvents from these interior spaces. 
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Reaction monitoring 
Compare to solution-phase organic synthesis, solid-phase reactions can not be followed by 
TLC or HPLC and are therefore more difficult to monitor. Product analysis can be achieved by 
cleavage from the solid support followed by traditional characterisation. Nevertheless, a large 
variety of analytical methods are available for product analysis on the bead. 
A number of classical reactions are used to monitor solid-phase reactions, including the 
titration of reactive functionalities such as amines, carboxylic acids, phenols or thiophenols. 
Resin loading is typically calculated using Volhard chloride titration or elemental analysis. These 
methods tend to be inaccurate due to low loadings of the substrates on the support. 
Support-bound products can be analysed on the bead by IR or NMR spectroscopy in a 
non-destructive manner. But due to the dominating strong resonance signals of the polymer 
backbone, interpretations of the analytical results are difficult. FT-IR is a very convenient 
method for the evaluation of resin-bound intermediates and can give information on the 
completion of reaction. Resin-bound substrates are also suitable for KBr pellet IR analysis and 
for photoacoustic IR. 
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Chapter 2: Polymer-supported DMI and DMC 
 
Esterification and amidation of carboxylic acids including peptides synthesis have wide 
academic as well as industrial applications. During the past decade, a number of useful and 
reliable methods activated by a variety of polymer-supported coupling reagents have appeared in 
the literature3-8) (Table 2-1).  
Table 2-1. Examples of polymer-supported reagents for the synthesis of esters and amides  
structure preparation references 
N C N
polymeric carbodiimide  
by treatment of chloromethylated polystyrene 
with the corresponding urea and dehydration 
 
    3 
N
N C N
polymer-supported EDC (EDAC)
Cl
 
by treatment of chloromethylated poly(styrene- 
DVB) with EDC 
 
4 
 
N N
N
polymer-bound HOBT
OH
 
by treatment of Bio-Rad SM-2 macroporous 
beads (polystyrene-DVB copolymer resin) with 
3-nitro-4-chlorobenzyl alcohol and hydrazine 
monohydrate 
 
5 
HN
N
N
N
Cl
Cl
solid-supported chloro[1,3,5]triazine  
by treatment of several types of amino-function- 
alized resins (e.g., polystyrene, Wage resin, 
Merrifield resin or polystyrene-PEG) with the 
corresponding triazine 
 
6 
S N-OH
O
O
polymer-bound HOSu  
by treatment of chloromethylated poly(styrene- 
DVB) with thiourea and N-hydroxymaleimide 
 
7 
 
N N
N
O
Me2N NMe2
BF4
polymer-bound TBTU  
by treatment of polymer-bound HOBT with 
chlorouronium tetrafluoroborate 
 
8 
 
This laboratory has established 2-chloro-1,3-dimethylimidazolinium chloride (DMC) (2),9) 
prepared from the corresponding urea (1,3-dimethyl-2-imidazolidinone: DMI) (1) by 
chlorination, as an effective dehydrating agent comparable to dicyclohexylcarbodiimide (DCC), 
in which DMC (2) is easily removable as a regenerated DMI (1) from the reaction mixture by 
washing with water after the condensation reaction (Scheme 2-1). However, the separation step 
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is often mandatory for large-scale applications. A promising solution for this problem seems to 
be the anchoring of the reagents on an insoluble matrix, thus enabling simple recovery of 
reagents by filtration.   
DMC 2
Cl
MeN NMe
Cl
X-OH
Y-H
X-Y
2 HCl
(COCl)2
MeN NMe
O
DMI 1
CO, CO2
N C N
DCC
 
Scheme 2-1. The relationship between DMI and DMC and relative structure with DCC 
 
With the aim of incorporating the advantages of heterogeneous reagent onto DMC 2, we set a 
research into the preparation of polymer-supported DMI (P-DMI) (P-3) and its application to 
dehydration reaction, after chlorination to the corresponding DMC (P-DMC) (P-4), as a 
recyclable heterogeneous reagent. 
We planned anchoring DMI to polymer possessing a benzylic functionalization through the 
nitrogen atom of imidazolidinone. Our first choice for a polymer backbone was the widely used 
Merrifield resin [4-chloromethylated poly(styrene-divinylbenzene copolymer)], since the 
chloromethyl groups contained in its structure provide a convenient means by which to tether the 
catalyst to the solid support. Moreover, as far as the choice of support is concerned, this resin 
seemed to be appropriate for our purposes, as it forms gels that swell and become highly solvated 
in organic solvents of intermediate polarity such as CH2Cl2 and DMF. The first one is a suitable 
solvent to use when testing the catalytic properties. 
 
Chloromethylated polystyrenes-divinylbenzene 
Chloromethylated polystyrene was introduced by Merrifield into peptide synthesis. It was 
used, however, first as an intermediate for the synthesis of anion exchange resins. The synthesis 
of chloromethylated polystyrenes is best achieved by Friedel-Crafts alkylation of polystyrene 
with methoxymethylene chloride in the presence of a Lewis acid catalyst such as SnCl4 or by 
copolymerization of styrene, divinylbenzene and chloromethylstyrene. 
Crosslinked polystyrene beads are obtained by free radical initiated copolymerization of 
styrene and varying amounts of DVB. The swelling of the resin beads depend in essence from 
the degree of crosslinking and thus from the relative amount of DVB to the core monomer. 
Resins containing a low degree of crosslinking (typically 1-2% DVB) show a more pronounced 
swelling capacity than those with a high content of DVB (> 5%). The size and the shape of resin 
particles can be directed to a certain extent by polymerization. The reactivity of functionalized 
crosslinked polymers may significantly differ from that of analogous soluble reagents. On one 
hand, it should be considered that not all functional groups are solvent-accessible. On the other 
hand, however, polymers may adsorb products. Hence, there is some optimal amount of reagent 
to be applied. Polymeric reagents are not always used in the same solvents as their low- 
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molecular weight analogues 
 
2.1 Synthesis and Characterization of Polymer-supported DMI 
Polymer-supported DMI (P-3) could be prepared by two different methods from imidazoli- 
dinone (5) through propionylimidazolidinone (6). The difference is dependent upon the step of 
loading onto polymer. 
Method 1: From N-propionylimidazolidinium salt (6)   
At first we examined the method in which imidazolidinone (5) was loaded onto a polymer 
before deprotection of the propionyl group because the operation is faster and without solution 
steps or purifications. In order to monitor the reaction and roughly analyze the structure by FT-IR 
and solid 13C-NMR, the preparation of model compounds is also important. 
Step 1: Loading of N-propionylimidazolidinium salt (6) onto a polymer 
N-Propionylimidazolidinium salt (6) is easily prepared by treatment of imidazolidinone (5) with 
NaH in DMF and propionyl chloride. Addition of 4-chloromethyl polystyrene-1% DVB 
copolymer resin (200-400 mesh, chloride content ca. 1.74 mmol/ g, TCI company) into this 
suspension mixture yielded an expected polymer-supported product P-7. The corresponding 
benzyl derivative (7) was given under solution conditions (Scheme 2-2). 
N N
O O
HN NH
O
Na
1. NaH, DMF
rt, 1 h
Cl
O
5 6
O
N N
7
O
Ph
BrPh
Cl
O
N N
P-7
O2.
rt, 3 h
  rt, 24 h
  (89.8%)
Scheme 2-2.  The preparation of polymer-supported N-propionylimidazolidinone       
                      (P-7) and a model compound (7)
rt, 24 h
 
 
Steps 2 and 3: Deprotection and methylation  
In solution method the propionyl group of the imidazolidinone is usually deprotected with 
sodium methoxide in MeOH. However, polystyrene cannot swell well in MeOH (see Table 2-2). 
Thus, we tried to use others for deprotection of the propionyl group. 
 
Table 2-2. The swelling of polystyrene 1% DVB in various solvent10)  
solvent  H2O  MeOH  EtOH  CH2Cl2  toluene  DMF  MeCN  THF  dioxane  ether 
swelling    
volume   -     1.6     1.6     8.3     8.5     5.6    3.2    8.8     7.8    4.0 
(ml/ g) 
 
   In model reaction, using THF could drive the reaction completely. Polymer-supported 
N-propionylimidazolidinone (P-7) was also deprotected with sodium methoxide in THF. 
Successive transformation into P-DMI (P-3) was done by treatment with iodomethane in DMF in 
the presence of sodium hydride (Scheme 2-3).  
 8 
MeI
NaOMe
THF
O
N NH
8
Ph
O
N NMe
3
Ph
O
N N
7
O
Ph
O
N N
P-7
O
NaOMe
THF
O
N NH
P-8
MeI
O
N NMe
P-3
NaH, DMF
NaH, DMF
Scheme 2-3.  The preparation of polymer-supported DMI (P-3) and a model  
                       compound (3)  
 
FT-IR spectral charts of reaction products obtained under homogeneous and heterogenous 
conditions are shown in Figure 2-1 and 2-2, respectively. 
 
N N
OO
Ph
7
N NH
O
Ph
8
N NMe
O
Ph
3
 
Figure 2-1. FT-IR spectra of model compounds 7 (thin film), 8 (KBr), and 3 (thin film) 
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N N
OO
P-7
N NH
O
P-8
N NMe
O
P-3
Cl
 
Figure 2-2. FT-IR spectra of P-Cl, P-7, P-8, and P-3 (KBr) 
FT-IR 
In general, FT-IR is best suited for the characterization of supported species since many 
functional groups are polar and give place to the appearance of strong absorption band. Figure 
2-2 shows FT-IR spectra of Merrifield resin and desired polymeric resin. Using the weak band at 
1265 cm-1 corresponding to the CH2-vibration, as no other bands interfere in this region, the 
polymer can be monitored through the disappearance of the 1265 cm-1 band and the new 
formation of the 1260 cm-1 band. Nevertheless, a few difference in wavelength value (△ l = 5 
cm-1) of the CH2-vibration band reduces an accuracy use of FT-IR technique for the reaction 
monitoring. 
 
Method 2?From N-methylimidazolidinone (10) 
In method 1, if all the derivatized sites on the polymer are not reacted, then undesirable side 
reactions can take place. The analysis of polymeric species is rather difficult and, their exact 
structure is not always known. 
The second method is the loading of N-methylimidazolidinone (10)12) (Scheme 2-4) onto a 
polymer in the last step. In this case purity of polymeric support could be expected to be higher. 
 
 10 
N NMe
OO
9
HN NMe
O
10
NaOMe
MeOH
N N
O
HN NH
O
Na
1. NaH, DMF
Cl
O
5
6
O
Scheme 2-4.  The synthesis of N-methylimidazolidinone (10)
rt, 3 h
2.
rt, 1 h MeI
rt, 3 h
(90.9%)
rt, 12-21 h
   (93.3%)
 
 
The condition used to load 10 onto polymer was optimized (Scheme 2-5, Table 2-3) and it was 
found that prolonged sonication for 7-14 d in an ultrasonic apparatus caused good conversion, 
analyzed by elemental analysis (entries 2 and 3). 
 
O
N NMe
P-3
Cl
NaH, DMF
HN NMe
O
10
Scheme 2-5.  The loading of 10 onto Merrifield resin (P-Cl)
))), 7-14 days
(P-Cl)
 
Table 2-3. The conditions used for the synthesis of P-DMI (P-3) 
 
entry conditions
% element
% conversion1)
1 stirred at rt for 24 h
C H N O Cl
- - - - 0.14 97.9
2 sonicated for 7 d - - - - 0.09 98.6
3 sonicated for 14 d 84.3 7.4 4.6 - 0.08 98.8
P-Cl 85.6 7.1 0.4 - 6.6 -
 
1) Calculated by ion chromatography of chloride.  
   Elemental analysis showed that the content of N-methylimidazolidinone units in the P-DMI 
under condition in entry 3 (Table 2-3) were very close to the calculated value, for chorine atom. 
   This result indicates that the alkylation process of N-methylimidazolidinium salt grafted onto 
the polymer backbone is taking place with high efficiency. This resin is also confirmed the 
functional group by solid 13C-NMR (Figure 2-3). 
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(a)
(b)
(c)
P-Cl
P-3
3
 
Figure 2-3. Solid 13C-NMR spectra of (a) P-Cl and (b) P-DMI (P-3, from method 2) (CP-MAS 
method: neat, spin rate 6500 Hz, scan times 10000, rt) and 13C-NMR spectra of   
(c) a model compound in solution phase (100 MHz, CDCl3). 
 
Solid 13C-NMR  
In the solid 13C-NMR spectra, the chloromethyl carbon signal in the starting polymer (P-Cl) 
appears at 45 ppm. After the reaction was complete (under condition in entry 3, Table 2-3), new 
broad resonances attributed to the imidazolidinone skeleton appeared at 32 (NCH3) and 161 
(C=O) ppm.13) It is worth pointing out that these chemical shifts are fully coincident with the 
ones observed in the solution for the model compound 7. The signals in region of 30 to 50 ppm 
were significantly overlapped with the polymer backbone signals and it is difficult to distinguish 
between the starting polymer (P-Cl) and target polymer (P-3) in that region (Table 2-4).  
Table 2-4. Peak assignment in the solid 13C-NMR of P-Cl and P-DMI (P-3)  
polymer chemical shift (d) (ppm) No. of carbon 
P-Cl 
 
 
 
41 
45 
128 
146 
1, 2, 7, 8 
13 
4, 5, 6, 10, 11 
3, 9, 12 
 
P-3 
 
 
 
32 
41  
45 
128 
146 
161 
23 
1, 2, 14, 15  
20, 21, 22 
4, 5, 6, 17, 18 
3, 16, 19 
24 
  
 
 
 
 
 12 
1
2
3
44
5 5
6
78
9
1010
11 11
12
Cl 13
1
2
3
44
5 5
6
N
Me
N
O
1415
16
1717
18 18
19
20
21
22
23P-Cl
P-DMI (P-3)
24
 
 
2.2 Synthesis and Characterization of Polymer-supported DMC 
Benzene is usually used as solvent in this laboratory. We followed the reaction condition for 
chlorination step of imidazolidinones including DMI (1) (Table 2-5). In the case of 3 (entry 3), 
chlorination was performed in 89.3%. Next, the solvent-free condition, which always gives a 
higher percentage of conversion for a short reaction time, was further examined (entry 4). The 
results showed that 3 necessarily has to use a longer reaction time than DMI (1) and 
1,3-dimethyl-4,5-diphenylimidazolidinone (11).   
Table 2-5. The conditions used for the chlorination of imidazolidinone derivatives  
(COCl)2 5.0 Meq
Cl
Cl
N NMe
O
N NMe
  solvent,
temp, time2R R2 2R R2
  1: R1= Me, R2= H
  3: R1= CH2Ph, R2= H
11: R1= Me, R2= Ph
  2: R1= Me, R2= H
  4: R1= CH2Ph, R2= H
12: R1= Me, R2= Ph
R1 R1
  
entry SM solvent temp (oC) time (h) % conversion1) 
1 
 
1 benzene 80 9 9514) 
2 
 
3 
 
4 
11 
 
3 
 
3 
benzene 
 
benzene 
 
- 
75 
 
75 
 
63 
9 
 
24 
 
26.5 
91.5 
 
89.3 
 
93.5 
1) Estimated by 1H-NMR (400 MHz).  
Therefore, chlorination of P-DMI (P-4) with oxalyl chloride in solvent-free condition gave 
slightly more the percentage of conversion than in benzene (Table 2-6). Although the full 
characterization of P-4 was not successful because of its partial regeneration to P-3 with 
moisture during purification, the conversion can be easily estimated to be 80-90% by FT-IR, in 
which a strong carbonyl band at 1700 cm-1 in P-3 was reduced and, instead, an iminium band at 
1627 cm-1 was newly born in P-4 (Figure 2-4). 
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Table 2-6. The conditions used for the chlorination of P-DMI (P-3) 
 
(COCl)2 Cl
Cl
N NMe
P-4
O
N NMe
P-3
  solvent,
temp, time
PF6
Cl
N NMe
P-12
NH4PF6
H2O
  
entry P-3 (mg) (COCl)2 (ml) solvent (ml) temp (oC) time (h) % conversion1,2) 
1 
 
296.0 2.0 - 63 35 98 (91) 
2 
 
141.5 0.5 CH2Cl2 2.0 40 24 85 (81) 
3 
 
4 
300.1 
 
984.1 
3.0 
 
1.5 
- 
 
benzene 10 
40-503) 
 
75 
48 
 
27 
90 (85) 
 
88 (84) 
1) Estimated by FT-IR (area). 2) Parentheses show the data calculated by using DMC calibration curve.  
3) Ultrasonic apparatus.  
Attemp to convert the chloride salt (P-4) to hexafluorophosphate salt (P-12), a more stable 
intermediate, failed. 
 
C=O
C=O
C=N
P-Cl
P-3
P-4
 
Figure 2-4. FT-IR spectra of P-DMI (P-3) and P-DMC (P-4) 
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To test quantitative estimation of the conversion by FT-IR technique, we calibrated a commercial 
available DMC (2) with variety of purity, which were prepared by exposure of 2 with moisture 
for some time in air, using 1H-NMR spectra (Table 2-7).   
Table 2-7. The percentage of conversion of DMC (2) to DMI (1)  
entry time1)(h) % DMC in a crude mixture
2) 
by 1H-NMR     by FT-IR3) 
1 0 91            97 
2 9 87            92 
3 
4 
30 
40 
66            67 
48            46 
5 50 28            29 
1) Time for DMC to react with moisture in air at 10-18 oC.  
2)  Integration area ratio between DMC and DMI. 
3) Averaged from double measurements (CDCl3).  
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Figure 2-5. The relationship between integration area ratio of DMC (2) and DMI (1) 
using 1 H-NMR (CDCl3) and FT-IR technique (CDCl3) 
 
From Table 2-7, FT-IR technique could be used as a standard for estimation of conversion of 
DMC (2) to DMI (1). 
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2.3 Applications of Polymer-supported DMC 
We examined the ability of P-DMC (P-4) as a dehydrating agent. P-4 was prepared in situ 
from P-DMI (P-3) by chlorination with oxalyl chloride because of its instability to moisture. The 
purity of a crude P-4 was estimated by disappearance of the carbonyl band in the starting P-3 in 
the FT-IR spectra. Solution-phase reaction using DMC (2) itself was also carried out. 
 
Esterification 
At first, we examined esterification of hindered components such as pivalic acid or tert-butyl 
alcohol (Table 2-8). In accordance with the results in solution, 9) effective and clean conversion 
was observed in both cases (entries 2 and 4). In these reactions P-DMI (P-3) could be easily 
recovered from the reaction mixture. Esterification using the recovered P-3 after successive 
washings with H2O, MeOH, and CH2Cl2 afforded a product with the same effectivity (entry 5). 
We also observed that P-DMI (P-3) was active even in the third cycle reaction (entry 6).  
 
Table 2-8. Esterification under either homogeneous (with 2) or heterogeneous (with P-4) 
conditions1) 
2 or P-4R1COOH    +   R2OH
  (1 Meq)  (1 Meq)
R1COOR2  +  1 or P-3
 
entry R1 R2 2 or P-42) yield (%)3) 
1 
 
2 
 
t-Bu 
 
t-Bu 
Ph(CH2)3 
 
Ph(CH2)3 
2 
 
P-4 
86 
 
82 
3 
 
Ph(CH2)2 t-Bu 2 86 
4 
 
Ph(CH2)2 t-Bu P-4 80 
5 
 
6 
Ph(CH2)2 
 
Ph(CH2)2 
t-Bu 
 
t-Bu 
P-4 
 
P-4 
814) 
 
815) 
1) Heterogeneous reactions were performed in CH2Cl2 in the presence of NEt3 (3-5 Meq) at rt for 48 h.  
2) Using 2 (1 Meq) or P-4 (1.3-1.5 Meq), the latter was prepared in situ from P-3.  
3) Isolated yield based on carboxylic acid used.  
4) Used a recycled polymer from entry 4. 5) Used a recycled polymer from entry 5. 
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Amidation 
Next, heterogeneous amidation including peptide synthesis was attempted in comparison with 
the reactions under homogeneous conditions (Table 2-9). Treatment of benzoic acid with aniline 
in the presence of P-DMC (P-4) under the same heterogeneous conditions in Table 2-8 gave an 
amide in 82% yield (entry 2) as well as in the homogeneous reaction (entry 1). Slightly increased 
yield (86%) was obtained when the heterogeneous reaction was carried out at 40 oC. But reaction 
under heating led to the formation of the corresponding polymer-bound guanidine, which can be 
estimated in ca. 15% yield by FT-IR, as a side product15). 
 
In peptide coupling, 2-chloro-1,3-dimethylimidazolinium hexafluorophosphate (CIP)16), the 
counter anion substitute of DMC (2), is an established reagent due to its efficiency and the low 
degree of epimerization compared to the use of the classical carbodiimide coupling method. 
Thus, we applied both reagents of 2 and P-4 to three representative couplings17) between an 
N-protected amino acid and an O-protected amino acid such as Cbz-Gly-OH and L-Phe-OEt, 
Cbz-Phe-OH and L-Pro-OMe, and Cbz-Trp-OH and L-Pro-OMe respectively, as shown in Table 
2-9. Smooth reactions were observed under homogeneous conditions (entries 3, 5-7, and 9-10), 
as expected, and practically no epimerization was observed (entries 6, 7 and 10), even in the use 
of a phenylalanine derivative (Cbz-Phe-OH) as an acid component. Treatment of Cbz-Gly-OH 
and L-Phe-OEt in CH2Cl2 with an insoluble P-DMC (P-4) led to a clean reaction affording the 
desired peptide with the same effectivity (entry 4) as that in the homogeneous reaction (see entry 
3). Similar satisfactory results were obtained in the coupling reactions between either 
Cbz-Phe-OH (entry 8) or Cbz-Trp-OH (entries 11 and 12) and L-Pro-OMe. It was noteworthy 
that the reaction also proceeded with retention of configuration under these heterogeneous 
conditions and that P-DMC (P-4) acted as an effective dehydrating agent even at a lower 
temperature (2 oC). As a solvent, CH2Cl2 could be replaceable by DMF (entry 8). In the previous 
reports18), the epimerization of some peptide synthesis could be reduced by addition of HOBt; 
however, no positive effects of this additive (1 Meq) was observed in the coupling of 
Cbz-L-Phe-OH and L-Pro-OMe, instead lowering the chemical yield (64%) (data not shown). 
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Table 2-9. Amidation including peptide synthesis under either homogeneous (with 2) or  
heterogeneous (with P-4) conditions.1)  
2 or P-4R1COOH    +   R2R3NH
(1 Meq) (1 Meq)
R1CONR2R3  +  1 or P-3
 NEt3 (or pyridine)
 CH2Cl2 (or DMF) 
entry R1CO R2R3NH      2 or P-4 temp (oC) time (h)  yield 2) 
(%) 
1           2 20 24 90 
 PhCO PhNH2     
23)   P-4 20 (40) 48 (24) 82 (86) 
       
3   2 20 7 75 
 Cbz-Gly L-Phe-OEt     
4   P-4 20 24 72 
       
54) Cbz-DL-Phe  L-Pro-OMe 2 20 7 85 
       
6   2 20 2 83 
75) Cbz-L-Phe L-Pro-OMe 2 2 (2) 2 (2) 80 (76) 
86)   P-4 2 (2) 4 (4) 77 (73) 
       
9 Cbz-DL-Trp L-Pro-OMe 2 20 7 97 
       
10   2 20 2 95 
11 Cbz-L-Trp L-Pro-OMe P-4 20 4 90 
127) 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 P-4 2 (2) 4 (13) 86 (92) 
1) 1H-NMR (400 MHz) analysis of crude products in entries 6-8 and 10-12 indicated less than 2% of epimerization. 
2) Isolated yield. 3) Parentheses show the data on the reaction at 40 oC.  
4) The same result was obtained in the use of pyridine in place of NEt3.  
5) Parentheses show the data on the reaction in DMF.  
6) Parentheses show the data on the reaction for a longer time. 
 
In conclusion, it was clear that P-DMC (P-4) could effectively acted as a new and reusable 
polymer-supported dehydration agent, the preparation of which was summarized in Scheme 2-6, 
even in situ preparation from P-DMI (P-3) in the practical dehydration reaction. The general 
procedure for the heterogeneous reaction using P-4 is given in Scheme 2-7. 
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Scheme 2-6. Conclusion of the possible pathways used in the synthesis 
of polymer-supported DMI and DMC 
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Scheme 2-7. General procedure for heterogeneous dehydrations
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Chapter 3: Polymer-supported Chiral Guanidines 
 
The asymmetric synthesis of a-amino acids was first introduced by O’Donnell et al. in 
198919), used the liquid/ liquid phase-transfer catalyzed asymmetric alkylation of N-diphenyl 
methyleneglycine tert-butyl ester with the aid of N-benzyl or O-alkyl cinchona alkaloid salts as 
phase-transfer catalysts (PTC). Following by Lygo et al.20) and Corey et al.,21) they reported a 
modification of these PTC in which a 9-anthracenylmethyl group was introduced as a unit for 
masking the nitrogen, leading to substantially improve enantiomeric excess up to 95% (Figure 
3-1).  
N
R'
N
H
HO
H
X
N
R'
N
H
RO
H
X
N
R'
N
H
HO
H
X
First generation
by O' Donnel et al.
Second generation
by O' Donnell et al.
Third generation
by Lygo et al. and Corey et al.
R= ally
R'= H, OMe
13 14 15
Figure 3-1. The generation of cinchona alkaloid phase-transfer catalysts.  
 
Guanidines and their chiral derivatives, as a strong organic base (pH 14), have been variously 
used as a catalyst for carbon-carbon bond formation. In 1999, Ma and Cheng examined an 
asymmetric Michael addition of the glycine imines with vinyl carbonyl compounds in the 
presence of several linear-type chiral guanidines instead of PTC, affording the best enantiomeric 
excess up to 30%22).  
Chiral guanidine (17), prepared from the corresponding urea (1,3-dimethyl-4,5-diphenylimi- 
dazolidin-2-one) (11)23) by chlorination to DMC-type key intermediate (16) and reaction with 
phenylalaninol (Scheme 3-1), efficiently catalyzed the asymmetric Michael reaction of a 
prochiral glycine derivative with acrylate or its related compounds either in solution or without a 
solvent, leading to enantiomeric excess up to 97%24) (Scheme 3-2). 
NMeMeN
N
OH
Ph
Ph
Ph
NMeMeN
O
PhPh
NMeMeN
Cl
PhPh
Cl
(COCl)2
benzene
reflux, 9 h
(91-95%)
H2N
OH
Ph
NEt3, CH2Cl2
rt, 6 h, (quant.)
11 16 17   
Scheme 3-1. The preparation of chiral guanidine (17) 
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Scheme 3-2. Michael addition of N-diphenyl methylene glycine tert-butyl ester with acrylate
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A further development in this field on a heterogeneous system has been reported a little, 
such as polymer-supported PTC of cinchona alkaloid25) (Scheme 3-3). Thus, we focused on 
polymer-supported chiral guanidines as heterogeneous chiral auxiliaries in asymmetric synthesis. 
 
Ph
Ph
N CO2tBu
BnBr
50% KOH aq, toluene
Ph
Ph
N Bn
CO2tBu
18 24
10 mol% 22 or 23
0 oC-rt, 12-96 h
26-80% (4-81% ee) 
 
N
R
N
H
HO
H
I
SPACER
R= allyl, H, OMe N
R
N
H
HO
HSPACER
22 23
+
I
 
 
  
Scheme 3-3. Alkylation of the prochiral glycine catalyzed by polymer-supported cinchona 
alkaloids 
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3.1 Synthesis of Polymer-supported Chiral Guanidine by Grafting 
 
For the studies on the polymer-supported chiral guanidine, we selected (R)-3-methyl 
4-phenylimidazolidin-2-one (33) as a basic function unit, in place of an expensive 1,3-dimethyl- 
4,5-diphenylimidazolidin-2-one (11) for chiral guanidine 17. It could be prepared from an 
inexpensive and commercially available phenylglycine (25) and anchored onto Merrifield resin 
(Scheme 3-4). 
NMeN
N
OH
Ph
Ph
NMeMeN
N
OH
Ph
Ph
Ph
NMeHN
O
Ph
H2N
OH
Ph
X
NH2HO
PhO
17 P-56
33
25
 
 
Scheme 3-4. Retro-synthesis of polymer-supported chiral guanidine (P-56) by grafting 
 
3.1.1 Synthesis of (R)-3-Methyl-4-phenylimidazolidin-2-one 
An achiral 3-methyl-4-phenylimidazolidin-2-one was basically prepared according to the 
reported methods26) (Scheme 3-5). Thus, reduction of (R)-phenylglycine (25) with LiAlH4 
followed by N-protection with Boc group gave a protected amino alcohol (27). After mesylation 
substitution with NaN3 afforded a protected azide (29). Replacement of Boc group in 29 to 
formyl function was performed by deprotection with TFA followed by formylation with a mixed 
anhydride between acetic anhydride and formic acid.  
 
THF
LiAlH4
NaN3,  DMF
THF
LiAlH4
NHBocN3
Ph
NHMeH2N
Ph
NH2HO
Ph
TFA, CH2Cl2
Boc2O
CH2Cl2
CDI
NH2N3
Ph
NMeHN
O
Ph
NHBocHO
Ph
Ac2O, HCO2H
MsCl, NEt3
   CH2Cl2
NHBocMsO
Ph
NHCHON3
Ph
reflux, 17 h
 (78.9%)
1N NaOH aq
     rt, 12 h
    (89.3%)
reflux, 15 h,  
    (99.0%)
80 oC,  3 h
  (82.4%)
  rt, 1 h
 (quant.)
[a]D23 - 48 (c 1.25, MeOH)
25
 rt, 18 h
 (95.1%)
26 27 28
29 30 31
32 33
0 oC, 40 min
    (94.4%)
rt, 2 h
(quant.)
  
Scheme 3-5. 
 
Reduction of N-formylazide (31) with LiAlH4 gave (R)-N-methyl-1-phenylethane-1,2-diamine 
(32)28) as a precursor for a desired imidazolidinone (33). In this route 33 was given in overall 
52% yield through 8 steps and its [a]D23 -48 (MeOH).  
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During these synthetic studies, we tried to examine other possible pathways. Direct 
conversion of the N-Boc group of 29 to methyl group by reduction with LiAlH4 resulted in the 
formation of mixture containing an expected 32 as a minor component (29%) (Scheme 3-6).  
Examination of the reaction mixture led to the isolation of an imidazolidinone (35)29) lacking an 
N-methyl group in 32%, which could be produced by intramolecular cyclization as shown in 
Scheme 3-6. Using the N-Cbz group instead of Boc group yielded also an undesired product 35.  
 
NH2HO NH-BocN3 NH-MeH2N
LiAlH4
THF
NHHN
O
Ph Ph Ph
Ph
HNH2N
Ph
O
O
O
ref 27)
low yield
side product
25 29 32
34
35
(29.0%)
(32.3%)  
Scheme 3-6.
This side reaction prompted us to utilize the reaction condition for preparation target compound 
(Scheme 3-7). Thus, 25 was treated with formic acid and acetic anhydride30) to give 36.
N-Methylphenylaminoethanol (37)30) was prepared by the 
reduction of compound 36 and the secondary amine group 
was protected by (Boc)2O to give 38. But trial for  
mesylation leading to an azide group failed, instead 
intramolecular cyclization to oxazolidine (41) was formed  
NMeBocN3
Ph
NMeHN
O
Ph
40 33  
Scheme 3-7. 
as a sole product31) (Scheme 3-8). Interestingly, from the above results, the N-Boc group is able 
to react intramolecularly with both nucleophiles and electrophiles, provided that they are in its 
vicinity.  
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Me
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Scheme 3-8. 
 
Short course synthesis of N-formylazide (31) was attempted. Although the steps could be 
reduced into 3 steps, the chemical yield of azidation of 43 was so low (Scheme 3-9). 
 
NH2HO
Ph
HCO2Et
NHCHOHO
Ph
   CH2Cl2
MsCl, NEt3
NHCHOMsO
Ph
NaN3,  DMF NHCHON3
Ph0 
oC, 20 min
    (87.8%)
80 oC,  2.5 h
    (38.0%)26 42 43 31
rt, 24 h
(89.2%)  
Scheme 3-9. 
 
We also tried an alternative synthesis of the N-methylimidazolidinone (33) through an 
N-formylamide (48). The amide 48 was prepared by using a non-racemization azide method28) 
(Scheme 3-10). Esterification of 25 was accomplished by methanol and thionyl chloride to give 
44, which was converted to the free base and reacted with formic acid and acetic anhydride to 
produce the formyl methyl ester 45. The hydrazides 46 obtained from the reaction of hydrazine 
in methanol with 45 are readily transformed into the activated azide by generating nitrous acid in 
aqueous acetic acid solution. The azide 47 was extracted with cold ether and immediately 
subjected to aminolysis affording 48 in 77% yield with a little lower of optical purity than the 
reported value {[a]D23-177 (c 0.93, MeOH); lit.28) [a]D -185 (c 1.08, MeOH)}. 
 
NH2HO
PhO
NH2. HClMeO
PhO
NH-CHOMeO
PhO
NH-CHOH2NHN
PhO
NH-CHON3
PhO
NH-CHOH2N
PhO
SOCl2
MeOH
reflux, 3 h
rt, 9 h
(quant.)
1. NEt3, CH2Cl2
    0 oC to rt, 10 min
2. Ac2O, HCO2H
    0 oC, 30 min
         (82.7%)
rt, 5 h
(92.2%)
NaNO2, AcOH
    1 N HCl
-5 oC, 4 h
NH3 (g)
rt, 19.5 h
(77.0%)
25 44 45
46 47 48
[a]D23 - 177 
(c 0.93, MeOH)
H2NNH2. H2O
     MeOH
 
Scheme 3-10. 
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Corey et al.33) reported effective aminolysis of phenylglycine methyl ester hydrochloride (44) 
to give an amide 49 with [a]D –103 (EtOH). Shibasaki et al.34) also prepared 49 with high optical 
purity by application of asymmetric synthesis (Scheme 3-11). Selected preparation methods of 
amide derivatives and their [a]D data are given in Table 3-1. 
 
Ph
NHH
CN
HCl (g)
HCO2H
rt, 1h
(100%)
95% ee
Ph
NHH
CONH2
DDQ, THF
3 oC, 1 h
Ph
NH
CONH2
1. N HCl, 3 oC, 5 min
2. Amberlyst A-21, MeOH
                91%, 98% ee
49
 
Scheme 3-11. 
 
Table 3-1. The conditions for the synthesis of 48 and 49  
products entry  reagents/ conditions [a]D 
 
 
NH2H2N
PhO
49  
 
1 
2 
 
3 
4 
NH3 (g), EtOH, rt, 14 d 
NH3 (g), MeOH, 0 oC, 3 h,  
22 oC, 16 h  
see Scheme 3-8 
NH3 (g), MeOH, -2 oC, 15 h, 
7 oC, 9 h 
-42.0 (c 0.51, EtOH)32) 
-103 (c 0.51, EtOH)33) 
 
-108.5 (c 1.26, EtOH)34) 
-112.5 (c 1.02, EtOH) 
 
 
NH-CHOH2N
PhO
48  
 
 
5 
6 
 
Azide method 
formamide, 150 oC, 15 min 
 
-185 (c 0.58, MeOH)28) 
-19.3 (c 0.41, MeOH)32) 
 
We followed the Corey’s method at lower temperature (Scheme 3-12). An amide (49) was 
obtained in 85% yield with high optical purity (see Table 3-1, entry 4). 
 
NH2MeO
PhO
NH2H2N
PhO
Ac2O, HCO2H
NMeHN
O
Ph
THF
LiAlH4 NHMeH2N
Ph
NHCHOH2N
PhO
44' 49 48
NH3(g)
MeOH
-2 oC, 15 h
 7 oC, 9 h
   (84.9%, from 44)
0 oC, 30 min
     (quant.)
reflux, 21 h,  
    (82.0%) [a]D23 - 51.2 (c 1.25, MeOH)
32 33  
 
Scheme 3-12. 
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Further formylation of this compound with formic acid and acetic anhydride to produce 
chiral diamide 49 with high yield and excellent in the optical rotatory encourage us to continue 
reduction and cyclization as same as method in Scheme 3-5 affording the desired product 33 in 5 
steps, total yield 66% from 25 with [a]D23-51.2 (c 1.25, MeOH). Related chiral imidazolidin-2- 
ones are shown in Figure 3-2.  
 
NHMeN
O
    [a]D23 -33 
(c 1.0, MeOH)35)
Ph
NHHN
O
  [a]D23 -35 
 (c 0.5, H2O)29)
Ph
NHHN
O
    [a]D23 +58.6 
 (c 1.06, CHCl3)36)
PhPh
NMeMeN
O
    [a]D23 +41.8 
  (c 1.0, CHCl3)37)
PhPh
   
Figure 3-2. Known chiral imidazolidin-2-one derivatives with reported [a]D 
 
3.1.2 Anchoring (R)-3-Methyl-4-phenylimidazolidin-2-one onto Polymer 
 
Cl I
I
NaH, DMF
   ))), 2 d
NaI, acetone
50 oC, 48 h
NMeHN
O
Ph
NMeN
O
Ph
P-Cl P-I
33 P-53  
Scheme 3-13. 
The immobilization of chiral imidazolidinone 33 onto polymeric support was carried out 
using the same general strategy as described in the preparation of P-DMI. However, in this case, 
to reduce the reaction time, an iodomethylpolystyrene-divinylbenzene resin,25) prepared from 
Merrifield resin, was used as the alkylating agent (Scheme 3-10). A quantitative transformation 
of polymeric functional groups was achieved as shown by the FT-IR. The spectrum of the 
resulting solid (P-53) showed the disappearance of the C-I band at 1150 cm-1, instead the C=O 
band at 1702 cm-1 was newly born.  
At first attempt to prepare polymer supported chiral guanidine, we used P-DMC (P-4) 
instead of P-54 to react with phenylalaninol in various solvents and conditions (Scheme 3-14, 
Table 3-2). The best conversion to P-55 is the sonication for 2 d in CH2Cl2 as solvent and NEt3 
or DIPA as base. 
Chlorination of P-53 with oxalyl chloride in benzene gave the desired P-54 (in 86% 
conversion) and further reacted with phenylalaninol in CH2Cl2 under sonication to give the 
desired polymer-supported chiral guanidine (P-56). The conversion of P-53 to P-56 could be 
estimated to be 79% by FT-IR. The reaction was monitored by FT-IR, in which a strong carbonyl 
band at 1702 cm-1 was reduced and a guanidine band at 1635 cm-1 was newly born. 
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Scheme 3-14. 
 
Table 3-2. The conditions used for the synthesis polymer-supported chiral guanidine P-55  
entry P-4 (mg)1)  solvent base (ml) conditions % conversion2,3) 
1 102.9 CH2Cl2 DIEA 0.12 rt, 24 h 48 
2 109.5 DMF DIEA 0.12 rt, 24 h 52 
3 105.2 CH2Cl2 collidine 0.45 ml rt, 60 h 23 
4 
5 
6 
108.7 
102.8 
102.7 
DMF 
CH2Cl2 
CH2Cl2 
DIEA 0.12 
NEt3 0.10 
DIEA 0.12 
80 oC, 24 h 
sonicate, 2 d 
sonicate, 2 d 
51 
87 
88 
1) Using a stored P-4 (85% conversion from P-3).  
2) Estimated by FT-IR (integration area ratio between C=N band and C=O band).  
3) Calculated from P-3. 
 
3.2 Synthesis of Polymer-supported Chiral Guanidines by Polymerization 
In the preparation of polymer-supported chiral catalysts, polymerization can be also provided 
and in this case better result, in the purity of catalyst, is expected than in grafting because of 
similar reactivities in solution. Thus, monomers 57, 61, and 62 were prepared as starting 
materials for polymerization. These monomers having vinylbenzyl group were prepared without 
any problems as shown in Scheme 3-15. 
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   rt, 24 h
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Scheme 3-15. 
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Either copolymerization of the monomers with styrene or their polymerization were 
examined (Scheme 3-16). Copolymerization of 61 with styrene initial molar ratio = 1: 4 afforded 
an insoluble polymer P-63, but the yield was low. To prepare soluble polymer supported 
guanidine, we adjusted the initial ratio of monomer 62 and styrene to 1: 37, as expected, 
affording a soluble P-64 in good yield. These P-64 and P-65 were characterized by elemental 
analysis.  
P-67 was prepared by successive reactions of copolymerization of monomer 57 with styrene, 
chlorination of the formed soluble P-65 with oxalyl chloride, and reaction with phenylalaninol to 
produce a soluble P-67. Overall conversion was estimated to be 75% by FT-IR.  
Next, polymerization of monomer 62 was examined after trial for polymerization of styrene 
itself (Scheme 3-16). Thus, polystyrene (P-68) and poly(chiral guanidine) (P-69) were prepared. 
The reaction conditions and results were summarized in Table 3-3. 
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Scheme 3-16. Synthesis of polymer-supported guanidines by polymerization 
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Scheme 3-16. Synthesis of polymer-supported guanidine by polymerization (continue) 
The structure of soluble polymer-supported guanidine (P-67) was analyzed by 1H-NMR with 
comparison of reaction intermediates (P-65 and P-66) and polystyrene (P-68) (Figure 3-3). 
However, the signals were quite broad and overlapped. Therefore, it is difficult to correctly 
estimate the conversion of P-65 to P-66 and P-67. Polymer-supported chiral guanidines (P-64 
and P-69) with a phenyl group as ring substituent were also analyzed by 1H NMR using a model 
compound (71) prepared from DMC derivative (70) as shown in Scheme 3-17 (Figure 3-4). 
Related signals between P-69 and 71 were observed even signal broadening in P-69. 
Table 3-3. Reaction condition and result of polymerization  
entry polymer  
products 
conditions 
monomer    styrene   AIBN    porogen 
yield  
(%) 
[a]D23 
in CHCl3 
1 P-63 61 :  1        4       0.3       mix1) 11.72) - 
2 P-64 62 :  1       37       0.3     benzene 84.03) -0.28 (c 4.4) 
3 P-65 57 :  1        5.5     0.05     toluene 69.23) - 
4 P-68 -        only     0.04     toluene 96.4 - 
5 P-69 62 : only       -       0.2     toluene 92.93) -35.7 (c 2.4) 
1) (1: 1) benzene-toluene. 2) Characterized by FT-IR. 3) Analyzed by elemental analysis.  
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Figure 3-3. 1H-NMR spectra (400 MHz, CDCl3) of P-68, P-65, P-66, and P-67 
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Figure 3-4. 1H-NMR spectra (400 MHz, CDCl3) of P-68, P-64, P-69, and 71. 
 
 
NMeN
N
Ph
OH
Ph
Ph
a model compound 71
N NMe
Cl
Ph
Cl
Ph
70   
Scheme 3-17. Preparation of a model compound 71  
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3.3 The Reactivity of Polymer-supported Chiral Guanidines 
As mentioned above in our laboratory, it had been observed that chiral guanidine 17 
effectively catalyzed the asymmetric Michael reaction of tert-butyl diphenyliminoacetate (18) 
with methyl vinyl ketone (19b) either in THF solution or without a solvent under mild conditions 
(Scheme 3-2). These results led us to further examine the reaction using chiral guanidines 
prepared by us (Table 3-4). At first we followed the reaction in the presence of 17 according to 
the reported conditions (in THF) and obtained the same results (entry 3). On the other hand in the 
use of 71,38) as a model compound for polymer reagents, it showed that both chemical yield and 
asymmetric induction were lowered considerably than using 17 (entries 4-6). 
Polymer-supported guanidines P-63, P-64, and P-67 (from polymerization) and P-56 (from 
grafting) were further used as catalysts for this reaction. The results of the reaction were shown 
in Table 13. A heterogeneous mixture of the two components containing an insoluble P-56, P-63, 
and P-67 was simply stirred at 20-80 oC for 3 to 7 days but no reaction or trace was observed 
(entries 7-10, 11, and 16). The use of a soluble P-64 and P-69 resulted in better yield (entries 
12-15, 17, and 19) than the former heterogeneous catalyst, P-67 (entry 16). However, they 
showed in lowering both chemical and stereochemical yields compared to the homogeneous 
catalysts 17 and 71, even with the longer reaction time.  
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Ph
Ph
N CO2
tBu COMe
Ph
Ph
N COMe
CO2
tBu
catalyst
solvent, condition
18 19b 20b  
 
Table 3-4. Michael addition under either homogeneous or heterogeneous conditions  
entry catalyst C/ S1,2) solvent conditions yield3) (%) ee5) (%) 
1 17 0.2 THF 20 oC, 6 d 904) 964) 
2 17 0.2 - 20 oC, 15 h 904) 804) 
3 17 0.2 THF 40 oC, 7 d 91 89 
4 71 0.2 THF 20 oC, 7 d 75 74 
5 71 0.2 - 20 oC, 1 d 79 54 
6 
7 
8 
9 
10 
11 
12 
 
 138) 
14 
15 
16 
17 
18 
19 
71 
P-56 
P-56 
P-56 
P-56 
P-63 
P-64 
 
P-64 
P-64 
P-64 
P-67 
P-69 
P-69 
P-69 
0.2 
10 
30 
30 
30 
2.1 
2.4 
 
9.1 
9.2 
10 
10 
0.5 
2.0 
2.0 
THF 
CHCl36) 
CHCl36) 
THF6) 
CHCl36) 
THF6) 
THF7) 
 
-6) 
THF7) 
THF7) 
THF7) 
THF7) 
THF7) 
CHCl37) 
40 oC, 7 d 
20 oC, 7 d 
40 oC, 7 d 
80 oC, 3 d 
sonicate, 7 d 
80 oC, 3 d 
25 oC, 9 d 
40 oC, 4 d 
25 oC, 21 d 
25 oC, 21 d 
80 oC, 3 d 
80 oC, 3 d 
40 oC, 7 d 
40 oC, 7 d 
40 oC, 7 d 
83 
trace 
trace 
trace 
trace 
12 
32 
 
48 
45 
51 
19 
19 
39 
19 
60 
- 
- 
- 
- 
- 
45 
 
43 
48 
31 
- 
28 
12 
24 
1) Molar ratio of the catalyst (C, 17 or 71) relative to substrate (S, 18).  
2) Weight ratio of catalyst (C, P-56, P-63, P-64, P-67or P-69) relative to substrate (S, 18). 
3) Isolated yield. 4) The results from previous report. 24)  
5) Determined by HPLC (DAICEL CHIRALCEL OD-H).  
6) The heterogeneous reaction mixture. 7) The homogeneous reaction mixture. 8) Using 19b 30 Meq. 
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3.4 Mechanistic Consideration for Michael Reaction Catalyzed by Polymer- 
supported Chiral Guanidines 
 
Comparison of chiral guanidines 17 and 71  
For chiral guanidine 17, it was previously investigated by Araki and co-workers.24) Steric 
requirement was pointed out as the most importance stereodifferentiating factor. The following 
features are described in the transition state characteristic: 
(a) The chiral guanidine catalyst abstracts a proton from 18, whereas the hydroxyl group of 
the chiral guanidine hold 18 by hydrogen bond and orbital-orbital interaction between 
phenyl groups occur to give an intermolecular complex (Figure 3-5).  
(b) The configuration of three chiral centers of the catalyst is very importance for 
asymmetric. An enolate complex of 18 with chiral guanidine should be attacked by 19b 
from the phenyl its si-face to yield an (S)-excess of 20b. 
On the other hand, for chiral guanidine 71 having only one phenyl group is not restricted 
to a preferred conformation. Therefore, one of three chiral centers in the transition state 
complex, orbital-orbital interaction, is loosen to lead relatively lower enantioselectivity. 
 
On polymer-supported chiral guanidines P-64 and P-69 
It is well known that results obtained in an enantioselective transformation can dramatically 
change when going from homogeneous to heterogeneous phase. The reason for these phenol- 
mena is unclear at present, but at least the result cannot be attributed to spontaneous reaction in 
the presence of polymeric matrix. It should be considered that not all functional groups of 
polymer-supported catalyst are solvent-accessible, due to steric effect that results in the reduction 
of the catalytic ability.   
The transition state using our polymer catalysts could be also supposed like homogeneous 
reaction using 71 (Figure 3-6). The transition state in the reaction catalyzed by P-69, comparable 
to P-64, is so crowded with neighbouring active functional groups that cause both of chemical 
yield and enantiomeric excess to be poor. 
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Possible orientation in the transition states 
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H
CH2=CHCOMe
H
Figure 3-5. The transition state using the chiral guanidine 17-catalyst
R= Ph, polymer backbone
Figure 3-6. The transition state using the chiral guanidine 71, P-64,                        
and P-69-catalysts
N
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Chapter 4: Conclusion 
 
Polymer-supported DMI and DMC 
1. Two methods for the synthesis of P-DMI (P-3) were explored. The first method (method 
1) is faster and without solution steps or purifications. But, if all the derivatized sites on the 
polymer are not reacted, then undesirable side reactions could take place. The second method 
(method 2) operated in one step and gave polymer-supported product with good purity. 
2. P-DMI (P-3) is analyzed by elemental analysis and confirmed the functional group by 
FT-IR and solid 13C-NMR. Although the full characterization of P-DMC (P-4) was not 
successful because of its partial regeneration to P-3 with moisture during purification, the 
conversion can be easily estimated by FT-IR. 
3. P-DMI (P-3) could be used as a recyclable reagent in dehydration reaction because of 
easy conversion to a reactive P-DMC (P-4) in situ, P-3 can be stored at room temperature with 
retention of its original activity.  
4. The use of this heterogeneous agent makes product isolation easier than the usual 
solution phase, and is, of course, advantageous in an economical and environmental sense due to 
reusablility. 
 
Polymer-supported chiral guanidines 
1. Polymer-supported chiral guanidine was first synthesized by grafting chiral imidazolidi- 
none (33) onto Merrifield resin, and further reaction in 2 steps to give the desired an insoluble 
polymer-supported chiral guanidine which was characterization by FT-IR. 
Polymerization of the corresponding vinylbenzyl monomer of 33 with or without styrene 
gave, in this case, gave a better result, purity of catalyst, than grafting. In 1H NMR technique 
could be characterized all of soluble polymers, but the signals were quite broad and overlapped. 
Therefore, their exact structure is unclear at present. 
2. The asymmetric Michael reaction of tert-butyl diphenyliminoacetate (18) with methyl 
vinyl ketone (19b) catalysed by insoluble polymer-supported chiral guanidine P-56, P-63, and 
P-67 or soluble polymer-supported chiral guanidine P-64 and P-69, results in lower chemical 
yield and stereochemical yield than by soluble homogeneous phase catalysts 17 and 71.  
3. Due to the low reactivity of polymeric catalysts, the reaction has to operate for a long time 
that could be lead polymer backbone beak to powder. 
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Chapter 5: Experimental Section 
 
Instrumentation 
Analytical thin layer chromatography (TLC) was performed on Merck silica gel 60 F254 and 
Fuji silysia NH-silica gel 60 F254 glass plates precoated with a fluorescent indicator. Column 
chromatography was performed using silica gel 60 (63-210 mm) from Kanto-Cica or NH-silica 
gel (100-200 mesh) from Fuji silysia. Melting points were measured on a Yanaco micro melting 
point apparatus and were uncorrected. HPLC was performed on a Jasco Gulliver-series 
instrument equipped with a variable wavelength detector and Daicel Chiracel OD-H or AD-H 
column. Optical rotations were measured on a Jasco P-1020 polarimeter with a sodium lamp, and 
were reported as follows: [α]DTemp (oC) (c g/ 100 ml, solvent). IR spectra were recorded as a thin 
film between NaCl plates, KBr plates or ATR method on a Jasco FTIR 300E spectrophotometer. 
1H NMR spectra and 13C NMR spectra were recorded on a JOEL JNM-ECP400 (solution phase) 
and JEOLJMN-LA400S (solid phase) spectrometer. Chemical shifts for protons and carbons 
were reported in part per million (ppm) downfield from tetramethylsilane and were calibrated at 
d 0.00 and 77.00 ppm). Data were presented as follows: chemical shift, multiplicity (br= broad, 
s= singlet, d= doublet, t= triplet, m= multiplet), coupling constants in Hertz (Hz) and integration. 
Low resolution mass spectra were obtained on a JOEL JMS-AX 500-505 and high resolution 
mass spectra were obtained on a JOEL JMS-HX110A. 
 
THF was distilled from sodium/ benzophenone under an atmosphere of argon. 
DMF and MeCN was distilled from calcium hydride. 
MeOH was distilled from calcium oxide, or magnesium metal. 
NEt3 was distilled from potassium hydroxide. 
CHCl3 was distilled from phosphorus pentoxide. 
Commercially available dry CH2Cl2 is used. 
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Polymer-supported DMI and DMC 
 
Synthesis of polymer-supported DMI 
Model compounds 
1-Benzyl-3-propionylimidazolidin-2-one (7) (Scheme 2-2) 
 
NHHN
O
Cl
O
BrPh
NN
O O
Ph
1. NaH, DMF
2.
3.
5 7  
To a suspension of NaH (60% in mineral oil, 1.59 g, 39.8 mmol, 2.20 Meq) and imidazolidinone 
(5) (1.55 g, 18.0 mmol, 1.00 Meq) in DMF (14 ml) under an argon atmosphere which was stirred 
at room temperature for 1 h was added propionyl chloride (1.57 ml, 18.1 mmol, 1.01 Meq) 
dropwise at 0 oC, and stirred at room temperature for 3 h. After addition of benzyl bromide (2.80 
ml, 23.5 mmol, 1.31 Meq) at 0 oC, the reaction mixture was further stirred at room temperature 
for 23.5 h. The reaction was quenched by the addition of H2O (50 ml), and the organic materials 
were extracted with AcOEt (100 ml x 2), then the organic phase was washed with H2O (100 ml x 
5), brine (100 ml x 2), dried over MgSO4, and evaporated. Purification of the residue by silica 
chromatography (n-hexane/ AcOEt= 10: 1 to 3: 10) yielded the desired product (7) (4.01 g, 
95.9%). 
7: pale yellow oil; IR (thin film): nmax 1725 and 1679 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): 
d (ppm) 1.18 (3H, t, J=7.6 Hz, CH2CH3), 2.99 (2H, q, J=7.6 Hz, CH2CH3), 3.29 (2H, dd, J=8.0, 
8.0 Hz, CH2CH2), 3.81 (2H, dd, J=8.0, 8.0 Hz, CH2CH2), 4.44 (2H, s, PhCH2), 7.26-7.38 (5H, m, 
PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 8.26, 28.20, 39.00, 39.87, 47.19, 127.34, 127.65, 
128.28, 135.39, 154.29, 173.93; LRFABMS m/z: 233 (MH+, 100%). 
 
1-Benzylimidazolidin-2-one (8) (Scheme 2-3) 
 
NN
O O
Ph
7
NHN
O
Ph
8
THF-MeOH (4 : 1)
NaOMe
 
To a benzyl propionylimidazolidinone (7) (2.42 g 10.4 mmol, 1.00 Meq) was added a 
THF-MeOH solution (4: 1, 50 ml) of NaOMe (4.66 g, 86.3 mmol, 8.30 Meq) dropwise at 0 oC, 
and stirred at room temperature for 4 h. The reaction was quenched by the addition of H2O (50 
ml), and the organic materials were extracted with AcOEt (50 ml x 2), then the organic phase 
was washed with H2O (50 ml x 2), brine (50 ml x 2), dried over MgSO4, and evaporated. 
Purification of the residue by silica chromatography (n-hexane/ AcOEt= 10: 1 to 1: 10) yielded 
the desired product (8) (1.80 g, 98.0%). 
8: colorless prisms, mp 178-179 oC (lit.39) mp 180 oC); IR (KBr): nmax 3237 cm-1 (NH), 1686 
cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 3.29-3.42 (4H, m, CH2CH2), 4.38 (2H, s, 
 39
PhCH2), 4.49 (1H, brs, NH), 7.26-7.36 (5H, m, PhH). 
 
1-Benzyl-3-methylimidazolidin-2-one (3) (Scheme 2-3) 
 
NHN
O
Ph NMeN
O
Ph
38
1. NaH, DMF
2. MeI
 
To a suspension of NaH (60% in mineral oil, 665.5 mg, 16.6 mmol, 2.06 Meq) and 
benzylimidazolidinone (8) (1.42 g, 8.06 mmol, 1.00 Meq) in DMF (12 ml) under an argon 
atmosphere which was stirred at room temperature for 1 h was added methyl iodide (0.6 ml, 9.64 
mmol, 1.20 Meq) dropwise at 0 oC, and stirred at room temperature for 31 h. The reaction was 
quenched by the addition of H2O (20 ml), and the organic materials were extracted with AcOEt 
(50 ml x 2). Then the organic phase was washed with H2O (50 ml x 5), brine (50 ml x 2), dried 
over MgSO4, and evaporated. Purification of the residue by distillation (150 oC/ 7 mmHg) 
yielded the desired product (3) (1.45, 94.6%). 
3: colorless oil; IR (thin film): nmax 1690 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 2.83 
(3H, s, NCH3), 3.16 (2H, dd, J=8.0, 8.0 Hz, CH2CH2), 3.29 (2H, dd, J=8.0, 8.0 Hz, CH2CH2), 
4.37 (2H, s, PhCH2), 7.26-7.34 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 31.34 
41.97, 44.93, 48.36, 127.24, 128.02, 128.43, 137.19, 161.45; LRFABMS m/z: 191 (MH+, 100%). 
 
Synthesis of Polymer-supported DMI 
Method 1 
1-[4-Copoly(styrene-1%-divinylbenzene)]methyl-3-propionylimidazolidin-2-one (P-7) 
(Scheme 2-2) 
 
NHHN
O
Cl
O
Cl
NN
O O
1. NaH,  DMF
2.
3.5 P-7
 
To a suspension of NaH (60% in mineral oil, 229.8 mg, 5.75 mmol, 6.61 Meq) and 
imidazolidinone (5) (224.7 mg, 2.61 mmol, 3.00 Meq) in DMF (8.0 ml) under an argon 
atmosphere which was stirred at room temperature for 1 h was added propionyl chloride (0.23 ml, 
2.65 mmol, 3.05 Meq) dropwise at 0 oC, and stirred at room temperature for 3 h. After addition 
of Merrifield resin (500 mg, 0.87 mmol, 1.00 Meq) at 0 oC, the reaction mixture was further 
stirred at room temperature for 24 h. The reaction was quenched by the addition of H2O (10 ml). 
The polymer was filtered out, washed with MeOH (10 ml x 6), H2O (10 ml x 6), MeOH (10 ml x 
6), and CH2Cl2 (10 ml x 6) and dried at 40 oC for 80 h to yield P-7 (534.0 mg). 
P-7: yellow solid, mp > 300 oC; IR (KBr): nmax 1734 and 1685 cm-1 (C=O). 
1-[4-Copoly(styrene-1%-divinylbenzene)]methylimidazolidin-2-one (P-8) (Scheme 2-3) 
 
 40 
NN
O O
P-7
NHN
O
P-8
THF
NaOMe
 
To a polymer P-7 (348.8 mg) was added a solution of NaOMe (65.6 mg, 1.21 mmol) in THF (5.0 
ml) dropwise, and stirred at room temperature for 4 h. The reaction was quenched by the addition 
of H2O (10 ml). The polymer was filtered out, washed with MeOH (10 ml x 6), H2O (10 ml x 6), 
MeOH (10 ml x 6), and CH2Cl2 (10 ml x 6) and dried at 40 oC for 50 h to yield P-8 (312.0 mg). 
P-8: yellow solid, mp > 300 oC; IR (KBr): nmax 3239 cm-1 (NH), 1701 cm-1 (C=O). 
 
1-[4-Copoly(styrene-1%-divinylbenzene)]methyl-3-methylimidazolidin-2-one (P-3)  
(Scheme 2-3) 
 
NHN
O
NMeN
O
1. NaH, DMF
P-3
2. MeI
P-7  
To a suspension of NaH (60% in mineral oil, 119.2 mg, 2.98 mmol) and polymer P-7 (512.0 mg) 
in DMF (5.0 ml) under an argon atmosphere which was stirred at room temperature for 2 h was 
added methyl iodide (0.18 ml, 2.89 mmol) dropwise at 0 oC, and stirred at room temperature for 
55 h. The reaction was quenched by the addition of H2O (10 ml). The polymer was filtered out, 
washed with MeOH (10 ml x 6), H2O (10 ml x 6), MeOH (10 ml x 6), and CH2Cl2 (10 ml x 6) 
and dried at 40 oC for 50 h to yield P-3 (528.0 mg). 
P-3: yellow solid, mp > 300 oC; IR (KBr): nmax 1701 cm-1 (C=O); 13C-NMR (100 MHz, CDCl3):  
d (ppm) 32, 41, 45, 128, 146, 161.  
 
Method 2 
1-Methyl-3-propionylimidazolidin-2-one (9) (Scheme 2-4) 
 
NHHN
O
Cl
O
NMeN
O O1. Na, DMF
2.
5 93. MeI  
To a suspension of NaH (60% in mineral oil 1.76 g, 44.0 mmol, 2.20 Meq) and imidazolidinone 
(5) (1.72 g, 20.0 mmol, 1.0 Meq) in DMF (18 ml) under an argon atmosphere which was stirred 
at room temperature for 1 h was added propionyl chloride (1.74 ml, 20.0 mmol, 1.0 Meq) 
dropwise at 0 oC, and stirred at room temperature for 1.5 h. After addition of methyl iodide (1.25 
ml, 20.1 mmol, 1.0 Meq) at 0 oC, the reaction mixture was further stirred at room temperature for 
12 h. The reaction was quenched by the addition of H2O (30 ml), AcOEt (50 ml), dried over 
MgSO4, and evaporated (50 oC/ 20 mmHg) to yield the desired product (9) (2.91 g, 93.2%). 
9: pale yellow solid, mp 45-47.5 oC; IR (KBr): nmax 1718 and 1685 cm-1 (C=O); 1H-NMR (400 
MHz, CDCl3): d (ppm) 1.16 (3H, t, J=7.5 Hz, CH2CH3), 2.88 (3H, s, CH3), 2.94 (2H, q, J=7.5 
Hz, CH2CH3), 3.42 (2H, dd, J=8.4, 7.9 Hz, CH2CH2), 3.83 (2H, dd, J=8.4, 7.9 Hz, CH2CH2);  
 41
13C-NMR (100 MHz, CDCl3): d (ppm) 8.69, 28.56, 30.62, 39.36, 43.06, 154.98, 174.52;  
LRFABMS m/z: 157 (MH+, 100%). 
 
1-Methylimidazolidin-2-one (10) (Scheme 2-4) 
 
NMeN
O O
9
NHMeN
O
10
       MeOH
NaOMe
 
To 1-methyl-3-propionylimidazolidinone (9) (5.00 g 32.0 mmol, 1.0 Meq) was added a solution 
of NaOMe (4.45 g, 82.4 mmol, 2.58 Meq) in MeOH (20 ml) dropwise at 0 oC, and stirred at 
room temperature for 3 h. The reaction was quenched by the addition of 3 N HCl in MeOH until 
the solution became pH 6, and evaporated to dryness. The residue was dissolved in AcOEt (50 
ml) and filtered out. The combined organic phase were dried over Mg2SO4 and evaporated. 
Purification of the crude product by recrystallization from n-hexane/ AcOEt yielded the desired 
product (10) (2.91 g, 90.8%). 
10: colorless needles, mp 112-114 oC (lit.11) mp 112.5-114 oC); IR (KBr): nmax 3237 cm-1 (NH), 
1686 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 2.79 (3H, s, CH3), 3.38-3.46 (4H, m, 
CH2CH2), 4.68 (1H, brs, NH); LREIMS m/z: 100 (M+, 100%). 
 
1-[4-Copoly(styrene-1%-divinylbenzene)]methyl-3-methylimidazolidin-2-one (P-3)  
(Scheme 2-5) 
 
NMeHN
O
Cl
NMeN
O
P-3
1. NaH, DMF
10
2.
 
To a suspension of NaH (60% in mineral oil, 243.0 mg, 6.08 mmol, 7.76 Meq) and methylimida- 
zolidinone (10) (276.5 mg, 2.76 mmol, 3.52 Meq) in DMF (9.5 ml) under an argon atmosphere 
which was stirred at room temperature for 1 h was added Merrifield resin (450 mg, 0.78 mmol, 
1.00 Meq) at 0 oC, and sonicated at room temperature for 14 days. The reaction was quenched by 
the addition of H2O (10 ml). The polymer was filtered out, washed with MeOH (10 ml x 6), H2O 
(10 ml x 6), MeOH (10 ml x 6), and CH2Cl2 (10 ml x 6) and dried at 40 oC for 80 h to yield P-3 
(513.0 mg). 
P-3: pale yellow solid, mp > 300 oC; IR (KBr): nmax 1702 cm-1 (C=O); 13C-NMR (100 MHz, 
CDCl3):  d (ppm) 32.22, 41.16, 45.72, 128.39, 146.27, 161.62; Anal. Found: C, 84.3; H, 7.4; N, 
4.6; Cl, 0.08. 
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Synthesis of Polymer-supported DMC 
Model compound 
1-Benzyl-2-chloro-3-methylimidazolinium chloride (4) (entry 4 in Table 2-5) 
 
NMeN
O
Ph
 (COCl)2 NMeN
Cl
Ph
Cl
43  
A mixture of 1-benzyl-3-methylimidazolidinone (3) (163.6 mg, 0.86 mmol, 1.00 Meq) and 
oxalyl chloride (0.39 ml, 4.47 mmol, 5.20 Meq) was stirred at 63 oC for 24 h, cooled down to 
room temperature and evaporated to yield a crude desired product (4) (197.1 mg, 93.5% 
conversion, estimated by 1H-NMR).  
4: brown oil; IR (thin film): nmax 1627 cm-1 (C=N); 1H-NMR (400 MHz, CDCl3):d (ppm) 3.37 
(3H, s, NCH3), 4.10 (2H, dd, J=10, 10 Hz, CH2CH2), 4.29 (2H, dd, J=10, 10 Hz, CH2CH2), 4.83 
(2H, s, PhCH2), 7.28-7.40 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 35.34, 48.03, 
50.39, 52.46, 128.46, 129.45, 129.34, 131.67, 155.71. 
 
Polymer-supported DMC 
2-Chloro-1-[4-copoly(styrene-1%-divinylbenzene)]methyl-3-methylimidazolinium chloride 
(P-4) (entry 4 in Table 2-6) 
 
NMeN
O
(COCl)2 N NMe
Cl
Cl
P-3 P-4  
A mixture of P-DMI (P-3) (984 mg) and oxalyl chloride (1.71 mmol) in dry benzene (10 ml) was 
stirred at 63 oC for 24 h, cooled down to room temperature and evaporated under reduce pressure 
to yield crude P-DMC (P-4) (1.19 g, 84% conversion, estimated by FT-IR by using DMC 
calibration curve). 
P-4: brown solid; IR (KBr): nmax 1627 cm-1 (C=N).  
 
Applications 
Esterification 
3-Phenylpropyl-2,2-dimethylpropanoate (entries 1 and 2 in Table 2-8) 
 
    Et3N 
     CH2Cl2
            DMC or P-DMCOH
O
a
Ph OH
Ph O
O
b
c
 
: using DMC 
To a solution of DMC (674.4 mg, 75.4% purity, 3.01 mmol, 1.02 Meq) and pivalic acid (a) 
 43
(304.0 mg, 2.98 mmol, 1.00 Meq) in CH2Cl2 (8.5 ml) were added alcohol (c) (0.40 ml, 2.96 
mmol, 1.00 Meq) and NEt3 (1.25 ml, 8.97 mmol, 3.01 Meq) at 0 oC, and then stirred at room 
temperature for 24 h. The reaction was quenched by the addition of H2O (20 ml), and the organic 
materials were extracted with AcOEt (20 ml x 2). Then the organic phase was washed with 1 N 
HCl (20 ml x 2), sat NaHCO3 (20 ml x 2), H2O (20 ml x 5), brine (20 ml x 2), dried over Na2SO4, 
and evaporated. Purification of the residue by silica chromatography (n-hexane/ AcOEt= 10: 2) 
yielded the desired product (b) (560.2 mg, 85.9%). 
: using P-DMC 
To a suspension of crude P-DMC (991.5 mg, 65.0% conversion) and pivalic acid (a) (88.0 mg, 
0.86 mmol, 1.06 Meq) in CH2Cl2 (10.0 ml) were added alcohol (c) (0.11 ml, 0.81 mmol, 1.00 
Meq) and NEt3 (0.57 ml, 4.09 mmol, 5.02 Meq) at 0 oC, and then stirred at room temperature for 
48 h. The polymer was recovered by filtration and washing with CH2Cl2. The filtrate and 
washings were combined, washed with 1 N HCl (10 ml x 2), sat NaHCO3 (10 ml x 2), H2O (10 
ml x 2), brine (10 ml x 2), dried over Na2SO4, and evaporated. Purification of the crude product 
by distillation (bp 200 oC/ 3.0 mmHg) yielded the corresponding ester (b) (147.1 mg, 82.0%) as 
a colorless oil. The recovered P-3 was successively washed with 1 N HCl, H2O, MeOH, and 
CH2Cl2, and dried at 40 oC for 12 h.  
b: colorless oil (lit.40) bp not report); IR (thin film): nmax 1729 cm-1 (C=O); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 1.21 (9H, s, OC(CH3)3), 1.92-1.99 (2H, m, OCH2CH2CH2Ph), 2.69 (2H, t, 
J=8.0 Hz, OCH2CH2CH2Ph), 4.08 (2H, t, J=6.4 Hz, OCH2CH2 CH2Ph), 7.17-7.30 (5H, m, PhH). 
 
3-Phenylpropionic acid tert-butyl ester (entries 3-6 in Table 2-8) 
 
            DMC  or P-DMC
Ph OH
O
Ph O
O
     Et3N 
     CH2Cl2
ed
t-BuOH
 
: using DMC  
To a solution of DMC (339.5 mg, 83.3% purity, 1.67 mmol, 1.00 Meq) in CH2Cl2 (8.0 ml) and 
dihydrocinnamic acid (d) (250.6 mg, 1.67 mmol, 1.00 Meq) in CH2Cl2 (3.0 ml) were added 
tert-butyl alcohol (0.16 ml, 1.67 mmol, 1.00 Meq) and NEt3 (0.70 ml, 5.02 mmol, 3.01 Meq) at 0 
oC, and then stirred at room temperature for 24 h. The reaction was quenched by the addition of 
H2O (10 ml), and the organic materials were extracted with CH2Cl2 (10 ml x 2). Then the organic 
phase was washed with 1 N HCl (10 ml x 2), sat NaHCO3 (10 ml x 2), H2O (10 ml x 5), brine 
(10 ml x 2), dried over Na2SO4, and evaporated. Purification of the residue by silica 
chromatography (n-hexane/ AcOEt= 10: 3) yielded the desired product (319.8 mg, 92.9%) as a 
pale yellow oil. Then distillation (bp 150 oC/ 2.0 mmHg) gave the corresponding ester (e) (296.2 
mg, 86.1%).  
: using P-DMC  
To a suspension of crude P-DMC (984.1 mg, 88.2% conversion) and dihydrocinnamic acid (d) 
(150.9 mg, 1.01 mmol, 1.00 Meq) in CH2Cl2 (10 ml) were added tert-butyl alcohol (0.10 ml, 
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1.05 mmol, 1.04 Meq) and NEt3 (0.70 ml, 5.05 mmol, 5.00 Meq) at 0 oC, and then the 
suspension was stirred at room temperature for 48 h. The polymer was recovered by filtration 
and washing with CH2Cl2. The filtrate and washings were combined, washed with 1 N HCl (10 
ml x 2), sat NaHCO3 (10 ml x 2), H2O (10 ml x 2), brine (10 ml x 2), dried over Na2SO4, and 
evaporated. Purification of the crude product by distillation (bp 150 oC/ 2.0 mmHg) yielded the 
corresponding ester (e) (166.3 mg, 80.2%). The recovered P-3 was successively washed with 1 
N HCl, H2O, MeOH, and CH2Cl2, and dried at 40 oC for 12 h. Esterification of dihydrocinnamic 
acid with tert-butyl alcohol using a recycled P-3, after chlorination, under the same conditions 
described above yielded tert-butyl dihydrocinnamate (e) in 81% yield. 
e: colorless oil, bp 150 oC/ 2.0 mmHg (lit.41) bp 120-122 oC/ 7 mmHg); IR (thin film): nmax 1730 
cm-1 (C=O). 1H-NMR (400 MHz, CDCl3): d (ppm) 1.42 (9H, s, OC(CH3)3), 2.54 (2H, t, J=8 Hz, 
CH2CH2Ph), 2.90 (2H, t, J=8 Hz, CH2CH2Ph), 7.19-7.30 (5H, m, PhH). 
 
Amidation including dipeptides synthesis 
N-Phenylbenzamide (entries 1 and 2 in Table 2-9) 
 
            DMC  or P-DMC
Ph OH
O
Ph NHPh
OPhNH2
       Et3N 
     CH2Cl2
gf
 
: using DMC 
To a solution of DMC (500.1 mg, 83.3% purity, 2.46 mmol, 1.00 Meq) and benzoic acid (f) 
(300.7 mg, 2.46 mmol, 1.00 Meq) in CH2Cl2 (8.0 ml) were added aniline (0.23 ml, 2.53 mmol, 
1.03 Meq) and NEt3 (1.03 ml, 7.39 mmol, 3.00 Meq), and then stirred at room temperature for 24 
h. The reaction was quenched by the addition of H2O (10 ml), and the organic materials were 
extracted with CH2Cl2 (2 x 20 ml). Then the organic phase was washed with 1 N HCl (20 ml x 2), 
sat NaHCO3 (20 ml x 2), H2O (20 ml x 5), brine (20 ml x 2), dried over Na2SO4, and evaporated. 
Purification of the residue by silica chromatography (n-hexane/ AcOEt= 10: 1 to 1: 10) yielded 
the desired product (g) (437.0 mg, 90.0%). 
: using P-DMC 
To a suspension of crude P-DMC (2.01 g, 69.5% conversion), benzoic acid (f) (209.9 mg, 1.72 
mmol, 1.00 Meq) in CH2Cl2 (20 ml) were added aniline (0.16 ml, 1.75 mmol, 1.02 Meq) and 
NEt3 (1.20 ml, 8.61 mmol, 5.00 Meq), and then stirred at room temperature for 48 h. The 
polymer was recovered by filtration and washing with CH2Cl2. The filtrate and washings were 
combined, washed with 1 N HCl (20 ml x 2), sat NaHCO3 (20 ml x 2), H2O (20 ml x 2), brine 
(20 ml x 2), dried over Na2SO4, and evaporated. Purification of the crude product by 
recrystallization from EtOH yielded the corresponding amide (g) (278.2 mg, 82.0%). The 
recovered P-3 was successively washed with 1 N HCl, H2O, MeOH, and CH2Cl2, and dried at 40 
oC for 24 h.  
g: colorless prisms, mp 164-166.5 oC (lit.50) mp 163 oC); IR (KBr): nmax 3292 cm-1 (NH), 1689 
cm-1 (C=O).1H-NMR (400 MHz, CDCl3): d (ppm) 7.14-7.88 (10H, m, PhH).  
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2-(2L-Benzyloxycarbonylamino-acetyl)-3-phenylpropionic acid ethyl ester (entries 3 and 4 
in Table 2-9) 
NHHN
O
O
Ph
O
Ph
O
O
NH OH
O
O
Ph
O
NH2. HCl
Ph
O
O
       Et3N 
     CH2Cl2
         DMC  or P-DMCh i
(L)
(L)
j
 
: using DMC 
To a solution of DMC (108.8 mg, 91% purity, 0.59 mmol, 1.04 Meq) and N-Cbz-glycine (h) 
(118.9 mg, 0.57 mmol, 1.00 Meq) in CH2Cl2 (1.5 ml) were added a solution of L-phenylalanine 
ethyl ester hydrochloride (j) (134.0 mg, 0.58 mmol, 1.02 Meq) in CH2Cl2 (3.0 ml) and NEt3 
(0.33 ml, 2.37 mmol, 4.16 Meq) at 0 oC, and then stirred at room temperature for 7 h. The 
reaction was quenched by the addition of H2O (10 ml) and evaporated. The organic materials 
were extracted with CH2Cl2 (10 ml x 2). Then the organic phase was washed with 1 N HCl (10 
ml x 2), sat NaHCO3 (10 ml x 2), H2O (10 ml x 5), brine (10 ml x 2), dried over Na2SO4, and 
evaporated. Purification of the residue by silica chromatography (n-hexane/ AcOEt= 10: 1 to 5: 
1) yielded the desired product (i) (164.3 mg, 75.0%, 99.8% ee) (determined by chiral HPLC: 
DAICEL CHIRALPAK AD-H, eluent EtOH, 30 oC, MaxAbs, flow rate 1.0 ml/ min, t1= 7.76 min, 
t2= 9.81 min). 
: using P-DMC 
To a suspension of crude P-DMC (991.0 mg, 74% conversion) and N-Cbz-glycine (h) (160.1 mg, 
0.77 mmol, 1.00 Meq) in CH2Cl2 (8.0 ml) were added a solution of L-phenylalanine ethyl ester 
hydrochloride (j) (175.8 mg, 0.77 mmol, 1.00 Meq) in CH2Cl2 (3.0 ml) and NEt3 (0.55 ml, 3.95 
mmol, 5.16 Meq) at 0 oC, and then stirred at room temperature for 24 h. The polymer was 
recovered by filtration and washing with CH2Cl2. The filtrate and washings were combined, 
washed with 1 N HCl (10 ml x 2), sat NaHCO3 (10 ml x 2), H2O (10 ml x 2), brine (10 ml x 2), 
dried over Na2SO4, and evaporated. Purification of the crude product by silica chromatography 
(n-hexane/ AcOEt= 10: 1 to 5: 1) yielded the corresponding dipeptide (i) (212.0 mg, 72.1%, 
99.4% ee; determined by chiral HPLC same as above). The recovered P-3 was successively 
washed with 1 N HCl, H2O, MeOH, and CH2Cl2, and dried at 40 oC for 12 h.  
i: pale yellow oil; IR (thin film): nmax 3320 cm-1 (NH), 1735 and 1676 cm-1 (C=O); 1H-NMR 
(400 MHz, CDCl3): d (ppm) 1.25 (3H, t, J= 7.2 Hz, OCH2CH3), 3.11 (2H, d, J= 4 Hz, NCH2), 
3.86 (2H, m, PhCH2), 4.17 (2H, q, J= 7.2 Hz, OCH2CH3), 4.86 (1H, m, NCH), 5.13 (2H, s, 
OCH2Ph), 5.33 (1H, brs, NH), 6.37 (1H, brs, NH), 7.08-7.37 (10H, m, PhH); LRFABMS m/z: 
385 (MH+, 49%). 
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1-(2L-Benzyloxycarbonylamino-3-phenylpropionyl)pyrrolidine-2L-carboxylic acid methyl 
ester (entries 6 and 8 in Table 2-9) 
 
            DMC  or P-DMC
Ph O N
H
N
OCH3
O
O
O
H. HCl
N
H3CO
O
Ph
Ph O N
H
O
O
Ph
OH
     Et3N 
     CH2Cl2
(L)
l
(L)
(L)
(L)
k
m
 
: using DMC 
To a solution of DMC (92.1 mg, 75.4% purity, 0.41 mmol, 1.00 Meq) and N-Cbz-L-phenyl 
alanine (k) (123.0 mg, 0.41 mmol, 1.00 Meq) in CH2Cl2 (2.0 ml) were added a solution of 
L-proline methyl ester hydrochloride (m) (67.5 mg, 0.41 mmol, 1.00 Meq) in CH2Cl2 (0.7 ml) 
and NEt3 (0.17 ml, 1.22 mmol, 2.98 Meq) at 0 oC, and then stirred at room temperature (20 oC) 
for 1.5 h. The reaction was quenched by the addition of H2O (10 ml), and the organic materials 
were extracted with CH2Cl2 (10 ml x 2). Then the organic phase was washed with 1 N HCl (10 
ml x 2), sat NaHCO3 (10 ml x 2), H2O (10 ml x 5), brine (10 ml x 2), dried over Na2SO4, and 
evaporated. Purification of the residue by silica chromatography (n-hexane/ AcOEt= 3: 1 to 1: 1) 
yielded the desired product (l) (139.1 mg, 83.1%, 98% de) (determined by 1H-NMR, 400 MHz). 
: using P-DMC 
To a suspension of crude P-DMC (303.8 mg, 90% conversion) and N-Cbz-L-phenyl alanine (k) 
(108.8 mg, 0.36 mmol, 1.00 Meq) in CH2Cl2 (4.0 ml) were added a solution of L-proline methyl 
ester hydrochloride (m) (61.2 mg, 0.37 mmol, 1.02 Meq) in CH2Cl2 (0.6 ml) and NEt3 (0.15 ml, 
1.08 mmol, 2.96 Meq) at 0 oC, and then stirred at 2 oC for 4 h. The polymer was recovered by 
filtration and washing with CH2Cl2. The filtrate and washings were combined, washed with 1 N 
HCl (10 ml x 2), sat NaHCO3 (10 ml x 2), H2O (10 ml x 2), brine (10 ml x 2), dried over Na2SO4, 
and evaporated. Purification of the crude product by silica chromatography (n-hexane/ AcOEt= 
3: 1 to 1: 1) yielded the corresponding dipeptide (l) (115.3 mg, 77.3%, 98% de). The recovered 
P-3 was successively washed with 1 N HCl, H2O, MeOH, and CH2Cl2, and dried at 40 oC for 12 
h.  
l: colorless oil; IR (thin film): nmax 3284 cm-1 (NH), 1738 and 1639 cm-1 (C=O); 1H-NMR (400 
MHz, CDCl3): d (ppm) 1.92-2.18 (4H, m, NCH2CH2CH2CH), 2.90-3.22 (3H, m, NCH2CH2 
CH2CH), 3.54-3.65 (1H, m, NCH), 3.75 (3H, s, OCH3), 4.49-4.74 (2H, m, PhCH2), 5.05 (2H, m, 
PhCH2), 5.52 (1H, br d, J=8.8 Hz, NH), 7.20-7.36 (10H, m, PhH); LREIMS m/z: 410 (M+, 
3.2%). 
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1-(2L-Benzyloxycarbonylamino-3-(2-indol)propionyl)pyrrolidine-2L-carboxylic acid 
methyl ester (entry 10, 12 in Table 2-9) 
    Et3N 
     CH2Cl2
            DMC  or P-DMC
H. HCl
N
H3CO
O
(L)
NH
N
H
HO O
O
O
Ph
(L)
NH
N
H
N O
O
O
Ph
H3CO
O(L)
(L)
n
o
m
 
: using DMC 
To a solution of DMC (78.9 mg, 75% purity, 0.35 mmol, 1.03 Meq) in CH2Cl2 (0.8 ml) and 
N-Cbz-L-typtophan (n) (116.3 mg, 0.34 mmol, 1.00 Meq) in CH2Cl2 (1.2 ml) were added a 
solution of L-proline methyl ester hydrochloride (m) (58.2 mg, 0.35 mmol, 1.02 Meq) in CH2Cl2 
(0.6 ml) and NEt3 (0.14 ml, 1.00 mmol, 2.92 Meq), and then stirred at room temperature (20 oC) 
for 2 h. The reaction was quenched by the addition of H2O (10 ml), and the organic materials 
were extracted with CH2Cl2 (10 ml x 2). Then the organic phase was washed with 1 N HCl (10 
ml x 2), sat. NaHCO3 (10 ml x 2), H2O (10 ml x 5), brine (10 ml x 2), dried over Na2SO4, and 
evaporated. Purification of the residue by washing with Et2O yielded the desired product (o) 
(146.8 mg, 95.0%, 99% de) (determined by 1H-NMR, 400 MHz). 
: using P-DMC 
To a suspension of crude P-DMC (307.2 mg, 90% conversion) and N-Cbz-L-typtophan (n) 
(115.3 mg, 0.34 mmol, 1.00 Meq) in CH2Cl2 (4.0 ml) were added a solution of L-proline methyl 
ester hydrochloride (m) (57.2 mg, 0.35 mmol, 1.03 Meq) in CH2Cl2 (0.6 ml) and NEt3 (0.14 ml, 
1.00 mmol, 2.95 Meq) at 0 oC, and then stirred at 2 oC for 4 h. The polymer was recovered by 
filtration and washing with CH2Cl2. The filtrate and washings were combined, washed with 1 N 
HCl (10 ml x 2), sat NaHCO3 (10 ml x 2), H2O (10 ml x 2), brine (10 ml x 2), dried over Na2SO4, 
and evaporated. Purification of the crude product by washing with Et2O yielded the 
corresponding dipeptide (o) (131.2 mg, 85.6%, 99% de). The recovered P-3 was successively 
washed with 1 N HCl, H2O, MeOH, and CH2Cl2, and dried at 40 oC for 12 h.  
o: colorless prisms, mp 89-91 oC (lit.17c) mp 88-92 oC); IR (KBr): nmax 3305 cm-1 (NH), 1718 and 
1637 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.83-2.18 (4H, m, NCHCH2CH2CH2), 
3.03-3.30 (3H, m, NCHCH2CH2CH2), 3.51-3.59 (1H, m, NCH), 3.74 (3H, s, OCH3), 4.48-4.86 
(2H, m, HaPro and HbTrp), 5.04 (2H, s, PhCH2), 5.58 (1H, br s, O=CNH), 7.09-7.72 (10H, m, 
C=CH), 8.09 (1H, s, NH); LRFABMS m/z: 450 (MH+, 100%). 
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Polymer-supported guanidine 
 
Synthesis of polymer-supported chiral guanidine by grafting 
 
Synthesis of 3-methyl-4-phenylimidazolidinone (33) 
(R)-2-Amino-2-phenylethanol (26) (Scheme 3-5) 
 
THF
25 26
NH2HO
PhO
NH2HO
Ph
LiAlH4
 
Lithium aluminium hydride (2.32 g, 61.1 mmol, 3.10 Meq) was suspended in THF (150 ml) at 0 
oC. Then, 25 (2.98 g, 19.7 mmol, 1.00 Meq) was added slowly in small portions. The reaction 
mixture was stirred at reflux for 17 h and cooled down to room temperature. H2O (3.0 ml), 15% 
NaOH aq. (3.0 ml), H2O (12.0 ml), and K2CO3 were added slowly at 0 oC. The filtrate was 
evaporated. Purification of the residue by recrystallization from n-hexane/ benzene yielded the 
desired product 26 (2.13 g, 78.8%). 
26: pale-yellow needles, mp 77-78 oC (lit.42) mp 78 oC); [a]D23 -28.5 (c 1.00, MeOH) [lit.42)  [a] 
D
22 -26.1 (c 5.36, MeOH)]; IR (KBr): nmax 3328 cm-1 (OH), 3029 cm-1 (NH); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 3.55 (1H, dd, J=10.8, 8.3 Hz, OCHH), 3.75 (1H, dd, J=10.8, 4.4 Hz, OCHH), 
4.05 (1H, dd, J=8.3, 4.4 Hz, NCHPh), 7.38-7.28 (5H, m, PhH). 
 
(R)-N-(tert-Butoxycarbonyl)-1-phenyl-2-hydroxyethylamine (27) (Scheme 3-5) 
 
(Boc)2O
CH2Cl2
26 27
1 N NaOH aq
NH2HO
Ph
NHBocHO
Ph
 
To a solution of (R)-phenylglycinol (26) (390.1 mg, 2.84 mmol, 1.00 Meq) in CH2Cl2 (8.0 ml) 
was added dropwise 1 N NaOH aq (8.0 ml) and (Boc)2O (681.8 mg, 3.12 mmol, 1.10 Meq) in 
CH2Cl2 (3.0 ml) at 0 oC, then stirred at room temperature for 12 h. The organic phase was 
washed with 1 N HCl (10 ml x 2), sat NaHCO3 (10 ml x 2), H2O (10 ml x 2), brine (10 ml x 2), 
dried over Na2SO4, and evaporated. Purification of the residue by silica chromatography 
(n-hexane/ AcOEt= 2: 1) yielded the desired product 27 (602.6 mg, 89.4%). 
27: colorless needles, mp 137-138.5 oC (lit.43) mp 138-139 oC); [a]D23-50.7 (c 1.80, EtOH) 
[(lit.44) [a]D22 -48.2 (c 0.4, EtOH)]; IR (KBr): nmax 3315 cm-1 (OH), 3245 cm-1 (NH), 1671 cm-1 
(C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.44 [9H, s, OC(CH3)3], 2.30 (1H, br s, OH), 3.84 
-3.87 (2H, br m, OCH2), 4.79 (1H, br s, NCHPh), 5.22 (1H, br s, NH), 7.27-7.39 (5H, m, PhH). 
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(R)-N-(tert-Butoxycarbonyl)amino-1-phenylethyl methanesulphonate (28) (Scheme 3-5) 
 
NHBocHO
Ph
Me
S
Cl
O O
27 Et3N 
 CH2Cl2
28
NHBocMsO
Ph
 
To a solution of N-(tert-butoxycarbonyl)-(1R)-phenyl-2-hydroxyethylamine (27) (502.0 mg, 2.12 
mmol, 1.00 Meq) in CH2Cl2 (16.0 ml) was added dropwise NEt3 (0.59 ml, 4.23 mmol, 2.00 Meq) 
and mesyl chloride (0.17 ml, 2.20 mmol, 1.04 Meq) at 0 oC, and then further stirred at the same 
temperature at for 45 min. The organic phase was washed with 1 N HCl (20 ml x 2), sat NaHCO3 
(20 ml x 2), H2O (20 ml x 2), brine (20 ml x 2), dried over Na2SO4, and evaporated. Purification 
of the residue by silica chromatography (n-hexane/ AcOEt= 2: 1) yielded the desired product 
(28) (630.1 mg, 94.4%). 
28: colorless needles, mp 112-114 oC (lit.45) mp 114-115 oC); [a]D23 -23.5 (c 1.00, CHCl3) [(lit.45) 
[a]D -21 (c 1 weight percent in CHCl3); IR (KBr): nmax 3357 cm-1 (NH), 1694 cm-1 (C=O); 
1H-NMR (400 MHz, CDCl3): d (ppm) 1.44 [9H, s, OC(CH3)3], 2.88 (3H, s, SCH3), 4.38-4.50 
(2H, br m, OCH2), 5.02 (1H, br s, NCHPh), 5.15 (1H, br s, NH), 7.31-7.40 (5H, m, PhH). 
 
(R)-N-(tert-Butoxycarbonyl)amino-2-azido-1-phenylethyl amine (29) (Scheme 3-5) 
 
NHBocN3
Ph
NHBocMs-O
Ph
NaN3
DMF
2928 29'
NHO
O
Ph
 
A suspension of 28 (584.4 mg, 1.85 mmol, 1.00 Meq) and NaN3 (640.6 mg, 9.85 mmol, 5.32 
Meq) in DMF (6.0 ml) was stirred at 80 oC for 3 h and then cooled down to room temperature. 
The reaction was quenched by the addition of H2O (30 ml), and the organic materials were 
extracted with Et2O (3 x 20 ml). Then the organic phase was washed with H2O (2 x 20 ml), brine 
(2 x 20 ml), dried over MgSO4, and evaporated. Purification of the residue by silica chromato- 
graphy (n-hexane/ AcOEt= 5: 1 to 1: 1) yielded the desired product 29 (400.4 mg, 82.5%) and 
29’ (15.1 mg, 5.0%). 
29: colorless needles, mp 85.5-87.0 oC (lit.45) mp 86.0 oC); IR (KBr): nmax 3284 cm-1 (NH), 2108 
cm-1 (N=N=N), 1709 cm-1 (C=O); [a]D23 -19.1 (c 1.02, CHCl3) [(lit.45) [a]D -8.7 (c 1 weight 
percent in CHCl3); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.44 [9H, s, OC(CH3)3], 3.63 (2H, br 
m, N3CH2), 4.87 (1H, br s, NCHPh), 5.06 (1H, br s, NH), 7.29-7.39 (6H, m, PhH). 
29’: colorless needles, mp 123-125 oC (lit.31) mp 126-127 oC); IR (KBr): nmax 1748 cm-1 (C=O); 
1H-NMR (400 MHz, CDCl3): d (ppm) 2.72 (3H, s, NCH3), 4.09 (1H, dd, J=8.0, 6.4 Hz, NCHPh),  
4.65 (2H, m, OCH2), 7.29-7.45 (5H, m, PhH); LREIMS m/z: 163 (M+, 64.5%). 
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(R)-2-Azido-1-phenylethylamine (30) (Scheme 3-5) 
 
NHBocN3
Ph
F3CCO2H (TFA)
CH2Cl2
29 30
NH2N3
Ph
 
To a solution of (N-tert-butoxycarbonyl)amino-2-azido-(1R)-phenylethyl amine (29) (2.75 g, 
10.5 mmol, 1.00 Meq) in CH2Cl2 (28 ml) was added dropwise TFA (7.0 ml, 90.9 mmol, 8.66 
Meq) at 0 oC, and then stirred at room temperature for 1 h. The reaction was quenched by the 
addition of 20% NaOH aq (100 ml, pH >11) slowly at 0 oC, and the organic materials were 
extracted with CH2Cl2 (30 ml x 2). Then the organic phase was washed with H2O (30 ml x 2), 
brine (30 ml x 2), dried over Na2SO4, and evaporated to yield the desired product 30 (1.71 g, 
100.6%). 
30: pale-yellow oil (lit.46) not report); IR (thin film): nmax 3368 and 3298 cm-1 (NH), 2104 cm-１
(N=N=N). 
 
(R)-N-Formyl-amino-2-azido-1-phenylethylamine (31) (Scheme 3-5 and 3-9) 
 
NH2N3
Ph
3130
HCO2H 
 Ac2O
NHCHON3
Ph
 
To a solution of (R)-2-azido-1-phenylethylamine (30) (1.71 g, 10.5 mmol, 1.00 Meq) in formic 
acid (5.90 ml, 156 mmol, 14.9 Meq) was added dropwise acetic anhydride (14.8 ml, 157 mmol, 
15.0 Meq) at 0 oC, and then stirred at room temperature for 2 h. The solvent was removed under 
reduced pressure to give the desired product 31 (2.01 g, 100.6%) {[a]D23-119.8 (c 2.27, 
MeOH)}. 
 
NHCHON3
Ph
43 31
NaN3
DMF
NHCHOMsO
Ph
 
To a solution of (R)-(N-formyl)amino-2-phenylethyl methanesulphonate (43) (707.1 mg, 2.91 
mmol, 1.00 Meq) in DMF (7.0 ml) was added NaN3 (940.2 mg, 14.5 mmol, 4.98 Meq). Then, the 
suspension was stirred at 80 oC for 3 h and cooled down to room temperature. The reaction was 
quenched by the addition of H2O (15 ml), and the organic materials were extracted with Et2O (20 
ml x 2). Then, the organic phase was washed with H2O (20 ml x 5), brine (20 ml x 2), dried over 
Na2SO4, and evaporated. Purification of the residue by silica chromatography (n-hexane/ 
AcOEt= 5: 1 to 1: 1) yielded the desired product 31 (210.3 mg, 38.0%) {[a]D23 -69.7 (c 1.15, 
MeOH)}. 
31: a pale-yellow oil; IR (thin film): nmax 3276 cm-1 (NH), 2104 cm-1 (N=N=N), 1663 cm-1 
(C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 3.72 (2H, d, J=5.20 Hz, CH2N3), 5.32-5.27 (1H, m, 
NCHPh), 6.16 (1H, br s, NH), 7.29-7.43 (5H, m, PhH), 8.27 (1H, s, CHO); 13C-NMR (100 MHz, 
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CDCl3): d (ppm) 51.23, 54.99, 126.59, 128.31, 128.95, 138.06, 160.66; LRFABMS m/z: 191 
(MH+, 100%). 
 
(R)-N-Methyl-1-phenylethane-1,2-diamine (32) (Scheme 3-5, 3-6 and 3-12) 
 
32
THF
NHMeH2N
Ph
NHBocN3
Ph
29
NHHN
O
Ph
35
LiAlH4
 
Lithium aluminium hydride (48.7 mg, 1.28 mmol, 5.12 Meq) was suspended in THF (2.50 ml) at 
0 oC. 29 (65.6 mg, 0.25 mmol, 1.00 Meq) was added slowly in small portions. The reaction 
mixture was stirred at reflux for 18.5 h and then cooled down to room temperature. H2O (0.1 ml), 
15% NaOH aq (0.1 ml), H2O (0.3 ml), and K2CO3 were added slowly at 0 oC. Filtration and 
evaporation of the solvent gave crude products (28.5 mg) as yellow oil-solid. Purification of the 
residue by distillation (150 oC/ 8 mmHg) yielded the desired product (32) (10.9 mg, 29.0%) and 
the side product (35) (13.1 mg, 32.3%). 
 
NHCHON3
Ph
31 32
THF
NHMeH2N
Ph
LiAlH4
 
Lithium aluminium hydride (1.61 g, 42.4 mmol, 4.00 Meq) was suspended in THF (100 ml) at 0 
oC. The solution of 31 (2.01 g, 10.6 mmol, 1.00 Meq) in THF (10 ml) was added dropwise. The 
reaction mixture was stirred at reflux for 15 h and then cooled down to room temperature. H2O 
(2.0 ml), 15% NaOH aq (2.0 ml), H2O (6.0 ml), and K2CO3 were added slowly at 0 oC. Filtration 
and evaporation of the solvent. Purification of the residue by distillation (150 oC/ 8 mmHg) 
yielded the desired product (32) (1.58 g, quant.). 
 
NHCHOH2N
PhO
48 32
THF
NHMeH2N
Ph
LiAlH4
 
Lithium aluminium hydride (270.4 mg, 7.13 mmol, 4.03 Meq) was suspended in THF (100 ml) 
at 0 oC. 48 (315.0 mg, 1.77 mmol, 1.00 Meq) was added. The reaction mixture was stirred at 
reflux for 21 h and then cooled down to room temperature. H2O (0.3 ml), 15% NaOH aq. (0.3 
ml), H2O (1.0 ml), and K2CO3 were added slowly at 0 oC. Filtration and evaporation of the 
solvent. Purification of the residue by distillation yielded the desired product (32) (217.8 mg, 
82.0%). 
32: a colorless oil (lit.28) 90 oC/ 0.2 mmHg); IR (thin film): nmax 3391 and 2922 cm-1 (NH); 
1H-NMR (400 MHz, CDCl3): d (ppm) 2.32 (3H, s, NCH3), 2.83 (1H, dd, J=12.8, 6.8 Hz, CHHN), 
2.91 (1H, dd, J=12.8, 5.6 Hz, CHHN), 3.48 (1H, dd, J=6.8, 5.6 Hz, NCHPh), 7.37-7.25 (5H, m, 
PhH). 
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(R)-N-formylamino-phenyl-acetic acid (36) (Scheme 3-8) 
 
25
HCO2H 
 Ac2O
36
NH2HO
PhO
NHCHOHO
PhO
 
To a solution of (R)-phenylglycine (25) (1.40 g, 9.28 mmol, 1.00 Meq) in formic acid (8.50 ml, 
226 mmol, 24.4 Meq) was added dropwise acetic anhydride (9.0 ml, 95.4 mmol, 10.3 Meq) at 0 
oC, and then stirred at room temperature for 22.5 h. The reaction was quenched by the addition of 
H2O (10 ml), and the solvent was removed under reduced pressure. The residue was washed with 
cold (1: 1) MeOH/ H2O to give 36 (1.64 g, 98.8%). 
36: colorless plates, mp 185-187 oC (lit.30) mp 188-189 oC); IR (KBr): nmax 3157 cm-1 (OH), 1775 
and 1671 cm-1 (C=O); 1H-NMR (400 MHz, DMSO-d6): d (ppm) 5.37 (1H, d, J=7.6 Hz, NCHPh), 
7.32 -7.37 (5H, m, PhH), 8.06 (1H, s, CHO), 8.91 (1H, d, J=7.6 Hz, NH). 
 
(R)-2-(N-Methylamino)-2-phenylethanol (37) (Scheme 3-8) 
 
THF
36 37
NHCHOHO
PhO
NHMeHO
Ph
LiAlH4
 
Lithium aluminium hydride (2.04 g, 53.8 mmol, 6.26 Meq) was suspended in THF (90 ml) at 0 
oC. 36 (1.54 g, 8.60 mmol, 1.00 Meq) was added slowly in small portions. The reaction mixture 
was stirred at reflux for 18.5 h and then cooled to room temperature. H2O (3.0 ml), 15% NaOH 
aq. (3.0 ml), H2O (9.0 ml), and K2CO3 were added slowly at 0 oC. Filtration and evaporation of 
the solvent, the residue was distillated under reduced pressure (bp 110 oC/ 1.0 mmHg) to give 37 
(1.13 g, 86.9%). 
37: a pale-yellow oil (lit.30) bp 90-92 oC/ 0.4 mmHg); IR (thin film): nmax 3328 cm-1 (OH), 3029 
cm-1 (NH); 1H-NMR (400 MHz, CDCl3): d (ppm) 2.34 (3H, s, NCH3), 3.56 (1H, dd, J=10.4, 8.4 
Hz, OCHH), 3.65 (1H, dd, J=8.4, 4.0 Hz, NCHPh), 3.72 (1H, dd, J=10.4, 4.0 Hz, OCHH), 
7.28-7.37 (5H, m, PhH). 
 
(R)-(2-Hydroxy-1-phenyl)methyl-carbamic acid tert-butyl ester (38) (Scheme 3-8) 
 
(Boc)2O
CH2Cl237 38
1 N NaOH aq
NHMeHO
Ph
NMeHO
Ph
Boc
 
To a solution of (R)-2-(N-methylamino)-2-phenylethanol (37) (391.4 mg, 2.59 mmol, 1.00 Meq) 
in CH2Cl2 (8.0 ml) was added dropwise 1 N NaOH aq (8.0 ml) and (Boc)2O (617.5 mg, 2.83 
mmol, 1.09 Meq) in CH2Cl2 (6.0 ml) at 0 oC, then stirred at room temperature for 21 h. The 
organic phase was washed with 1 N HCl (10 ml x 2), sat. NaHCO3 (10 ml x 2), H2O (10 ml x 2), 
brine (10 ml x 2), dried over Na2SO4, and evaporated. Purification of the residue by silica 
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chromatography (n-hexane/ AcOEt= 2: 1 to 1: 1) yielded the desired product (38) (364.1 mg, 
55.9%). 
38: colorless oil; IR (thin film): nmax 3431 cm-1 (OH), 1671 cm-1 (C=O); 1H-NMR (400 MHz, 
CDCl3):d (ppm) 1.48 (9H, s, OC(CH3)3), 2.69 (3H, br s, NCH3), 3.99-4.11 (2H, br m, OCH2), 
5.32 (1H, br s, NCHPh), 7.22-7.36 (5H, m, PhH); LRFABMS m/z: 252 (MH+, 45%). 
 
(R)-3-Methyl-4-phenyloxazolidin-2-one (41) (Scheme 3-8) 
 
Me
S
Cl
O O
38
Et3N
CH2Cl2
41
NMsO
Ph
O
O
NMeO
O
Ph
NMeBocHO
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To a solution of (R)-N,N-tert-butoxycarbonyl-methyl-1-phenyl-2-hydroxyethylamine (38) (127.0 
mg, 0.51 mmol, 1.00 Meq) in CH2Cl2 (1.2 ml) was added dropwise NEt3 (0.14 ml, 1.00 mmol, 
1.96 Meq) and mesyl chloride(0.04 ml, 0.52 mmol, 1.02 Meq) at -10 oC, and then stirred at -10 
oC at for 50 min. The organic phase was washed with 1 N HCl (10 ml x 2), sat NaHCO3 (10 ml x 
2), H2O (10 ml x 2), brine (10 ml x 2), dried over Na2SO4, and evaporated. Purification of the 
residue by silica chromatography (n-hexane/ AcOEt= 2: 1 to 1: 1) yielded the product (41) (82.8 
mg, 91.6%) . 
41: colorless needles, mp 77-78 oC (lit.31) mp 78 oC); IR (KBr) nmax 1748 cm-1 (C=O); 1H-NMR 
(400 MHz, CDCl3): d (ppm) 2.72 (3H, s, NCH3), 4.09 (1H, dd, J=8.0, 6.4 Hz, NCHPh), 4.65 (2H, 
m, OCH2), 7.29-7.45 (5H, m, PhH); LREIMS m/z: 177 (M+, 72.2%). 
 
(R)-N-Formyl-2 -amino-2-phenylethanol (42) (Scheme 3-9) 
 
NHCHOHO
Ph
HCO2Et
26 42
NH2HO
Ph
 
A suspension of (R)-phenylglycinol (26) (398.1 mg, 2.90 mmol, 1.00 Meq) in ethyl formate 
(0.70 ml, 8.67 mmol, 2.99 Meq) was stirred at room temperature for 24 h. The reaction mixture 
was evaporated to dryness. Purification of the residue by washing with AcOEt yielded the 
desired product 42 (427.6 mg, 89.3%). 
42: colorless plates, mp 98-100 oC (lit.47) mp 100 oC); [a]D23 -138 (c 1.5, MeOH) {(lit.47) [a]D22 
-149 (c 0.7, MeOH)}; IR (KBr): nmax 3332 cm-1 (OH), 3148 cm-1 (NH), 1664 cm-1 (C=O); 
1H-NMR (400 MHz, CDCl3): d (ppm) 2.64 (1H, br s, OH), 3.90 (2H, d, J=4.40 Hz, CH2), 
5.11-5.16 (1H, m, NCHPh), 6.40 (1H, br s, NH), 7.29-7.41 (5H, m, PhH), 8.26 (1H, s, CHO). 
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(R)-N-Formylamino-2-phenylethyl methanesulphonate (43) (Scheme 3-9) 
 
NHCHOHO
Ph
Me
S
Cl
O O
42 Et3N 
CH2Cl2
43
NHCHOMsO
Ph
 
To a solution of (R)-N-formyl-2-amino-2-phenylethanol (42) (660.0 mg, 4.00 mmol, 1.00 Meq) 
in MeCN (7.0 ml) was added dropwise NEt3 (0.56 ml, 4.02 mmol, 1.01 Meq) and mesyl chloride 
(0.31 ml, 4.01 mmol, 1.00 Meq) at 0 oC, then stirred at 0 oC for 20 min. The reaction was 
quenched by the addition of H2O (10 ml) and evaporated. The reaction mixture was evaporated 
and the organic materials were extracted with CH2Cl2 (20 ml x 3). Then the organic phase was 
washed with 1 N HCl (20 ml x 2), sat NaHCO3 (20 ml x 2), H2O (20 ml x 2), brine (20 ml x 2), 
dried over Na2SO4, and evaporated. Purification of the residue by recrystallization from AcOEt 
yielded the desired product 43 (854.5 mg, 87.8%). 
43: colorless needles, mp 110-112 oC; [a]D23 -98.1 (c 1.00, MeOH); IR (KBr): nmax 3362 cm-1 
(NH), 1665 cm-1 (C=O); 1H-NMR (400 MHz, DMSO-d6): d (ppm) 3.16 (3H, s, SCH3), 
4.31-4.39 (2H, m, CH2), 5.26- 5.31 (1H, m, NCHPh), 7.31-7.42 (5H, m, PhH), 8.14 (1H, s, 
CHO), 8.83 (1H, br d, J= 8.4 Hz, NH); 13C-NMR (100 MHz, DMSO-d6): d (ppm) 36.65, 50.03, 
71.32, 127.05, 127.80, 128.53, 138.01, 160.89. 
 
(R)-amino-phenyl-acetic acid methyl ester hydrochloride (44) (Scheme 3-10) 
 
NH2HO
PhO
MeOH
25 44
NH2. HClMeO
PhO
SOCl2
 
To a solution of thionyl chloride (3.0 ml, 48.0 mmol, 1.45 Meq) in MeOH (250 ml) was slowly 
added 25 (5.01 g, 33.1 mmol, 1.00 Meq) in small portions at 0 oC. The reaction mixture was 
stirred at reflux for 3 h and at room temperature for 9 h. Then, the reaction mixture was 
evaporated to dryness. Purification of the residue by recrystallization from Et2O/ MeOH yielded 
the desired product 44 (6.69 g, quant). 
44: colorless prisms, mp 198-201 oC (lit. no report); [a]D23 -120 (c 1.00, H2O); IR (KBr): nmax 
2987 and 2851 cm-1 (NH), 1738 cm-1 (C=O); 1H-NMR (400 MHz, D2O): d (ppm) 3.84 (3H, s, 
OCH3), 5.31 (1H, s, NCHPh), 7.56-7.50 (5H, m, PhH). 
 
(R)-N-Formyl phenylglycine methyl ester (45) (Scheme 3-10) 
 
NH2. HClMeO
PhO
44 4544'
CH2Cl2
NHCHOMeO
PhO
NH2MeO
PhO
Et3N HCO2H
Ac2O
 
To a solution of (R)-amino-phenyl-acetic acid methyl ester hydrochloride (44) (2.50 g, 12.4 
mmol, 1.00 Meq) in CHCl3 (25 ml) was added dropwise NEt3 (1.73 ml, 12.4 mmol, 1.00 Meq) at 
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0 oC, and then stirred at 0 oC for 5 min and at room temperature for 5 min. The reaction mixture 
was evaporated to dryness and the residue was washed with Et2O (30 ml x 3). The filtrate was 
evaporated to give 44’ (1.99 g, 97.2%) as a colorless oil. Then a solution of 44’ (1.99 g, 12.1 
mmol, 1.00 Meq) in formic acid (1.15 ml, 30.5 mmol, 2.52 Meq) was added dropwise acetic 
anhydride (2.85 ml, 30.2 mmol, 2.50 Meq) at 0 oC, and then stirred for 30 min. The reaction 
mixture was evaporated to dryness. Purification of the residue by silica chromatography 
(n-hexane/ AcOEt= 1: 1) yielded the desired product 45 (1.99 g, 82.7% from 44). 
45: colorless prisms, mp 63-64.5 oC (lit.48) mp 64 oC); [a]D23 -255 (c 1.00, CHCl3) {(lit.48) [a]D 
-196 (c 1.00, CHCl3)}; IR (KBr): nmax 3298 cm-1 (NH), 1745 and 1663 cm-1 (C=O); 1H-NMR 
(400 MHz, CDCl3): d (ppm) 3.75 (3H, s, OCH3), 5.67 (1H, d, J=7.2 Hz, NCHPh), 6.73 (1H, br s, 
NH), 7.27-7.41 (5H, m, PhH), 8.24 (1H, s, CHO). 
 
(R)-N-Formylphenylglycine hydrazide (46) (Scheme 3-10) 
 
NHCHOMeO
PhO
45 46
MeOH
H2NNH2. H2O NHCHOH2NHN
PhO
 
To a solution of (R)-N-formyl phenylglycine methyl ester (45) (1.12 g, 5.80 mmol, 1.00 Meq) in 
MeOH (3.5 ml) was added dropwise hydrazine monohydrate (0.28 ml, 5.77 mmol, 1.00 Meq) at 
0 oC, and then stirred at room temperature for 5 h. The reaction mixture was evaporated to 
dryness. Purification of the residue by washing with Et2O/ EtOH (1: 1) yielded the desired 
product 46 (1.03 g, 92.4%). 
46: colorless plates, mp 171-172.5 oC (lit.49) mp 170-171 oC); [a]D23 -167 (c 1.50, 1N HCl aq) 
{(lit.28) [a]D -161 (c 0.77, HCl aq)}; IR (KBr): nmax 3291 cm-1 (NH), 1644 cm-1 (C=O); 1H-NMR 
(400 MHz, DMSO-d6): d (ppm) 4.31 (2H, br s, O=CNHNH2), 5.47 (1H, br d, J=8.4 Hz, 
HNCHPh), 7.27-7.41 (5H, m, PhH), 8.05 (1H, s, CHO), 8.91 (1H, br d, J=8.4 Hz, HNCHPh), 
9.54 (1H, brs, NH).  
 
(R)-N-Formylphenylglycine amide (48) (Scheme 3-10 and 3-12) 
 
NHCHOH2NHN
PhO
4846 47
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NHCHON3
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NHCHOH2N
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To a solution of (R)-N-formylphenylglycine hydrazide (46) (503.0 mg, 2.60 mmol, 1.00 Meq) in 
1 N HCl aq (10.5 ml) was added dropwise AcOH (2.60 ml, 44.7 mmol, 17.2 Meq), and a solution 
of NaNO2 (197.3 mg, 2.86 mmol, 1.10 Meq) in H2O (1.0 ml) at -5 oC, and then stirred for 4 h. 
The organic materials were extracted with cold Et2O (4 x 10 ml). Then the organic phase was 
washed with cold H2O (20 ml x 2), cold 3% NaHCO3 aq (20 ml x 2), and dried over MgSO4 at 0 
oC. NH3 (gas) was bubbled into the filtrate slowly at 0 oC for 15 min and further stirred for 1 h 
and at room temperature for 19.5 h. The reaction mixture was evaporated to dryness. Purification 
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of the residue by recrystallization from Et2O/ MeOH yielded the desired product 48 (357.0 mg, 
77.1%) {[a]D23 -177 (c 0.93, MeOH), lit.28) [a]D -185 (c 0.58, MeOH)}. 
 
NHCHOH2N
PhO
NH2H2N
PhO
4849
HCO2H 
 Ac2O
 
To a solution of (R)-amino-phenyl-acetic acid amide (49) (5.08 g, 33.7 mmol, 1.00 Meq) in 
formic acid (6.4 ml, 170 mmol, 5.04 Meq) was added dropwise acetic anhydride (16 ml, 170 
mmol, 5.04 Meq) at 0 oC, and then stirred for 30 min. Then, the reaction mixture was evaporated 
to dryness. Purification of the residue by recrystallization from Et2O/ MeOH yielded the desired 
product 48 (6.00 g, quant) {[a]D23 -194.8 (c 1.08, MeOH)}. 
48: colorless plates, mp 161-163 oC (lit.28) mp 164 oC); IR (KBr): nmax 3277 and 3198 cm-1 (NH), 
1693 and 1639 (C=O); 1H-NMR (400 MHz, CDCl3 + TFA): d (ppm) 5.60 (1H, dd, J=16, 6.8 Hz, 
NCHPh), 7.23-7.51 (5H, m, PhH), 8.31 (1H, s, CHO). 
 
(R)-Amino-phenyl-acetic acid amide (49) (Scheme 3-12) 
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To a solution of (R)-amino-phenyl-acetic acid methyl ester hydrochloride (44) (7.18 g, 35.6 
mmol, 1.00 Meq) in CHCl3 (72 ml) was added dropwise NEt3 (5.00 ml, 35.9 mmol, 1.01 Meq) at 
0 oC, and further stirred for 10 min. The reaction mixture was evaporated to dryness and the 
residue was washed with Et2O (100 ml x 2). The filtrate was evaporated to give 44’ (5.79 g, 
98.5%) as a colorless oil. Then NH3 (gas) was slowly bubbled into a solution of 44’ (5.79 g, 35.1 
mmol, 1.00 Meq) in MeOH (70 ml) at 0 oC for 1 h. The reaction mixture was stood at –2 oC for 
15 h and at 7 oC for 9 h. The reaction mixture was evaporated to dryness. Purification of the 
residue by recrystallization from benzene/ EtOH yielded the desired product 49 (4.54 g, 84.6% 
from 44). 
49: colorless needles, mp 130-132.5 oC (lit.33) mp 127-131 oC); [a]D23 -112.5 (c 1.02, EtOH) 
{lit.34) [a]D24 -108.5 (c 1.26, EtOH)}; IR (KBr): nmax 3305 and 3034 cm-1 (NH), 1664 cm-1 
(C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 4.53 (2H, s, NCHPh), 5.87 (1H, br s, C=ONHH), 
6.88 (1H, br s, C=ONHH), 7.43-7.29 (5H, m, PhH). 
 
(R)-N-Methyl-5-phenylimidazolidin-2-one (33) (Scheme 3-12) 
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To a solution of (R)-N-methyl-1-phenylethane-1,2-diamine (32) (158.5 mg, 1.06 mmol, 1.00 
Meq) in CH2Cl2 (1.5 ml) was added the solution of CDI (171.9 mg, 1.06 mmol, 1.00 Meq) in 
CH2Cl2 (2.0 ml) dropwise at 0 oC, then stirred at room temperature for 18 h. The solvent was 
evaporated. Purification of the residue by silica chromatography (AcOEt) and recrystallization 
from AcOEt yielded the desired product 33 (177.1 mg, 94.8%). 
33 : colorless prisms, mp 168-169 oC (lit.26) racemic compound 33 mp 148 oC); [a]D23 -51.2 (c 
1.25, MeOH); IR (KBr): nmax 3293 cm-1 (NH), 1703 and 1663 cm-1 (C=O); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 2.63 (3H, s, NCH3), 3.25 (1H, ddd, J=8.8, 8.8, 1.6 Hz, CHHCHPh), 3.75 (1H, 
ddd, J=8.8, 8.8, 1.6 Hz, CHHCHPh), 4.53 (1H, t, J=8.8 Hz, NCHPh), 4.85 (1H, br s, NH), 
7.32-7.42 (5H, m, PhH); LRFABMS m/z: 177 (MH+, 100%); Anal. Calcd for C10H12N2O: C, 
68.16; H, 6.86; N, 15.90. Found: C, 67.65; H, 6.86; N, 15.71. 
 
Anchoring 3-methy-4R-phenylimidazolidin-2-one onto polymer 
4-Iodomethylpoly(styrene-1%-divinylbenzene (P-I) (Scheme 3-14) 
 
Cl I
acetone
reflux, 2 d
NaI
P-Cl P-I  
 
To a polymer P-Cl (10.03 g, 17.5 mmol, 1.00 Meq) in acetone (200 ml) was added NaI (5.25 g, 
35.0 mmol, 2.00 Meq) and stirred at reflux for 2 d. The reaction was quenched by the addition of 
H2O (100 ml). The polymer was filtered out, washed with H2O, MeOH, CH2Cl2, and dried at 40 
oC for 12 h to yield P-I (12.53 g). 
P-8: yellow solid, mp > 300 oC; IR (KBr): nmax 1150 cm-1 (C-I). 
 
1-Methylcopoly(styrene-1%-divinylbenzene)-3-methyl-(4R)-phenylimidazolidin-2-one 
(P-53) (Scheme 3-13) 
NMeHN
O
NMeN
O
IPh Ph
1. NaH, DMF
2.
33 P-53  
To a suspension of NaH (60% in mineral oil, 502.3 mg, 12.6 mmol) and 33 (1.84 g, 10.4 mmol, 
Meq) in DMF (20 ml) under an argon atmosphere which was stirred at room temperature for 1 h 
was added 4-iodomethylpoly(styrene-1%-divinylbenzene) (3.00 g) at 0 oC, and further stirred at 
room temperature for 22.5 h and sonicated for 2 d. The reaction mixture was quenched by the 
addition of H2O (50 ml), and filtrated. The obtained solid was successively washed with 1 N HCl, 
H2O, MeOH, and CH2Cl2, and dried at 40 oC for 24 h to give P-53 (3.39 g).  
P-53: pale-yellow solid, mp > 300 oC; IR (KBr): nmax 1701 cm-1 (C=O). 
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2-Chloro-1-methylcopoly(styrene-1%-divinylbenzene)-3-methyl-(4R)-phenylimidazolinium 
chloride (P-54) (Scheme 3-14) 
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Ph Ph
P-53 P-54  
A mixture of P-53 (2.50 g) and oxalyl chloride (5.0 ml, 57.3 mmol) in benzene (25 ml) was 
stirred at refluxing for 24 h, cooled down to room temperature and evaporated under reduce 
pressure to yield crude P-54 (2.43 g, 86% conversion by FT-IR). 
P-54: IR (KBr): nmax 1627 cm-1 (C=N).  
 
2-[(1S)-1-Benzyl-2-Hydroxyethylimino]-1-methylpoly(styrene-1%-divinylbenzene)-3- 
methyl-(4R)-phenylimidazolidine (P-56) (Scheme 3-14) 
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To a suspension of P-54 (2.43 g) in CH2Cl2 (25 ml) was added dropwise a solution mixture of 
NEt3 (2.4 ml, 17.2 mmol) and (S)-phenylalaninol (2.5 g, 16.5 mmol) in CH2Cl2 (25 ml) at 0 oC, 
then ultrasonicated for 2 d. The reaction mixture was quenched by the addition of H2O (30 ml), 
and filtrated. The solid was successively washed with 1 N HCl, H2O, 20% NaOH aq, H2O, 
MeOH, and CH2Cl2, and dried at 40 oC for 24 h to give P-54 (2.38 g). 
P-54: pale-brown solid, mp > 300 oC; IR (KBr): nmax 1635 cm-1 (C=N). Anal. Cald for 
(C28H31N3O)n: C, 79.02; H, 7.34; N, 9.87. Found: C, 83.49; H, 7.46; N, 5.09. 
 
Synthesis of polymer-supported chiral guanidines by polymerization 
3-Methyl-1-(4-vinylbenzyl)imidazolidin-2-one (57) (Scheme 3-15) 
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To a suspension of NaH (60% in mineral oil, 145.6 mg, 3.64 mmol, 1.20 Meq) and 
N-methylimidazolidinone (10) (303.3 mg, 3.03 mmol, 1.00 Meq) in DMF (3.0 ml) under an 
argon atmosphere which was stirred at room temperature for 1 h was added vinylbenzyl chloride 
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(0.43 ml, 3.03 mmol, 1.00 Meq) at 0 oC, and further stirred at room temperature for 24 h. The 
reaction was quenched by the addition of H2O (30 ml), and the organic materials were extracted 
with AcOEt (20 ml x 2). The organic phase was washed with H2O (20 ml x 10), 1 N HCl (20 ml 
x 2), sat NaHCO3 (20 ml x 2), brine (20 ml x 2), dried over Na2SO4, and evaporated. Purification 
of the residue by silica chromatography (n-hexane/ Et2O = 2: 1) yielded the desired product 57 
(530.2 mg, 80.9%). 
57: a pale-yellow oil; IR (thin film): nmax 1690 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d 
(ppm) 2.83 (3H, s, NCH3), 3.13-3.18, 3.24-3.29 (each 2H, m, Ha x 2, Hb x 2), 4.35 (2H, s, 
ArCH2N), 5.23 (1H, dd, J=10.8, 0.9 Hz, Hy), 5.73 (1H, dd, J=18.0, 0.9 Hz, Hx), 6.70 (1H, dd, 
J=18.0, 10.8 Hz, Hz), 7.30 (2H, d, J= 8.0 Hz, Hm), 7.37 (2H, d, J= 8.0 Hz, Hn); 13C-NMR (100 
MHz, CDCl3): d (ppm) 31.17, 41.78, 44.75, 47.92, 113.51, 126.12, 128.10, 136.16, 136.45, 
136.68, 161.24; HRFABMS m/z: 217.1323 (Calcd for C13H16N2O: 217.1341). 
 
2-Chloro-3-methyl-1-(4-vinylbenzyl)imidazolinium chloride (59) (Scheme 3-15) 
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A mixture of 3-methyl-1-vinylbenzylimidazolidinone (57) (209.0 mg,0.97 mmol, 1.00 Meq) and 
oxalyl chloride (0.43 ml, 4.93 mmol, 5.08 Meq) in benzene (2.0 ml) was stirred at 75 oC for 9 h, 
and evaporated under reduce pressure to yield crude desired product (59) (239.8 mg, estimated 
by 1H-NMR 57: 59 = 30.2: 69.8).  
59: a brown oil; IR (thin film): nmax 1628 cm-1 (C=N); 1H-NMR (400 MHz, CDCl3): d (ppm) 
3.38 (3H, s, NCH3), 4.15, 4.31 (each 2H, br t, J= 9.4 Hz, Ha x 2, Hb x 2), 4.86 (2H, s, ArCH2N), 
5.32 (1H, d, J=10.8 Hz, Hy), 5.78 (1H, d, J=18.0 Hz, Hx) , 6.71 (1H, dd, J=18.0, 10.8 Hz, Hz), 
7.29 (2H, d, J= 8.0 Hz, ArH), 7.44 (2H, d, J= 8.0 Hz, ArH). 
 
2-[(S)-1-Benzyl-2-hydroxyethylimino]-1-(4-vinylbenzyl)-3-methylimidazolidine (61) 
(Scheme 3-15) 
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To a solution of 2-chloro-3-methyl-1-vinylbenzylimidazolinium chloride (59) (239.8 mg, 69.9% 
purity, 0.62 mmol, 1.61 Meq) in CH2Cl2 (2.4 ml) was added dropwise a solution mixture of NEt3 
(0.11 ml, 0.79 mmol, 2.06 Meq) and (S)-phenylalaninol (58.0 mg, 0.38 mmol, 1.00 Meq) in 
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CH2Cl2 (1.0ml) at 0 oC, then stirred at room temperature for 12 h. The reaction mixture was 
quenched by the addition of 10% citric acid aq (10 ml, to pH 3), and extracted with CH2Cl2 (20 
ml x 2). The solvent was evaporated to give brown solid which was dissolved in H2O (20 ml) 
and extracted with toluene (20 ml). The organic phase was evaporated to yield 3-methyl-1- 
vinylbenzylimidazolidinone (57) (120.5 mg) as a pale yellow oil. Then, the aqueous phase was 
added dropwise of 20% NaOH aq (10 ml, to pH >11) at 0 oC. The organic phase was extracted 
with CH2Cl2 (20 ml x 2), washed with brine (10 ml x 2), dried over Na2SO4 and evaporated. 
Purification of the residue by NH-silica chromatography (CHCl3 to 10% MeOH in CHCl3) 
yielded the desired product 61 (139.2 mg, 104%). 
61: a pale brown oil; IR (thin film): nmax 3259 cm-1 (OH), 1629 cm-1 (C=N); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 2.85 (1H, dd, J= 13.8, 4.4 Hz, PhCHHCH), 3.07 (1H, dd, J= 13.8, 9.8 Hz, 
PhCHHCH), 3.16 (3H, s, NCH3), 3.55-3.27 (4H, m, Ha x 2, Hb x 2), 3.82 (1H, d, J=12.0 Hz, 
CHCHHO), 3.91 (1H, br s, NCHCHH), 4.08 (1H, dd, J= 12.0, 8.8 Hz, CHCHHO), 4.45 (1H, d, 
J=16.4 Hz, Hk or Hl), 4.47 (1H, d, J=16.4 Hz, Hl or Hk), 5.29 (1H, d, J=11.2 Hz, Hy), 5.77 (1H, d, 
J=17.6 Hz, Hx), 6.71 (1H, dd, J=17.6, 11.2 Hz, Hz), 7.13-7.41 (9H, m, PhH); 13C-NMR (100 
MHz, CDCl3): d (ppm) 35.32, 37.28, 46.55, 48.70, 51.73, 60.24, 64.03, 114.10, 126.33, 126.36, 
127.59, 128.00, 129.31, 133.86, 135.80, 137.01, 137.57, 159.82; HRFABMS m/z: 350.2233 
(Calcd for C22H28N3O: 350.2232). 
 
(R)-3-Methyl-4-phenyl-1-(4-vinylbenzyl)imidazolidin-2-one (58) (Scheme 3-15) 
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To a suspension of NaH (60% in mineral oil, 68.8 mg, 1.72 mmol, 1.14 Meq) and (R)-N-methyl- 
5-phenylimidazolidinone (33) (266.3 mg, 1.51 mmol, 1.00 Meq) in DMF (2.7 ml) under an argon 
atmosphere which was stirred at room temperature for 1 h was added vinylbenzyl chloride (0.22 
ml, 1.56 mmol, 1.03 Meq) at 0 oC, and further stirred at room temperature for 24 h. The reaction 
was quenched by the addition of H2O (20 ml), and the organic materials were extracted with 
AcOEt (2 x 20 ml). The organic phase was washed with H2O (10 x 20 ml), 1 N HCl (2 x 20 ml), 
sat NaHCO3 (2 x 20 ml), brine (2 x 20 ml), dried over Na2SO4, and evaporated. Purification of 
the residue by silica chromatography (n-hexane/ Et2O = 2: 1) yielded the desired product 58 
(407.5 mg, 93.5%).  
58: pale yellow oil.; IR (thin film): nmax 1698 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 
2.68 (3H, s, NCH3), 2.96 (1H, ddd, J=8.8, 8.8, 2.0 Hz, NCHHCHPh), 3.52 (1H, ddd, J=8.8, 8.8, 
2.0 Hz, NCHHCHPh), 4.33 (1H, d, J=15.2 Hz, ArCHHN), 4.37 (1H, t, J =8.8 Hz, NCHHCHPh), 
4.51 (1H, d, J=15.2 Hz, ArCHHN), 5.23 (1H, d, J=10.8 Hz, Hy), 5.73 (1H, d, J=17.6 Hz, Hx), 
6.69 (1H, dd, J=17.6, 10.8 Hz, Hz), 7.23-7.38 (9H, m, PhH); 13C-NMR (100 MHz, CDCl3): d 
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(ppm) 29.36, 47.78, 51.03, 60.17, 113.59, 126.19, 126.59, 128.07, 128.67, 136.15, 136.55, 
139.24, 161.01; HRFABMS m/z: 293.1655 (Calcd for C19H20N2O: 293.1654). 
 
(R)-2-Chloro-3-methyl-4-phenyl-1-(4-vinylbenzyl)imidazolinium chloride (60) (Scheme 
3-15) 
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A mixture of 3-methyl-(4R)-phenyl-1-(4-vinylbenzyl)imidazolidinone (58) (400.7 mg,1.37 mmol, 
1.00 Meq) and oxalyl chloride (0.60 ml, 6.87 mmol, 5.01 Meq) in benzene (4.0 ml) was stirred at 
75 oC for 9 h. The reaction mixture was sampled to decide the percentage of conversion 
(estimated by 1H-NMR 58: 60 = 54.4: 45.6). After the addition of an oxalyl chloride (0.60 ml, 
6.87 mmol, 5.01 Meq), the reaction was further stirred at 75 oC for 30 h, and then evaporated 
under reduce pressure to yield crude desired product (3) (458.8 mg, estimated by 1H-NMR 58: 
60 = 24.7: 75.3). 
60: brown solid; IR (KBr): nmax1627 cm-1 (C=N); 1H-NMR (400 MHz, CDCl3): d (ppm) 3.16 
(3H, s, NCH3), 3.73 (1H, dd, J=10, 9.6 Hz, NCHHCHPh), 4.77 (1H, dd, J=10, 9.6 Hz, 
NCHHCHPh), 4.85 (1H, d, J=15.2 Hz, ArCHHN), 5.05 (1H, d, J=15.2 Hz, ArCHHN), 5.32 (1H, 
d, J=10.8 Hz, Hy), 5.75 (1H, t, J=9.6 Hz, NCHHCHPh), 5.78 (1H, d, J=17.6 Hz, Hx), 6.66-6.74 
(1H, dd, J=17.6, 10.8 Hz, Hz), 7.25-7.46 (9H, m, ArH). 
 
2-[(1S)-1-Benzyl-2-hydroxyethylimino]-1-(4-vinylbenzyl)-3-methyl-(4R)-phenylimidazoli- 
dine (62) (Scheme 3-15) 
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To a solution of 2-chloro-3-methyl-(4R)-phenyl-1-(4-vinylbenzyl)imidazolinium chloride (60) 
(458.8 mg, 75.3% purity, 1.00 mmol, 1.43 Meq) in CH2Cl2 (4.6 ml) was added dropwise a 
solution mixture of NEt3 (0.30 ml, 2.15 mmol, 3.10 Meq) and (S)-phenylalaninol (105.0 mg, 
0.69 mmol, 1.00 Meq) in CH2Cl2 (2.0 ml) at 0 oC, then stirred at room temperature for 12 h. The 
reaction mixture was quenched by the addition of 10% citric acid aq (10 ml, to pH 3), and 
extracted with CH2Cl2 (20 ml x 2). The solvent was evaporated to give brown solid which was 
dissolved in H2O (20 ml) and extracted with toluene (20 ml). The organic phase was evaporated 
to yield 3-methyl-(4R)-phenyl-1-(4-vinylbenzyl)imidazolidinone (58) (198.0 mg) as a pale 
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yellow oil. Then the aqueous phase was added dropwise of 20% NaOH aq (20 ml, to pH >11) at 
0 oC. The organic phase was extracted with CH2Cl2 (20 ml x 2), washed with brine (10 ml x 2), 
dried over Na2SO4 and evaporated. Purification of the residue by NH-silica chromatography 
(CHCl3 to 10% MeOH in CHCl3) yielded the desired product 62 (289.5 mg,98.0%). 
62: brown prisms, mp 55-57.5 oC; IR (KBr): nmax 3259 cm-1 (OH), 1629 cm-1 (C=N); 1H-NMR 
(400 MHz, CDCl3): d (ppm) 2.90 (1H, dd, J=14, 4.0 Hz, PhCHHCH), 3.00 (1H, dd, J=10, 10 Hz, 
NCHHCH), 3.07 (3H, s, NCH3), 3.14 (1H, dd, J=14.0, 4.0 Hz, PhCHHCH), 3.77 (1H, dd, J=10, 
10 Hz, NCHHCH), 3.87-3.93 (1H, br m, PhCHHCH); 4.11-4.22 (2H, br m, CHCHHO); 4.43 
(1H, dd, J=10.0, 10.0 Hz, NCHHCH), 4.46 (1H, d, J=15.6 Hz, ArCHHN); 5.13 (1H, d, J=15.6 
Hz, ArCHHN), 5.27 (1H, d, J=10.8 Hz, Hy); 5.75 (1H, d, J=17.6 Hz, Hx), 6.67 (1H, dd, J=17.6, 
10.8 Hz, Hz); 7.16-7.37 (14 H, m, ArH); 13 C-NMR (100 MHz, CDCl3) d (ppm): 35.34, 38.02, 
52.35, 55.40, 60.31, 63.89, 64.70, 114.10, 126.6, 127.9, 128.1, 128.2, 128.5, 128.8, 129.0, 129.2, 
129.6, 134.3, 135.80, 137.2, 137.9, 159.5; HRFABMS m/z: 426.2538 (Calcd for C28H32N3O: 
426.2545). 
 
2-[(S)-1-Benzyl-2-hydroxyethylimino]-1-methylpoly(styrene)-3-methylimidazolidine (P-63) 
(Scheme 3-16) 
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To a solution of vinyl benzyl guanidine 61 (137.2 mg, 0.39 mmol, 1.00 Meq) in dry toluene (2.0 
ml) was added styrene (0.18 ml, 1.57 mmol, 4.02 Meq) and AIBN (18.5 mg, 0.11 mmol, 0.3 
Meq), stirred at 80 oC for 48 h. The suspension was cooled down to room temperature, added dry 
benzene (2.0 ml), and further stirred at 80 oC for 48 h. The reaction mixture was evaporated and 
dissolved in CH2Cl2 (2.0 ml). Then, the solution mixture was added dropwise to MeOH (25 ml), 
and the obtained solid was filtered, washed with MeOH, CH2Cl2 and dried at 40 oC for 12 h to 
give an insoluble P-63 (85.5 mg, 11.7% by weight). The filtrate was evaporated to give pale 
yellow solid which was dissolved in CH2Cl2 (2.0 ml) and added to MeOH (20 ml). The solid was 
filtered, washed with MeOH, and dried at 40 oC for 12 h to give a soluble P-63 (183.8 mg, 
61.1% by weight)  
Insoluble P-63: pale brown solid, mp > 300 oC; IR (KBr): nmax 3364 cm-1 (OH), 1626 cm-1 
(C=N).  
Soluble P-63: pale yellow solid, mp >300 oC; IR (KBr): nmax 3364 cm-1 (OH), 1626 cm-1 (C=N). 
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2-[(S)-1-Benzyl-2-hydroxyethylimino]-1-methylpoly(styrene)-3-methyl-(4R)-phenylimida- 
zolidine (P-64) (Scheme 3-16) 
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To a solution of vinylbenzyl guanidine 62 (100.8 mg, 0.24 mmol, 1.00 Meq) in dry benzene (2.0 
ml) was added styrene (1.01 ml, 8.82 mmol, 36.8 Meq) and AIBN (10.5 mg, 0.064 mmol, 0.3 
Meq), stirred at 80 oC for 48 h. The reaction mixture was evaporated and dissolved in CH2Cl2 
(5.0 ml). Then, the solution mixture was added dropwise to MeOH (50 ml), and the solid was 
filtered, washed with MeOH, and dried at 40 oC for 50 h to give P-64 (856.3 mg, 84.0% by 
weight). 
P-64: colorless solid, mp >300 oC; [α]D23 -0.28 (c 4.4, CHCl3); IR (KBr): nmax 3367 cm-1 (OH), 
1637 cm-1 (C=N); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.5-2.0 (br, CH2CH), 2.68-4.50 (br, 
NCH3 + NCHCH2 + NCH2Ar + PhCH2CHCH2), 6.49-7.29 (2C6H5 + C6H4);  
Anal. Cald for (C28H32N3O) (C8H8)32: C, 90.73, H, 7.72, N, 1.12. Found: C, 90.24; H, 7.94; N, 
1.11. 
 
1-Methylpoly(styrene)-3-methylimidazolidin-2-one (P-65) (Scheme 3-16) 
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To a solution of vinylbenzyl imidazolidinone 57 (342.0 mg, 1.58 mmol, 1.0 Meq) in dry toluene 
(3.0 ml) was added styrene (1.0 ml, 8.73 mmol, 5.52 Meq), AIBN (13.9 mg, 0.085 mmol, 0.05 
Meq) and stirred at 80 oC for 96 h. The reaction mixture was evaporated and dissolved in CH2Cl2 
(5.0 ml). Then, the solution mixture was added dropwise to MeOH (50 ml), and the solid was 
filtered, washed with MeOH, and dried at 40 oC for 41 h to give P-65 (865.5 mg, 69.2% by 
weight). 
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P-65: colorless solid, mp >300 oC; IR (KBr): nmax 1702 cm-1 (C=O); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 1.5-2.0 [45H, br, (CH2CH)13 + (CH2CH)2], 2.82 [6H, s, (NCH3)2], 2.9-3.1 [4H, 
br s, (NCH2CH2)2], 3.1-3.3 [4H, br s, (NCH2CH2)2], 4.25 [4H, br s, (NCH2Ar)2], 6.3-7.2 [73H, br, 
(C6H5)13 + (C6H4)2]; Anal. found: C, 85.34; H, 7.61; N, 3.22. 
 
2-Chloro-1-methylpoly(styrene)-3-methylimidazolinium chloride (P-66) (Scheme 3-16) 
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To a solution of soluble P-65 (805.2 mg) in dry benzene (4.0 ml) was added oxalyl chloride (1.5 
ml, 17.2 mmol) and stirred at 75 oC for 24.5 h. The reaction mixture was evaporated to give 
crude P-66 (910.5 mg). 
P-66: brown solid, mp > 300 oC; IR (KBr): nmax cm-1 1627 (C=N); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 1.5-2.0 [45H, br, (CH2CH)13 + (CH2CH)2], 3.25 [6H, s, (NCH3)2], 3.6-4.2 [8H, 
br, (NCH2CH2)2], 4.55-4.74 [4H, br, (NCH2Ar)2], 6.2-7.2 [73H, br, (C6H5)13 + (C6H4)2]. 
 
2-[(S)-1-Benzyl-2-hydroxyethylimino]-1-methylpoly(styrene)-3-methylimidazolidine (P-67) 
(Scheme 3-16) 
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To a solution of P-66 (209.8 mg) in CH2Cl2 (1.0 ml) was added dropwise a solution mixture of 
DIPA (0.24 ml, 1.38 mmol, 1.0 Meq) and (S)-phenylalaninol (208.5 mg, 1.38 mmol, 1.0 Meq) in 
CH2Cl2 (3.0 ml) at 0 oC and sonicated for 48 d. The reaction mixture was evaporated and 
dissolved in CH2Cl2 (2.0 ml). Then, the solution mixture was added dropwise to MeOH (20 ml), 
and the solid was filtered, washed with MeOH, and dried at 40 oC for 12 h to give P-67 (217.9 
mg). 
P-67: pale-brown solid, mp > 300 oC; IR (KBr): nmax 3320 cm-1 (OH), 1656 cm-1 (C=N); 
1H-NMR (400 MHz, CDCl3): d (ppm) 1.5-2.0 [br, (CH2CH)n + (CH2CH)m], 2.5-3.5 [br, 
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(PhCH2CH)k + (NCHHCH)m + (NCH3)m], 3.5-4.5 [br, (NCHHCH)m + (PhCH2CH)k + (CH2O)k + 
(NCHHCH)m + (NCH2Ar)m], 6.2-7.2 [br, (C6H5)n + (C6H4)m+(C6H5)k]. 
 
Polystyrene (P-68) (Scheme 3-17) 
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To a solution of styrene (0.20 ml, 1.75 mmol, 1.0 Meq) in dry benzene (1.0 ml) was added AIBN 
(12.8 mg, 0.08 mmol, 0.04 Meq), stirred at 80 oC for 48 h. The reaction mixture was evaporated 
to dryness. The reaction mixture was evaporated and dissolved in CH2Cl2 (1.0 ml). Then, the 
solution mixture was added dropwise to MeOH (20 ml), and the solid was filtered, washed with 
MeOH, and dried at 40 oC for 12 h to give P-68 (168.9 mg, 92.9%).  
P-68: colorless solid; mp >300 oC; IR (KBr): nmax 1601 cm-1 (C=C); 1H-NMR (400 MHz, 
CDCl3) d (ppm): 1.5-2.0 (br, CH2CH), 6.2-7.2 (br, C6H5). 
 
Poly{1-benzyl-2-[(1S)-1-benzyl-2-hydroxyethylimino]-3-methyl-(4R)-phenylimidazolidine} 
(P-69) (Scheme 3-17) 
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To a solution of vinylbenzyl guanidine 62 (145.0 mg, 0.34 mmol, 1.00 Meq) in dry benzene (1.0 
ml) was added AIBN (13.0 mg, 0.08 mmol, 0.2 Meq), stirred at 80 oC for 48 h. The reaction 
mixture was evaporated to dryness. The crude solid was washed with MeOH, and dried at 40 oC 
for 12 h to give P-69 (139.8 mg, 96.4%). 
P-69: pale-brown solid; mp >300 oC; [a]D23 -35.7 (c 2.4, CHCl3); IR (KBr): nmax 3364 cm-1 (OH), 
1626 cm-1 (C=N). 1H-NMR (400 MHz, CDCl3): d (ppm) 1.5-2.0 [br, (CHCH2)m], 2.7-3.5 [br, 
(PhCH2CH)m + (NCHHCH)m + (NCH3)m], 3.5-5.5 [(NCHHCH)m + (PhCH2CH)m + (CH2O)m + 
(NCHHCH)m + (ArCH2N)m], 6.2-7.2 [(C6H4)2m + (C6H5)m]; Anal. Cald for (C28H31N3O)n: C, 
79.02, H, 7.34, N, 9.87. Found: C, 67.55; H, 7.06; N, 9.14. 
 
 
 66 
(R)1-Benzyl-2-chloro-3-methyl-4-phenylimidazolinium chloride (70) (Scheme 3-18) 
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A mixture of 72 (267.0 mg, 0.95 mmol, 1.00 Meq) and oxalyl chloride (0.50 ml, 5.72 mmol, 6.1 
Meq) in benzene (2.5 ml) was stirred at 75 oC for 24 h. The reaction mixture was evaporated 
under reduce pressure to yield crude desired product (70) (342.0 mg, estimated by 1H-NMR 72 : 
70 = 5.4: 94.6). 
70: brown solid; IR (KBr): nmax 1618 cm-1 (C=N); 1H-NMR (400 MHz, CDCl3): d (ppm) 3.17 
(3H, s, NCH3), 3.75 (1H, br s, NCHHCHPh), 4.79 (1H, br s, NCHHCHPh), 4.89 (1H, d, J=15.2 
Hz, ArCHHN), 5.09 (1H, d, J=15.2 Hz, ArCHHN), 5.77 (1H, br s, NCHHCHPh), 7.26-7.41 
(10H, m, ArH). 
 
1-Benzyl-2-[(S)-1-Benzyl-2-hydroxyethylimino]-3-methyl-4R-phenylimidazolidin-2-one (71) 
(Scheme 3-18) 
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To a solution of 1-benzyl-2-chloro-3-methyl-(4R)-phenylimidazolinium chloride (70) (303.8 mg, 
94.6% purity, 0.89 mmol, 1.48 Meq) in CH2Cl2 (3.0 ml) was added dropwise a solution mixture 
of NEt3 (0.25 ml, 1.79 mmol, 2.97 Meq) and (S)-phenylalaninol (91.2 mg, 0.60 mmol, 1.00 Meq) 
in CH2Cl2 (1.0 ml) at 0 oC, then stirred at room temperature for 12 h. The reaction mixture was 
quenched by the addition of 10% citric acid aq (10 ml, to pH 3), and extracted with CH2Cl2 (20 
ml x 2). The solvent was evaporated to give brown solid which was dissolved in H2O (15 ml) 
and extracted with toluene (20 ml). The organic phase was evaporated to yield 72 and the 
corresponding imidazolidinone (91.8 mg) as a pale-yellow oil. Then the aqueous phase was 
added dropwise of 20% NaOH aq. (20 ml, to pH >11) at 0 oC. The organic phase was extracted 
with CH2Cl2 (20 ml x 2), washed with brine (10 ml x 2), dried over Na2SO4 and evaporated. 
Purification of the residue by NH-silica chromatography (CHCl3 to 10% MeOH in CHCl3) 
yielded the desired product 62 (240.8 mg, 100%). 
71: a pale-yellow solid, mp 110-112 oC; [a]D23 -61.7 (c 1.00, CHCl3); IR (KBr): nmax 3259 cm-1 
(OH), 1629 cm-1 (C=N); 1H-NMR (400 MHz, CDCl3): d (ppm) 2.91 (1H, dd, J=14, 4.0 Hz, 
PhCHHCH), 3.00 (1H, dd, J=10.0, 10.0 Hz, NCHHCH), 3.07 (3H, s, NCH3), 3.15 (1H, dd, 
J=14.0, 4.0 Hz, PhCHHCH), 3.78 (1H, dd, J=10.0, 10.0 Hz, NCHHCH), 3.87-3.96 (1H, br m, 
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PhCHHCH), 4.11-4.21 (2H, br m, CHCHHO), 4.43 (1H, dd, J=10, 10 Hz, NCHHCH), 4.50 (1H, 
d, J=15.6 Hz, ArCHHN), 5.12 (1H, d, J=15.6 Hz, ArCHHN), 7.16-7.37 (15 H, m, ArH). 
 
The reactivity of polymer-supported chiral guanidines 
2-(Benzhydrylidene-amino)-5-oxo-hexanoic acid tert-butyl ester (20b) (entries 4 and 14 in 
Table 3-4) 
 
Ph
Ph
N CO2tBu COMe
Ph
Ph
N COMe
CO2tBu
18 19b 20b
71 or P-64
THF
 
: using 71 
To a solution of tert-butyl diphenyliminoacetate (30.5 mg, 0.10 mmol, 1.00 Meq) and 71 in dry 
THF (0.5 ml) was added MVK (19b) (0.03 ml, 0.36 mmol, 3.60 Meq), and stirred at 20 oC for 7 
d. The reaction mixture was evaporated. Purification of the residue by preparative thin layer 
chromatography (n-hexane/ Et2O= 1: 3) yielded the desired product (20b) (27.4 mg, 75.0%, 74% 
ee; determined by chiral HPLC (DAICEL CHIRALCEL OD-H, eluent n-hexane/ 2-propanol, 30 
oC, 254 nm, flow rate 1.0 ml/ min, t1= 11.0 min, t2= 15.7 min). 
: using P-64 
To a solution of tert-butyl diphenyliminoacetate (33.1 mg, 0.11 mmol, 1.00 Meq) and P-64 
(303.8 mg) in dry THF (1.0 ml) was added MVK (19b) (0.03 ml, 0.36 mmol, 3.30 Meq), and 
stirred at 20 oC for 21 d. The reaction mixture was evaporated and dissolved in CH2Cl2 (1.0 ml). 
Then, the solution mixture was added dropwise to MeOH (20 ml), and the solid was filtered, 
washed with MeOH, and dried at 40 oC for 50 h to give recovered P-64 (298.1 mg). The organic 
phase was evaporated. Purification of the residue by thin layer chromatography (n-hexane/ 
Et2O= 1: 3) yielded the desired product (20b) (18.1 mg, 45%, 48% ee) 
20b : a colorless oil; IR (thin film): nmax 1735 and 1718 cm-1 (C=O), 1625 cm-1 (C=N). 1H-NMR 
(400 MHz, CDCl3): d (ppm) 1.44 [9H, s, O(CH3)3], 2.15 (3H, s, CH3), 2.14-2.17 (2H, m, 
NCHCH2CH2), 2.49-2.55 (2H, m, NCHCH2CH2), 3.96 (1H, m, NCHCH2CH2), 7.16-7.65 (10H, 
m, PhH). 
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PART 2 
Chapter 1: Aziridine Chemistry 
1.1 Introduction 
Aziridines have been synthetic targets as well as useful building blocks in synthesis since 
discovery of the smallest nitrogen containing heterocycle by Gabriel in 1888.1) Under attraction 
by the increased strain and unique reactivity of the three-membered ring, synthetic chemists 
have extensively explored the various manipulations of aziridine-containing compounds. 
Ring strain energy and N-inversion energy of simple aziridines 
According to computational method using ab initio molecular orbital calculation, Bach et 
al.2) reported the predictation of ring strain energy (SE) of parent (unsubstituted) aziridine to be 
27.0 kcal/mol in agreement with the experimental value (26.7 kcal/mol),3) as shown in Table 
1-1. 
Table 1-1. Ring strain energy (kcal/mol) calculated by ab initio, G2 method a 
XXX
X
substituent (X)
CH2
O
NH
0.2 6.4 25.7 27.3
0.0 6.2 26.5 27.5
1.2 5.7 24.9 26.4
0.0 5.4 24.7 26.3
1.1 6.1 25.4 27.0
0.0 5.8 25.2 26.7  
a Experimental SEs are taken from ref. 3 and given in bold type. 
Aziridines have a significantly larger barrier to nitrogen inversion than other amines (18.9 
kcal/mol for the parent aziridine compared to 5-7 kcal/mol for most amines based on 6-31G* 
MP2 geometries).4) This gives rise to two distinguishable invertomers in the case of 
N-substituted aziridines: one with the nitrogen substituent cis to the carbon substituent and 
another with a trans relationship between the two substituents (Figure 1-1).5) 
N
P R
H
N
P
R
H
cis-invertomer trans-invertomer 
Figure 1-1. Possible nitrogen inversion of aziridines 
 
The N-inversion energies of aziridines was investigated using 
B3LYP/6-31+G* methods, where substituents (R) on the nitrogen atom 
are H, Me, Ph, Bn, CHMePh, CO2Me, COPh and SOPh .  H2C CH2
N
R
 
The order of N-inversion energy with R group is decreased as the following order: R = 
CHMePh (17.06 kcal/mol) > Me (16.97) > Bn (16.70) > H (16.64) > SO2Ph (12.18) > Ph (8.91) 
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> COPh (5.75) > CO2Me (5.48).6) 
1.2 Synthesis of Aziridines 
1.2.1 Reported Asymmetric Synthesis of Aryl- and Alkylaziridines 
1. From enantiopure amino alcohols 
The simplest preparation of aziridines is the ring closure of a β-functional ethylamine. 
Using enantiopure amino alcohols 1, chiral aziridines 3 could be synthesized by intramolecular 
nucleophilic displacement reaction as illustrated in Scheme 1-1.  
N
H
3
H2N
R
OH H2N
R
X
Intramolecular
cyclization
1 2
R
X= good leaving group
R= phenyl, benzyl, alkyl
* * *
 
Scheme 1-1. General synthesis of aziridines from amino alcohols 
Although ring closure itself is quite facile, the synthesis of the required precursors can be 
problematic.  
2 From epoxides 
An efficient and stereoselective approach to aziridines has been developed by extension of 
Jacobsen’s hydrolytic kinetic resolution of epoxides (HKR) (Scheme 1-2).7) Doubly protected 
amine 5 reacts with racemic epoxides 4 in the presence of catalyst 6 to provide amino alcohol 7 
in an excellent yield of albeit with limited enantioselectivity. In practice, this nucleophilic ring 
opening affords highly enantio-enriched 1,2-amino alcohols in excellent yields via a one-pot 
process from racemic terminal epoxides. The protected amino alcohol is then converted to the 
corresponding aziridine by conventional method. Excellent enantioselectivitie and high yield 
are observed. Unfortunately, this method requires the loss of the “matched” enantiomer (50% of 
the starting material). 
O
tBu
1. (S,S)-6 (2 mol%)
H2O (0.55 equiv.)
THF, 0 oC to rt, 3 h
2. 5 (0.4 equiv.)
THF, rt, 3 h
tBu
N
OH Boc
Ns
1. THF
2. Ms2O, pyr.
3. K2CO3
H2O/ THF
reflux
N
tBu
(74%, 99% ee)
O
Co
N
O
N
OAc
tBu tBu
tBu tBu
4 7 8
6
Ns
H
N
Boc
5
Ns
 
Scheme 1-2. Enantiopure aziridines from epoxides by modified HKR  
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3. Addition of Nitrene (or Nitrenoid) to Olefins 
The strategy of nitrogen transfer in aziridine synthesis to olefins does not require highly 
functionalized precurors. The use of a diaziridine provides an alternative method for 
diastereoselective aziridination of α,β-unsaturated amides, as reported by Ito et al.(Scheme 
1-3).9)  
Ph N
O
Ph N
ON Ph
N
N
H N Ph
N
n-BuLi (2 equiv.)
THF, -78 to -30 oC, 4 h
(77%, 94% ee) (5%, 98% ee)
O
H
H H
9
10
11 12
 
Scheme 1-3 Asymmetric aziridination of a,b-unsaturated amide  
with optically active diaziridine 
Diaziridine-based nitrogen transfer allows for reagent-controlled diastereoselective 
synthesis of either cis- or trans-aziridines in good to excellent yields (73-99%) from single 
alkenes. Aldehyde-derived diaziridines provide the trans-aziridines in good chemical and 
stereochemical yields, whereas ketone-derived diaziridines with bulkiness allow access to 
cis-aziridines in excellent enantioselecivity albeit low chemical yield. Unfortunately, this 
reagent requires the use of an α,β-unsaturated amide as an olefinic unit, thus severely limiting 
its scope, and it also suffers further from the requisite preparation of the diaziridines. 
Although diaziridines are prepared from the reaction of phenylethylamine, aldehyde and 
hydroxylamine-O-sulfonic acid in the presence of NEt3, the method is not completely practical, 
thus efficient catalytic enantioselective nitrogen transfer method has been extensively explored. 
Transition metal catalysis, which causes enantioselection using chiral ligands, was first 
introduced in aziridination by Evans, who demonstrated that a catalytic amount of copper(II) 
triflate could facilitate nitrene transfer to a variety of olefins in high yields (Scheme 1-4). 
Ph Ph
NTs
CuOTf (5 mol%)
0 oC, 2.5 h
(89%, 63% ee)
ligand 15 (6 mol%)
N N
O O
ligand 15
PhI=NTs
13 14
 
Scheme 1-4. Bis(oxazoline)-copper complex catalyzed aziridination 
 
 
Jacobsen and Katsuki have 
developed copper- or manganese- 
catalyzed asymmetric aziridination 
by application of Salen ligands 16 
and 17, respectively.10-12) 
Cl
N
Cl
N
R R
16
O
Mn
N
O
N
17
Cl Cl
Ph Ph
Figure 1-2. Jacobsen and Katsuki’s ligands 
 74 
More recently, a new series of Schiff base ligands has been applied to catalytic, 
enantioselective copper-nitrenoid additions.13) 2,2’-Diarylimino-6,6’-dimethylbiphenyl-derived 
ligand 20 highly facilitates stereoselective aziridination of chromenes (99% ee) and 
trans-cinnamate esters (60-98% ee). However, poor selectivity is observed with other olefins, 
emphasizing the limited scope of substrate in the copper-catalyzed asymmetric aziridination 
(Scheme 1-5). 
O
O
O
O
NTsPhI=NTs
CH2Cl2, -40 oC, 5 h
[Cu(MeCN)4][BF4]2
(87%, 99% ee)
Ar
Ar
Ar= 2,6-C6H3Cl2ligand 20
 2018 19
Scheme 1-5. Enantioselective aziridination of chromene catalyzed by  
biaryl Schiff base-copper complex 
A newly-developed alternative to the copper-based aziridinations introduced by Bois uses a 
dimeric rhodium catalyst (Scheme 1-6).14) This method torelates a wider range of aziridine 
structures in high yields (57-84%). Iminoiodananes required for the rhodium-nitrene transfer 
are generated in situ from sulfamate ester and diacetoxy- iodosobenzene. Rhodium trifluoro- 
acetamide exhibits the greatest activity among rhodium sources screened, allowing reactions at 
low catalyst loadings (1-2 mol %). The protecting group of sulfamate ester can be easily 
cleaved by zinc amalgam.  
benzene, 0 oC, 5 h
Ph
Me
H2N
S
O
O O
CCl3
Rh2(tfacam)4
PhI(OAc)2, MgO+
Ph
Me
N
SO3CH2CCl3
(72%)
21 22 23
 
Scheme 1-6. Rhodium-catalyzed nitrene transfer 
4. Carbene Transfer to Imines 
The potential for highly enantioselective aziridination has been realized in two particular 
systems. Aggarwal et al. has reported a highly enantioselective aziridination by transferring 
carbene generated from a tosylhydrazone 25 to an imine 24.15) Rhodium initially traps the 
generated carbene and transfers it to chiral sulfides, which provide a chiral environment for 
subsequent nucleophilic attack on the imine. This process shows wide generality and excellent 
enantioselectivity (73-98%), but suffers from lower diastereoselectivities (~ 2:1) for most 
substrates (Scheme 1-7).  
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dioxane, 40 oC
Ph N
R
BnEt3N+Cl- (10 mol%)
+
Ph
Ph
N
R
Ph N
N
Ts
Rh2(OAc)4 (1 mol%)
sulfide 26 (20 mol%) 27: R= SES, 75% , dr= 2.5 : 1, 94% ee
28: R= Boc, 33%, dr= 8 : 1, 89% ee
29: R= Ts, 68%, dr= 2.5 : 1, 98% ee
S
O
24
25
26
 
Scheme 1-7. Asymmetric aziridination of imines with chiral sulfides 
An alternative method for a chiral carbene transfer is the desymmetrization of imines by 
complexation with a chiral Lewis acid (S-VAPOL-Boron) (Scheme 1-8).16) The use of an aryl 
borate catalyst derived from (S)-VAPOL ligands in the aziridination of aryl imines with ethyl 
diazoacetate represents a highly diastereo- and enantioselective method. This chiral ligand 
greater promotes not only reactivity but also selectivity (20-65 : 1 er, > 50 : 1 dr).  
Ph N
+
N2
OEt
O
Ph
Ph
S-VAPOL-Boron (2.5 mol%)
CH2Cl2, 22 oC, 2 h
N
CO2Et
Ph
Ph
Ph
(79%, 98% ee)
dr > 50 : 1
Ph
OHPh
OH
S-VAPOL (33)
30 31 32
Scheme 1-8. Catalytic asymmetric aziridination of imines with VAPOL-boron 
This method is compatible with a wide range of imines, including aromatic and aliphatic 
imines. 
1.2.2 Reported Asymmetric Synthesis of Vinylaziridines 
A major interest in vinylaziridine syntems stems from their use as synthetic tools in 
rearrangement to produce ring-expanded molecules such as pyrrolines and azepines (Scheme 
1-9).17) These transformations have been applied as key steps in the synthesis of several 
nitrogen containing natural products.18)  
NR
R1
O
R2
[3,3]-Claisen
N
H
R1
R2
O
R
NR
R1
[2,3]-Wittig
CO2tBu
N
H
R1
CO2tBu
R
34 35
3637  
Scheme 1-9. Aza-Wittig and aza-Claisen rearrangements of vinylaziridines 
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Although vinylaziridines have also found increasingly as useful intermediates in organic 
synthesis, there are surprisingly few general enantiomeric methods for their preparation. The 
simplest method for their synthesis is carbon-carbon double bond formation after the 
construction of aziridine ring.19) Efficient routes to vinylaziridines may be the reaction of 
N-sulfonylimines with allylic ylides, which was developed by Chen20) and Stockman.21) Allylic 
sulfonium, telluronium or arsonium salts react with a,b-unsaturated N-sulfonylimines under 
solid-liquid phase-transfer conditions in the presence of KOH to produce vinylaziridines in 
moderate to excellent yield, albeit low diastereoselecitvity. Unfortunately, the formed 
zwitterionic intermediate has a tendency to undergo an intramolecular 1,5-elimination, 
generating a pyrroline as a side product. Improvement in diastereoselecitvity by using a bulky 
trimethylsilyl-substituted ylide was done but no significant change in enantioselectivity. 
Stockman demonstrated the utility of ylide derived from allyl tetrahydrothiophenium bromide 
39 for reacting with tert-butylsulfinylimines 38 (Scheme 1-10). The reaction is generally 
stereoselective (dr >1/50) and proceeds in good yield (44-78%).  
N R + R
N
S
S
O
S
Br
tBuOLi
THF, rt
O
~1/ 4.8   cis/ trans
up to 95% de (trans isomer)
R= aryl, alkyl
38 39 40
 
Scheme 1-10. Aziridination of chiral sulfinyl imines with allyl sulfur ylide 
 
1.3 Asymmetric Synthesis of Aziridines from Guanidinium Ylides and Aryl 
Aldehydes 
In our laboratory aziridine was first unexpectedly synthesized by Hada et al. in 1999 in the 
reaction of guanidinium bromide 41 and an aryl aldehyde 42c in the presence of NaH as base at 
low temperature followed by the purification by SiO2 column chromatography (Scheme 1-11). 
Optimization of the reaction conditions allowed to use tetramethylguanidine (TMG) as an 
alternative base. Thus, a novel synthetic method for the preparation of 3-arylaziridine-2- 
carboxylates has been established.22)   
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NN MeMe
Ph CO2EtN
Br
Cl CHO
NaH, DMF, -20 oC
N
Ph
CO2Et
Cl
NN MeMe
Ph CO2EtN
Br
HO
Cl
+
NN MeMe
O
41
42c
43
44c 45  
Scheme 1-11. Aziridine formation from guanidinium salt and ary aldehyde 
Introduction of chiral units into the imidazolidine ring of guanidinium salts could cause rate 
acceleration of the reaction and effective product formation with satisfactory enantioselectivity. 
In particular, both high diastereo- and enantioselectivities were observed when of 42c and 42d 
were used as aryl aldehydes the TMG-mediated aziridination (entries 3 and 4, Table 1-2).  
Table 1-2. TMG-mediated asymmetric aziridination  
entry
total
cis trans
(% ee) (% ee)
 de
(%)
time
(d)
47
N N
N
MeMe
CO2tBuPh
PhPh
Br
O
Ar
H N
CO2tBu
Ar
Ph
PhPh
N N
O
MeMe
60
(79)
6
31
(77)
82
(97)
yield (%) of 44
2
3
1
91
88
32
86
51 35
(59)
86 18
91
-
883
4
4
(4S,5S)-46 44 (4S,5S)-47
+
42 (1 Meq.)
1. TMG
    rt., time
+
2. SiO2/ CHCl3
    rt, 1 d
5 87
(76)
9 96 82 905.5
6 70
(95)
4 76 84 877
42: Ar
Cl
N
Boc
N
Boc
O
O
b:
c:
a:
d:
e:
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The absolute stereochemistries of aziridine products were determined by chemical 
correlation of 3-phenylaziridine-2-carboxylates (cis-44b: 79% ee; trans-44b: 77% ee) obtained 
in entry 1 of Table 1-2 with commercially available tert-butyl (S)-phenylalaninate (49). 
Independent hydrogenation of cis-44b and trans-44b with Pd(OH)2/C in the presence of 
(Boc)2O afforded an identical N-Boc-protected tert-butyl phenylalaninate (48), which was 
found to be an (R)-excess product (77% ee for each) compared to an authentic (S)-derivative, 
indicating that the (S,S)-guanidinium ylide mainly produced (2R,3R)-cis and (2R,3S)- 
trans-aziridines.  
N
CO2tBu
Ph
Ph
cis-44b
N
CO2tBu
Ph
Ph
trans-44b
Pd(OH)2, H2
Boc2O
MeOH, rt
(91.4%, 77% ee)
BocHN CO2tBu
Ph
(78.8%, 77% ee)
(R)-48
H2N CO2tBu
Ph
(S)-49
BocHN CO2tBu
Ph
(S)-48
Boc2O
NaHCO3 aq
 NaCl
CHCl3, H2O
(90.8%)  
Scheme 1-12. Determination of the absolute configurations of aziridines  
 
 79
Chapter 2: Vicinal Amino Alcohols  
2.1 Introduction 
A vicinal amino alcohol moiety is a common structural component in a vast array of 
naturally occurring and synthetic molecules. Common name for the alcohol varies from vicinal 
amino alcohol to b-amino alcohol to 1,2-amino alcohol. The presence of this moiety and their 
relative (as well as absolute) stereochemistry are generally important for the biological activity 
of molecules containing a vicinal amino alcohol. Thus, a variety of stereoselective synthetic 
methods leading to vicinal amino alcohols have been developed. 
Vicinal amino alcohols can be generally classified into three groups based on their functions as 
follows 
(1) Naturally occurring molecules 
(2) Synthetic pharmacologically active molecules 
(3) Catalysts containing vicinal amino alcohols 
Hydroxy amino acids are one of the most common naturally occurring molecules that contain 
the amino alcohol moiety. Serine and threonine are useful members of the chiral pool.23) Other 
well known examples include statin (50),24) bestatin (51),25) valinoctin A (52),26) and microginin 
(53),27) (Figure 2-1). 
HO2C NH
O
OH
NH2
Ph
NH2
OH
CO2H
Bestatin (51)Statin (50)
Valinoctin A (52)
Microginin (53)
HO2C NH
O
OH
NH2
N
H
H
N
N
H
CO2H
O
OH
O
OH
H
N
Me
OH
NH2 O
O
 
Figure 2-1. Examples of naturally occurring molecules containing the amino alcohol moiety 
Lipids and lipid-like molecules make up a large class of naturally occurring molecules 
containing vicinal amino alcohol moiety. Possibly, sphingosine (54),28) is a typical amino alcohol 
accessed by synthesis. Sphinganine (55),29) phytosphingosine (56),29) sulfobacin B (57) 30) and 
myriocin (58) 31) are its related vicinal amino alcohols (Figure 2-2). 
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O
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6 5
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Figure 2-2. The examples of lipids and lipid-like amino alcohols 
Cyclic amino alcohols constitute another larger class, in which the nitrogen atom is contained 
within a ring. Penaresidin A (59),32) anisomysin (60),33) preussin (61),34) febrifugine (62) 35) and 
swainsonine (63) 36) are well known examples (Figure 3-3). 
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HO
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N
H
HO OAc
OMe
N
HO
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Figure 2-3. Examples of cyclic amino alcohols 
A variety of compounds containing the vicinal amino alcohol moiety has been isolated from 
natural sources. These compounds have a wide range of biological activities. The intriguing 
biological activity of these molecules as well as their structural complexity attracts much interest 
of synthetic chemists and forces them to develop new synthetic method of vicinal amino 
alcohols. 
 
2.2 Reported Synthesis Vicinal Amino Alcohols 
It is rather difficult to list every method, but several examples can be typified in the main 
disconnections used to prepare vicinal amino alcohols. Conceptually one can divide these 
syntheses into four different classes as shown below.  
(1) Functional group manipulation of a molecule containing both heteroatoms 
(2) Intramolecular addition of one heteroatom to a molecule which already contains the other  
(3) Addition of both heteroatoms to a molecule which has neither (aminohydroxylation) 
(4) Coupling of two molecules, each of which has one heteroatom. 
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2.2.1 Functional Group Manipulation 
There are two general versions of disconnection. One involves the addition of nucleophiles 
(hydride) to an imine or carbonyl group. The second involves the ring opening of epoxide, 
aziridine, cyclic thiocarbonate or cyclic sulfite/ sulfate with an appropriate nucleophile. 
(i) Addition of a nucleophile to an a-amino aldehydes.37-41) 
ex. 
TBSO H
NBn2
O
iPrMgCl, Et2O TBSO
NBn2
OH
(88-95%)
64 65  
 
(ii) Reduction of a-amino ketones.42,43) 
ex. 
Ph
O
NHPf
Ph
OH
NHPf
Ph
OH
NHPf
reagent
L-selectride, 98%, 67 : 68= 1 : 18
BH3-Me2S, 98%, 67 : 68= 6 : 1
66 67 68
+
 
 
(iii) Addition of a nucleophile to a-hydroxy imine.44) 
ex. 
H
O
O
OBn
NHBn
H
O
O
OBn
NHBn
H
O
O
OBn
NHBn
Ph MgBr
+
78%
70 : 71= 95 : 5
69 70 71  
 
(iv) Reductive amination of a-hydroxy ketone.45) 
ex. 
O
Ph
O
(Me4N)BH(OAc)3
MeNH2 O
Ph
NHMe
(70%)72 73  
 
(v) Ring opening reactions of epoxides with N-nucleophiles.46-48) 
      ex. 
OH
OH
N3
OH
O OH
OH
NHCHPh2
(99%)
Ph2CHNH2
(61%)
Ti(OiPr)2(N3)2
Ti(OiPr)4
7475 76  
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(vi) Ring opening reaction of hydroxymethylaziridine.49,50) 
          ex. 
N
Ts
OH KH
O
NTs
R2Cu(CN)Li2
NHTs
R
OH
(91%)
77 78 79  
 
(vii) Ring opening reactions of cyclic thiocarbonates 51,52) and cyclic sulfites/ sulfates with 
N-nucleophile.53) 
ex. 
O
O
PriO2C
CO2iPr
S
PriO2C
CO2iPr
OH
N3
NaN3
80 81  
Thus, a number of routes using functional group manipulations are available to prepare 
vicinal amino alcohols. Most of these methods rely upon the stereochemical information already 
contained within the molecule to control the stereochemistry of the stereogenic center.  
2.2.2 Intramolecular Addition of One Heteroatom 
Either a nitrogen or an oxygen atom can intramolecularly add to the unsaturated function of a 
molecule already containing the other to give vicinal amino alcohol derivatives as follows. 
(i) Addition of nitrogen.54) 
ex. 
O
C5H11 •
NHTs
O
Ph2IBF4
Pd(PPh3)4
(71%)
O
NTs
C5H11
Ph
O
82 83  
(ii) Addition of oxygen.55) 
      ex. 
BocN
MeO2C OH Pd(OAc)2
Cu(OAc)2
BocN
MeO2C
O
BocN
MeO2C
O
(32%) (46%)
84 85 86
 
2.2.3 Aminohydroxylation 
The aminohydroxylation (or hydroxyamination) reaction of olefins is possibly the most basic 
route to vicinal amino alcohols. Two general methods are known and are listed below. 
(i) The Davies method, wherein a chiral amide anion is added to an a,b-unsaturated ester, 
followed by trapping of the enolate with an oxygen electrophile.56) 
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Ph
CO2tBu
1. Ph N
Li
Bn
O
N
O
SO
2.
Ph N
Bn
Ph
OH
CO2tBu
87
89
90
88
 
(ii) The Sharpless method wherein metal catalyzes aminohydroxylation in presence of 
cinchona alkaloid ligands.57) 
Ph OMe
O
AcNHBr
(DHQ)2PHAL
K2OsO2(OH)4
Ph OMe
O
NHAc
OH
(81%)91 92  
The both methods are complementary. The former gives anti-a-hydroxy-b-amino ester, while 
the latter gives syn-product. In the latter, the regioselectivity can be reversed by addition of 
tBuOCl.58) 
Ph O
O
tBuOCl
BnOCONH2
K2OsO2(OH)4
Ph O
OOH
NHCBz
Br
(DHQ)2AQN
Br
93 94  
 
2.2.4 Coupling reaction 
There are two general types of coupling reactions that have been used in the synthesis of 
vicinal amino alcohols. 
(i) Aldol reaction in the presence of a chiral catalyst. The Henry reaction59) is a typical 
example. 
     ex. 
Ph H
O
NO2+
La-BINOL
85%, 
95% ee, 93% de
Ph
OH
NO2
95 96 97  
 
(ii) Pinacol-type reaction.60,61) 
N
Boc
O
NOBn
SmI2
53%
N
Boc
OH
NHOBn
N
Boc
OH
NHOBn
99 : 100= 6.6 : 1
98 99 100  
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There are numerous routes to the vicinal amino alcohol moiety. The choice of synthetic route 
for desired application will vary depending upon substitution pattern as well as relative and/ or 
absolute stereochemistry in the products. A key theme in many of these methods is the 
generation of enantiomerically pure compounds achieved either from enantiomerically pure 
starting material or via chiral catalysis. 
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Chapter 3: Lactacystin and b-Lactone Derivatives 
3.1 Introduction 
Lactacystin (101) is a Streptomyces metabolite that was isolated and identified by Ōmura and 
initially reported in 1991.62) It has been found to be an affecter of neurite outgrowth in mouse 
neuroblastoma cell line Neuro 2A.63) The scientific community was excited by the discovery of 
the first non-protein microbial metabolite exhibiting neurotrophic activity and total syntheses of 
the new agent were achieved over the next 3 years.64-66) Corey et al. reported that inhibition of 
the cell cycle of Neuro 2A and MG-63 human osteosarcoma cells past the G1 phase occurs upon 
treatment with lactacystin and related analogs 102-105 (Figure 3-1).67) 
NH
HO
S
OH
O
CO2HAcHN
O
NH
OH
O
O O
NH
O
HO
CO2H
HO
NH
HO
S
O
CO2HAcHN
O
H
NH
S
OH
O
CO2HAcHN
O
NH
HO
S
OH
O
R'R
O
Corey-Schreiber Analogs
Smith Side-Chain Analogs
Lactacystin (101) clasto-Lactacystin 
b-lactone (102)
clasto-Lactacystin 
dihydroxy acid (103)
Des-hydroxyisobutyllactacystin (104) 6-Deoxylactacystin (105)
106 : R= NHAc, R'= CO2Allyl
107 : R= NHAc, R'= H
108 : R= H, R'= CO2Et
 
Figure 3-1. Structures of lactacystin and its analogs 
The specific cellular target was identified by Schreiber et al. as 20S proteasome using 
tritium-labled lactacystin analogs.68) The 20S proteasome is the catalytic core of 26S proteasome 
responsible for the degradation of denatured and misfolded proteins. It is also instrumental in the 
degradation of regulatory proteins in charge of cellular growth and metabolism.69) Specifically it 
is known to exhibit chymotrypsin-like, trypsin-like and peptidylglutamyl-peptide hydrolyzing 
(PGPH) activities toward small peptides.68) The 20S proteasome is arranged by four stacked 
rings (α- and β-units) consisting of seven protein subunits (28 total protein subunits) reminiscent 
of a cylinder (Figure 3-2). 
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Figure 3-2. Schematic diagram of 20S and 26S proteasomes 
Two threonine residues present on the β-units of 20S proteasome are responsible for much of 
its catalytic activity.70) Lactacystin and its analogs have shown to affect these sites by 
irreversibly acylating the N-terminus of the threonine residues rendering them inactive.68) 
Schreiber’s data is confirmed by X-ray crystallographic analysis of the 20S proteasome 
deactivated by lactacystin.71,72) 
Kinetic Inhibition Studies 
Extensive studies concerning the structural requirements for biological activity of the 
γ-lactam were performed. The obvious alterative points for lactacystin were the C-7 methyl, the 
hydroxyl isobutyl group, and variations of the N-acetylcysteine side chain. Schreiber’s initial 
report of the activity of lactacystin toward the 20S proteasome included a structural activity 
study of lactacystin (101) and related β-lactone 102 and 103, des-hydroxybutyllactacystin (104) 
and 6-deoxylactacystin 105 (Figure 3-1).67)  
Kinetic inhibition data show that the γ-lactam core and stereochemistry thereof are 
requirements for activity. The dramatic increase in kinetic inhibition of the β-lactone 
intermediate implies that the electrophilic nature of the carbonyl governs the rate of inhibition. 
For instance, the dihydroxy acid analog exhibits no activity presumably due to the lack of 
electrophilic character of the carboxyl moiety. The β-lactone exhibits 15-fold more activity that 
is than that of lactacystin due to the increased electrophilicity of the lactone carbonyl as opposed 
to the carbonyl of the thioester. Smith et al. studied on focusing the N-acetylcysteine side chain 
of lactacystin.73)  
Variations of the carboxylate function as well as deletion of the amide function had little 
effect on the activity of the analogs, thus corroborating Schreiber’s presumption that the 
presence of the C-4 carbonyl is crucial. Corey’s efforts toward elucidation of the ideal affecter 
molecule focused on optimization of the C-7 alkyl and hydroxyisobutyl substituents of the more 
potent β-lactone.74)  
Analogs prepared with variations to the hydroxyisobutyl substituent involved exchange of 
the isopropyl portion of the side chain for simple alkyls and unsaturated moieties and specifically 
9-deoxy, 9-epi and 9-keto groups (Figure 3-3).  
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Figure 3-3. b-Lactone analogs for kinetic inhibition studies  
Ultimately, the hydroxyisobutyl side chain was proved to be necessary for sufficient 
inhibition, that which was 10-fold greater than the most active analog. Eventually, X-ray studies 
revealed that the isopropyl group of the hydroxyisobutyl side chain was bound by a hydrophobic 
pocket of the lactacystin-labeled proteasome subunit.75) Conversely, C-7 analogs of the β-lactone 
showed remarkable increase of inhibition when the methyl was exchanged to ethyl, n-Bu and 
especially i-Pr alkyl substituents. Over 2-fold inhibition was observed by introduction of longer 
alkyl chains. The 7-epi analog resulted in decrease in activity, reflecting the importance of the 
original stereochemistry of lactacystin. 
 
3.2 Reported Syntheses of Lactacystin and b-Lactone Derivatives 
Lactacystin (101) was discovered after screening thousands of soil samples for differentiation 
of the Neuro 2A cell line and the structure was elucidated using 1H- and 13C-NMR techniques. 
The absolute stereochemistry was determined using single-crystal X-ray analysis. The positive 
identification of lactacystin as a potential neurotrophic factor, its unique structure and its scant 
supply made the γ-lactam an extremely hot target for total synthesis. 
1. Corey’s First Total Synthesis of Lactacystin 
One year after Ōmura’s initial paper, Corey reported the first total synthesis of lactacystin 
starting from N-benzyl protected serine methyl ester which was converted to the oxazolidine 110 
with a 9: 1 diastereomeric ratio by simultaneously protection of the amine and hydroxyl 
functionalities (Scheme 3-1).64)  
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Scheme 3-1. Corey' s synthesis of the first key lactacystin intermediate 
Aldol reaction of 110 with isobutylaldehyde utilizing LDA-LiBr system yielded 
diastereomerically pure product 111 in 51% yield after recrystallization. The significance of this 
transformation lies in the control by which C-5 and C-9 stereocenters are formed. These 
seemingly simple transformations take advantage of the stereogenic environment indigenous to 
the enolate itself which controls the conformation of the enolate and facial approach of the 
aldehyde under non-chelated conditions resulting in formation of the quaternary C-5 center. With 
the C-5 and C-9 stereocenters established, the focus turned to the formation of the remaining 
stereocenters of the lactam ring. The oxazolidine was opened under acidic conditions and the 
resulting primary hydroxyl was protected as silyl ether 112. Again, simultaneous protection of 
the amine and hydroxyl functionalities with paraformaldehyde resulted in an oxazolidine system 
(113) with diminished stereochemical bias. The methyl ester was reduced to the primary alcohol 
and oxidized back to the aldehyde 114. 
Intermediate 114 was served as a key electrophilic fragment for the second aldol reaction. 
Application of Pirrung-Heathcock 76) anti-aldol conditions afforded a product 115 in 48% yield 
with low (1.5:1) diastereomeric ratio. Next, trial under Braun’s chiral /Cp2ZrCl enolate 
conditions,77) in the light of good diastereoselectivity, were not practical for gram scale reactions.  
Catalytic hydrogenation of 115 yielded the bicyclic γ-lactam 116 with the C-6 and the C-7 
stereochemistries intact in a tandem debenzylation/ cyclization sequence (Scheme 3-2).  
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Scheme 3-2. Completion of the first total synthesis of lactacystin 
The first total synthesis of 101 was completed by coupling N-acetylcysteine allyl ester with 
the acid functionality of 103, derived from 116 by desilylation, oxidation and deprotection of 
N/ O acetal, using BOPCl and subsequent deallylation with formic acid and Pd(0). This Corey’s 
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total synthesis of lactacystin (101) was a 15 steps protocol with an overall yield of 6%, featuring 
two diastereoselective aldol reactions. 
Corey’s Extended Methodology 
Eventually, a follow-up to Corey’s lactacystin synthesis reported numerous improvements 
over the first, most notably of which was a superior methodology for the diastereoselective 
anti-aldol coupling as an alternative to the Pirrung-Heathcock conditions. 
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Scheme 3-3. Chelate model for the double diastereoselective Mukaiyama aldol coupling 
A novel magnesium-catalyzed doubly diastereoselective anti-aldol coupling78) of aldehyde 
114 and the tert-butyldimethylsilyl enol ether of methyl propionate under the Mukaiyama 
conditions resulted in the 90% yield of anti-aldol product 117 without evidence of the 
corresponding diastereomer (Scheme 3-3). Though Mukaiyama-type aldol couplings normally 
occur in antiperiplanar mode, the steric repulsion illustrated above makes synclinal transition 
state a much more energetically favorable arrangement. 
2. Omura-Smith’s Total Synthesis of Lactacystin 
The collaboration between Smith’s and Ōmura’s groups succeeded in the second total 
synthesis of lactacystin (101).65) This is an easily accessible route to 101 and a variety of analogs. 
This 10-step protocol offered an efficient and high yielding method. From the previously 
prepared unnatural (2R,3S)-β-hydroxyleucine methyl ester (118), oxazoline derivative 119 was 
prepared using methyl benzimidate (Scheme 3-4). Utilization of 119 circumvented the 
installation of crucial and synthetically challenging hydroxyisobutyl side chain. 
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Scheme 3-4. The Smith-Omura’s total synthesis of lactacystin 
A stereoselective hydroxymethylation of the oxazoline 119 using LHMDS/ formaldehyde 
afforded a desired 120 in excellent yield with diastereoselectivity (>98% de). A two-step 
procedure including Moffatt oxidation of primary alcohol 120 to the corresponding aldehyde 
followed by Brown’s asymmetric allylation79) resulted in the stereoselective construction of the 
C-6 hydroxyl and C-7 methyl substituents 121 in good yield.  
The highlights of the synthesis are the stereoselective hydroxylmethylation and 
anti-allylation steps and overall yield was 13%. The authors also implied that the synthesis was 
designed in such a way as to allow providing its analogs for further study by minor modifications 
of the protocol. 
3. Baldwin’s Total Synthesis of Lactacystin 
The two total syntheses of lactacystin mentioned above had similar strategies and utilize 
variations of the Seebach’s oxazolidine/ oxazoline alkylation protocol80) for the formation of the 
C-5 quaternary center.  
Baldwin et al. employed a chiral bicyclic γ-lactam 123 derived from (R)-glutamic acid for 
stereochemical induction (Scheme 3-5).81) A sequence of methylation, selenation and oxidation 
yielded the α,β-unsaturated γ-lactam (124). Aromatization of 124 provided a key siloxypyrrole 
intermediate 125 which was eventually utilized as the silyl enol ether in a Mukaiyama type aldol 
coupling. Using isobutyraldehyde as an electrophile and SnCl4 as a Lewis acid afforded an aldol 
coupling product 126 in moderate yield with a favorable 9: 1 diastereomeric ratio. 
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Scheme 3-5. Baldwin’s total synthesis of lactacystin 
The Baldwin’s synthesis was similar to Corey’s first synthesis dependent on the 
stereochemical nature of starting amino acid for stereochemical induction and achieved in 4.3% 
overall yield through 20 steps. Drawbacks of this synthetic route were low yield in the aldol 
coupling and the production of diastereoisomers in no less than three steps of the synthesis.  
4. Chida’s Total Synthesis of Lactacystin 
Chida’s total synthesis of 10182), in which D-glucose serves as a starting material and a 
stereogenic template, was novel in the sense that the previous three reports started from amino 
acid derivatives. The primary and secondary hydroxyl functions of 3-deoxy-1,2-O-isopropyli- 
dene-3-C-methyl-α-D-allofuranose (128), derived from glucose, were benzylated and oxidized, 
respectively, to give ketone (Scheme 3-6). Wittig reaction of the ketone resulted in an 
inseparable 1:1 mixture of (E)- and (Z)-isomers 129. After reduction of ester function, reaction 
with trichloroacetonitrile gave trichloroacetimidate 130, the substrate for Overman rearrange- 
ment.83) The rearrangement was preformed in a sealed tube by heating 130 to 150 °C in toluene 
for 89 h to give a terminal olefin 131 as a favorable 5: 1 mixture of C-5 epimers in 60% yield. 
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Scheme 3-6. Chida’s total synthesis of lactacystin 
 
 92 
Deprotection followed by oxidative cleavage of diol functional formed afforded a 
hemiaminal. Subsequent chromic acid oxidation gave the g-lactam which, upon treatment with 
NaBH4, was yielded a g-lactam 132. A sequence of reactions including protection of the 
secondary hydroxyl of 132, deprotection of the benzyl ether and oxidation to the aldehyde and 
addition of isopropylmagnesium bromide resulted in a complex mixture of C-9 epimers and 
reduced primary alcohol. Chromatographic separation of the mixture enabled recycling of the 
reduced product back into the sequence. The undesired C-9 epimer was subject to Moffatt 
oxidation and selectively reduced to yield a desired alcohol 133. Desilylation, ozonolysis and 
selective oxidation of the formed aldehyde function using sodium chlorite provided the common 
intermediate 103.  
As was the case with the other syntheses, Chida et al. also finished the total synthesis of 
lactacystin (101) using the Corey’s protocol. The novelty of this synthesis, in addition to starting 
with D-glucose, lies in the formation of the C-5 quaternary center via Overman rearrangement 
while the previous syntheses constructed the C-5 quaternary center via stereoselective aldol 
reaction. The shortcomings of the chida’s protocol are evident not only in the poor selectivities 
of the Wittig reaction and the Overman rearrangement, but in the necessity of a sealed tube for 
the latter transformation. The rearrangement, particularly, puts an original twist on the protocol 
but rendered it impractical. 
5. Corey’s Second Total Synthesis of Lactacystin 
Corey et al. eventually reported a new, shorter, and more efficient synthesis of lactacystin 
utilizing a unique blocking group for controlling diastereoselectivity.75) This report featured an 
expedient construction of the γ-lactam moiety and later installation of the isopropyl side-chain 
focusing on synthesis of lipophilic analogs.  
The effectiveness of the blocking group itself relied on three requirements;  
(a) it had to be readily reducible,  
(b) it had to be sufficiently bulky to control the stereochemistry of the hydroxymethylation of 
the β-keto ester and 
(c) it had to facilitate a scalable enantioselective process.  
At this point they selected a methylsulfide blocking group. Thus, a γ-lactam skeleton 134 
was smoothly formed from methylthiomalonate 134 for aldol reaction. Enolization using DBU 
and addition of formaldehyde afforded an adduct in a diastereomeric 9:1 ratio, which underwent 
stereoselective reduction of ketoic moiety to glycol 137 in 95% yield with 99% ee.  
The use of 2-propenyl Grignard reagent in conjunction with TMSCl as an anion trap reagent 
was efficient and the reaction occurred stereospecifically to give a secondary alcohol 138 in high 
yield without trace of retro-aldol cleavage. Corey et al. proposed that the stereocontrol is a result 
of the steric blocking caused by the chelation of Mg2+ with the 1,3-dicarbonyl system in 138. 
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Scheme 3-7. Corey’s enantioselective total synthesis of b-lactone 102 
This protocol touts applicability from economical standpoint as well as efficiency in each 
step in addition to easy isolation of pure products. Furthermore, it should be pointed versatility in 
the diverse synthesis of analog for bioassay studies. 
6. Kang’s First Formal Synthesis of Lactacystin  
Shortly after Corey’s second generation synthesis, Kang et al. reported two novel routes84) to 
lactacystin (101), both employing an intramolecular mercurioamidation of an allylic trichloro- 
acetimidate.85)  
The first protocol started with the base promoted ring opening of the Sharpless epoxide 
14186) followed by functionalization of the primary hydroxyl group as the trichloroacetimidate 
142 using trichloroacetonitrile and DBU (Scheme 3-8). Treatment of 142 with mercuric 
trifluoroacetate and K2CO3 resulted in oxazolidine formation via intramolecular mercurio- 
amidation to give oxazolidine 143 by workup using TEMPO and LiBH4. Protection of the 
secondary hydroxyl group, silylation and Swern oxidation of the primary alcohol gave 
oxazolidine carboxylic acid 144. Reflux under acidic conditions followed by reduction with zinc 
initiated decomposition of the oxazolidine skeleton with concomitant γ-lactam cyclization. 
Protection of glycol functions as acetonide preferred on the cis-arranged glycol unit to the 
gem-hydroxymethyl groups (selectivity = 7:1), presumably based on cyclization to spiro system. 
After oxidation of the remaining hydroxymethyl group to the aldehyde, Grignard addition of 
i-PrMgBr to the formed aldehydic function resulted in the formation of an addition product at a 
disappointing 1:1 ratio of C-9 epimers.  
Intermediate 146 was the trihydroxy intermediate in the Baldwin’s synthesis, thus 
completing the first formal synthesis of lactacystin (101) utilizing intramolecular mercurioami- 
dation methodology. 
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Scheme 3-8. Kang’s first formal synthesis of lactacystin 
7. Kang’s Second Formal Synthesis of Lactacystin b-lactone 
The second report by Kang et al. involves an original route to 101. The key step in the 
synthesis was, again, the intramolecular mercurioamidation of an allylic trichloroacetimidate. 
The Sharpless epoxide 147 was subjected to base-promoted ring opening and the primary alcohol 
unit of the resulting allylic alcohol was selectively oxidized and then the remaining secondary 
alcoholic function was benzoylated (Scheme 3-9).  
Stereoselective crotylboration of α,β-unsaturated aldehyde 148 provided alcohol 149 in a 
50:1 diastereomeric ratio, which was transformed to the trichloroacetimidate 151. Treatment of 
151 with mercuric trifluoroacetate caused spontaneous cyclization to oxazoline to give a mixture 
of separable diastereomers, from which the desired mercurate was obtained in 64% yield. As in 
the previous synthesis problematic oxidative demercuration issues were circumvented by 
exposing the oxazoline to LiBH4/ TEMPO providing 152. Exposure to 6 N HCl and then AcOH 
hydrolyzes the oxazoline to initiate cyclization and removal of the TEMPO group resulted in the 
production of known triol 146.  
Overall, both of Kang’s syntheses of 101 rely on Sharpless asymmetric epoxidation early in 
the synthetic scheme and utilize the intramolecular mercurioamidation of a trichloroacetimidate 
to set up the zinc promoted cyclization to the γ-lactam. 
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Scheme 3-9. Kang’s second formal synthesis of lactacystin 
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8. Adams’ Total Synthesis of Lactacystin Analog PS-519  
Recently, Adams’ team conducted an independent synthesis and structure-activity 
relationship (SAR) study of lactacystin b-lactone 102 and its analogs. 87) By confirming and 
building upon Corey’s data, the team found that increasing the bulk of the C-7 alkyl substituent 
caused activity to be higher (up to 2-fold). The novelty of this synthesis lies in the use of a 
semi-convergent route, while all other syntheses to date have been strictly linear routes based on 
the nature of 102 and 103.  
The convergence was achieved by doubly diastereoselective aldol reaction of a stereogenic 
aldehyde and a trans-oxazoline. The construction of the oxazoline fragment begins with 
Sharpless’ asymmetric dihydroxylation88) of olefin 153 obtained by the Wittig reaction of 
isobutyraldehyde and methyl triphenylphosphoranylideneacetate. The quatitative conversion to 
diol 154 occurred with only 77% ee but was improved to > 99% ee after recrystalization. Upon 
addition of trimethyl orthobenzoate the diol was tied up as the cyclic orthoester and subsequently 
opened by addition of acetyl bromide resulting in the formation of bromohydrin 155. Azide 156 
is the product of bromide-displacement and its hydrogenation yields amine 157. Refluxing in 
toluene with toluenesulfonic acid provided stereogenic oxazoline 158 that would ultimately 
provide the hydroxylisobutyl and C-5 portions of PS-519 (109). The coupling partner of 158 is a 
chiral α-alkyl-β-formyl amide that will provide chelation control in doubly diastereoselective 
aldol reactions. 
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Scheme 3-10. Synthesis of the trans-oxazoline coupling partner 
The formyl amide coupling fragment is derived from acyloxazolidinone 159 (Scheme 3-11). 
Alkylation of the titanium enolate using benzyloxymethyl chloride gave an alkylated product 
160 which, after hydrolysis with peroxide, yielded carboxylic acid 161. Transformation to 
diethyl amide 162 was achieved by treatment with diethylamine. Hydrogenolysis of the benzyl 
ether yielded the hydroxy amide 163 which, upon exposure to Dess-Martin oxidation conditions, 
resulted in giving α-alkyl-β-formyl amide 164. 
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Scheme 3-11. Synthesis of the α-alkyl-β-formyl amide coupling partner 
After exploring conditions for the aldol reaction of 158 and 164, it was determined that 
enolization of the oxazoline 158 and sequential addition of dimethylaluminum chloride followed 
by the aldehyde 164 gave the 5S,6S-alcohol 165 exclusively. The structure with stereochemistry 
was confirmed using X-ray diffraction analysis. The stereochemical rationale was explained 
using the transition state model shown in Figure 3-4. Chelation of the 1,3-dicarbonyl system of 
164 with the Lewis acid requires the n-propyl substituent to adopt a si-face-blocked position. 
This leaves only approach from the re-face possible in anti-Felkin-Ahn-Eisenstein fashion.  
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Figure 3-4. Stereochemical rationalization of Adams' doubly diastereoselective aldol 
While the stereochemistry of C-6 was a direct result of the chelation model, the C-5 stereo- 
chemistry is purely based on steric bias of the isopropyl substituent of the oxazoline. The 
significance of this transformation lies in the use of dialkylaluminum chloride as a bidentatable 
Lewis acid. 
As seen in the previous syntheses, hydrogenolysis of the γ-lactam 165 followed by 
saponification yielded dihydroxy acid 166, which was then activated by conversion to mixed 
anhydride using isopropenyl chloroformate. Subsequent cyclization provided β-lactone PS-519 
(109), an analog of the highly potent β-lactone 102 (Scheme 3-12). Thus, PS-519 was prepared 
by a semiconvergent protocol requiring 10 steps in 20% overall yield starting from readily 
available oxazoline 158. 
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Scheme 3-12. Completion of Adams' total synthesis of PS-519 (109) 
This Adam’s synthesis was also applied to the total synthesis of 102 using a parallel method 
with only slight variations in the preparation of starting material.  
9. Panek’ Formal Synthesis of Lactacystin  
Panek’s objective in the development of a more practical synthesis of oxazoline 158 was to 
devise a concise and stereoselective synthesis of the hydroxyleucine unit. An additional 
important step in the synthesis is a catalytic asymmetric aminohydroxylation used as the key step 
in the synthesis of the (2R,3S)-hydroxyleucine synthon.89) 
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Scheme 3-13. Panek’s formal synthesis of lactacystin 
The asymmetric aminohydroxylation (AA) of 167 using the benzylcarbamate-based 
Sharpless oxidation gave 168 with a good levels of regioselectivity (7: 1) in favor of the a-amino 
ester and high levels of enantioselectivity (87% ee) which could be raised to >99% by 
recrystallization (2 times) from EtOH/ H2O (1: 1).  
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Scheme 3-14. A double stereodifferentiating crotylation 
The preparation of the heterocyclic aldehyde was accomplished according to a literature 
precedent established by Omura et al. through the aldol condensation of oxazoline 158 with 
formaldehyde to afford 169 as a single diastereomer controlled by the chirality of the oxazoline, 
in which the bulky isopropyl group functions as the controller of diastereoselectivity.  
The anti-selective crotylation reaction was then carried out to establish the relative 
configuration at the C-6 and C-7 centers. This double stereodifferentiating reaction was readily 
accomplished with TiCl4 to generate a 5-membered chelation complex affording alcohol 170 
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with high levels of diastereoselectivity (anti : syn > 30 : 1) and in around 60% yield (Scheme 
3-14).  
As mentioned above, Corey, Omura-Smith, Adam and Panek groups applied b-hydroxyleuci- 
nate to asymmetric C-C bond construction (via aldol or anti-aldol-type reaction). In literatures 
(2R,3S)-3-hydroxyleucine derivatives had been prepared in 48-65% overall yields using aldol- 
type reaction (92% ee),90) epoxidation (97% ee),65) dihydroxylation (70% ee),89b) and 
aminohydroylation (87% ee)87) as a key step under asymmetric conditions.  
 
Examples of the asymmetric synthesis of b-hydroxyleucinate 
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3. Adam group 
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Chapter 4: Sphingosines  
4.1 Introduction 
Sphingosines constitute a group of related long-chain aliphatic 2-amino-1,3-diols, of which 
D-erythro-2-amino-4(E)-octadecene-1,3-diol (commonly called as sphingosine 54) occurs most 
frequently in animal glycosphingolipids.91) Sphingosines are known inhibitors of protein kinase 
C and are the backbone structures to glycosphingolipids. This larger family of biomolecules is 
involved in a plethora of processes related to cell growth, differentiation, adhesion, and neuronal 
repair.92) 
Glycosphingolipids contain two basic structural motifs: carbohydrate and ceramide (Figure 
4-1). The ceramide portion consists of a sphingoid base and an amide-linked fatty acyl chain, e.g., 
stearoyl or palmitoyl. The structural variation in fatty acids (N-acyl portion), sphingosines and 
carbohydrates results in a great variety of chemically distinct glycosphingolipids.91)     
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**
Sphingosine
Ceramide
Lysosphingolipid
 
Figure 4-1. Glycosphingolipid structure 
Glycosphingolipids are found in the cell membrane of all animal and many plant cells, where 
they serve as identifying markers and regulate cellular recognition, growth and development.3a 
They are thought to function by anchoring the hydrophobic ceramide portion in the plasma 
membrane exposing the hydrophilic carbohydrate portion to the surrounding exterior which 
specifies the intended biological function.93b)  
They display several biological functions such as 
(1) binding to galactosyl ceramide receptor sites in cells lacking the principal CD4 cellular 
receptor,94)  
(2) being unambiguous links between specific sphingolipids and malignant tumors which enable 
them to be used as ‘biological markers’ for possible early detection of cancer,93a)  
(3) potent and reversible inhibition of protein kinase C by breakdown products of glycosphingo- 
lipids, e.g. sphingosine, sphinganine (dihydrosphingosine) and lysophingolipids. 
Sphinganine or dihydrosphingosine 55 is a biosynthetic precursor to sphingosine 54 which is 
the most abundant long chain amino alcohol possessing generally 18 or 20 carbon atoms. 
Dihydrosphingosine is an intermediate in the biosynthesis of sphingolipids such as ceramides, 
sphingomyelin, cerebrosides and gangliosides, which play important roles in cell regulation and 
signal transduction95) and are found to be an inhibitor of protein kinase C.96) 
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Two problems make the utilization of sphingolipids from natural sources 
problematic. First, there are a large number of known sphingolipids which vary     
R3
OR1
NHCOR2
OH
in the head group (R1), N–acyl groups (R2) and/ or tail group (R3) thus making the isolation of 
homogeneous materials from natural sources difficult. Second, the allylic alcohol function in 
their structures undergoes epimerization readily during isolation or manipulation to produce 
partially epimerized mixtures.97) For these reasons, synthetic access to individual sphingosines is 
an attractive alternative. 
 
4.2 Reported Synthesis of D-erythro-Sphingosine 
Large numbers of syntheses of sphingosine, dihydrosphingosine and their derivatives have 
been reported. Most synthetic approaches describe the synthesis of sphingosine and its 
derivatives. However, saturation of the olefin bond in sphingosine gives sphinganine. Hence all 
syntheses leading to sphingosine could be elaborated to sphinganine syntheses. Some synthetic 
routes are developed to produce the dihydrosphingosine directly. 
Sphingosine was first isolated in 1884 by Thudichum as a waxy unstable substance obtained 
from the hydrolysate of a lipid fraction of brain tissue and after 63 years, the correct relative 
orientations of the key functional moieties, two hydroxyl groups, one amino functionality and a 
double bond, was presented by Carter and coworkers.  
The sphingosine syntheses published before mid-1991 have been thoughly reviewed by 
Devant. In the following, Koskinen98b) described the early syntheses of sphingosine in 
considerable detail. In general, key strategies for the construction of a chiral amino alcohol unit 
in the reported syntheses of sphingosine can be classified into six-types of reactions and 
examples for the syntheses of sphingosine are discussed below. 
(1) The ring-opening of aziridines,99)  
(2) C-C bond formation,100)  
(3) The ring-opening of epoxides with a nitrogen nucleophile,101)  
(4) Displacement of alcohols or halides with a nitrogen nucleophile,102)  
(5) Reduction of aminoketones,103)  
(6) Modification of natural chiral sources including phytosphingosines.104) 
The Ring-opening Reaction of Aziridines 
The synthesis of (±)-D-erythro-sphingosine from aziridine was reported by Cargillo in 1986. 
Ten years later, Davis and coworkers used the chiral cis-aziridine 188 which was prepared by 
treatment of sulfinimine 187 with the lithium enolate of methyl bromoacetate according to the 
previous method reported for Darzens-type synthesis of cis-N-sulfinylaziridine carboxylic 
acids.105) The product was isolated by flash chromatography in 67% yield along with ca. 3% of 
the (2R,3S)- isomer as shown in Scheme 4-1.99)  
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Scheme 4-1. Synthesis of D-erythro-sphingosine from cis-aziridine by Davis 
The synthesis was then completed utilizing selected condition for ring-opening reaction and 
two-step protocol for reduction and hydrolysis. The highlights of the synthesis are the ability to 
access both of isomers by selecting a reagent in the ring-opening reactions.  
Ring-opening of cis-aziridine 188 with TFA in H2O-acetone gave syn-isomer through regio- 
and stereospecific SN2 mechanism. However, this cis-aziridine could be converted to unusual 
selectivity by a novel Pummerer-type rearrangement. Treatment of 188 with trifluoroacetic 
anhydride (TFAA) gave predominantly syn-opening of the aziridine ring resulting in 
trifluoroacetylated sphingosine 191.  
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F3C Ar H  
Figure 4-2. Transition state in Pummerer-type rearrangement 
Preparation of the starting 188 requires a two-step synthesis with barely 54% yield. Thus, based 
on calculating from commercially available starting materials this synthesis reaches just over 
10% overall yield. 
C-C Bond Formation  
The key intermediate 195 was constructed by asymmetric aldol reaction between lithiated 
bislactim ether 193 and (2E)-hexadecenal by aim to obtain an anti-aldol product. The selected 
condition resulted in a 1:1 mixture of diastereomers in 45% yield. Although these results were 
obviously disappointing, the diastereomers are chromatographically separable and the undesired 
syn-isomer can be recycled by oxidation/ reduction/ separation procedures. 
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Scheme 4-2. Synthesis of D-erythro-sphingosine using asymmetric aldol reaction 
Groth’s synthesis of sphingosine was a 5-step protocol with an overall yield of 21%, 
featuring two diastereoselective aldol couplings.100j)  
The Ring-opening of Epoxides with a Nitrogen Nucleophile  
The polar head group 202 is available from epoxide 200, which is readily prepared from 
divinylcarbinol (198).101e) Sharpless asymmetric epoxidation of commercially available 
divinylcarbinol 198 afforded epoxide 199, followed by base-induced Payne rearrangement to 
give 200 in high yield (84% over 2 steps) with excellent enantiomeric purity (> 99% ee), as 
previously reported (Scheme 4-3).106)  
OH (-)-DIPT, cumene hydroperoxide
86%, > 99% ee
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198 199 200  
Scheme 4-3. Sharpless asymmetric epoxidation of divinylcarbinol 
The C-2 amino functionality was introduced through a two-step procedure using an 
intramolecular epoxide-opening via a tethered carbamate. As expected, product 202 derived from 
the favored 5-exo-tet cyclization was the only detected product; the product derived from the 
6-endo-tet cyclization being disfavored according to the Baldwin rules (Scheme 4-4). 
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Scheme 4-4. Construction of E-olefin moiety by cross-metathesis after ring-opening of epoxide 
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Compound 204 was synthesized by an olefin cross-metathesis reaction of allylic alcohol 
202 and 1-pentadecene in the presence of Ru-catalysts. When employing Grubbs’ phosphine-free 
3-bromopyridine catalyst 203, the yield and E: Z selectivity was increased to 59% (82% based on 
recovered starting material) and 17:1 respectively. Removal of the benzyl group in 204 with 
sodium in liquid ammonia and hydrolyzed with 1N KOH in refluxing EtOH to yield the desired 
D-erythro-sphingosine (54) over seven steps from commercially available 198 in 33% overall 
yield. 
Displacement of Alcohols or Halides with a Nitrogen Nucleophile102s) 
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OH
OH
D-tartaric acid
205
O O
OMeMeO
O O
Ph
HO
OH
OBn
OH
OH
OBn
O
O
Et
Et
206
207
LiAlH4, AlCl3
Et2O, reflux, 30 min
80%
Et Et
OMeMeO
10% CSA, THF
reflux, 30 min
91%
O
OBn
O
O
Et
Et
208
OBn
O
O
Et
Et
209
OEt
O
OBn
O
O
Et
Et
210
OAc
OBn
O
O
Et
Et
211
C13H27
OBn
HO
OH
212
C13H27
PCC, NaOAc
CH2Cl2, MS
91%
(iPrO)2P(O)CH2CO2Et
NEt3, LiBr, THF, rt
77%
i. DIBAL, CH2Cl2, -78 oC
ii. AcCl, iPr2NEt, CH2Cl2
    -40 oC to rt
                   76%
C12H25MgBr, Li2CuCl4
Et2O, -78 oC to rt
5% H2SO4, MeOH
63%
Scheme 4-5. Synthesis of a key compound 212 
 
OBn
HO
N3
213
C13H27
OH
HO
NH2
214
C13H27 54212
ii. TMSN3, 0 oC to rt
iii. TBAF, THF
   61%
i. PPh3, DIAD, CH2Cl2, 0 oC
PPh3
THF/ H2O (9:1)
90%
Na, liq NH3, THF
-78 oC, 30 min
85%
Scheme 4-6. Completion of the synthesis of sphingosine by displacement of alcohol with azide 
 
Reduction of Aminoketones103e) 
O
NBoc
OMe
O
Me
Me
215
O
NBoc
O
Me
Me
216
PhS(O)C15H31, LDA
-78 oC to rt
C14H29
S(O)Ph
CCl4, reflux O
NBoc
O
Me
Me
217
C13H27
36%
NaBH4, CeCl3
MeOH, -15 oC
72%
O
NBoc
OH
Me
Me
218
C13H27
1 N HCl
dioxane, 100 oC
72%
54
Scheme 4-7. Synthesis of sphingosine by reduction of aminoketone as a key step 
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Modification of Natural Chiral Sources including Phytosphingosine104d) 
C14H29
HO
NH2 OH
OH
219
ethyl benzimidate
40 oC, 48 h
95%
CH2Cl2
C14H29
OH
OH
220
N
O
Ph
C14H29
OTs
OH
221
N
O
Ph
TsCl, pyridine
DMAP, CH2Cl2
75%
tBuOK, THF
0 oC, 1 h
99%
C14H29
222
N
O
Ph
O
OTMS
223
N
O
Ph
TMSI, DBN
MeCN, reflux
94%
C13H27
i. 2 N HCl, THF
 rt, 18 h
ii. NaOH, MeOH
          100 oC, 2 h, 
          79%
54
Scheme 4-8. Synthesis of sphingosine by modification of phytosphingosine  
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Chapter 5: New Vinylaziridination 
5.1 Aims of Project and Proposed Synthetic Approach 
When we started our work on the asymmetric synthesis of 3-vinylaziridine-2-carboxylates, 
there are a few methods for their preparation, leaving us ample opportunity in the development 
of our new synthetic method. 
The requirements for this approach are follows: 
 The value of the recovery of a chiral template is well-established in the asymmetric 
synthesis, and we obviously hoped to make our synthesis in the same way.  
 Furthermore, the synthesis should be amenable to the facile and straightforward preparation 
of analogues. 
   We aim to develop a new general synthetic method for the preparation of enantiomerically 
pure amino alcohols that are essential key compounds for the synthesis of bioactive complex 
molecules. Our synthetic plan based on our arylaziridination from guanidinium ylide 227 is 
showed in Scheme 5-1. 
N N
Cl
MeMe
PhPh
Cl
PhCH2Br
2HCl
(COCl)2
N
Ph
CO2tBu
Vinyl
NH2CH2CO2tBu
Vinyl-CHO
CO2
CO
N N
O
MeMe
PhPh
B:
N N
N
MeMe
CO2tBuPh
PhPh
N N
N
MeMe
CO2tBuPh
PhPh
Br
BH Br
(4R,5R)-224
(4R,5R)-47
(2S)-229
H2N CO2tBu
175
HO
H2N
54
HO
OH
C13H27
225
226
228
(2R,3S)-t-butyl hydroxyleucinate D-erythro-sphingosine
application
(4R,5R)-46
(4R,5R)-227
 
Scheme 5-1. General synthetic plan: The utilization of a chiral guanidinium template 
for the synthesis of vicinal amino alcohols. 
This approach, which in principle allows access to all the stereoisomer of selected amino 
alcohols, involves a key step, aziridination, and general functional group conversions. 
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In this section, we describe a general asymmetric synthesis of 3-vinylaziridine- 
2-carboxylates from chiral guanidinium ylides and a,b-unsaturated aldehydes and application 
to the synthesis of hydroxyleucinate (172) and D-erythro-sphingosine (54). 
 
5.2 Reaction of Guanidinium Ylides with a,b-Unsaturated Aldehydes 
5.2.1 Preparation of a Chiral Guanidinium Bromide 
Core chiral template was prepared from diphenylethylenediamine according to our method. 
Thus, treatment of the (R,R)-diamine 230 afforded the cyclic urea (4R,5R)-47 by a 
high-yielding two-steps reaction sequence (93%) as shown in Scheme 5-2. 107) 
HN NH
O
PhPh
H2N NH2
PhPh
(4R,5R)-230
N N
O
MeMe
PhPh
Im2CO, DME
80 oC, 4 h
231: 97%
 Imidazole: quant.
1. NaH, DMF
    rt, 45 min
2. MeI, rt, 4 h
(96%)
(4R,5R)-231 (4R,5R)-47
 
Scheme 5-2 Synthesis of the (4R,5R)-diphenyl-2-imidazolidinone (47) 
    Chlorination of (4R,5R)-47 with oxalyl chloride, using conditions reported by Isobe108) and 
Oda,109) afforded the corresponding chloroamidinium 224 in high conversion (approximately 
47 : 224 = 6 : 94). Then, the obtained crude mixture was treated with glycine t-butyl ester 
hydrochloride 225 in the presence of NEt3 leading to chiral guanidine 211, which was reacted 
with benzyl bromide (226) to give the desired guanidinium bromide 46 in 96% yield 
(calculated from 204) (Scheme 5-3). 
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N N
Cl
MeMe
PhPh
Cl
PhCH2Br 226
HCl-NH2CH2CO2tBu 225
N N
O
MeMe
PhPh
N N
N
MeMe
CO2tBu
PhPh
(4R,5R)-47
N N
N
MeMe
CO2tBuPh
PhPh
Br
N N
O
MeMe
PhPh
N N
O
MeMe
PhPh
reflux, 9 h
(COCl)2, benzene
conversion ratio 
47 : 224 = 6 : 94
NEt3, CH2Cl2
rt, 10 h
crude 232: quant.
47: 34% recoverd
MeCN
rt, 4 h
(96%)
(4R,5R)-224 (4R,5R)-47
+
(4R,5R)-232 (4R,5R)-47
+
(4R,5R)-46  
Scheme 5-3. Synthesis of (4R,5R)-guanidinium bromide 46 
5.2.2 Reaction of Guanidinium Ylides with Methacrolein 
Just prior to the beginning of a,b-unsaturated aldehyde endeavor, Hada had developed a 
procedure for aziridination using various aryl aldehydes in the presence of TMG or NaH either 
in an appropriate solvent or solventless condition. In collaboration with Oda and Haga, a 
general protocol for aziridine synthesis from the reaction of guanidinium ylides with aryl 
aldehyde had been elaborated. 
According to the Haga’s protocol110), we first examined the reaction of (4R,5R)-46 with 
methacrolein (228a) (0.9 equiv) in THF in the presence of TMG (1.5 equiv) at 25 oC for 4.5 h, 
followed by SiO2 treatment for 24 h to result in the clean formation of  3-vinylaziridine- 
2-carboxylate 229a in 60% yield with a good diastereoselecitvity (89 : 11 ratio of cis and trans 
derivatives) together with the recovered chiral cyclic urea 47 (50%) and another urea with a 
glycinate function 233 (40%).  
N N
N
MeMe
CO2tBuPh
PhPh
Br
O
Me
H
N
CO2tBu
Ph Me
PhPh
N N
O
MeMe
(4R,5R)-46 229a
+
228a (0.9 equiv.)
1. TMG, THF
    25 oC, 4.5 h
+
2. SiO2/ CHCl3
    rt, 24 h
(4R,5R)-47
N HN
N
MeMe
CO2tBuPh
PhPh
233
+
O
(61% yield, 78% de) (50% yield) (40% yield)
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Inspection of coupling constant (J = 7.1 Hz) between H-2 (d 2.35 ppm) and H-3 (d 2.31 
ppm) in the 1H NMR spectrum of the major diastereoisomer indicated that cis-aziridine was 
preferentially formed. In a NOE experiment, irradiation at H-1’ in this isomer showed 3.8% 
NOE enhancementof the t-butyl sign even though difficult observation of NOE enhancement 
between H-2 and H-3 due to their peak overlaping (Figure 5-1). On the other hand, no NOE 
enhancement was observed in a minor product (Figure 5-2). This is in accordance with cis 
stereochemistry in the major isomer. 
N
O
O
1 2
3
1'
3'
2'
Me Me
H
H H
H
3.8%
H
H
1.4%
4.4%
N
H
H O
O
H
H
Me
Me
80.95
H
28.05
20.70
45.44
48.78
63.45
113.42138.34
167.38
1.43
1.71
2.35
2.32
3.38
3.88
5.10
4.92
H
HH
  
Figure 5-1. The nuclear overhauser effect (left) and HMBC correlation (right) 
in cis-aziridine 229a 
 
N
O
O Me
Me Me
(IRR at H-2 of a a major invertmer*)
HH
H
N
O
O Me
Me Me
H
(IRR at H-3 of a major invertmer*)
HH
HHH
*% NOE for a minor invertmer could not determine (invertmer ratio= 10: 1).
HH H
3.8%
3.7%2.4%
2.3%
1.9%
2
3
 
Figure 5-2. The nuclear overhauser effect in trans-aziridine 229a 
To optimize of the reaction conditions, solvents (THF, DMF, toluene), bases (NaH and 
TMG), reaction temperatures and times (at -10 to 50 oC for 1-7 d) were investigated (Table 5-1). 
The results showed that the reaction of (4R,5R)-46 with 228a (3 equiv.) in THF or toluene in 
the presence of TMG at 0 to 25 oC for 3-7 d gave desired vinylaziridines 229a as a 
diastereomeric mixture in 63-92% combined yields with a rang of 68-74% de. The 
enantioselectivities ranged from 84 to 89% ee for the cis-isomer and 81 to 85% ee for the 
trans-one. Under solventless condition (entry 1), with NaH in DMF (entry 4) or at higher 
temperature (entry 3) the production of aziridine lowered in either diastereoselectivities or 
chemical yields. In all case, a recyclable chiral urea 47 could be isolated as an alternative 
product in good yields. 
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Table 5-1. Reaction of (4R,5R)-gaunidinium bromide (46) with methacrolein 228a 
entry
total
cis trans
(% ee)4) (% ee)4)
 de
(%)
temp.
(oC)
time
(d)
47base1) solvent2)
N N
N
MeMe
CO2tBuPh
PhPh
Br
O
Me
H
TMG
THFTMG
TMG THF
N
CO2tBu
Ph Me
PhPh
N N
O
MeMe
62.3
(84)
75.8
(89)
9.2
(81)
14.3
(81)
yield (%) of 229a3)
1
2
3
71.5
90.1
74.3
68.3
64.2
(89)
26.1
(82)
90.3 42.2
92.9
quant.
quant.- 25
25
50
1
3
1.5
(4R,5R)-46 229a (4R,5R)-47
+
228a (3 equiv.)
1. base, solvent
    temp., time
+
2. SiO2/ CHCl3
    rt, 2 d
THFTMG5 0
TMG 0toluene6
TMG 25toluene7
12.7
(-)
78.7
(87)
91.5 72.1 93.37
7 80.1
(86)
12.3
(-)
92.3 73.5 quant.
3 74.6
(88)
12.2
(83)
86.8 71.9 92.5
DMFNaH 38.6
(86)
24.7
(85)
4 63.3 22.0 78.0-10 2
 
1) TMG = 1.5 equiv., NaH = 2.0 equiv.  2) Concentration of the reaction: 46 100 mg/ solvent 0.1 ml.   
3) Isolated yield after SiO2 chromatrography.  4) Determined by chiral HPLC. 
 
We had already observed in aziridination using aryl aldehydes that the diastereoselectivity 
of aziridine products is dependent upon the electronic character of substituent on aryl aldehydes 
used. In general, major isomers are trans derivatives in the cases of aldehydes carrying an 
electron-donating group, whereas cis ones mainly observed with aldehydes either carrying an 
electron-withdrawing group or without substituent.110) Thus, cis-rich diastereoselectivity in the 
reaction of 46 and 228a can be reasonably accepted as an example of the latter cases. 
Next, the couterions of guanidinium salts were also investigated under non-chiral conditions. 
Thus, bromonium anion (Br-) in guanidinium salt 234a was changed to hexafluorophosphate 
(PF6-) and tetrafluoroborate (BF4-) anions according to the procedure developed in our laboratory 
(Table 5-2). 
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Table 5-2. Synthesis of achiral guanidinium salts (234) varied on counterions 
NaBF4
NaBF4
source of counter ion
N N
N
MeMe
CO2tBuPh
X
0.5
0.5
2.8
57
234a (mmol) yield (%) of 2341)entry
1
2
3
4
234b: X = PF6
234c: X = BF4
N N
N
MeMe
CO2tBuPh
Br
234a
salt (~ 1.1 equiv.), H2O
rt, 30 - 1 h
NH4PF6 b: 95.2
c: 57.3
NaBF4 c: 65.8
c: 89.4
 
1) Isolated yield after recrystallization from n-hexane/ AcOEt 
 
We continued to investigate the role of the solvent and counterion in this vinylaziridination 
using various guanidinium salts (Table 5-3). Almost no change in yields or reaction outcomes 
was observed under the conditions used. Thus, we decided to apply a guanidinium bromide in 
our asymmetric aziridination because of its easy preparation. 
 
Table 5-3. Reaction of achiral guanidinium salts with methacrolein 
22.1
21.7
cis
23.6
16.3
THF
temp.
(oC)
50
50
50
50
6.3
5.0
3.4
trans
4.5
total
28.4
26.7
27.0
20.8
 de
55.6
62.5
74.8
(%)
56.7
THF
THF
solvent
toluene
N N
N
MeMe
CO2tBuPh
X
O
Me
H
 a: Br
a: Br
b: PF6
c: BF4
234: X
N
CO2tBu
Ph Me N N
O
MeMe
yield (%) of dl-229a1)
entry
1
2
3
234 dl-229a 235
+
228a  (3 equiv.)
235
1. TMG, solvent
    temp., 5 d
+2. SiO2/ CHCl3
    rt, 2 d
4
60.8
66.1
80.9
73.9
 
1) Isolated yield after SiO2 chromatography. 
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5.2.3 Absolute Configuration of Aziridines Derived from Methacrolein 
On the basis of our previous works,22) the stereogenic centers of the major enantiomers in 
cis-aziridines are expected to be (2S,3S) configuration when (R,R)-guanidinium bromide 46 is 
used as a chiral source. The expected absolute stereochemistry could be confirmed by chemical 
correlation of the cis-aziridine 229a to tert-butyl N-Boc-(-)-leucinate (238)111), which was 
independently derived from (S)-(+)-leucine (236)112) (Scheme 5-4).  
CO2tBu
N
Ph
BocHN CO2tBu
 (2S,3S)-229a
[a]20 -51.3 (c 0.9, CHCl3), 89% ee
 20% Pd(OH)2/C, H2 (1 atm)
Boc2O, MeOH
rt, 12 h
(90%)
(S)-238
[a]25 -8.5 (c 1.0, CHCl3)
CO2tBu
N
Ph
BocHN CO2tBu
 (2R,3R)-229a
[a]20 +51.1 (c 2.0, CHCl3), 89% ee
 20% Pd(OH)2/C, H2 (1 atm)
Boc2O, MeOH
rt, 12 h
(94%)
(R)-238
[a]25 +8.8 (c 1.5, CHCl3)
D
D D
D
H2N CO2H BocHN CO2H
Boc2O
D
BocHN CO2tBu
(S)-238
[a]25 -9.8 (c 0.9, CHCl3)
(S)-236
1 N NaOH aq.,
rt, 15 h
(95%)
(tBuO)2CHNMe2
benzene
rt-50 oC, 27 h
(55%)(S)-237
 tBuOH
enantiomer
 
Scheme 5-4. Determination of the absolute configurations of cis-aziridines 229a 
5.2.4 Reaction of Guanidinium Ylides with various a,b-Unsaturated Aldehydes 
1. Preparation of vinyl and alkynyl aldehydes  
In general, aldehydes used in our asymmetric vinylaziridination were either commercially 
available compounds or easily prepared from available alcohols according to known procedures. 
Alcohols 242c and 242k (entries 1 and 2 in Table 5-4) were prepared from commercial 
propargyl alcohol (239) by two methods as shown in Scheme 5-5.113) 
In method 1, propargyl alcohol 239 was reacted with dihydropyran in the presence of a 
catalytic amount of p-TsOH to afford a THP ether 240 in 82% yield after distillation.113a,b) Then, 
a lithium salt of 240 was treated with bromotridecane to obtain the desired 242k after 
deprotection of the THP group113b,c) In method 2, one pot synthesis was applied by the reaction 
of the dianion of 239, generated either by using commercially available lithium amide 
(LiNH2)113d) or in situ using lithium in liquid ammonia in the presence of catalytic amount of 
Fe(NO3)3,113e) and bromotridecane to afford 242k in ca 70% yield. This alcohol was converted 
into the corresponding (E)-allyl alcohol 242c by reduction of the triple bond with LAH. 
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H
OH
O
p-TsOH
rt, 1 h
H
O
O
(81.8%)
1. n-BuLi in n-hexane
    THF-HMPA, 
    -80 oC, 40 min
2. C13H27Br, THF
    -40 oC, 3 h
H27C13
O
O
p-TsOH, MeOH
rt-60 oC, 4 h
H27C13
OH
LiAlH4, THF
reflux, 6 h
(88% from 240)
(72% from 239)
242k
H27C13 OH
242c
(excess)
239240
241 (95%)
A. LiNH2 (6.4 equiv.), liq NH3
     THF, -40 oC, 16.5 h
     then NH4Cl  (73.6%)  
                     or
B. Li (6.3 equiv.), Fe(NO3)3  9H2O
     liq NH3, THF, -40 oC, 17 h
     then NH4Cl  (72.4%)
H
OH
C13H27Br
239
.
method 1
method  2
Scheme 5-5. Synthesis of alcohols 242c and 242k from propargyl alcohol (239) 
PCC is a well-known oxidizing agent for conversion of alcohols to aldehydes or ketones 
with high efficiency. This makes PCC a versatile oxidant in organic synthesis. We prepared 
aldehydes used in this aziridination by oxidation of commercially available alcohols with PCC 
as shown in Table 5-4. 
Table 5-4. Oxidization of vinyl- and alkynyl alcohols with PCC 
entry  yield (%)1)
H27C13
1
3
2
OH
R
2.1
242: R
PCC, celite
84.3
76.2
PCC (equiv.)
CH2Cl2, rt, time
O
R
242 228
Ph
H27C13
H
1.4 5
time (h)
15
2.1 5 76.2
c:
k:
l:
 
1) Isolated yield after distillation. 
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b-Benzyloxyacrolein (228e) was prepared as follows. Tetramethoxypropane (TMP) (243) 
was hydrolyzed into malondialdehyde (MDA) followed by neutralization, to obtain a sodium 
salt of MDA 244 after evaporation of the solvent and treatment of the formed residue with 
acetone.114a) O-Benzylation of 244 afforded a desired aldehyde 228e in high yield, the 
configuration of which was confirmed by NOE experiment (Scheme 5-6).114b) 
O O
O O
NaO H
O
1. 2 N HCl aq
    25 oC, 2 h
2. 5 N NaOH aq
    25 oC, 2 h
(75%, 96% purity)
BnBr, DMF
80 oC, 3 h
(90.3%)
BnO H
O
H
H
12%
8%243 244
228e  
Scheme 5-6. Synthesis of b-benzyloxyacrolein (228e) from 1,1,3,3-tetramethoxypropane (243) 
 
Trial for the synthesis of a-phenylacrolein (atropaldehyde) (228m) from phenylacetadehyde 
(245) according to the reported method115) obtained only a dimerization product 246, not a 
desired aldehyde, after distillation of the crude product. 
Ph CHO Ph CHO O CHO
PhMe2N CH2
Cl
NEt3, CH2Cl2
dimerization
245 228m 246
Ph
 
Scheme 5-7. Trial for the synthesis of atropaldehyde (2-phenylpropenal)  
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2. Asymmetric Vinylaziridination  
Under the identical conditions as entry 2 in Table 5-1, scope and limitations of this 
asymmetric aziridination were investigated by varying the substituents on the a and b positions 
of unsaturated aldehydes, using enantiomeric (S,S)-guanidinium bromide 46 as a chiral source 
for the asymmetric induction of (2R)-aziridines (Table 5-5).  
Table 5-5. Reaction of guanidinium bromide (4S,5S)-46 with various a,b-unsaturated 
aldehydes 
entry
total
cis trans
(%ee) (%ee)
 de
(%)
H
47
Ph
1 1)
3
N N
N
MeMe
CO2tBuPh
PhPh
Br
O
R
H
A
A
228: R
N
CO2tBu
RPh PhPh
N N
O
MeMe
(4S,5S)-46
(0.2 mmol scale)
229 (4S,5S)-47
+
228 (3 Meq.)
1. TMG (1.5 equiv), 
    THF, 25 oC, 3 d
+
2. A: SiO2/ CHCl3
    rt, 2 d
or B: Ac2O/ CHCl3 
    25 oC, 30 min or 1 d
30.6
(58)
30.7
yield (%) of 229
61.3 0
22.1
(75)
59.4
(65)
81.5 45.8 90.6
94.0
step 2.
H27C13
2 A 46.1
(95)
40.8
(97)
86.9 6.0 quant.
b:
c:
d:
BnO
4 A - - - - 85.0e:
Me
Me
A
A
Ph
Ph
5 4.0 0.7 4.7 70.2 89.9
6 2) 31.9
(91)
9.5
(89)
41.4 53.8 93.5
A
Ph Me
7 2) 9.4
(92)
41.7
(93)
51.1 63.1 91.4
A
Me Ph
8 3) 28.1
(98)
2.3 30.4 84.8 89.9
f:
g:
h:
i:
 
 
 
 
 
 
 116 
Table 5-5 (continued) 
A
B: 30 min
B: 1 d
A
Ph
Me
11 20.0
(91)
3.5
(98)
23.5 70.2
16.0
(92)
45.0
(98)
61.0 47.6
20.9
62.1
10
21.5
(92)
17.6
48.2
(98)
25.6
69.7
43.2
38.4
18.5 94.1
63.4
12
k:
l:
O
Bn
N
O
CO2tBu
HO
BnHN
Ph
CO2tBu
Ph
HO
BnHN
Ph
CO2tBu
Me
OPh
Me
CHO
Ph
Me
1) 1 d, for step 1. 
2) Concomitant with a ring-opened products 247 (7.7%) for run 8 and 248 (4.4%) for run 9, respectively. 
3) Concomitant with a pyran derivative 249 (25.7%).
4) Concomitant with an oxazolidinone 250 (5.2-10.6%).
250247 248 249
9 4) A
B: 30 min
A: wet CHCl3
33.3
(99)
18.2 51.5 29.3 93.7
29.0
(98)
32.4
(98)
13.6
14.0
42.6
46.4
36.0
39.8 88.8
91.9
j:
entry
total
cis trans
(% ee) (% ee)
 de
(%)
47228: R
yield (%) of 229
step 2.
(syn : anti= 3 : 1) (dr= 2 : 1)  
Aziridines were generally formed in good to moderate yields with high ee; however, 
conversion and selectivity were strongly influenced by the substituent introduced on the a and 
b positions of unsaturated aldehydes. Thus, no diastereoselectivity was observed in the cases of 
vinyl and b-alkylvinyl aldehydes (entries 1 and 2). Interestingly, cis- and trans-aziridines 229c, 
possible synthetic precursors for D-erythro-sphingosine (54), were smoothly produced from 
(E)-hexadec-2-enal (228c) not only in high combined yield but also with high ee (entry 2). The 
reaction was greatly retarded when a,b-dialkylvinyl aldehyde was used (entry 5) and no 
aziridine was observed on b-benzyloxycinnamaldehyde; only benzyl alcohol was isolated after 
purification a crude mixture. Introduction of a substituent at the position like methacrolein 
(228a) led to the preferential production of cis-isomers (entries 8 and 9), whereas in the 
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cinnamaldehyde series trans-aziridines were obtained as major isomers (entries 3 and 7), as 
expected from the result in the previous achiral version. It was found that this aziridination was 
applicable to alkynyl aldehydes (entries 10 and 11). High ee was also observed in 
3-phenylprop-2-ynal (228l).  
Using Ac2O instead of SiO2 also afforded aziridines in the same both enantioselectivity and 
chemical yields (entry 9), except for aziridine derived from phenylpropargyl aldehyde (entry 
11). 
We assumed that spiro intermediate derived from phenylpropargyl alcohol was difficult to 
fragment or needed longer time under SiO2/ CHCl3 condition. This problem could be solved by 
Ac2O. Trial for asymmetric aziridination on undistillated a-phenylacrolein (228m) instead of 
methacrolein was unsuccessful (not shown in this Table). No aziridine formation due to its 
reactivity dimerization occurred before or faster than aziridination.  
 
5.3 Isolation of Spiro Intermediate derived from a-Bromocinnamaldehyde 
According to the results from Table 5-5, we could make the assumption that the tendency of 
diastereo- and enantioselectivies was greatly dependent on substituents on the a position of the 
aldehyde used. Thus, if we put a substituent on a position of 207c and 207d, the selectivity will 
be better. At first, we had an idea to put trimethylsilylgroup (TMS) on 207c using the synthetic 
method as shown in Scheme 5-8. But disappointingly, only hydrogenated product 233 was 
obtained as a major compound. 
H SiMe3 H27C13 SiMe3
H27C13 SiMe3
OHDIBAL, MeLi
CH2O
H27C13 SiMe3
n-BuLi,
H27C13Br
251 252
253
254   
Scheme 5-8. Trial for the synthesis of a-trimethylsilyl derivative 
In order to test our hypothesis, initial studies with a commercially available a-bromocinna- 
maldehyde 228n and a racemic guanidinium bromide dl-46 were at first carried out as shown in 
Table 5-6. 
 
On a Racemic Guanidinium Bromide dl-46 
1. Initial trial for the synthesis of aziridine derived from a-bromocinnamaldehyde  
Reaction in DMF with NaH as base at low temperature afforded aziridine in low chemical 
yield, in which spiro intermediate dl-255a was concomitantly obtained as a crystalline product 
even a minute amount. We next examined this aziridination reaction using TMG as base 
followed by Ac2O treatment (2 equiv. with respect to TMG). The starting aldehyde 228n or 
spiro intermediate 255a completely disappeared on TLC after prolonged reaction time. 
However, the yield of the desired aziridine dl-229n did not increase (entry 2 in Table 5-6).  
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Table 5-6. Reaction of guanidinium bromide dl-46 with a-bromocinnamaldehyde 228n 
H
O
Br
Ph
NMeMeN
N CO2tBuPh
Ph Ph
Br N
CO2tBu
Ph Br
Ph
NMeMeN
O
Ph Ph
NMeMeN
Ph Ph
ONPh
ButO2C
PhBr
dl-46 228n
dl-229n
dl-47
dl-255a
1. base, solvent
2. SiO2 in MeCN
    or Ac2O in CHCl3
+
 
entry
1
2
yield 1) (%)
dl-255a trans-dl-229n
0.9 25.0
0 31.4
step 1 step 2
NaH 2.0 equiv/ DMF
-40 oC, 5 h 2)
SiO2/ MeCN
rt, 30 h
conditions
cis-dl-229n
10.2
8.4
dl-47
TMG 1.6 equiv/ THF
-40 oC, 3 h to 0 oC, 3.5 h
Ac2O/ CHCl3
0 oC, 30 min to rt, 16 h
63.9
81.8
 
1) Isolated yield after SiO2 column chromatography  
2) An aldehyde 228n still remained in the reaction mixture. 
 
2. Isolation of Spiro Intermediate dl-255a 
The above result that a spiro intermediate could be separated in pure form forced us to 
confirm the structure of this adduct. Thus, the reaction between racemic guanidinium bromide 
dl-46 and a-bromocinnamaldehyde (228n) was conducted in the presence of TMG at low 
temperature to give a spiro intermediate 255a in pure form after purification by NH-SiO2 as 
shown in Table 5-7. 
Table 5-7. Initial trial for the isolation of spiro intermediate 255a1) 
entry
1
2
conditions
-40 oC, 2.5 h 
-10 oC, 3.5 h
-40 oC, 18 h
     rt, 1.5 h
yield 2, 3) (%)
dl-255a trans-dl-229n
73.1 9.1
64.4 21.3
NHMeMeN
N CO2tBuPh
Ph Ph
dl-233
O
 
1. Guanidinium bromide dl-46 1.3 equiv., aldehyde 228n 1.0 equiv., and TMG 1.5 equiv. were used. 
2. Isolated yield after NH-SiO2 column chromatography. 
3. dl-47 and dl-233 were also isolated as a mixture without further purification. 
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During purification, other possible spiro intermediates could also be detected as minor 
isomers. Trials for the isolation of these minor components were unsuccessful due to their low 
stability on NH-SiO2 chromatography because these intermediates disappeared during the 
purification and, instead, trans-aziridine 229n was detected.  
In order to obtain high levels of diastereoselecitvity, the reaction conditions used were 
optimized as shown in Table 5-8. Purification of the major spiro intermediate dl-255a could be 
expected to be more facile according to Scheme 5-9. 
Reaction mixture
1. evaporated
2. triturated
    with AcOEt
Solids-1 (256)
Filtrate-1
 with 
n-hexane
Solids-2 (dl-255a, dl-46)
Filtrate-2 (dl-255a,b,c,d and others)
Purification by 
NH-SiO2 column
1 H-NMR Estimation
of their ratios
Me2N NMe2
NH2Br
256
triturated
 
Scheme 5-9. Purification procedure for the isolation of spiro intermediates dl-255 
 
First, we examined the effect of temperature on C-C bond formation of step 1 to determine 
whether the reaction was controlled by either kinetic or thermodynamic mode (entries 1-3). 
Diastereomeric ratio was estimated on Filtrate-1 (see Scheme 5-9). A high level of diastereo- 
selectivity in favor of an isolable spiro intermediate 255a was observed in the reactions at room 
temperature and -20 oC (entries 1 and 2) compared to at -60 to -40 oC (entry 3). These facts 
suggested that the spiro intermediate is a thermodynamically-favored product. 
Table 5-8. Optimization according to the purification procedure in Scheme 5-91) 
entry
1
2
temp, time yield
 (%) of dl-255a
estimation   isolation3)
76.3
77.5
solvent
reaction 
concentration (M)
TMG
(equiv.)
isomeric ratio2)
(255a : b : c : d)
1.4
1.4
THF
THF
rt, 30 min
-20 oC, 5 h
-60 oC, 8 h
-40 oC, 26 h
0.14
0.13
1.40.13 THF
134 : 12 : 13 : 10
209 : 32 : 13 : 10
174 : 37 : 10 : 123 73.2
79.3
79.2
74.7
   
1) Guanidinium bromide dl-46 1.3 equiv., aldehyde 228n 1.0 equiv., and TMG 1.5 equiv. were used. 
2) Estimated on Filtrate-1 by 1H-NMR spectrum (see Scheme 5-9). The ratio of 255b : c : d was based on  
the tentative assignment of their structures.     
3) Isolated yield after NH-SiO2 short-column chromatography.  
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3. Structural elucidation of spiro intermediates 
Structure of the major spiro intermediate dl-255a was elucidated through the use of a 
combination of basic analytical methods: NMR, IR and HR-FAB-MS, and confirmed its stereo- 
chemistry by X-ray crystallography. A single crystal of dl-255a was obtained after recrystalliza- 
tion from n-hexane and AcOEt. Thus, the trans-relationship between C-2 and C-3 was 
established (Figure 5-3).  
 
Figure 5-3. ORTEP drawing of a spiro intermediate dl-255a 
Assignment of the relative configurations at C-2 and C-3 for minor spiro isomers in the 
Filtrate-2 (Scheme 5-9) was possible by using NOE experiment as shown in Figure 5-4. 
NN
Ph Ph
dl-255a
ONPh
ButO2C
PhBr
NMeMeN
Ph Ph
dl-255b
ONPh
ButO2C
PhBr
NMeMeN
Ph Ph
dl-255c
ONPh
ButO2C
PhBr
NMeMeN
Ph Ph
dl-255d
ONPh
ButO2C
PhBr
H
H
H
H
7.2% 11.3%
H
H
H
H2
1
d H-2= 4.91 ppm
d H-3= 3.83 ppm
J2,3=  7.9 Hz
d N-Me= 2.38 ppm
               2.50 ppm
d H-2= 5.31 ppm
d H-3= 4.20 ppm
J2,3=  7.6 Hz
d N-Me= 2.47 ppm
               2.70 ppm
d H-2= 5.25 ppm
d H-3= 4.19 ppm
J2,3=  8.9 Hz
d N-Me= 2.28 ppm
               2.74 ppm
uncertain in the relationship of spectal 
data and structure
H3C CH3
H
3.3%
2.8%
d H-2= 4.90 ppm
d H-3= 3.95 ppm
J2,3=  8.7 Hz
d N-Me= 2.35 ppm
               2.57 ppm
H
8
 
Figure 5-4. Assignment of the relative configurations at C-2 and C-3 by NOE experiment 
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The NOE enhancement in an isolable spiro compound dl-255a was observed peaks at d 2.50 
ppm (NMe peak) and d 4.2 ppm when peak at d 4.91 ppm was irradiated, while no NOE 
experiment was detected peak at d 3.83 ppm as expected from their trans-relationship confirmed 
by X-ray analysis. Irradiation of peaks in the Filtrate-2 (diastereomeric ratio= 1 : 1 : 6 : 3) at d 
4.19 and 4.20 ppm induced enhancement of peaks at d 5.25 and 5.31 ppm, respectively, 
suggesting cis-relationship between H-2 and H-3. However, further structural informations on 
minor spiro intermediates were not available. 
 
4. Fragmentation of the major spiro intermediate dl-255a 
In the context of this analysis, a pure spiro intermediate was fragmented under the 
conditions shown in Table 5-9. 
Table 5-9. Fragmentation of dl-255a 
N
CO2tBu
Ph Br
Ph
NMeMeN
O
Ph Ph
NMeMeN
Ph Ph
ONPh
ButO2C
PhBr
dl-229n dl-47
dl-255a
conditions
 
entry
1
2
conversion ratio
dl-255a : cis-dl-229n : trans-dl-229n : dl-47conditions
NH-SiO2 5.1 g in n-hexane/ AcOEt 
(10 : 1) 12 ml, rt, 1 d
CHCl3 5 ml, rt to reflux, 1 d
dl-255a
22.2 mg
23.2 mg
37.1 mg3 SiO2 1.1 g in CHCl3 4 ml
rt, 1 d
1 : 0 : 0 : 0
1 : 0 : 0 : 0
0 : 1 : 4 : 5
 
No fragmentation was observed either in stirring with NH-SiO2 (entry 1) or refluxing in 
CHCl3 (entry 2), whereas aziridine dl-229n was smoothly obtained together with a urea dl-47 
when conventionally treated with SiO2 (entry 3), in which the same diastereoselecitvity as one 
pot aziridination (see Table 5-6) was observed. 
 
On a Chiral Guanidinium Bromide (4S,5S)-46 
According to our achievement on the isolation of the spiro intermediate 255a, we next 
examined this aziridination reaction using a chiral guanidinium bromide (4S,5S)-46. The 
reaction of (4S,5S)-46 (1.2 equiv.) with a-bromocinnamaldehyde (228n) (1.0 equiv.) in THF in 
the presence of TMG (1.4 equiv) at -20 oC to room temperature for 2 h, followed by trituration 
with AcOEt to afford the Solids-1 (256) and the Filtrate-1. The ratio of spiro intermediates in 
the Filtrate-1 was estimated (approximately 255a : b : c : d = 21 : 3 : 1 : 1). Trial for the 
isolation of major spiro intermediate 255a in the Filtrate-1 by trituration with n-hexane, 
according to Scheme 5-9, was unsuccessful due to its high solubility in this solvent. Thus, the 
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obtained crude mixture was purified by NH-SiO2 to give spiro intermediate 255a and 
trans-aziridine 229n (Scheme 5-10). 
The isolable spiro intermediate 255a was treated with SiO2 treatment for 20 h to result in 
the formation of 3-vinylaziridine-2-carboxylate 229n in 75% yield with high diastereo- and 
enantioselecitvities together with the recovered chiral cyclic urea 47. 
NMeMeN
N CO2tBuPh
Ph Ph
Br
N
CO2tBu
(4S,5S)-46 228n (2R,3S)-229n
H
O
Br
Ph
NMeMeN
Ph Ph
(2R,3R,7S,8S)-255a
ON
Ph
Ph
ButO2C
PhBr
Br
Ph
1. TMG (1.4 equiv.), THF
    -20 oC 30 min, 0 oC, 1.5 h
2. purification by NH-SiO2
(1.2 equiv.) (1.0 equiv.) (74.4%) (11.0%, 35.0% ee)
3. SiO2 in CHCl3
    rt, 20 h
N
CO2tBu
(2R,3S)-229n
Ph Br
Ph
(63.1%, 98.0% ee)
N
CO2tBu
(2R,3R)-229n
Ph Br
Ph
(11.5%, 93.9% ee)
NMeMeN
O
Ph Ph
(4S,5S)-47
(96.5%)
+
  
Scheme 5-10. Reaction of guanidinium bromide (4S,5S)-46 with a-bromocinnamaldehyde (228n) 
Based on this results, we conclude that the stereochemical configuration at C-2 and C-3 of 
major spiro intermediate 255a were R and R, respectively. Lower enantioselectivity of trans- 
aziridine-229n obtained in step 1 might result from fragmentation of unstable spiro intermediate 
255b,c and d.  
 
5.4 Mechanistic Aspects 
   Haga has approached to mechanism for the asymmetric synthesis of aziridines from guanidi- 
nium ylides and a variety of p-substituted benzaldehydes under modified condition.110) Two 
kinds of reaction mechanisms controlled by the nature of the p-substituents of aryl aldehydes is 
proposed for the two-steps aziridine synthesis composed of a C-C bond formation by 
nucleophilic addition of guanidinium ylides to aryl aldehydes (step 1) and the fragmentation of 
intermediate adducts to aziridine products by intramolecular nucleophilic substitution (step 2). 
A SNi-like mechanism via cationic-like transition state is proposed for step 2 in the asymmetric 
synthesis using electron donating group (EDG) substituted benzaldehydes, whereas with 
electron withdrawing group (EWG) substituted benzaldehydes, a SN2-like mechanism is 
proposed. 
In our asymmetric vinylaziridination of a-bromocinnamaldehyde 228n, aldehyde 
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approaches to the less hindered Re-face [Re(Gua)] of the ylide enolate because the Si-face is 
blocked by the N-Me group located in the stable Z-configuration of the C=N+ bond. Thus, R 
stereochemistry of the stereogenic center should be induced. The step 1 is relatively fast due to 
the high electrophilicity of the carbonyl group, and the less hindered Re-face [Re(Ald)] of the 
aldehyde greatly participates to the bond formation. This situation led to the production a 
trans-configuration between the ester and vinyl groups (Figure 5-5). 
H O
Br
Ph
O H
Br
Ph
NN
Ph Ph
255a
ONPh
ButO2C
PhBr
N
N
Ph
Ph
Ph
OtBu
O
N
H
Me
Me
N
N
Ph
Ph
Ph
OtBu
O
N
H
Me
Me
O H
Br
Ph
H O
Br
Ph
NN
Ph Ph
255c
ONPh
ButO2C
PhBr
Re(Gua)-Re(Ald) Re(Gua)-Si(Ald)>>
NN
Ph Ph
255b
ONPh
ButO2C
PhBr
N
N
Ph
Ph
Ph
OtBu
O
N
H
Me
Me
N
N
Ph
Ph Ph
OtBu
O
N
H
Me
Me NN
Ph Ph
255d
ONPh
ButO2C
PhBr
Si(Gua)-Si(Ald) Si(Gua)-Re(Ald)>>
Me Me
Me Me
Me Me
Me Me
R R
S S
S S
S S
 
Figure 5-5. Mechanistic consideration for the formation of the spiro intermediates 255a  
In fragmentation step (step 2), SNi type reaction should occur for the production of 
trans-aziridine 229n from the spiro intermediate 255a (Figure 5-6). The cationic character of 
the allylic position (C-2) of 255a may be deactivated due to the presence of a bromine atom on 
the vinyl function. This discrepancy would be addressed by computer-based calculation. 
NMeMeN
Ph Ph
ONPh
ButO2C
PhBr
NMeMeN
Ph Ph
ONPh
ButO2C
PhBr
OH
d
SiO2
N
Ph
CO2tBu
Br
Ph
N
Ph
CO2tBu
Br
Ph
OH SiO2
d
NMeMeN
Ph Ph
ONPh
ButO2C
PhBr
OH SiO2
d
SN2
A
A B
trans-229n
cis-229n
SNi
(major isomer)
255a
 Figure 5-6. Mechanistic consideration for fragmentation of the spiro intermediate 255a  
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5.5 Aziridines Ring-opening Reaction 
With the development of diastereo- and enantioselective syntheses of aziridine, their ring- 
opening reactions by oxygen nucleophiles have become one of the most investigated routes to 
vicinal amino alcohols. Lewis acids have been identified as a major group of catalysts for this 
reaction.116) Despite high ring strain energy, non-activated aziridines (aziridines with electron 
donating group on the nitrogen atom such as alkyl groups) are generally not susceptible to ring 
opening via nucleophilic attack. While the reactivity of non-activated aziridines is relatively 
low, activation by protonation, quaternization, adduct formation with a Lewis acid, or 
replacement of the N-hydrogen with an electron-withdrawing substituent in the case of 
NH-aziridines may increases its susceptibility to ring opening through nucleophilic attack. 
N
R2
R1 CO2R3
Nu-
C-3 attack
C-2 attack
Nu NHR2
R1 CO2R3
R2HN Nu
R1 CO2R3
a-amino acid
b-amino acid
23
1
 
Figure 5-7. Schematic nucleophilic attacks at the C-2 or C-3 position in 
aziridine-2-carboxylates 
Ring opening reaction of aziridines by water is well known as the oldest reaction and has 
been studies extensively, although only a few data on unsymmetrically substituted aziridines 
were reported. The stereochemistry observed in this reaction has been discussed in terms of SN1 
and/or SN2 mechanisms depending on the extent of bond forming and bond-breaking in the 
transition state. The regio-chemistry is largely dependent on the reaction conditions chosen. 
Steric and electronic effects from the functional group present in the substrates play important 
roles in governing the site of the addition.  
In this section, we investigated the influence of substituents on acid catalyzed ring-opening 
of the non-activated aziridines-2-carboxylates117) obtained by our asymmetric aziridination 
using p-TsOH and acetic acid as summarized in following Table. 
5.5.1 Aziridine Ring-opening Reaction on Arylaziridines  
As preliminary examination,118) water-mediated ring-opening reactions were firstly 
attempted by using arylaziridines, which were independently prepared by us, in the presence of 
p-TsOH (1.2 equiv.) as summerized in Table 5-10.   
Ring-opening reactions in trans-aziridines possessing unsubstituted or chloro-substituted 
aromatic ring (entries 1, 2) occurred exclusively at the C-3 position with inversion to give 
anti-amino alcohols in excellent yield (see section 5.3.3 for determination of the relative 
configuration of ring-opening products). On the other hand, in the cases of aziridines derived 
from p-anisaldehyde and piperonal (entries 3-7), it was found that solvents controlled the 
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stereoselectivity. In homogeneous conditions using THF, the reaction was relatively faster but 
no stereoselectivity was observed (entries 3 and 6), while the use of CH2Cl2 under 
heterogeneous conditions led to better diastereoselectivity (entries 4,5 and 7), even after longer 
reaction time.  
Next, cis-aziridines were subjected to the ring-opening reaction. Aziridines possessing 
unsubstituted or chloro-substituted aromatic ring resisted to the reaction and needed longer 
reaction time comparable to trans-isomer at high temperature, however, good diastereo- 
selecitvity did not lost (entries 8 and 9). Moreover, in the case of cis-aziridine derived from 
p-anisaldehyde gave similar diastereoselectivity of syn product in the same ratio as 
trans-isomer.  
Table 5-10. Ring-opening reaction of aryl substituted cis- and trans-aziridines with p-TsOH 
time
2 h
11.5 h
2 h
10 min
temp.
(oC)
rt-45
rt-45
rt
0
H
OMe
Cl
N
CO2tBu
Ph
entry
1
2
3
6
44
p-TsOH H2O
R1
R2
solvent, H2O
temp., time
CO2tBu
R1
R2
H
N
HO
Ph
H
H
H
-OCH2O-
R1 R2
yield of 2572)dr1)
syn : anti
solvent
THF
THF
THF
THF
96.90 : 1
98.50 : 1
quant.1.1 : 1
rt 2 h 98.83.6 : 1
93.10.6 : 1
rt 17 h 96.23.3 : 1
CH2Cl2
CH2Cl2
4
7
(%)
-OCH2O-
OMe H
anti-257
CO2tBu
R1
R2
H
N
HO
Ph
syn-257
trans-
44:
.
21.5 h
3 d
rt-45
rt-45
H
Cl8
9 H
H
THF
THF
93.71 : 0
71.81 : 0
rt 15 h quant.3.3 : 1CH2Cl210 OMe H
cis-
a:
b:
c:
f:
a:
b:
f:
rt 3 h 88.35 : 1CH2Cl253) -OCH2O-
1) Estimated from the crude mixture by 1H-NMR.    
2) Isolated, combined yields of 257 after SiO2 column chromatography. In cases of entries 3,4,7 and 10 are 
percentage yields of the mixture. 3) Preliminary examination by Manaka.118) 
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Next, reactions using AcOH as not only a proton source but also nucleophile were 
investigated (Table 5-11). High diastereoselecitvity could be obtained when trans-isomer was 
treated with AcOH in CH2Cl2 at -10 oC for 2 h (entry 2). At low temperature for short reaction 
time, cis-aziridine was found (entry 3). This fact indicates that amino group at a position in the 
forming intermediate acts as internal nucleophile (Figure 5-8). 
Table 5-11. Ring-opening reaction of aziridines derived from p-anisaldehyde with AcOH 
time
40 min
temp.
(oC)
rt
entry
1
results1)solvent
-trans-
44f method
B
N
CO2tBu
OMe
H
N CO2tBu
OMe
AcO
H
N CO2tBu
OMe
HO N CO2tBu
H
MeO
Ac
H
O
MeO
44f
42f
method A
anti-258f: J2,3= 7.3 Hz
 syn-258f: J2,3= 5.5 Hz
method B
ii)i)
259
anti-257f: J2,3= 5.1 Hz
 syn-257f: J2,3= 8.1 Hz
AcOH
KOH
THF-MeOH
0 oC, 15 min
i) anti-258f : syn-258f = 1 : 0.25
ii) anti-257f : syn-257f : 259 : 42f
     = 1 : 0.21 : 0.04 : 0.03
temp., time
2 h-102 CH2Cl2trans- B i) anti-258f: syn-258f = 1 : 0.08
ii) anti-257f: syn-257f : 259 : 42f
     = 1 : 0.04 : 0.06 : 0.06
Ph
Ph
Ph
Ph
30 minrt4 -cis- B i) anti-258f : syn-258f = 1 : 0.43
ii) anti-257f : syn-257f : 259 : 42f
     = 1 : 0.34 : 0.03 : 0.07
15 min-53 THF-H2Otrans- A anti-257f : syn-257f : cis-44f
= 1 : 0.45 : 0.03
        1) Estimated from the crude mixture by 1H-NMR. 
 
Rationalization for the stereoselectivity in aziridine ring-opening reaction  
We can not apply only Cram’s or Felkin’s model to explain the diastereoselecitvity observed. 
In the addition of nucleophiles to a-chiral allyl chlorides or g-chiral-a,b-unsatuated carbonyl 
compounds, in principle, the Felkin rule is addressed; however, some important differences 
such as 1,3-allylic strain again apply. The anti-Felkin conformation increases in importance in 
order to minimize 1,3-allylic strain (Figure 5-7, model B). This model lead to anti-amino- 
alcohol corresponding to the experiment observed when the polar solvent such as THF was 
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used. In order to stabilized the forming cation, the polar solvent solvates around, thus, 
1,3-allylic strain is the major effect to the diastereochemical outcome. Felkin’s model was 
applied in CH2Cl2 which cannot stabilize cation, and in the aziridine derived from piperonal 
which the lone pair electron on oxygen atom is difficult to delocalize in to the aromatic system. 
cis-aziridinetrans-aziridine
Amino group as an internal nucleophile
RL
RM RS
H
O
Me
A B
RL
RM
RS
H
O
Me
cis-aziridine
C
RS
RL
RM
H
O
Me
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RM RS
H
O
Me
A
Nu
C
anti-aminoalcoholsyn-aminoalcohol
RL represents NHCH2Ph, RM represents CO2tBu and RS represents H
syn-aminoalcohol
Hydroxy or acetoxy as an external nucleophile
RS
RL
RM
H
O
Me
Nu
B
RL
RM
RS
H
O
Me
Nu
 
Figure 5-8. A is Cram’s model, B is anti-Felkin’s model and C is Felkin’s model  
The explanation for the stereocemical outcome of the reactions involving the use of Cram’s 
or Felkin’s model was designed. Cram’s rule predicts that the nucleophile will attack from the 
side of the smallest group when the molecule adopts a conformation in which the largest group 
is syn coplanar to the carbonyl group. Cram’s model does not accurately represent either the 
ground state or the transition state of the reaction but it does provide a useful method for 
predicting the structure of the major product. A better mechanistic rationalization is provided by 
Felkin model, which is supported by ab initio calculations. Felkin’s rule considers two 
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conformations and predicts that the major one, or at least the one leading to the major product, 
will be the one show on the left-hand side of the equilibrium in Figure 5-8. These rules work 
well when only steric factors are involved. In such situations the degree of selectivity which can 
be achieved is usually modest.    
5.5.2 Ring-Opening Reactions on Vinylaziridines  
We applied water-mediated ring-opening reaction with p-TsOH to vinylaziridines (Table 
5-12).  Basically, very good diastereoselecitvity was observed in a-amino-b-hydroxy ester 
products, which were only ring-opening products in simple vinylaziridines (entries 1-4). 
However, in aziridines possessing cyclohexenyl and pentadecenyl groups, regioisomer 
b-amino- a-hydroxy ester products formed by a nucleophile attacking at C-2 were obtained as 
side- products (entries 5 and 6). 
Table 5-12. Reaction of vinyl substituted-aziridines with p-TsOH 
timetemp.
(oC)
N
CO2tBu
R
Ph
entry
1
2
3
229
p-TsOH
THF, H2O
temp., time
CO2tBu
R
H
N
HO
Ph
R
2603)
dr1)
syn-260: anti-260
4
anti-260
Me
H
cis
trans
cis
trans
rt-50
rt
rt-50
50
0 : 1
1 : 0
0 : 1
1 : 0
5
6
H
cis
trans rt
rt
1 : 81
55 : 1C13H27
H
HH
H
H
20
(h)
93
2 85
2 88
6 93
35 72
35 79
CO2tBu
R
H
N
HO
Ph
syn-260
CO2tBu
R
HO
N
H
261
Ph
74) cis rt 1 : 0
H
12 54
261
0
0
0
0
16
17
30
229:
yield (%)2)
a:
b:
c:
d:
 
1) Estimated from the crude mixture.    
2) Isolated yield after SiO2 column chromatography. 
3) Yield of a major-isomer. 
5.3.3 Determination of Relative Configuration of Ring-opening Products 
 The stereochemistry of the stereogenic centers in the ring-opening products was 
determined after conversion to the corresponding oxazolidinone 262 by reaction with 
carbonyldiimidazole (Im2CO), in which a racemic ring-opened product dl-260a was used as a 
starting material (Scheme 5-11). In general, the coupling constant between 4-H and 5-H is 
~9-10 Hz in cis-oxazolidinone systems, whereas ~4-6 Hz in trans-systems.11 The small 
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coupling constant (J4,5 = 5.2 Hz) observed in trans-262a indicates that the hydroxyl-inserted 
product 260a has syn (threo) stereochemistry. This deduction was supported by NOE 
enhancement (13.6%) between these protons observed in the corresponding cis-oxazolidinone 
derivative 262a (J4,5 = 9.2 Hz) derived from the trans-aziridines. Thus, the ring-opening 
reaction should be controlled by SN2 type substitution leading to inversion at the C-3 position.  
HO
H
N CO2
tBu
Ph
Im2CO, CH2Cl2
N
O
O
CO2tBu
Ph
trans-262a
(J4,5= 5.2 Hz)
2
3
syn-260a
(J2,3= 8.4 Hz)
35 oC, 2 d (89.5%)
4
5
N
O
O
CO2tBu
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H
H
4
5
NOE 13.6%
cis-262a
(J4,5= 9.2 Hz)  
Scheme 5-13. Determination of the relative configuration of 260a as an oxazolidinone 262a 
 
5.6 Application to the Synthesis of Hydroxyleucinate 
In order to evaluate the applicability of our asymmetric vinylaziridination, we applied 
1-methylvinylaziridine 229a to the synthesis of (2R,3S)-hydroxyleucinate 175 which has been 
used as a key compound in the synthesis of (+)-lactacystin (101) or clasto-lactacystin-b-lactone 
(102) by several groups (see Chapter 3).  
The synthetic route started by treatment of (2R,3R)-cis-aziridine 229a (89% ee) with 
p-TsOH.H2O to afford a-amino-b-hydroxy ester 260a in 93% yield as a single product (see 
entry 2 in Table 5-12). Catalytic hydrogenation of 260a in the presence of 10% palladium on 
carbon (Pd/C) smoothly gave (2R,3S)-3-hydroxyleucinate 175 in high chemical yield.  
CO2tBu
N
Ph
D
HO
H
N CO2
tBu
Ph
(2R,3R)-229a (2R,3S)-260a
[a]25 +8.8 (c 1.5, CHCl3)
p-TsOH H2O
THF-H2O (1 : 1)
rt-50 oC, 20 h
(93%)
. 10% Pd/C, H2 (1 atm)
EtOH, rt, 9.5 h
(91%)
HO
H2N
CO2tBu
175
 
Scheme 5-14. Synthesis of (2R,3S)-tert-butyl hydroxyleucinate 175 from cis-aziridine 229a  
The enantiomeric excess of obtained 175 was determined to be 87% by conversion to the 
known oxazolidinthione 263 (Scheme 5-13). Thus, high retention of chirality in 175 supported 
the stereoselective ring-opening reaction of cis-aziridine 229a with p-TsOH. 
HO
H2N
CO2tBu
Im2CS, CH2Cl2
H
N
O
S
CO2tBu
263
(J4,5= 5.4 Hz)
175
(J2,3= 8.4 Hz)
rt, 1 h
(90%)
 
Scheme 5-13. Determination of enantiomeric excess of 175 as thio-oxazolididinone 263 
In our method hydroxyleucinate 175 was prepared in 68% overall yield with 87% ee from 
the guanidinium salt 46. This synthesis can be also applied to the preparation of the enantiomer 
of 175 by starting from (2S,3S)-cis-aziridine ent-229a. 
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5.7 Application to the synthesis of D-erythro-Sphingosine 
Next, we examined the enantioselective synthesis of D-erythro-sphingosine (54) from both 
(2R,3S)-trans-aziridine 229c and (2R,3R)-cis-aziridine 229c obtained in entry 2 in Table 5-5 as 
extension of asymmetric vinylaziridination. The former trans-aziridine 229c (97% ee) was 
exiamined. 
5.7.1 Synthesis of D-erythro-Sphingosine (54) from trans-Aziridine 229c 
1. Ring-opening reaction of trans-isomer 
The ring-opening reactions of trans-aziridine are shown in Scheme 5-14. The previous studies 
(Table 5-12) showed that under a protic condition with p-TsOH, the ring-opening reaction 
preferentially proceeded at the b-position to give a 4~5 : 1 regioisomeric mixture of 260c and 
261c. Thus, a desired a-amino-b-hydroxy ester 260c was obtained in 71% yield with good de, 
and a regioisomeric b-amino-a-hydroxy ester 261c was produced in 16% yield with low 
diastereoselectivity. 
N
Ph
C13H27
CO2tBu
AcO
H
N CO2
tBu
Ph
C13H27
AcOH
KOH
HO
H
N CO2
tBu
Ph
C13H27
N
H
HO CO2
tBu
C13H27
Ph
p-TsOH H2O
THF-H2O (1 : 1)
rt, 35 h
anti-260c : 261c= 4.4 : 1, 87%
C3-product: 97% de
C2-product: 10% de
rt, 2.5 h
(quant.)
anti-260c: C3-product 261c: C2-product
THF-MeOH (34 : 1)
0 oC, 15 min
(99%)
+
trans-229c
.
anti-264
CO2tBuN
Ph
265
+
CO2tBuHN
HO
Ph
anti-260c
C13H27
K2CO3, MeOH
rt, 5 h
No reaction
KOH aq, EtOH
25 oC, 2 h
(52%) (18%)
H27C13
Ac
 
 Scheme 5-14. Ring-opening reaction of trans-229c 
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Figure 5-9. The nuclear overhauser effect (left) and HMBC correlation (right) in 265 
Therefore, acetic acid was used as an alternative nucleophile for the ring-opening reaction, 
and an acetoxy-inserted product 264 was quantitatively afforded as a single diastereoisomer. 
a-Amino-b-hydroxy ester 260c was obtained in 99% yield when 264 was subjected to 
methanolysis (KOH, THF/MeOH), whereas conventional alkaline hydrolysis (KOH, 
EtOH/H2O) afforded 260c only in low yield (18%); instead, a conjugated dehydration product 
265 was mainly produced (52%). The structure of the dehydration product 265 was deduced by 
NMR data (Figure 5-9). 
2. Preparation of oxazolidinone derivative 271 
Trials for reduction of the tert-butyl ester of a model amino alcohol 260a or debenzylation 
of anti-amino alcohol 260c were unsuccessful (Scheme 5-15), indicating that the alcohol and 
amine functions should be protected to avoid any side reactions. 
HO
H
N CO2
tBu
Ph
LiBH4, THF H
N
Ph
rt to reflux
syn-260a
266
HO
H
N CO2
tBu
Ph
C13H27
1. Li (26 equiv.), liq NH3
anti-260c
OH
-78 oC to -40 oC
2. NH4Cl
crude brown oil
 
Scheme 5-15. Trials for reduction and debenzylation of amino alcohol 260a and 260c 
Thus, the hydroxyl group of a-amino-b-hydroxy ester 260c was protected with triisopropyl- 
silyl (TIPS) function and the silyl ether 267 was treated with lithium aluminum hydride. An 
intended reduced product 268 was obtained in 82% yield, but concomitant removal of the TIPS 
function was also observed as diol 269 was formed in 18% yield (Scheme 5-16). Other reducing 
agents such as LiBH4, NaBH4/ LiCl or DIBAL led to a lower yield of 268 with unknown 
undesired compounds.  
 132
HO
H
N CO2
tBu
Ph
C13H27
TIPSOTf
TIPSO
H
N CO2
tBu
Ph
C13H27
LiAlH4
RO
H
N
Ph
C13H27
OH
NEt3, CH2Cl2
2 oC, 30 min
(95%)
anti-260c 267
THF, rt, 10 min
(268 : 269= 4 : 1, quant.)
268: R= TIPS (82%)
269: R= H (18%)  
Scheme 5-16. Protection and reduction of 260c 
After conversion of 268 to oxazolidinone 270, selective debenzylation was carried out 
under Birch reduction conditions according previous report120) to give an N-deprotected 
oxazolidinone 271 in high yields.  
TIPSO
H
N
Ph
C13H27
OH Im2CO
TIPSO
C13H27
O
N
O
Ph Li, liq NH3
TIPSO
C13H27
O
HN
O
CH2Cl2, rt, 12 h
(97%)
Et2O, -72 oC, 5 min
(91%)
268 270 271  
Scheme 5-17. Debenzylation of benzyl alcohol 268 after conversion to oxazolidinone 270 
3. Completion of the synthesis of D-erythro-sphingosine  
Successively, removal of the TIPS function of 271 with fluoride ion followed by alkaline 
hydrolysis quantitatively afforded D-erythro-sphingosine (54), which was fully characterized as 
a crystalline triacetate 272, melting point (mp) 100-102 oC, [a]D24 -13.0 (CHCl3).121) Thus, 272 
was synthesized in 62% overall yield with high optical purity (~97% ee), starting from the 
trans-aziridine 229c through nine steps.  
TIPSO
C13H27
O
HN
O
1. TBAF, THF           
rt, 1.5 h
HO
H2N
C13H27
OH
Ac2O, pyridine
2. 2 N NaOH
AcO
AcHN
C13H27
OAc
54: Sphingosine271
EtOH-H2O    
80 oC, 2.5 h
272: Sphingosine-triacetate
DMAP, CH2Cl2
       rt, 3 h
(93% from 271)
 
Scheme 5-18. Completion of sphingosine synthesis  
5.7.2 Synthesis of D-erythro-Sphingosine (54) from cis-Aziridine 229c 
Application of the above reaction scheme to the synthesis of D-erythro-sphingosine (54) 
from the corresponding cis-aziridine 229c requests stereochemical inversion at the C-3 position 
of a ring-opened product because of the undesired production of threo-(2R,3S)-amino alcohol 
by SN2-type ring-opening reaction of the cis-aziridine. According to the synthetic method by 
Johnson et al.,120) cis-oxazolidinone 262c can be a possible precursor for 
D-erythro-sphingosine.  
1. Ring opening reaction of cis-isomer 
Although treatment of cis-aziridine 229c (95% ee) with p-TsOH gave a desired a-amino- 
b-hydroxy ester 260c and a regioisomeric b-amino-a-hydroxy ester 261c in 77 and 11% yields, 
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respectively, similar to the trans-isomer, a ring-opened product 264c was unexpectedly 
produced in low yield (<50%) on exposure to AcOH without solvent at room temperature. The 
acetoxy-inserted product syn-264c was obtained when reaction was carried out in CH2Cl2, even 
in moderate yield (62-75%), and subsequent methanolysis afforded the a-amino-b-hydroxy 
ester syn-260c (93%) (Scheme 5-19).  
A small coupling constant (J = 5.6 Hz) between H-4 and H-5 of the corresponding 
oxazolidine derivative 262c indicates that the ring-opened product 260c with a syn stereo- 
chemistry is, as expected, formed by inversion at the C-3 position of an aziridine skeleton. 
rt, 35 h
syn-260c : 261c= 7 : 1, 88%
C3-product: 97% de
C2-product: 10% de
N
Ph
C13H27
CO2tBu
AcO
H
N CO2
tBu
Ph
C13H27
AcOH
HO
H
N CO2
tBu
Ph
C13H27
N
H
HO CO2
tBu
C13H27
Ph
cis-229c 261c: C2-product
+
p-TsOH H2O
THF-H2O (1:1)
.
CH2Cl2
-10 to 0 oC, 3 d
(62-75%)
syn-260c: C3-product
syn-264c
KOH
THF-MeOH (34 : 1)
0 oC, 15 min
(93%)
 
Scheme 5-19. Ring-opening reaction of cis-229c 
2. Trial for direct conversion of aziridine to oxazolidinone with stereochemical 
retention 
Recently Lee et al.122) reported direct conversion of a cis-aziridine system to a cis-oxazolidi- 
none. Thus, the reaction of cis-aziridine 229c with methyl chloroformate, in which double 
inversion processes should occur as a main reaction path, was attempted; however, a 3: 1 
mixture of cis-262c and trans-oxazolidinones 262c was formed in low yields (33%) (Scheme 
5-20). These situations made us return to a stepwise procedure as an alternative approach.  
N
Ph
C13H27
CO2tBu
ClCO2Me N
O
O
CO2tBu
Ph
C13H27
N
O
O
CO2tBu
Ph
C13H27
MeCN, reflux, 7 h
(cis : trans= 3.3 : 1, 33%)
cis-262ccis-229c trans-262c
+
 
Scheme 5-20. Double inversion at C-3 using methyl chloroformate 
3. Inversion of C-3-position of syn-amino alcohol 260c 
The amino alcohol syn-260c was converted to the tert-butoxycarbonyl (Boc) derivative 
under high concentration of Boc2O. In the dilution systems (THF or CH2Cl2 as solvent), in the 
presence of base such as NEt3, NaOH and NaHCO3, and at a higher reaction temperature (up to 
80 oC), syn-260c led to 273 in moderate chemical conversion (> 60%) with a trace amount of 
trans-oxazolidinone 262c (~ 4%) (Table 5-14).  
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  Table 5-14. Trial for protection of syn-260c with Boc2O under various conditions 
timetemp.
(oC)
entry
1
2
3
rt
rt
rt
12
24
36
solvent
1 N NaOH aq
CH2Cl2
THF
THF
yield (%)1)
no reaction
syn-260c: 8.0%
273: 62.4%
no reaction
sat. NaHCO3 aq
50 36
base
NEt3
(h)
4 80 1- 273: 58.6
trans-262c: 4.3
-
 
1) Isolated yield after SiO2 column chromatography 
After introduction of Boc group to the nitrogen atom, treatment with methanesulfonyl 
choloride led to an intramolecular cyclization123) with stereochemical inversion at the C-3 
position, resulting in the production of cis-oxazolidinone 262c in high yield (Scheme 5-21). 
HO
H
N CO2
tBu
Ph
C13H27
Boc2O
HO
N CO2
tBu
Ph
C13H27
Boc
MsCl, NEt3 N
O
O
CO2tBu
Ph
C13H27
syn-260c
50 oC, 4 h
(95%)
173
CH2Cl2,
 0 oC, 30 min
(95%)
cis-262c   
Scheme 5-21. Inversion at C-3 using Boc2O and mesyl chloride 
4. Completion of the synthesis of D-erythro-sphingosine 
According to the method of Johnson et al., the ester function was reduced with LiBH4 to 
afford the corresponding alcohol 274 in 73% yield with partial recovery of the starting cis-262c 
(20%). After protection of the alcoholic function of 274 with TIPSOTf, selective removal of the 
benzyl group of 275 was effected under Birch reduction conditions to give an N-deprotected 
oxazolidinone 276. Treatment of 276 with fluoride anion followed by alkaline hydrolysis 
completed the alternative synthesis of D-erythro-sphingosine (54) from the cis-aziridine 229c 
(95% ee) in 27% overall yield through nine steps (Scheme 5-22).  
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Scheme 5-22. Completion of sphingosine synthesis according to Johnson’s route 
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Chapter 6: Conclusion 
 
In conclusion, reaction of chiral guanidinium ylides with a,b-unsaturated aldehydes 
successfully gave a variety of a,b-unsaturated aziridine-2-carboxylates in good to moderate 
yields and chirality of the guanidinium ylides was effectively transferred to the 2 and 3 positions 
of aziridine products (up to 93% de and 99% ee). Additionally, The formed a,b-unsaturated 
aziridines are easily converted into a-amino-b-hydroxy esters synthetic precursors. Thus, 
(2R,3S)-3-hydroxyleucinate was enantioselectively prepared from (2R,3R)-3-isopropenyl- 
aziridine-2-carboxylate obtained using methacrolein as aldehyde substrate. In addition, 
D-erythro-sphingosine was synthesized in good overall yield with high optical purity starting 
from both trans-(2R,3S)- and cis-(2R,3R)-3-[(E)-pentadec-1-enyl]aziridine-2-carboxylates.  
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Chapter 7: Experimental Section  
Instrumentation 
Analytical thin layer chromatography (TLC) was performed on Merck silica gel 60 F254 
and Fuji silysia NH-silica gel 60 F254 glass plates precoated with a fluorescent indicator. 
Column chromatography was performed using silica gel 60 (63-210 mm) from Kanto-Cica or 
NH-silica gel (100-200 mesh) from Fuji silysia. Melting points were measured on a Yanaco 
micro melting point apparatus and were uncorrected. HPLC was performed on a Jasco 
Gulliver-series instrument equipped with a variable wavelength detector and Daicel Chiracel 
OD-H or AD-H column. Optical rotations were measured on a Jasco P-1020 polarimeter with a 
sodium lamp, and were reported as follows: [α]DTemp (oC) (c g/ 100 ml, solvent). IR spectra were 
recorded as a thin film between NaCl plates, KBr plates or ATR method on a Jasco FTIR 300E 
spectrophotometer. 1H NMR spectra and 13C NMR spectra were recorded on a JOEL 
JNM-ECP400, JNM-A400SW, or JNM-GSX500A spectrometer. Chemical shifts for protons 
and carbons were reported in part per million (ppm) downfield from tetramethylsilane and were 
calibrated at d 0.00 and 77.00 ppm). Data were presented as follows: chemical shift, 
multiplicity (br= broad, s= singlet, d= doublet, t= triplet, m= multiplet), coupling constants in 
Hertz (Hz) and integration. Low resolution mass spectra were obtained on a JOEL JMS-AX 
500-505 and high resolution mass spectra were obtained on a JOEL JMS-HX110A. 
Unless stated otherwise, all compounds were purchased from commercial suppliers 
(Aldrich, Nacalai, TCI, or Wako) and distilled before using. Tetrahydrofuran (THF), 
diethylether (Et2O) and dichloromethane (CH2Cl2) were anhydrous grade solvents which were 
purchased from Kanto-Cica and Wako. Ethanol was distilled from CaO and stored over 
microwave-activated 4 oA molecular sieves. 1,1,3,3-Tetramethylguanidine (TMG), 
triethylamine (NEt3) and pyridine were distillated and stored over KOH.   
 
Experimental Procedures and Characterization Data 
7.1 Reaction of Guanidinium Ylides with a,b-Unsaturated Aldehydes 
   7.1.1 Preparation of a Chiral Guanidinium bromide 
(4R,5R)-4,5-Diphenyl-2-imidazolidinone (231) (Scheme 5-2) 
NH2H2N
Ph Ph
NHHN
O
Ph Ph
230 231
Im2CO, DME
80 oC, 4 h
 
In a flask equipped with a stir bar under an argon atmosphere, a mixture of diamine 230 (82.3 
mg, 0.388 mmol, 1.00 Meq) and DME (0.78 ml) was heated at 80 oC. To the resulting solution 
was added carbonyldiimidazole (CDI) (82.0 mg, 0.480 mmol, 1.24 Meq) in DME (1.75 ml) and 
stirred at the same temperature for 4 h. The reaction mixture was concentrated and the residue 
(166.3 mg, 103%) was recrystallized from AcOEt to afford 231 as colorless needles (49.5 mg, 
53.5%). The remaining crude product was purified by column chromatography (silica gel 15 g, 
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CHCl3/ MeOH= 10:1) to afford 231 as colorless needles (40.1 mg, 43.4%) and imidazole as 
pale yellow needles (65.2 mg, 94.6%). 
210: mp 195-197 oC; Rf= 0.49 (CHCl3/ MeOH= 10: 1); IR (KBr): nmax 3201 cm-1 (NH) and 
1703 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d  (ppm) 4.60 (2H, s, PhCH), 4.90 (2H, br s, 
NH), 7.27-7.38 (10H, m, PhH). 
 
(4R,5R)-1,3-Dimethyl-4,5-diphenyl-2-imidazolidinone (47) (Scheme 5-2) 
NHHN
O
Ph Ph
231
NaH, MeI
DME, rt, 4 h
NMeMeN
O
Ph Ph
47  
In a flask equipped with a stir bar under an argon atmosphere, a gray suspension of NaH (60% 
in mineral oil, 1.51 g, 37.75 mmol, 2.24 Meq) in DMF (15 ml) was added carefully a solution 
of 231 (4.0147 g, 16.85 mmol, 1.00 Meq) in DMF (30 ml) at an ice-bath temperature and 
allowed to warm to room temperature. After being stirred for another 45 min, the resulting gray 
suspension was added methyl iodide (d= 2.280, 2.20 ml, 35.34 mmol, 2.10 Meq) and further 
stirred at room temperature for 4 h. The reaction mixture was neutralized by the addition of 1N 
HCl aq (40 ml) and extracted with AcOEt (100 ml x 2). The organic phase was washed with 
H2O (100 ml x 3), brine (100 ml x 2), dried over MgSO4, and concentrated. The residue (4.8748 
g, 109%) was recrystallized from AcOEt to afford 47 as colorless prisms (4.3135 g, 96.1%) 
47: mp 153-154 oC; [α]D24 -42.0 (c 2.2, CHCl3); Rf= 0.68 (AcOEt); IR (KBr): nmax 1711 cm-1 
(C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 2.71 (6H, s, -NCH3), 4.08 (2H, s, PhCH), 7.13- 
7.15 (4H, m, PhH), 7.34-7.37 (6H, m, PhH). 
 
(4R,5R)-2-Chloro-1,3-dimethyl-4,5-diphenylimidazolidinium chloride (224) (Scheme 5-3) 
benzene
75 oC, 9 h
NMeMeN
O
Ph Ph
47
NMeMeN
Cl
Ph Ph
224
+
Cl
-
(COCl)2
 
In a flask equipped with a stir bar under an argon atmosphere, to a suspension of 47 (1.0218 g, 
3.84 mmol, 1.00 Meq) in benzene (5.0 ml) was added oxalyl chloride (d= 1.453, 1.65 ml, 18.89, 
4.92 Meq). The resulting pale yellow solution was heated at 75 oC for 9 h. The reaction mixture 
was concentrated to dryness and the resulting white solids (1.2220 g) was used in the next step 
without purification (the percentage of conversion was estimated by 1H-NMR analysis to 
indicate the ratio of 224 : 47 to be 94.3 : 5.7). 
224: IR (KBr): nmax 1636 cm-1 (C=N); 1H-NMR (400 MHz, CDCl3): d (ppm) 3.20 (6H, s, 
-NCH3), 5.29 (2H, s, PhCH), 7.36-7.51 (10H, m, PhH). 
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(4R,5R)-2-(tert-Butoxycarbonylmethyl)imino-1,3-dimethyl-4,5-diphenylimidazolidine 
(232) (Scheme 5-3) 
CH2Cl2
rt, 10 h
NMeMeN
Cl
Ph Ph
224
+
Cl
-
NMeMeN
N
Ph Ph
232
H2N CO2tBuHCl.
225
CO2tBu
NEt3
 
In a flask equipped with a stir bar under an argon atmosphere, to a solution of 225 (430.1 mg, 
2.51 mmol, 1.00 Meq) in CH2Cl2 (4.3 ml) was added NEt3 (d= 0.726, 1.10 ml, 7.89 mmol, 3.14 
Meq) at an ice-bath temperature and then allowed to warm to room temperature. After being 
stirred for another 10 min, the resulting white suspension was cooled down under the ice-bath, 
added the pale yellow solution of 224 (crude solids 1.2220 g, 94.3% purity, 3.59 mmol, 1.43 
Meq) in CH2Cl2 (14 ml) and further stirred at room temperature for 10 h. Next, the reaction 
mixture was cooled down under the ice-bath, acidified (to pH 3) with 10% aqueous citric acid 
(30 ml) and the aqueous phase was extracted with CH2Cl2 (20 ml x 2). The combined organic 
extracts was concentrated, the resulting white solids was dissolved with H2O (40 ml) and 
extracted with toluene (40 ml). 
The combined toluene extracts was washed with H2O (20 ml x 2), brine (20 ml x 2), dried over 
MgSO4 and concentrated to afford pale yellow solids of 47 (328.0 mg, 34.3%). 
The combined aqueous extracts were basified (pH > 11) by addition of 20% NaOH aq (20 ml) 
and extracted with CH2Cl2 (20 ml x 2). The organic layer was washed with H2O (20 ml x 2), 
dried over Na2SO4, and concentrated to afford 232 as pale yellow solids (958.9 mg, quant.) 
which was used in the next step without purification. 
232: m.p. 102-105 oC; Rf= 0.48 (Et2O, NH-TLC); IR (KBr): nmax 1751 cm-1 (C=O), 1670 cm-1 
(C=N); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.51 [9H, s, -CO2C(CH3)3], 2.74 (6H, br s, 
-NCH3), 3.91 (2H, s, PhCHN-), 4.23 [1H, d, J=18.0 Hz, -NCHHCO2CH(CH3)3], 4.35 [1H, d, 
J=18.0 Hz, -NCHHCO2CH(CH3)3], 7.13-7.16 (4H, m, PhH), 7.30-7.32 (6H, m, PhH). 
 
N-Benzyl-N-tert-butoxycarbonylmethyl-N’,N’’-dimethyl-N’,N’’-(1R,2R-diphenylethylene) 
guanidinium bromide (46) (Scheme 5-3) 
MeCN
rt, 4 h
NMeMeN
N
Ph Ph
46
CO2tBu
NMeMeN
N
Ph Ph
232
CO2tBu Ph
Br-
BnBr
 
In a flask equipped with a stir bar under an argon atmosphere, to a solution of 232 (811.1 mg, 
2.14 mmol, 1.00 Meq) in MeCN (8.1 ml) was added benzyl bromide (d= 1.438, 0.31 ml, 2.61 
mmol, 1.22 Meq). The reaction mixture was stirred at room temperature for 4 h and 
concentrated to dryness. Next, the residue (1.2610 g, 107%) was recrystallized from n-hexane/ 
AcOEt at 50 oC (a water-bath temp.) to obtain 46 as colorless solids (958.5 mg, 81.4%, mp 
192-195 oC) and the remaining crude residue was washed with n-hexane and Et2O to gave 46 
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(167.7 mg, 14.2 %, mp 185-188 oC) and a yellow crude oil (137.2 mg) 
46: IR (KBr): nmax 1743 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.51 [9H, s, 
-CO2C(CH3)3], 3.17 (6H, s, -NCH3), 4.28 [1H, d, J=19.0 Hz, -NCHHCO2CH(CH3)3], 4.46 [1H, 
d, J=19.0 Hz, -NCHHCO2CH(CH3)3], 4.68 (2, s, -NCHPh), 4.74 (1H, d, J=14.5 Hz, -NCHHPh), 
5.09 (1H, d, J=14.5 Hz, -NCHHPh), 7.19-7.21 (4H, m, PhH); 7.34-7.36 (6H, m, PhH), 
7.43-7.47 (3H, m, PhH); 7.70 (2H, dif. dd, J=7.9, 1.8 Hz, PhH). 
 
7.1.2 Synthesis of a,b-Unsaturated Aldehydes 
1. Preparation of a,b-Unsaturated Alcohol 
Tetrahydro-2-(2-propynyloxy)-2H-pyran (240) (Scheme 5-5) 
rt, 1 h
239
p-TsOH H2OH
OH
O
+
. H
O
O
240  
In a flask equipped with a stir bar under an argon atmosphere, propargyl alcohol 239 (d= 0.963, 
1.10 ml, 18.9 mmol, 1.01 Meq) was added dropwise to a stirred solution of 3,4-dihydro-2H- 
pyran (1.5760 g, 18.74 mmol, 1.00 Meq) and p-toluenesulfonic acid monohydrate 
(p-TsOH.H2O) (51.7 mg, 0.27 mmol, 0.01 Meq) under an ice-bath. The reaction mixture was 
allowed to stir at room temperature for 1 h and then, basified with 5% aqueous KOH (2 ml). 
The residue was purified by distillation (100 oC/ 30 mmHg) to afford 240 as a colorless oil 
(2.1430 g, 81.8%). 
240: 1H-NMR (400 MHz, CDCl3): d (ppm) 1.50-1.86 [6H, m, -(CH2)3-], 2.42 (1H, t, J= 2.4 Hz, 
HC?C-), 3.52-3.57 (1H, m, -HHCO), 3.82-3.88 (1H, m, -HHCO), 4.23 (1H, dd, J= 16.0, 2.4 
Hz, HC?CHHO), 4.30 (1 H, dd, J= 16.0, 2.4 Hz, HC?CHHO), 4.83 (1H, t, J= 3.4 Hz, 
OCHO). 
Tetrahydro-2-(2-hexadecynyloxy)-2H-pyran (241) (Scheme 5-5) 
H
O
O
240
H27C13
O
O
241
1. n-BuLi (1.43 M)
      THF/ HMPA
     -80 oC, 40 min
2. H27C13Br 
         THF
 -40 oC, 8.5 h  
In a flask equipped with a stir bar under an argon atmosphere, n-BuLi (1.43 M in n-hexane, 35 
ml, 50.05 mmol, 1.68 Meq) was added dropwise to a stirred solution of 240 (5.0058 g, 35.71 
mmol, 1.00 Meq) in THF (120 ml) at -40 oC. After being stirred for 30 min, HMPA (35 ml) was 
added and the reaction mixture was cooled down to -80 oC. Next, the solution of tridecyl 
bromide (7.8338 g, 29.76 mmol, 1.00 Meq) in THF (15 ml) was added and allowed to stir at -40 
oC for 8.5 h. The mixture was quenched with H2O (100 ml) and extracted with AcOEt (100 ml 
x 2). The organic phase was washed with H2O (100 ml x 2), brine (100 ml x 2), dried over 
MgSO4, and concentrated to obtain a crude oil of 241 (11.0435 g, 115.1%) which was used in 
the next step without purification (1H-NMR analysis to indicate the ratio of 240 : 241 to be 1 : 
3). 
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Hexadec-2-yn-1-ol (242k) (Scheme 5-5) 
Method 1: 
H27C13
OH
242k
H27C13
O
O
241
p-TsOH H2O.
MeOH
rt to reflux, 4 h  
In a flask equipped with a stir bar, a solution mixture of 241 (crude 16.6582 g, 51.65 mmol, 
1.00 Meq) and p-TsOH.H2O (1.0012 g, 5.26 mmol, 0.10 Meq) in MeOH was stirred at room 
tempera- ture for 2 h and then heated to reflux. After being stirred 2 h, the mixture was cooled 
down and quenched with H2O (100 ml) and 20% NaOH aq (16.7 ml). The mixture was 
concentrate and extracted with AcOEt (150 ml x 3). The organic layer was washed with H2O 
(100 ml x 3), brine (100 ml x 2), dried over MgSO4 and concentrated to afford a pale brown oil 
(12.5016 g, 101.5%). The residue was purified by column chromatography (silica gel 190 g, 
n-hexane/ AcOEt = 10:1) to afford 242k as colorless solids (10.8362 g, 88.0%).  
242k: Rf= 0.43 (n-hexane/ AcOEt= 10: 1); IR (KBr): nmax 3306 cm-1 (OH), 2217 cm-1 (C?C); 
1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 7.1 Hz, -(CH2)12CH3], 1.22-1.40 [20H, m, 
-(CH2)10CH3], 1.50 [2H, dt, J= 7.3, 6.3 Hz, -CH2(CH2)10CH3], 2.21 [2H, ddt, J= 7.1, 2.2, 2.2 Hz, 
-CH2(CH2)11CH3], 4.25 (2H, br s, -CH2OH). 
  
Method 2-B: 
H27C13
OH
242k
H
OH
239
Li , Fe(NO3)3 9H2O.
liq NH3, THF, -40 oC, 17 h
C13H27Br
 
To a stirred dark-blue solution of lithium (170.2 mg, 24.52 mmol, 6.27 Meq) in liquid ammonia 
(15 ml) at -70 oC was added Fe(NO3)3 . 9H2O (1 crystal) and stirred at the same temperature for 
30 min. After the mixture turned gray (LiNH2), the mixture was allowed to warm to -40 oC and 
the solution of propagyl alcohol (239) (683.7 mg, 12.20 mmol, 3.12 Meq) in THF (3.4 ml) was 
added dropwise and further stirred for 2 h. Next, a solution of tridecyl bromide (1.0300 g, 3.91 
mmol, 1.00 Meq) in THF (2 ml) was added to the mixture and stirred overnight (18.5 h). The 
mixture was allowed to stir at an ice-bath temperature until the ammonia disappeared. Then, 
ammonium chloride (2.01 g), H2O (20 ml) and Et2O (50 ml) was added. After being stirred at 
room temperature for 30 min, the organic layer was washed with water (10 ml x 2), brine (10 
ml x 2), dried over MgSO4 and concentrated. The residue was purified by column 
chromatography (silica gel 35 g, n-hexane/ AcOEt= 10: 1, 4: 1) to afford 242k as colorless 
solids (675.0 mg, 72.4%, mp 51-52.5 oC) and tridecyl bromide as an colorless oil (98.3 mg, 
9.5%). 
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E-Hexadec-2-en-1-ol (242c) (Scheme 5-5) 
OH
242c
THF
reflux, 6 h
H27C13
OH
242k
LiAlH4 H27C13
 
In a flask equipped with a stir bar under an argon atmosphere, a suspension of LiAlH4 (1.0948 g, 
80% purity, 23.08 mmol, 1.10 Meq) in THF (11 ml) was added a solution of 242k (5.0013 g, 
20.98 mmol, 1.00 Meq) in THF (50 ml) at an ice-bath temperature, stirred for 30 min and then 
heated to reflux. After being stirred 6 h, the mixture was cooled down under an ice-bath, 
quenched with H2O (5 ml), diluted with E2O (30 ml) and dried over MgSO4. The reaction 
mixture was filtered through a glass filter and completely washed with AcOEt. The combined 
filtrates were concentrated to afford the residue (5.0850 g) which was purified by column 
chromatography (silica gel 100 g, n-hexane/ AcOEt= 10: 1, 4: 1) to give 242c as colorless 
plates (4.7918 g, 95.0%).  
242c: Rf= 0.60 (n-hexane/ AcOEt= 4: 1); IR (KBr): nmax 3294 cm-1 (OH); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.21-1.40 [22H, br m, -CH2(CH2)11 CH3], 
2.04 [2H, dt, J= 6.4, 6.4 Hz, -CH2(CH2)11CH3], 4.08 (1H, d, J= 5.6 Hz, -CHHOH), 4.09 (1H, d, 
J= 5.6 Hz, -CHHOH), 5.67 (2H, m, -HC=CH-). 
 
2. Preparation of a,b-Unsaturated Aldehydes. 
(2E)-Hexadec-2-en-1-al (228c) (entry 1 in Table 5-4)                       
HH27C13
OH3
H2                         
In a flask equipped with a stir bar under a CaCl2 tube, a suspension of PCC (1.8902 g, 98% 
purity, 8.59 mmol, 1.37 Meq) and celite (7.40 g) in CH2Cl2 (30 ml) which was stirred at room 
temperature for 30 min was added a solution of 242c (1.5078 g, 6.27 mmol, 1.00 Meq) in 
CH2Cl2 (20 ml) at an ice-bath temperature, further stirred for 20 min and then warmed up to 
room temperature. After being stirred 5 h, the mixture was concentrated and Et2O (30 ml) was 
added into this residue. The mixture was filtered through a celite pad and completely washed 
with Et2O. The combined filtrates were concentrated to afford the residue which was purified 
by column chromatography (neutral silica gel 50 g, n-hexane/ AcOEt= 10: 1). The obtained 
colorless solids (1.2158 g, 81.3%) were purified again by distillation (220 oC/ 1 mmHg) to give 
228c as colorless plates (1.1383 g, 76.2%).  
228c: Rf= 0.64 (n-hexane/ AcOEt= 10: 1); IR (KBr): nmax 1694 cm-1 (C=O) and 1671 cm-1 
(C=N); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 6.8 Hz, -(CH2)12CH3], 1.22-1.38 
[20H, br m, -CH2CH2(CH2)10CH3], 1.51 [2H, dt, J= 7.2, 7.2 Hz, -CH2CH2(CH2)10CH3], 2.33 
[2H, ddd, J= 7.2, 7.2, 1.2 Hz, -CH2CH2(CH2)11CH3], 6.12 (1H, ddt, J= 15.6, 8.0, 1.2 Hz, C2-H), 
6.85 (1H, ddd, J= 15.6, 7.2, 7.2 Hz, C3-H), 9.51 (1H, d, J= 8.0 Hz, -CHO); 13C-NMR (100 MHz, 
CDCl3): d (ppm) 14.09 (CH3), 22.67 (CH2), 27.83 (CH2), 29.12 (CH2), 29.33 (CH2), 29.48 
(CH2), 29.59 (CH2), 29.62 (CH2), 29.64 (CH2), 31.90 (CH2), 32.71 (CH2), 132.96 (CH), 159.01 
(CH), 194.12 (CH). 
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Hexadec-2-yn-1-al (228k) (entry 2 in Table 5-4)                           
H
O
H27C13                        
228k: colorless needles, mp 41-42 oC; Rf= 0.64 (n-hexane/ AcOEt= 10: 1); IR (thin film): nmax 
2279 cm-1 (C?C) and 1673 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 
6.8 Hz, -(CH2)12CH3], 1.22-1.45 [20H, br m, -CH2CH2(CH2)10CH3], 1.60 [2H, dt, J= 7.2, 6.8 
Hz, -CH2CH2(CH2)10CH3], 2.41 (2H, dd, J= 7.2, 6.8 Hz, -CH2CH2(CH2)10CH3), 9.18 (1H, s, 
-CHO);  
3-Phenyl-2-propynal (228l) (entry 3 in Table 5-4)                           H
O
Ph
                       
228l: a pale yellow oil; Rf= 0.45 (n-hexane/ AcOEt= 10: 1); IR (thin film): nmax 2189 cm-1 (C?
C) and 1655 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 7.39-7.63 (5H, m, PhH), 9.43 
(1H, s, CHO). 
 
E-3-Benzyloxyacrolein (228e) (Scheme 5-6) 
O
243
O
O
O
2. 5 N NaOH aq
       rt, 2 h
BnBr, DMF
  80 oC, 3 h
H1
244
O
O
H1
228e
BnO
O1. 2 N HCl aq
       rt, 2 h
Na
H3
H2
H3
H2
 
In a flask equipped with a stir bar, TMP 243 (3.9880 g, 24.29 mmol, 1.00 Meq) was hydrolyzed 
with 2 N HCl aq (12.2 ml) at room temperature for 2 h. The reaction mixture was neutralized 
with 5 N NaOH aq to pH 7 and concentrated to dryness. The residue was treated with acetone 
(50 ml) to give brown solids which were filtered off. The obtained solids (4.4255 g) were 
recrystallization from MeOH (80 ml) and then decolorized with charcoal (5 spoons) to afford 
244 as pale brown solids (1.7233 g, 75.0%, 96% purity). 
244: mp 235-240 oC; IR (KBr): nmax 1592 cm-1 (C=O); 1H-NMR (400 MHz, D2O): d (ppm) 
5.18 (1 H, t, J= 10.4 Hz, C2-H), 8.53 (2H, d, J= 10.4 Hz, C1-H and C3-H). 
NaMDA 244 (2.0069 g) was reacted with benzyl bromide (862.8 mg, 5.04 mmol, 1.00 Meq) at 
80 oC for 35 min. The reaction mixture was quenched with H2O (100 ml) and AcOEt (100 ml). 
The organic layer was washed with H2O (50 ml x 5) (until color disappeared), brine (50 ml x 2) 
and dried over MgSO4. The resulting pale yellow oil (947.4 mg, 116%) was purified by flash 
column (neutral silica gel 40 g, n-hexane/ AcOEt= 4: 1) to afford a colorless oil (808.5 mg, 
98.9%). The obtained oil was purified again by distillation (200 oC/ 1 mmHg) to give 228e as a 
colorless oil (737.8 mg, 90.3%, isomeric ratio= 24: 1). 
228e: Rf= 0.30 (n-hexane/ AcOEt= 4: 1); IR (KBr): nmax 1677 cm-1 (C=O), 1616 cm-1 (C=C); 
1H-NMR (400 MHz, CDCl3): d (ppm) major isomer: 4.97 (2H, s, -CH2Ph), 5.70 (1H, dd, J= 
12.8, 8.0 Hz, C2-H), 7.32-7.40 (5H, m, PhH), 7.43 (1H, d, J= 8.0 Hz, C3-H), 9.36 (1H, d, J= 8.0 
Hz, CHO); 13C-NMR (100 MHz, CDCl3): d (ppm) 73.39 (CH2), 110.82 (CH), 127.73 (CH), 
128.74 (CH), 128.77 (CH), 134.46 (C), 169.88 (CH), 191.10 (CH). 
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Dimerization of atropaldehyde (228m) (Scheme 5-7) 
CHO
245
Ph
N CH2
Me
Me Cl
NEt3, CH2Cl2
rt, 16 h
CHOPh O
Ph
CHO
246
heat
228m
1
3
4
5
Ph
 
In a flask equipped with a stir bar under an argon atmosphere, a solution mixture of 245 (309.2 
g, 90% purity, 2.52 mmol, 1.00 Meq) and methylene-N,N-dimethylammonium chloride (521.7 
mg, 90% purity, 5.02 mmol, 2.00 Meq) in CH2Cl2 (8 ml) was added NEt3 (d= 0.726, 1.4 ml, 
10.04 mmol, 4.00 Meq) and stirred at room temperature for 16 h. The mixture was quenched 
with H2O (10 ml) and extracted with CH2Cl2 (20 ml x 2). The organic layer was washed with 
H2O (10 ml x 1), brine (10 ml x 2) and dried over Na2SO4. The resulting pale yellow oil (268.1 
mg, 81.2%) was purified by flash column (neutral silica gel 20 g, n-hexane/ AcOEt= 4: 1) to 
afford the mixture of unknown compounds (238.4 g) which were purified again by distillation 
(120 oC/ 10 mmHg) to give 246 as a colorless oil. 
246: Rf= 0.36 (n-hexane/ AcOEt= 10: 1); IR (thin film): nmax 1732 cm-1 (C=O), 1637 cm-1 
(C=C); 1H-NMR (400 MHz, CDCl3): d (ppm) 2.21-2.65 (4H, m, -CH2CH2-), 7.17-7.51 (11H, m, 
PhH and C=CH), 9.56 (s, CHO); 13C-NMR (100 MHz, CDCl3): d (ppm) 20.25 (CH2), 27.87 
(CH2), 84.30 (C), 114.87 (C), 124.33 (CH), 125.60 (CH), 126.43 (CH), 128.36 (CH), 128.47 
(CH), 128.80 (CH), 136.34 (C), 138.29 (C), 140.02 (C), 199.71 (CH); HRFABMS m/z: 
264.1174 (Calcd for C18H16O2: 264.1150). 
 
7.1.3 Synthesis of Vinylaziridines 
General Procedure for Aziridines Formation: (Table 5-5) 
NMeMeN
N CO2tBuPh
Ph Ph
Br
RCHO
1. TMG or NaH
N
CO2tBu
R
NMeMeN
O
Ph Ph
2. SiO2/ CHCl3
    or Ac2O/ CHCl3
+ +
46 228 229 47
Ph
 
Method 1: TMG/ SiO2 or Ac2O: In a tube (18 x 150 mm) equipped with a stir bar under argon 
atmosphere, a solution of 46 (100 mg) and 228 (3 Meq) in organic solvent (0.10 ml) at 25 oC 
was added TMG (1.5 Meq). After being stirred at the same temperature for 3 d, the reaction was 
diluted with CHCl3 (2 ml) and slowly added into the suspension of SiO2 (3 g) in CHCl3 (10 ml) 
and further stirred for 2 d or slowly added with Ac2O (3 Meq) and further stirred for 30 min. 
The reaction mixture was filtered through a pad of celite. The celite was washed with CHCl3 
and the filtrate was concentrated to afford the residue which was purified by column 
chromatography to give 229 and 47. 
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Method 2: NaH/ SiO2: In a tube (18 x 150 mm) equipped with a stir bar under argon 
atmosphere, a suspension of NaH (2.0 Meq) in DMF (0.20 ml) at 25 oC was slowly added with 
a solution of 46 (100 mg) in DMF (0.3 ml). After stirring at the same temperature for 30 min, 
the mixture turned yellow, 228 (1.5 Meq) was added and further stirred for another 3 d. Next, 
the reaction was diluted with CHCl3 (4 ml) and slowly added into the suspension of SiO2 (3 g) 
in CHCl3 (10 ml) and further stirred for 2 d. The reaction mixture was filtered through a pad of 
celite. The celite was washed with CHCl3 and the filtrate was concentrated to afford the residue 
which was purified by column chromatography to give 229 and 47. 
tert-Butyl (2S,3R)-trans-1-Benzyl-3-isopropenylaziridine-2-carboxylate   
N
O
O
Ph
1 2
3
1'
2'
HaHb  
(229a) (Table 5-1) 
a pale yellow oil; 84.7% ee, determined by chiral HPLC (Daicel CHIRALCEL OD-H, 0.46 cm 
x 25 cm); n-hexane/ 2-propanol= 800: 1; flow rate= 0.5 ml/ min; detection wavelength= 215 
nm; tR (major)= 15.4 min, tR (minor)= 24.3 min; [α]D22 -59.1 (c 1.1, CHCl3); Rf= 0.56 
(n-hexane/ AcOEt= 10:1); IR (thin film): nmax 1719 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): 
d (ppm) invertmer ratio= ca. 1:0.1, major invertmer: 1.40 [9H, s, -CO2C(CH3)3], 1.64 (3H, s, 
C1’-CH3), 2.65 (1H, d, J= 2.0 Hz, C2-H), 2.77 (1H, br s, C3-H), 3.96 (1H, d, J= 14.1 Hz, 
PhCHH), 4.09 (1H, d, J= 14.1 Hz, PhCHH), 4.91 (1H, br s, Ha), 5.05 (1H, br s, Hb), 7.22 (1H, t, 
J= 7.1 Hz, PhHpara), 7.30 (2H, dd, J= 7.3, 7.1 Hz, PhHmeta), 7.35 (2H, dif. d, J= 7.2 Hz, 
PhHortho); observed minor invertmer: 2.33 (1H, br s, C2-H), 3.01 (1H, br s, C3-H), 3.47 (1H, br s, 
PhCHH), 3.79 (1H, br s, PhCHH), 4.98 (1H, br s, Ha), 5.20 (1H, br s, Hb), 7.21-7.36 (5H, m, 
PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) major invertmer: 18.18 (CH3), 28.95 (CH3), 41.37 
(CH), 50.51 (CH), 54.61 (CH2), 81.51 (C), 113.06 (CH2), 126.70 (CH), 127.91 (CH), 128.13 
(CH), 139.45 (CH), 142.16 (C), 168.16 (C), minor invertmer: could not observe; HRFABMS 
m/z: 274.1787 (Calcd for C17H24NO2: 274.1807). 
tert-Butyl (2R,3S)-trans-1-Benzyl-3-isopropenylaziridine-2-carboxylate   
N
O
O
Ph
1 2
3
1'
2'
HaHb  
(229a)  
a pale yellow oil; 82.3% ee, determined by chiral HPLC (Daicel CHIRALCEL OD-H, 0.46 cm 
x 25 cm); n-hexane/ 2-propanol= 800: 1; flow rate= 0.5 ml/ min; detection wavelength= 215 
nm; tR (major)= 15.7 min, tR (minor)= 23.8 min; [α]D23 +59.4 (c 0.8, CHCl3); Rf= 0.56 
(n-hexane/ AcOEt= 10: 1); IR (ATR): nmax 1720 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): 
d (ppm) invertmer ratio= ca. 1: 0.1, major invertmer: 1.39 [9H, s, -CO2C(CH3)3], 1.64 (3H, s, 
C1’-CH3), 2.65 (1H, d, J= 2.3 Hz, C2-H), 2.77 (1H, d, J= 2.3 Hz, C3-H), 3.96 (1H, d, J= 14.1 Hz, 
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PhCHH), 4.09 (1H, d, J= 14.1 Hz, PhCHH), 4.91 (1H, br s, Ha), 5.05 (1H, br s, Hb), 7.23 (1H, t, 
J= 7.1 Hz, PhHpara), 7.30 (2H, dd, J= 7.7, 7.1 Hz, PhHmeta), 7.35 (2H, dif. d, J= 7.0 Hz, 
PhHortho), observed minor invertmer: 2.33 (1H, br s, C2-H), 3.01 (1H, br s, C3-H), 3.45 (1H, br d, 
J= 13.6 Hz, PhCHH), 3.79 (1H, br d, J= 13.6 Hz, PhCHH), 4.97 (1H, br s, Ha), 5.21 (1H, br s, 
Hb), 7.23-7.35 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) major invertmer: 18.18 
(CH3), 27.96 (CH3), 41.38 (CH), 50.52 (CH), 54.61 (CH2), 81.52 (C), 113.07 (CH2), 126.71 
(CH), 127.92 (CH), 128.14 (CH), 139.46 (CH), 142.17 (C), 168.17 (C), minor invertmer: could 
not observe; HRFABMS m/z: 274.1787 (Calcd for C17H24NO2: 274.1807). 
tert-Butyl (2S,3S)-cis-1-Benzyl-3-isopropenylaziridine-2-carboxylate     
N
O
O
Ph
1 2
3
1'
2'
HaHb  
(229a) (Table 5-1) 
colorless needles, mp 65-66 oC; 88.5% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 1000: 1; flow rate= 0.5 ml/ min; detection 
wavelength= 215 nm; tR (minor)= 36.3 min, tR (major)= 44.8 min; [a]D20 -51.3 (c 0.9, CHCl3); 
Rf= 0.51 (n-hexane/ AcOEt= 10: 1); IR (KBr plates): nmax 1733 cm-1 (C=O); 1H-NMR (400 
MHz, CDCl3): d (ppm) 1.43 [9H, s, -CO2C(CH3)3], 1.71 (3H, s, C1’-CH3), 2.32 (1H, d, J= 7.0 
Hz, C3-H), 2.35 (1H, d, J= 7.0 Hz, C2-H), 3.38 (1H, d, J= 13.8 Hz, PhCHH), 3.88 (1H, d, J= 
13.8 Hz, PhCHH), 4.92 (1H, br s, Ha), 5.10 (1H, br s, Hb), 7.25-7.27 (1H, m, PhHpara), 7.32 (2H, 
dif. dd, J= 7.7, 6.8 Hz, PhHmeta), 7.40 (2H, dif. d, J= 7.5 Hz, PhHortho); 13C-NMR (100 MHz, 
CDCl3): d (ppm) 20.70 (CH3), 28.05 (CH3), 45.44 (CH), 48.78 (CH), 63.45 (CH2), 80.95 (C), 
113.42 (CH2), 127.04 (CH), 127.89 (CH), 128.23 (CH), 138.11 (CH), 138.34 (C), 167.38 (C); 
HRFABMS  m/z: 274.1783 (Calcd for C17H24NO2: 274.1807). 
tert-Butyl (2R,3R)-cis-1-Benzyl-3-isopropenylaziridine-2-carboxylate     
N
O
O
Ph
1 2
3
1'
2'
HaHb  
(229a) 
colorless needles, mp 65-66 oC; 88.6% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 1000: 1; flow rate= 0.5 ml/ min; detection 
wavelength= 215 nm; tR (minor)= 36.7 min, tR (major)= 46.3 min; [a]D20 +51.1 (c 2.0, CHCl3); 
Rf= 0.51 (n-hexane/ AcOEt= 10: 1); IR (ATR): nmax 1732 cm-1 (C=O); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 1.43 [9H, s, -CO2C(CH3)3], 1.70 (3H, s, C1’-CH3), 2.31 (1H, d, J= 7.1 Hz, 
C3-H), 2.35 (1H, d, J= 7.1 Hz, C2-H), 3.38 (1H, d, J= 13.7 Hz, PhCHH), 3.88 (1H, d, J= 13.7 
Hz, PhCHH), 4.92 (1H, br s, Ha), 5.10 (1H, br s, Hb), 7.23-7.27 (1H, m, PhHpara), 7.32 (2H, dif. 
dd, J= 7.6, 7.1 Hz, PhHmeta), 7.40 (2H, dif. d, J= 7.1 Hz, PhHortho); 13C-NMR (100 MHz, 
CDCl3): d (ppm) 20.71 (CH3), 28.04 (CH3), 45.41 (CH), 48.76 (CH), 63.42 (CH2), 80.94 (C), 
147  
113.41 (CH2), 127.02 (CH), 127.88 (CH), 128.22 (CH), 138.10 (CH), 138.32 (C), 167.36 (C); 
HRFABMS m/z: 274.1792 (Calcd for C17H24NO2: 274.1807). 
tert-Butyl (2R,3S)-trans-1-Benzyl-3-vinylaziridine-2-carboxylate         
N
O
O
Ph
1 2
3
HaHb
1'
2'
 
(229b) (entry 1 in Table 5-5) 
a colorless oil; [α]D21 +36.9 (c 0.7, CHCl3); Rf= 0.53 (n-hexane/ AcOEt= 10: 1); IR (thin film): 
nmax 1734 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) invertmer ratio= ca. 1: 0.7, major 
invertmer: 1.39 [9H, s, -CO2C(CH3)3], 2.60 (1H, d, J= 2.4 Hz, C2-H), 2.77 (1H, dd, J= 7.5, 2.4 
Hz, C3-H), 3.95 (1H, d, J= 14.1 Hz, PhCHH), 4.13 (1H, d, J= 14.1 Hz, PhCHH), 5.17 (1H, d, 
J= 10.3 Hz, Ha), 5.39 (1H, d, J= 17.4 Hz, Hb), 5.59 (1H, ddd, J= 17.4, 10.3, 7.5 Hz,C1’-H), 
7.21-7.35 (5H, m, PhH), minor invertmer: 1.47 [9H, s, -CO2C(CH3)3], 2.29 (1H, d, J= 2.0 Hz, 
C2-H), 3.04 (1H, dd, J= 8.8, 2.0 Hz, C3-H), 3.71 (1H, d, J= 14.1 Hz, PhCHH), 3.87 (1H, d, J= 
14.1 Hz, PhCHH), 5.38 (1H, d, J= 9.3 Hz, Ha); 5.52 (1H, d, J= 17.0 Hz, Hb), 5.81 (1H, ddd, J= 
17.0, 9.3, 8.8 Hz, C1’-H), 7.21-7.35 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) a 
mixture of invertmers: 27.97 (CH3), 28.05 (CH3), 43.09 (CH), 45.60 (CH), 45.96 (CH), 48.08 
(CH), 54.43 (CH2), 55.70 (CH2), 81.47 (C), 81.73 (C), 117.76 (CH2), 122.14 (CH2), 126.80 
(CH), 126.87 (CH), 127.51 (CH), 127.96 (CH), 128.22 (CH), 128.23 (CH), 128.24 (CH), 
128.49 (CH), 130.77 (CH), 136.54 (CH), 138.76 (C), 139.25 (C), 167.91 (C), 169.40 (C); 
HRFABMS m/z: 260.1651 (Calcd for C16H22NO2: 260.1651). 
tert-Butyl (2R,3R)-cis-1-Benzyl-3-vinylaziridine-2-carboxylate             
N
O
O
Ph
1 2
3
HaHb
1'
2'
 
(229b) (entry 1 in Table 5-5) 
colorless plates, mp 42-43 oC; 57.5% ee, determined by chiral HPLC (Daicel CHIRALPAK 
AD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 9: 1; flow rate= 1.0 ml/ min; detection 
wavelength= 254 nm; tR (major)= 6.6 min, tR (minor)= 7.7 min; Rf= 0.40 (n-hexane/ AcOEt= 
10: 1); IR (KBr plates): nmax 1734 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.46 [9H, 
s, -CO2C(CH3)3], 2.35 (1H, d, J= 6.8 Hz, C2-H), 2.40 (1H, dd, J= 8.0, 6.8 Hz, C3-H), 3.60 (1H, 
d, J= 14.1 Hz, PhCHH), 3.72 (1H, d, J= 14.1 Hz, PhCHH), 5.23 (1H, d, J= 10.4 Hz, Ha), 5.38 
(1H, d, J= 17.4 Hz, Hb), 5.59 (1H, ddd, J= 17.4, 10.4, 8.0 Hz, C1’-H), 7.22-7.36 (5H, m, PhH);  
13C-NMR (100 MHz, CDCl3): d (ppm) 28.13 (CH3), 47.66 (CH), 63.09 (CH2), 81.44 (C), 
118.95 (CH2), 127.01 (CH), 127.62 (CH), 128.27 (CH), 133.51 (CH), 137.88 (C), 167.96 (C); 
HRFAB- MS m/z: 260.1655 (Calcd for C16H22NO2: 260.1651). 
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tert-Butyl (2S,3R)-trans-1-Benzyl-3-pentadec-1-enylaziridine-2-         
N
O
O
Ph
C13H27
1 2
3
1'
2'
 
carboxylate (229c)  
a pale yellow oil; 94% ee, determined by chiral HPLC (Daicel CHIRALCEL OD-H, 0.46 cm x 
25 cm); n-hexane/ 2-propanol= 250: 1; flow rate= 0.5 ml/ min; detection wavelength= 215 nm; 
tR (minor)= 14.3 min, tR (major)= 19.4 min; [a]D21 +6.5 (c 2.9, CHCl3); Rf= 0.57 (n-hexane/ 
AcOEt= 20: 1, NH-TLC); IR (thin film): nmax 1720 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): 
d (ppm) invertmer ratio= ca. 1: 0.9, major invertmer: 0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3], 
1.26-1.35 [22H, br m, -CH2(CH2)11CH3], 1.38 [9H, s, -CO2C(CH3)3], 2.02 [2H, dt, J= 7.0, 7.0 
Hz, -CH2(CH2)11CH3], 2.56 (1H, d, J= 2.1 Hz, C2-H), 2.72 (1H, dd, J= 7.3, 2.1 Hz, C3-H), 3.93 
(1H, d, J= 14.0 Hz, PhCHH), 4.13 (1H, d, J= 14.0 Hz, PhCHH), 5.20 (1H, dd, J= 15.3, 7.3 Hz, 
C1’-H), 5.81 (1H, dt, J= 15.3, 7.0 Hz, C2’-H), 7.21-7.36 (5H, m, PhH), minor invertmer: 0.88 
[3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.26-1.35 [22H, br m, -CH2(CH2)11CH3], 1.46 [9H, s, 
-CO2C(CH3)3], 2.07 [2H, dt, J= 6.7, 6.7 Hz, -CH2(CH2)11CH3], 2.21 (1H, d, J= 2.1 Hz, C2-H), 
3.00 (1H, dd, J= 8.5, 2.1 Hz, C3-H), 3.66 (1H, d, J= 14.0 Hz, PhCHH), 3.84 (1H, d, J= 14.0 Hz, 
PhCHH), 5.41 (1H, dd, J= 15.3, 8.5 Hz, C1’-H), 5.92 (1H, dt, J= 15.3, 6.7 Hz, C2’-H), 7.21-7.36 
(5H, m, PhH); 
13C-NMR (100 MHz, CDCl3): d (ppm) a mixture of invertmers: 13.92 (CH3), 22.50 (CH3), 
27.73 (CH3), 27.83 (CH3), 28.85 (CH2), 28.92 (CH2), 28.95 (CH2), 29.18 (CH2), 29.31 (CH2), 
29.42 (CH2), 29.48 (CH2), 29.49 (CH2), 29.51 (CH2), 31.74 (CH2), 32.16 (CH2), 32.48 (CH2), 
42.70 (CH), 45.32 (CH), 45.37 (CH), 47.66 (CH), 54.22 (CH2), 55.42 (CH2), 80.83 (C), 81.06 
(C), 122.00 (CH), 126.46 (CH), 126.53 (CH), 127.34 (CH), 127.73 (CH), 127.91 (CH), 127.92 
(CH), 134.33 (CH), 138.84 (CH), 138.92 (C), 139.23 (C), 167.82 (C), 169.39 (C); HRFABMS 
m/z: 442.3678 (Calcd for C29H48NO2: 442.3685). 
tert-Butyl (2R,3S)-trans-1-Benzyl-3-pentadec-1-enylaziridine-2-         
N
O
O
Ph
C13H27
1 2
3
1'
2'
 
carboxylate (229c) (entry 2 in Table 5-5) 
a pale yellow oil; 97.4% ee, determined by chiral HPLC (Daicel CHIRALCEL OD-H, 0.46 cm 
x 25 cm); n-hexane/ 2-propanol= 250: 1; flow rate= 0.5 ml/ min; detection wavelength= 215 
nm; tR (major)= 13.4 min, tR (minor)= 18.0 min; [a]D23 -6.6 (c 2.7, CHCl3); Rf= 0.57 (n-hexane/ 
AcOEt= 20:1, NH-TLC); IR (thin film): nmax 1720 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): 
d (ppm) invertmer ratio= ca. 1: 0.9, major invertmer: 0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3], 
1.22-1.34 [22H, br m, -CH2(CH2)11CH3], 1.38 [9H, s, -CO2C(CH3)3], 2.02 [2H, dt, J= 7.0, 7.0 
Hz, -CH2(CH2)11CH3], 2.56 (1H, d, J= 2.6 Hz, C2-H), 2.72 (1H, dd, J= 7.3, 2.6 Hz, C3-H), 3.94 
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(1H, d, J= 13.9 Hz, PhCHH), 4.13 (1H, d, J= 13.9 Hz, PhCHH), 5.20 (1H, dd, J= 15.4, 7.3 Hz, 
C1’-H), 5.80 (1H, dt, J= 15.4, 7.0 Hz, C2’-H), 7.20-7.36 (5H, m, PhH), minor invertmer: 0.88 
[3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.22-1.34 [22H, br m, -CH2(CH2)11CH3], 1.46 [9H, s, 
-CO2C(CH3)3], 2.07 [2H, dt, J= 7.0, 7.0 Hz, -CH2(CH2)11CH3], 2.20 (1H, d, J= 2.8 Hz, C2-H), 
3.00 (1H, dd, J= 8.8, 2.8 Hz, C3-H), 3.65 (1H, d, J= 14.3 Hz, PhCHH), 3.84 (1H, d, J= 14.3 Hz, 
PhCHH), 5.41 (1H, dd, J= 15.6, 8.8 Hz, C1’-H), 5.92 (1H, dt, J= 15.6, 7.0 Hz, C2’-H), 7.20-7.36 
(5H, m, PhH);  
13C-NMR (100 MHz, CDCl3): d (ppm) a mixture of invertmers: 13.98 (CH3), 22.55 (CH3), 
27.78 (CH3), 27.88 (CH3), 28.86 (CH2), 28.90 (CH2), 28.96 (CH2), 29.01 (CH2), 29.23 (CH2), 
29.35 (CH2), 29.36 (CH2), 29.46 (CH2), 29.53 (CH2), 29.54 (CH2), 29.56 (CH2), 31.79 (CH2), 
32.21 (CH2), 32.53 (CH2), 42.72 (CH), 45.38 (CH), 45.40 (CH), 47.74 (CH), 54.27 (CH2), 
55.45 (CH2), 80.93 (C), 81.14 (C), 122.00 (CH), 122.01 (CH), 126.52 (CH), 126.59 (CH), 
127.39 (CH), 127.78 (CH), 127.92 (CH), 127.98 (CH), 134.47 (CH), 138.87 (CH), 139.02 (C), 
139.25 (C), 167.90 (C), 169.47 (C); HRFABMS m/z: 442.3663 (Calcd for C29H48NO2: 
442.3685). 
tert-Butyl (2S,3S)-cis-1-Benzyl-3-pentadec-1-enylaziridine-2-           
N
O
O
Ph
C13H27
1 2
3
1'
2'
 
carboxylate (229c)  
colorless needles, mp 45-46 oC; 93.7% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 1000: 1; flow rate= 0.5 ml/ min; detection 
wavelength= 215 nm; tR (minor)= 34.0 min, tR (major)= 39.0 min; [a]D25 +4.8 (c 1.3, CHCl3); 
Rf= 0.43 (n-hexane/ AcOEt= 20: 1, NH-TLC); IR (ATR): nmax 1720 cm-1 (C=O); 1H-NMR (400 
MHz, CDCl3): d (ppm) 0.88 (3H, t, J= 7.0 Hz, -(CH2)12CH3), 1.25-1.36 (22H, br m, 
-CH2(CH2)11 CH3), 1.46 [9H, s, -CO2C(CH3)3], 2.03 (2H, br dt, J= 7.1, 6.8 Hz, 
-CH2(CH2)11CH3), 2.29 (1H, d, J= 6.8 Hz, C2-H), 2.37 (1H, dd, J= 8.4, 6.8 Hz, C3-H), 3.63 (1H, 
d, J= 14.7 Hz, PhCHH), 3.66 (1H, d, J= 14.7 Hz, PhCHH), 5.46 (1H, dd, J= 15.6, 8.4 Hz, 
C1’-H), 5.80 (1H, dt, J= 15.6, 6.8 Hz, C2’-H), 7.22-7.24 (1H, m, PhHpara), 7.31 (2H, dif. dd, J= 
7.7, 7.1 Hz, PhHmeta), 7.35 (2H, dif. d, J= 7.1 Hz, PhHortho); 13C-NMR (100 MHz, CDCl3): d 
(ppm) 14.10 (CH3), 22.67 (CH2), 28.14 (CH3), 29.07 (CH2), 29.34 (CH2), 29.50 (CH2), 29.59 
(CH2), 29.64 (CH2), 29.67 (CH2), 31.90 (CH2), 32.43 (CH2), 45.04 (CH), 47.41 (CH), 63.11 
(CH2), 81.21 (C), 124.92 (CH), 126.89 (CH), 127.58 (CH), 128.21 (CH), 136.03 (CH), 138.08 
(C), 168.21 (C); HRFABMS m/z: 442.3690 (Calcd for C29H48NO2: 442.3685) 
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tert-Butyl (2R,3R)-cis-1-Benzyl-3-pentadec-1-enylaziridine-2-carboxy-    
N
O
O
Ph
C13H27
1 2
3 1'
2'
  
late (229c) (entry 2 in Table 5-5) 
colorless needles, mp 45-46 oC; 94.6% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 1000: 1; flow rate= 0.5 ml/ min; detection 
wavelength= 215 nm; tR (major)= 33.8 min, tR (minor)= 40.3 min; [a]D23 -5.3 (c 1.5, CHCl3); 
Rf= 0.43 (n-hexane/ AcOEt= 20: 1, NH-TLC); IR (KBr plates): nmax 1728 cm-1 (C=O); 
1H-NMR (500 MHz, CDCl3): d (ppm) 0.88 (3H, t, J= 7.0 Hz, -(CH2)12CH3), 1.25-1.35 (22H, br 
m, -CH2(CH2)11 CH3), 1.46 [9H, s, -CO2C(CH3)3], 2.03 (2H, br dt, J= 7.0, 7.0 Hz, 
-CH2(CH2)11CH3); 2.29 (1H, d, J= 6.7 Hz, C2-H), 2.36 (1H, dd, J= 8.2, 6.7 Hz, C3-H), 3.63 (1H, 
d, J= 14.7 Hz, PhCHH), 3.66 (1H, d, J= 14.7 Hz, PhCHH), 5.46 (1H, dd, J= 15.6, 8.2 Hz, 
C1’-H), 5.80 (1H, dt, J= 15.6, 7.0 Hz, C2’-H), 7.22-7.25 (1H, m, PhHpara), 7.31 (2H, t, J= 7.6 Hz, 
PhHmeta), 7.35 (2H, d, J= 7.0 Hz, PhHortho); 13C-NMR (100 MHz, CDCl3): d (ppm) 14.10 (CH3), 
22.67 (CH2), 28.15 (CH3), 29.07 (CH2), 29.34 (CH2), 29.50 (CH2), 29.59 (CH2), 29.64 (CH2), 
29.67 (CH2), 31.91 (CH2), 32.43 (CH2), 45.06 (CH), 47.41(CH), 63.13 (CH2), 81.20 (C), 124.94 
(CH), 126.90 (CH), 127.60 (CH), 128.21 (CH), 136.02 (CH), 138.10 (C), 168.21 (C); 
HRFABMS m/z: 442.3663 (Calcd for C29H48NO2: 442.3685) 
tert-Butyl (2R,3S,E)-trans-1-Benzyl-3-(2-phenylvinyl)aziridine-2-       
N
O
O
Ph
Ph
1 2
3
1'
2'
 
carboxylate (229d) (entry 3 in Table 5-5) 
pale yellow needles, mp 92-94 oC; 65.0% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 100: 1; flow rate= 1.0 ml/ min; detection 
wavelength= 254 nm; tR (major)= 8.3 min, tR (minor)= 10.8 min; [α]D23 -5.9 (c 1.0, CHCl3); Rf= 
0.49 (n-hexane/ AcOEt= 10: 1); IR (KBr plates): nmax 1718 cm-1 (C=O); 1H-NMR (400 MHz, 
CDCl3): d (ppm) invertmer ratio= ca. 1: 0.7, major invertmer: 1.40 [9H, s, -CO2C(CH3)3], 2.70 
(1H, d, J= 2.0 Hz, C2-H), 2.94 (1H, dd, J= 7.7, 2.0 Hz, C3-H), 4.01 (1H, d, J= 14.1 Hz, PhCHH), 
4.19 (1H, d, J= 14.1 Hz, PhCHH), 5.97 (1H, dd, J= 15.9, 7.7 Hz, C1’-H), 6.71 (1H, d, J= 15.9 
Hz, C2’-H), 7.21-7.38 (10H, m, PhH), minor invertmer: 1.48 [9H, s, -CO2C(CH3)3], 2.40 (1H, d, 
J= 1.3 Hz, C2-H), 3.20 (1H, dd, J= 8.4, 1.3 Hz, C3-H), 3.76 (1H, d, J= 14.3 Hz, PhCHH), 3.95 
(1H,  d, J= 14.3 Hz, PhCHH), 6.15 (1H, dd, J= 15.9, 8.4 Hz, C1’-H), 6.81 (1H, d, J= 15.9 Hz, 
C2’-H), 7.21-7.38 (m, 10H; PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) a mixture of 
invertmers: 27.98 (CH3), 28.04 (CH3), 43.48 (CH), 45.91 (CH), 46.28 (CH), 48.08 (CH), 54.50 
(CH2), 55.96 (CH2), 81.56 (C), 81.80 (C), 122.11 (CH), 126.23 (CH), 126.03 (CH), 126.85 
(CH), 126.93 (CH), 127.57 (CH), 127.64 (CH), 127.98 (CH), 128.04 (CH), 128.28 (CH), 
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128.56 (CH), 128.67 (CH), 132.65 (CH), 136.25 (C), 136.49 (C), 136.77 (CH), 138.75 (C), 
139.19 (C), 167.91 (C), 169.36 (C); HRFABMS m/z: 336.1945 (Calcd for C22H26NO2: 
336.1964). 
tert-Butyl (2R,3R,E)-cis-1-Benzyl-3-(2-phenylvinyl)aziridine-2-          
N
O
O
Ph
Ph
1 2
3 1'
2'
 
carboxylate (229d) (entry 3 in Table 5-5) 
pale yellow needles, mp 85-86 oC; 75.0% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 100: 1; flow rate= 1.0 ml/ min; detection 
wavelength= 254 nm; tR (minor)= 12.3 min, tR (major)= 14.2 min; [α]D23 -7.7 (c 1.0, CHCl3); 
Rf= 0.38 (n-hexane/ AcOEt= 20: 1, NH-TLC); IR (KBr plates): nmax 1734 cm-1 (C=O); 
1H-NMR (400 MHz, CDCl3): d (ppm) 1.45 [9H, s, -CO2C(CH3)3], 2.43 (1H, d, J= 6.8 Hz, 
C2-H), 2.57 (1H, br dd, J= 8.4, 6.8 Hz, C3-H), 3.67 (1H, d, J= 14.1 Hz, PhCHH), 3.76 (1H, d, 
J= 14.1 Hz, PhCHH), 6.26 (1H, dd, J= 16.1, 8.4 Hz, C1'-H), 6.70 (1H, d, J= 16.1 Hz, C2'-H), 
7.20-7.38 (10H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 28.11 (CH3), 45.58 (CH), 
47.55 (CH), 63.14 (CH2), 81.52 (C), 124.96 (CH), 126.28 (CH), 127.05 (CH), 127.58 (CH), 
127.63 (CH), 128.32 (CH), 128.52 (CH), 133.84 (CH), 136.64 (C), 137.80 (C), 168.07 (C); 
HRFABMS m/z: 336.1945 (Calcd for C22H26NO2: 336.1964).  
tert-Butyl(2R,3S)-trans-1-Benzyl-3-(2-methyl-1-propen-1-yl)aziridine-    
N
O
O
Ph
1 2
3 1'
2'
    
2-carboxylate (229f) (entry 5 in Table 5-5) 
a pale yellow oil; Rf= 0.66 (n-hexane/ AcOEt= 10: 1); IR (ATR): nmax 1724 cm-1 (C=O); 
1H-NMR (400 MHz, CDCl3): d (ppm) invertmer ratio= ca. 1: 0.8, major invertmer: 1.46 [9H, s, 
-CO2C(CH3)3], 1.75, 1.77 (each 3H, s, C2’-CH3), 2.16 (1H, d, J= 2.8 Hz, C2-H), 3.10 (1H, dd, 
J= 8.4, 2.8 Hz, C3-H), 3.63 (1H, d, J= 14.4 Hz, PhCHH), 3.83 (1H, d, J= 14.4 Hz, PhCHH), 
5.16 (1H, d, J= 8.4 Hz, C1’-H), 7.20-7.36 (5H, m, PhH), minor invertmer: 1.38 [9H, s, 
-CO2C(CH3)3], 1.72, 1.74 (each 3H, s, C2’-CH3), 2.55 (1H, d, J= 2.9 Hz, C2-H), 2.88 (1H, dd, 
J= 8.8, 2.9 Hz, C3-H), 3.96 (1H, d, J= 14.0 Hz, PhCHH), 4.14 (1H, d, J= 14.0 Hz, PhCHH), 
4.88 (1H, d, J= 8.8 Hz, C1’-H), 7.20-7.36 (5H, m, PhH); HRFABMS m/z: 288.1964 (Calcd for 
C18H26NO2: 288.1964) 
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tert-Butyl(2R,3R)-cis-1-Benzyl-3-(2-methyl-1-propen-1-yl)aziridine-      
N
O
O
Ph
1 2
3 1'
2'
      
2-carboxylate (229f) (entry 5 in Table 5-5) 
a pale yellow oil; Rf= 0.60 (n-hexane/ AcOEt= 10: 1); IR (ATR): umax 1720 cm-1 (C=O); 
1H-NMR (400 MHz, CDCl3): d (ppm) 1.45 [9H, s, -CO2C(CH3)3], 1.71, 1.72 (3H, s, each 
C2’-CH3), 2.31 (1H, d, J= 6.8 Hz, C2-H), 2.52 (1H, dd, J= 7.8, 6.8 Hz, C3-H), 3.65 (2H, s, 
PhCH2), 5.18 (1H, d, J= 7.8 Hz, C1’-H), 7.20-7.36 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): 
d (ppm) 18.31 (CH3), 25.77 (CH3), 28.13 (CH3), 43.73 (CH), 45.26 (CH), 63.36 (CH2), 81.13 
(C), 119.56 (CH), 126.93 (CH), 127.68 (CH), 128.25 (CH), 137.34 (C), 138.14 (C), 168.37 (C); 
HRFABMS m/z: 288.1964 (Calcd for C18H26NO2: 288.1964) 
tert-Butyl (2R,3S)-trans-1-Benzyl-3-(2,2-diphenyl)vinylaziridine-       
N
O
O
Ph
Ph
1 2
3
Ph
1'
2'
 
2-carboxylate (229g) (entry 6 in Table 5-5) 
colorless plates, mp 79-81 oC; 87.2% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 150: 1; flow rate= 1.0 ml/ min; detection 
wavelength= 254 nm; tR (minor)= 9.7 min, tR (major)= 14.0 min; [α]D23 -18.0 (c 0.30, CHCl3); 
Rf= 0.52 (n-hexane/ AcOEt= 10: 1, NH-TLC); IR (KBr plates): nmax 1719 cm-1 (C=O); 
1H-NMR (400 MHz, CDCl3): d (ppm) invertmer ratio= ca. 1: 1, major invertmer: 1.38 [9H, s, 
-CO2C(CH3)3], 2.71 (1H, d, J= 2.2 Hz, C2-H), 2.83 (1H, dd, J= 8.3, 2.2 Hz, C3-H), 3.92 (1H, d, 
J= 14.1 Hz, PhCHH), 3.99 (1H, d, J= 14.1 Hz, PhCHH), 5.75 (1H, d, J= 8.3 Hz, C1’-H), 
7.17-7.41 (15H, m, PhH), minor invertmer: 1.44 [9H, s, -CO2C(CH3)3], 2.38 (1H, d, J= 2.2 Hz, 
C2-H), 3.05 (1H, dd, J= 9.3, 2.2 Hz, C3-H), 3.92 (1H, d, J= 14.1 Hz, PhCHH), 4.06 (1H, d, J= 
14.1 Hz, PhCHH), 5.95 (1H, d, J= 9.3 Hz, C1’-H), 7.17-7.41 (15H, m, PhH); 13C-NMR (100 
MHz, CDCl3): d (ppm) a mixture of invertmers: 27.98 (CH3), 28.03 (CH3), 43.61 (CH), 43.69 
(CH), 46.44 (CH), 47.90 (CH), 54.41 (CH2), 56.27 (CH2), 81.39 (C), 81.62 (C), 121.29 (CH), 
126.85 (CH), 126.97 (CH), 127.43 (CH), 127.52 (CH), 127.59 (CH), 127.69 (CH), 127.75 (CH), 
128.13 (CH), 128.23 (CH), 128.26 (CH), 130.01 (CH), 130.11 (CH), 138.55 (C), 138.80 (C), 
139.05 (C), 139.27 (C), 141.62 (C), 142.13 (C), 145.54 (C), 149.01 (C), 167.83 (C), 169.24 (C); 
HRFABMS m/z: 412.2268 (Calcd for C28H30NO2: 412.2277). 
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tert-Butyl (2R,3R)-cis-1-Benzyl-3-(2,2-diphenyl)vinylaziridine-         
N
O
O
Ph
Ph
1 2
3
Ph
1'
2'
 
2-carboxylate (229g) (entry 6 in Table 5-5) 
colorless plates, mp 99-100 oC; 90.9% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 250: 1; flow rate= 1.0 ml/ min; detection 
wavelength= 254 nm; tR (minor)= 23.7 min, tR (major)= 31.1 min; [α]D23 -17.1 (c 1.1, CHCl3); 
Rf= 0.39 (n-hexane/ AcOEt= 10: 1, NH-TLC); IR (ATR): nmax 1719 cm-1(C=O); 1H-NMR (400 
MHz, CDCl3): d (ppm) 1.48 [9H, s, -CO2C(CH3)3], 2.34 (1H, d, J= 6.6 Hz, C2-H), 2.45 (1H, dd, 
J= 8.8, 6.6 Hz, C3-H), 3.50 (1H, d, J= 13.9 Hz, PhCHH), 3.65 (1H, d, J= 13.9 Hz, PhCHH), 
6.13 (1H, d, J= 8.8 Hz, C1'-H), 7.13-7.35 (15H, m, PhH); 13C-NMR (100 MHz, CDCl3): d 
(ppm) 28.17 (CH3), 45.17 (CH), 46.28 (CH), 63.00 (CH2), 81.50 (C), 124.18 (CH), 127.08 
(CH), 127.30 (CH), 127.40 (CH), 127.42 (CH), 127.85 (CH), 128.08 (CH), 128.25 (CH), 
128.29 (CH), 130.16 (CH), 137.92 (C), 139.31 (C), 141.61 (C), 145.99 (C), 168.25 (C); 
HRFABMS m/z: 412.2278 (Calcd for C28H30NO2: 412.2277).  
tert-Butyl (2R,3S,E)-trans-1-Benzyl-3-(3-phenyl-2-propen-2-yl)-         
N
O
O
Ph
Ph
1 2
3 1'
2'
3'
 
aziridine-2-carboxylate (229h) (entry 7 in Table 5-5) 
colorless plates, mp 44-45 oC; 92.0% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 100: 1; flow rate= 0.5 ml/ min; detection 
wavelength= 254 nm; tR (minor)= 9.5 min, tR (major)= 10.6 min; [α]D22 +33.7 (c 0.7, CHCl3); 
Rf= 0.57 (n-hexane/ AcOEt= 20: 1, NH-TLC); IR (ATR): nmax 1717 cm-1 (C=O); 1H-NMR (400 
MHz, CDCl3): d (ppm) 1.41 [9H, s, -CO2C(CH3)3], 1.79 (3H, s, C1’-H), 2.71 (1H, d, J= 1.1 Hz, 
C2-H), 2.91 (1H, d, J= 1.1 Hz, C3-H), 4.02 (1H, d, J= 13.9 Hz, PhCHH), 4.17 (1H, d, J= 13.9 
Hz, PhCHH), 6.58 (1H, s, C3’-H), 7.19-7.34 (8H, m, PhH), 7.38 (2H, d, J= 7.3 Hz, PhHortho); 
13C-NMR (100 MHz, CDCl3): d (ppm) 13.94 (CH3), 28.00 (CH3), 41.47 (CH), 52.50 (CH), 
54.59 (CH2), 81.63 (C), 126.39 (CH), 126.77 (CH), 127.44 (CH), 127.97 (CH), 128.10 (CH), 
128.20 (CH), 128.86 (CH), 135.07 (C), 137.49 (C), 139.48 (C), 168.26 (C); HRFABMS m/z: 
350.2114 (Calcd for C23H28NO2: 350.2120). 
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tert-Butyl (2R,3R,E)-cis-1-Benzyl-3-(3-phenyl-2-propen-2-yl)-           
N
O
O
Ph
Ph
1 2
3 1'
2'
3'
 
aziridine-2-carboxylate (229h) (entry 7 in Table 5-5) 
pale yellow needles, mp 81-83 oC; 92.7% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 400: 1; flow rate= 0.5 ml/ min; detection 
wavelength= 254 nm; tR (major)= 47.0 min, tR (minor)= 55.0 min; [α]D23 +34.7 (c 0.5, CHCl3); 
Rf= 0.33 (n-hexane/ AcOEt= 20: 1, NH-TLC); IR (ATR): nmax 1735 cm-1 (C=O); 1H-NMR (500 
MHz, CDCl3): d (ppm) 1.39 [9H, s, -CO2C(CH3)3], 1.87 (3H, s, C1'-H), 2.43 (1H, d, J= 7.0 Hz, 
C2-H), 2.50 (1H, d, J= 7.0 Hz, C3-H), 3.51 (1H, d, J= 13.7 Hz, PhCHH), 3.88 (1H, d, J= 13.7 
Hz, PhCHH), 6.67 (1H, s, C3'-H), 7.16-7.35 (8H, m, PhH), 7.45 (2H, d, J= 7.0 Hz, PhHortho); 
13C-NMR (100 MHz, CDCl3): d (ppm) 16.71 (CH3), 28.06 (CH3), 46.00 (CH), 50.46 (CH), 
63.36 (CH2), 81.00 (C), 126.16 (CH), 127.10 (CH), 127.63 (CH), 127.94 (CH), 127.97 (CH), 
128.30 (CH), 128.92 (CH), 131.19 (C), 137.64 (C), 138.09 (C), 167.44 (C); HRFABMS m/z: 
350.2114 (Calcd for C23H28NO2: 350.2120). 
tert-Butyl (2R,3S,E)-trans-1-Benzyl-3-(1-phenyl-1-propen-1-yl)-         
N
O
O
Ph
1 2
3 Ph
1'
2'
3'  
aziridine-2-carboxylate (229i) (entry 8 in Table 5-5) 
a colorless oil; Rf= 0.55 (n-hexane/ AcOEt= 10: 1); IR (ATR): nmax 1732 cm-1 (C=O); 1H-NMR 
(400 MHz, CDCl3): d (ppm) 1.37 [9H, s, -CO2C(CH3)3], 1.60 (3H, d, J= 7.0 Hz, C3'-H), 2.52 
(1H, d, J= 2.0 Hz, C2-H), 2.94 (1H, br s, C3-H), 3.98 (1H, d, J= 13.9 Hz, PhCHH), 4.12 (1H, d, 
J= 13.9 Hz, PhCHH), 5.85 (1H, q, J= 7.0 Hz, C2'-H), 7.16-7.30 (10H, m, PhH); 13C-NMR (100 
MHz, CDCl3): d (ppm) 14.52 (CH3), 28.00 (CH3), 42.62 (CH), 50.77 (CH), 54.87 (CH2), 81.49 
(C), 124.50 (CH), 126.72 (CH), 126.88 (CH), 127.95 (CH), 128.15 (CH), 128.90 (CH), 137.70 
(C), 139.52 (C), 168.19 (C): peaks for one arom. CH and vinylic quarternary carbon were not 
observed.; HRFABMS m/z: 350.2114 (Calcd for C23H28NO2: 350.2120). 
tert-Butyl (2R,3R,E)-cis-1-Benzyl-3-(1-phenyl-1-propen-1-yl)-           
N
O
O
Ph
1 2
3 Ph
1'
2'
3'  
aziridine-2-carboxylate (229i) (entry 8 in Table 5-5) 
pale yellow plates, mp 81-82 oC; 97.6% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 400: 1; flow rate= 0.5 ml/ min; detection 
wavelength= 254 nm; tR (major)= 33.2 min, tR (minor)= 44.4 min; [α]D22 +42.0 (c 0.4, CHCl3); 
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Rf= 0.41 (n-hexane/ AcOEt= 10: 1); IR (KBr plates): nmax 1742 cm-1 (C=O); 1H-NMR (400 
MHz, CDCl3): d (ppm) 1.40 [9H, s, -CO2C(CH3)3], 1.67 (3H, dd, J= 7.1, 1.2 Hz, C3'-H), 2.43 
(1H, d, J= 6.8 Hz, C2-H), 2.55 (1H, br ddd, J= 6.8, 0.9, 0.9 Hz, C3-H), 3.57 (1H, J= 13.9 Hz, 
PhCHH), 3.77 (1H, d, J= 13.9 Hz, PhCHH), 6.06 (1H, qd, J= 7.1, 0.9 Hz, C2'-H), 7.22-7.28 (4H, 
m, PhH), 7.33 (4H, dd, J= 7.1, 6.2 Hz, PhHmeta), 7.42 (2H, d, J= 7.3 Hz, PhHortho); 13C-NMR 
(100 MHz, CDCl3): d (ppm) 14.30 (CH3), 28.05 (CH3), 46.68 (CH), 49.59 (CH), 63.23 (CH2), 
80.95 (C), 125.21 (CH), 126.76 (CH), 126.97 (CH), 127.78 (CH), 128.02 (CH), 128.25 (CH), 
128.79 (CH), 132.90 (C), 138.21 (C), 139.15 (C), 167.26 (C); HRFABMS m/z: 350.2114 
(Calcd for C23H28NO2: 350.2120). 
tert-Butyl (2R,3S)-trans -1-Benzyl-3-(cyclohex-1-en-1-yl)aziridine-       
N
O
O
Ph
1 2
3
1'
2'
3' 4'
5'
6'
 
2-carboxylate (229j) (entry 9 in Table 5-5) 
a pale yellow oil; [α]D22 +32.0 (c 0.5, CHCl3); Rf= 0.63 (n-hexane/ AcOEt= 10: 1); IR (neat): 
nmax 1720 cm-1(C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) invertmer ratio= ca. 1: 0.2, major 
invertmer: 1.38 [9H, s, -CO2C(CH3)3], 1.43-2.09 (8H, br m, C3’-6’-H), 2.64 (1H, d, J= 2.6 Hz, 
C2-H), 2.70 (1H, br d, J= 2.6 Hz, C3-H), 3.95 (1H, d, J= 14.1 Hz, PhCHH), 4.09 (1H, d, J= 14.1 
Hz, PhCHH), 5.75 (1H, s, C2’-H), 7.21 (1H, dif. dd, J= 7.1, 7.1 Hz, PhHpara), 7.29 (2H, dd, J= 
7.3, 6.0 Hz, PhHmeta), 7.34 (2H, d, J= 7.1 Hz, PhHortho), minor invertmer: 1.38 [9H, s, 
-CO2C(CH3)3], 1.43-2.09 (8H, br m, C3’-6’-H), 2.32 (1H, br s, C2-H), 2.94 (1H, br s, C3-H), 3.45 
(1H, d, J= 13.9 Hz, PhCHH), 3.72 (1H, d, J= 13.9 Hz, PhCHH), 5.75 (1H, s, C2’-H), 7.21 (1H, 
dif. dd, J= 7.1, 7.1 Hz, PhHpara), 7.29 (2H, dd, J= 7.3, 6.0 Hz, PhHmeta), 7.34 (2H, d, J= 7.1 Hz, 
PhHortho); 13C-NMR (100 MHz, CDCl3): d (ppm) major invertmer: 22.37 (CH2), 22.44 (CH2), 
24.39 (CH2), 25.12 (CH2), 27.98 (CH3), 40.62 (CH), 51.17 (CH), 54.76 (CH2), 81.39 (C), 
125.10 (CH), 126.66 (CH), 127.97 (CH), 128.13 (CH), 134.48 (C), 139.64 (C), 168.53 (C), 
minor invertmer: could not observe; HRFABMS m/z: 314.2128 (Calcd for C20H28NO2: 
314.2120). 
tert-Butyl (2R,3R)-cis-1-Benzyl-3-(cyclohex-1-en-1-yl)aziridine-         
N
O
O
Ph
1 2
3
1'
2'
3' 4'
5'
6'
         
2-carboxylate (229j) (entry 9 in Table 5-5) 
pale yellow plates, 98.5% ee, determined by chiral HPLC (Daicel CHIRALCEL OD-H, 0.46 
cm x 25 cm); n-hexane/ 2-propanol= 800: 1; flow rate= 0.5 ml/ min; detection wavelength= 215 
nm; tR (major)= 37.2 min, tR (minor)= 45.4 min; [α]D23 +41.9 (c 0.5, CHCl3); Rf= 0.48 
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(n-hexane/ AcOEt= 10: 1); IR (KBr plates): nmax 1743 cm-1 (C=O); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 1.40 [9H, s, -CO2C(CH3)3], 1.47-1.62 (4H, m, C4’,5’-H), 1.80-1.85 (1H, br m, 
C3’or 6’-H), 1.99 (3H, br s, C3’,6’-H), 2.26 (1H, br d, J= 7.0 Hz, C3-H), 2.28 (1H, d, J= 7.0 Hz, 
C2-H), 3.45 (1H, d, J= 13.9 Hz, PhCHH), 3.76 (1H, d, J= 13.9 Hz, PhCHH), 5.79-5.83 (1H, br 
m, C2’-H), 7.23 (1H, t, J= 7.7 Hz, PhHpara), 7.32 (2H, dd, J= 7.5, 7.1 Hz, PhHmeta), 7.41 (2H, d, 
J= 7.0 Hz, PhHortho); 13C-NMR (100 MHz, CDCl3): d (ppm) 22.44 (CH2), 22.54 (CH2), 24.78 
(CH2), 26.91 (CH2), 28.07 (CH3), 45.39 (CH), 48.99 (CH), 63.46 (CH2), 80.71 (C), 124.74 
(CH), 126.94 (CH), 127.85 (CH), 128.20 (CH), 130.82 (C), 138.32 (C), 167.64 (C); 
HRFABMS m/z: 314.2120 (Calcd for C20H28NO2: 314.2120). 
tert-Butyl (2R,3S)-trans-1-Benzyl-3-(1-pentadecynyl)aziridine-2-         
N
O
O
Ph
C13H27
1 2
3
1'
2'
 
carboxylate (229k) (entry 10 in Table 5-5) 
pale yellow plates, mp 32-33 oC; [α]D23 -8.5 (c 1.1, CHCl3); Rf= 0.54 (n-hexane/ AcOEt= 10: 
1); IR (thin film): nmax 2243 cm-1 (C?C), 1741 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): 
d (ppm) 0.88 [3H, t, J= 6.8 Hz, -(CH2)12CH3], 1.20-1.39 [22H, br m, -CH2(CH2)11CH3]; 1.45 
[9H, s, -CO2C(CH3)3], 2.20 [2H, td, J= 7.1, 1.8 Hz, -CH2(CH2)11CH3], 2.22 (1H, d, J= 2.9 Hz, 
C2-H), 2.96 (1H, br dd, J= 2.9, 1.8 Hz, C3-H), 3.75 (1H, d, J= 14.1 Hz, PhCHH), 3.91 (1H, d, 
J= 14.1 Hz, PhCHH), 7.23 (1H, d, J= 7.7 Hz, PhHpara), 7.32 (2H, dd, J= 7.5, 7.1 Hz, PhHmeta), 
7.39 (2H, d, J= 7.1 Hz, PhHortho); 13C-NMR (100 MHz, CDCl3): d (ppm) 14.10 (CH3), 18.77 
(CH2), 22.68 (CH2), 28.00 (CH3), 28.53 (CH2), 28.86 (CH2), 29.11 (CH2), 29.34 (CH2), 29.52 
(CH2), 29.63 (CH2), 29.64 (CH2), 29.65 (CH2), 29.67 (CH2), 31.91 (CH2), 33.42 (CH), 46.02 
(CH), 57.22 (CH2) 74.00 (C), 81.69 (C), 85.68 (C), 126.92 (CH), 127.96 (CH), 128.21 (CH), 
138.62 (C), 168.50 (C); HRFABMS m/z: 440.3533 (Calcd for C29H46NO2: 440.3529). 
tert-Butyl (2R,3R)-cis-1-Benzyl-3-(1-pentadecynyl)aziridine-2-         
N
O
O
Ph
C13H27
1 2
3
1'
2'
        
carboxylate (229k) (entry 10 in Table 5-5) 
pale yellow plates, mp 40-42 oC; [α]D23 -9.4 (c 0.8, CHCl3); Rf= 0.43 (n-hexane/ AcOEt= 10: 
1); IR (KBr plates): nmax 2243 cm-1 (C?C), 1749 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): 
d (ppm) 0.88 [3H, t, J= 6.8 Hz, -(CH2)12CH3], 1.25-1.36 [22H, br m, -CH2(CH2)11CH3]; 1.48 
[9H, s, -CO2C (CH3)3], 2.16 [2H, br ddd, J= 7.3, 7.1, 1.7 Hz, -CH2(CH2)11CH3], 2.28 (1H, d, J= 
6.6 Hz, C2-H), 2.36 (1H, ddd, J= 6.6, 1.7, 1.7 Hz, C3-H), 3.43 (1H, d, J= 14.1 Hz, PhCHH), 
3.80 (1H, d, J= 14.1 Hz, PhCHH), 7.23-7.27 (1H, m, PhHpara), 7.32 (2H, dd, J= 7.5, 7.1 Hz, 
PhHmeta), 7.39 (2H, d, J= 7.1 Hz, PhHortho); 13C-NMR (100 MHz, CDCl3): d (ppm) 14.10 (CH3), 
18.88 (CH2), 22.68 (CH2), 28.15 (CH3), 28.58 (CH2), 28.90 (CH2), 29.16 (CH2), 29.34 (CH2), 
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29.49 (CH2), 29.64 (CH2), 29.65 (CH2), 29.66 (CH2), 31.91 (CH2), 33.82 (CH), 44.68 (CH), 
62.71 (CH2) 74.57 (C), 81.45 (C), 83.48 (C), 127.15 (CH), 127.84 (CH), 128.30 (CH), 137.29 
(C), 166.76 (C); HRFABMS m/z: 440.3507 (Calcd for C29H46NO2: 440.3529).  
tert-Butyl (2R,3S)-trans-1-Benzyl-3-phenylethynylaziridine-2-           
N
O
O
Ph
Ph
1 2
3 1'
2'
  
carboxylate (229l) (entry 11 in Table 5-5) 
colorless plates, mp 60-62 oC; 97.7% ee, determined by chiral HPLC (Daicel CHIRALPAK 
AD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 100: 1; flow rate= 1.0 ml/ min; detection 
wavelength= 254 nm; tR (minor)= 8.7 min, tR (major)= 11.0 min; [α]D23 -12.8 (c 1.0, CHCl3); 
Rf= 0.53 (n-hexane/ AcOEt= 10: 1); IR (KBr plates): nmax 2224 cm-1 (C?C), 1735 cm-1 (C=O); 
1H-NMR (400 MHz, CDCl3): d (ppm) 1.48 [9H, s, -CO2C(CH3)3], 2.42 (1H, d, J= 2.9, Hz, 
C2-H), 3.19 (1H, d, J= 2.9 Hz, C3-H), 3.88 (1H, d, J= 13.9 Hz, PhCHH), 3.99 (1H, d, J= 13.9 
Hz, PhCHH), 7.24-7.35 (6H, m, PhH), 7.41-7.45 (4H, m, PhH); 13C-NMR (100 MHz, CDCl3): 
d (ppm) 28.00 (CH3), 33.40 (CH), 46.44 (CH), 57.59 (CH2), 81.98 (C), 83.60 (C), 84.56 (C), 
122.20 (C), 127.07 (CH), 128.07 (CH), 128.28 (CH), 128.37 (CH), 128.65 (CH), 131.79 (CH), 
138.33 (C), 168.19 (C); HRFABMS m/z: 334.1817 (Calcd for C22H24NO2: 334.1807). 
tert-Butyl (2R,3R)-cis-1-Benzyl-3-phenylethynylaziridine-2-            
N
O
O
Ph
Ph
1 2
3 1'
2'
 
carboxylate (229l) (entry 11 in Table 5-5) 
colorless plates, mp 108-110 oC; 90.6% ee, determined by chiral HPLC (Daicel CHIRALPAK 
AD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 100: 1; flow rate= 1.0 ml/ min; detection 
wavelength= 254 nm; tR (major)= 19.3 min, tR (minor)= 28.4 min; [α]D23 -11.8 (c 1.2, CHCl3); 
Rf= 0.36 (n-hexane/ AcOEt= 10: 1); IR (KBr plates): nmax 2225 cm-1 (C?C), 1738 cm-1 (C=O); 
1H-NMR (400 MHz, CDCl3): d (ppm) 1.48 [9H, s, -CO2C(CH3)3], 2.45 (1H, d, J= 6.6, Hz, 
C2-H), 2.60 (1H, d, J= 6.6 Hz, C3-H), 3.55 (1H, d, J= 13.9 Hz, PhCHH), 3.87 (1H, d, J= 13.9 
Hz, PhCHH), 7.25-7.29 (4H, m, PhHpara), 7.35 (2H, dd, J= 7.5, 7.1 Hz, PhHmeta), 7.40-7.43 (4H, 
m, PhHortho); 13C-NMR (100 MHz, CDCl3): d (ppm) 28.12 (CH3), 33.81 (CH), 45.11 (CH), 
62.69 (CH2), 81.76 (C), 82.40 (C), 84.34 (C), 122.64 (C), 127.29 (CH), 127.90 (CH), 128.14 
(CH), 128.27 (CH), 128.38 (CH), 131.90 (CH), 137.01 (C), 166.63 (C); HRFABMS m/z: 
334.1808 (Calcd for C22H24NO2: 334.1807)  
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2-Benzylamino-5-diphenyl-3-hydroxy-4-pentenoic acid tert-butyl ester    
H
N
HO
PhPh
Ph
O
O2
3
4
5
 
(247) (Table 5-5) 
pale yellow oil; Rf= 0.21 (n-hexane/ AcOEt= 10: 1); IR (thin film): nmax 1765 cm-1 (C=O); 
1H-NMR (400 MHz, CDCl3): d (ppm) diastereomeric ratio (syn : anti)= ca. 3: 1, 
syn-isomer:1.38 [9H, s, -CO2C(CH3)3], 3.18 (1H, d, J= 8.0 Hz, C2-H), 3.71 (1H, d, J= 12.8 Hz, 
PhCHH), 3.84 (1H, d, J= 12.8 Hz, PhCHH), 4.05 (1H, dd, J= 9.6, 8.0 Hz, C3-H), 6.05 (1H, d, 
J= 9.6 Hz, C4-H), 7.17-7.36 (15H, m, PhH); anti-isomer: 1.36 [9H, s, -CO2C(CH3)3], 3.36 (1H, 
d, J= 5.2 Hz, C2-H), 3.67 (1H, d, J= 12.8 Hz, PhCHH), 3.86 (1H, d, J= 12.8 Hz, PhCHH), 4.40 
(1H, dd, J= 10, 5.2 Hz, C3-H), 5.91 (1H, d, J= 10 Hz, C4-H), 7.17-7.36 (15H, m, PhH); 
13C-NMR (100 MHz, CDCl3): d (ppm) mixture of invertmers: 27.99 (CH3), 28.03 (CH3), 52.60 
(CH2), 53.00 (CH3), 65.09 (CH), 67.13 (CH), 68.49 (CH), 69.77 (CH), 81.82 (C), 81.93 (C), 
125.93 (CH), 126.73 (CH), 127.28 (CH), 127.30 (CH), 127.55 (CH), 127.63 (CH), 127.70 (CH), 
127.72 (CH), 127.76 (CH), 127.85 (CH), 128.07 (CH), 128.08 (CH), 128.09 (CH), 128.10 (CH), 
128.29 (CH), 128.36 (CH), 128.48 (CH), 128.49 (CH), 129.91 (CH), 130.02 (CH), 138.88 (C), 
138.90 (C), 139.25 (C), 139.46 (C), 141.91 (C), 142.28 (C), 145.84 (C), 146.47(C), 171.63 (C), 
172.16 (C); LREIMS m/z: 429 (M+, 3%). 
(4E)-2-Benzylamino-3-hydroxy-4-methyl-5-phenyl-4-pentenoic          
H
N
HO
Ph
Ph
O
O2
3
4
5
 
acid tert-butyl ester (248) (Table 5-5) 
pale yellow oil; Rf= 0.20 (n-hexane/ AcOEt= 20: 1); IR (thin film): nmax 1759, 1765 cm-1 
(C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) diastereomeric ratio = ca. 2: 1, major isomer: 
1.41 [9H, s, -CO2C(CH3)3], 1.529 (3H, s, C4-CH3), 3.76 (1H, d, J= 12.8 Hz, PhCHH), 3.80 (1H, 
d, J= 12.8 Hz, PhCHH), 4.005 (1H, d, J= 8.8 Hz, C2-H), 5.15 (1H, s, C5-H), 5.53 (1H, d, J= 8.8 
Hz, C3-H), 723-7.36 (10H, m, PhH); minor-isomer: 1.44 [9H, s, -CO2C(CH3)3], 1.531 (3H, s, 
C4-CH3), 3.76 (1H, d, J= 12.8 Hz, PhCHH), 3.80 (1H, d, J= 12.8 Hz, PhCHH), 4.013 (1H, d, J= 
8.8 Hz, C2-H), 5.08 (1H, s, C5-H), 5.65 (1H, d, J= 8.8 Hz, C3-H), 723-7.36 (10H, m, PhH); 
LRFABMS m/z: 368 (MH+, 50%). 
trans-3-Benzyl-5-cyclohexenyl-4-tert-buthoxycarbonyl-2-oxazolidinone    
CO2tBuN
O
O
1'
2'
3'
4'
5'
6'
1
4
Ph
  
(250) (Table 5-5)  
colorless oil; Rf= 0.22 (n-hexane:AcOEt= 10: 1); IR (ATR): nmax 1763 cm-1 (C=O); 1H-NMR 
(400 MHz, CDCl3): d (ppm) 1.47 [9H, s, -CO2C(CH3)3], 1.58 (5H, m,  C4’,5’,6’-H), 1.89-2.01 
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(3H, br m, C3’,6’-H), 3.64 (1H, d, J= 5.2 Hz, C4-H), 4.17 (1H, d, J= 14.8 Hz, PhCHH), 4.71 (1H, 
d, J= 5.2 Hz, C5-H), 4.95 (1H, d, J= 14.8 Hz, PhCHH), 5.79-5.81 (1H, br m, C2’-H), 7.23-7.37 
(5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 21.92 (CH2), 21.95 (CH2), 22.34 (CH2), 
24.80 (CH2), 27.94 (CH3), 47.15 (CH2), 60.45 (CH), 79.88 (CH), 83.21 (C), 127.31 (CH), 
128.11 (CH), 128.54 (CH), 128.80 (CH), 133.47 (C), 135.14 (C), 157.50 (C), 168.62 (C); 
HRFABMS m/z: 358.2036 (Calcd for C21H28NO4: 358.2018). 
 
Determination of Absolute Configuration from cis-229a 
(S)-2-tert-Butoxycarbonylamino-4-methyl-pentanoic acid tert-butyl ester [(S)-238]  
N
CO2tBu
Pd(OH)2/ C, H2
CO2tBu
H
N
Boc
cis-229a
rt, 12 h
2
3
4
5
Boc2O, MeOH
238
Ph
 
In a flask equipped with a stir bar under a hydrogen atmosphere (1 atm), a suspension of 5% 
Pd(OH)2 (124.6 mg) in MeOH (5.0 ml) at room temperature was treated with a solution of 
cis-229a (156.2 mg, 0.57 mmol) and Boc2O (142.0 mg, 0.65 mmol, 1.14 Meq) in MeOH (5.0 
ml) and the mixture was stirred at same temperature for 12 h. The reaction was filtered through 
celite pad and the filtrate was concentrated to afford a crude oil (175.2 mg, 107%). The residue 
was purified by column chromatography (silica gel 18 g, n-hexane/ AcOEt= 20: 1, 10: 1) to 
afford 238 as a colorless oil (154.2 mg, 94.0%) 
238: [a]D24 -8.5 (c 0.87, CHCl3); Rf= 0.51 (n-hexane/ AcOEt= 10: 1); IR (thin film): nmax 3374 
cm-1 (NH), 1718 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.94 (6H, d, J= 6.7 Hz, 
C4-CH3 and C5-H), 1.44 [9H, s, -CO2C(CH3)3], 1.46 [9H, s, -NHCO2C(CH3)3], 1.51-1.75 (3H, 
m, C3-H and C4-H), 4.18 (1H, m, C2-H), 4.88 (1H, d, J= 8.0 Hz, NH); 13C-NMR (100 MHz, 
CDCl3): d (ppm) 22.08 (CH3), 22.78 (CH3), 24.83 (CH), 27.97 (CH3), 28.31 (CH3), 42.12 (CH2), 
52.68 (CH), 79.51 (C), 81.50 (C), 155.40 (C), 172.67 (C); LRFABMS m/z: 288 (MH+, 12%). 
 
CO2HH2N CO2H
H
N
Boc
tBuO
N
Me
MetBuO
(DFBA) CO2
tBu
H
N
Boc
rt, 15 h
Boc2O, NaOH
tBuOH, H2O
rt, 21 h
50 0C, 6 h
dry benzene
236 237 238  
In a flask equipped with a stir bar under an argon atmosphere, a solution of (S)-leucine 236 
(507.6 mg, 3.87 mmol) in 1 N NaOH aq (8.0 ml) at room temperature was treated with a 
solution of Boc2O (888.3 mg, 4.07 mmol, 1.05 Meq) in tBuOH (8.0 ml) and the mixture was 
stirred at same temperature for 15 h. The reaction was cooled down to 0 oC, quenched with 1 N 
HCl (26 ml) to pH 3, and extracted with AcOEt (50 ml x 2). The organic layer was washed with 
H2O (20 ml x 1), dried over Na2SO4 and concentrated to afford the residue of N-Boc-leucine 
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237 (crude 847.8 mg, 94.7%) as a colorless oil which was used in the next step without 
purification.  
In a flask equipped with a stir bar under an argon atmosphere, a solution of N-Boc-leucine 
(109.7 mg, 0.47 mmol) in dry benzene (1.0 ml) was treated with DFBA (0.56 ml, 2.34 mmol, 
4.98 Meq) and the mixture was stirred at room temperature for 21 h and heated to 50 oC and 
further stirred for 6 h. Then, the reaction was cooled down to room temperature, quench with 
H2O (10 ml), and extracted with AcOEt (30 ml x 1). The organic layer was washed with H2O 
(10 ml x 2), brine (10 ml x 2), dried over Na2SO4 and concentrated. The residue (152.3 mg, 
111.8%) was purified by column chromatography (silica gel 15 g, n-hexane/ AcOEt = 10: 1) to 
afford 238 as a colorless oil (75.2 mg, 55.2%).  
238: [α]D24 -9.8 (c 0.9, CHCl3)] 
 
7.2 Isolation of Spiro Intermediate derived from a-Bromocinnamaldehyde 
1. Synthesis of an Achiral Intermediate (dl-255a) (entry 1 in Table 5-7) 
 
NMeMeN
N CO2tBuPh
Ph Ph
Br N
CO2tBu
NMeMeN
O
Ph Ph
dl-46 228n
dl-229n
dl-47
H
O
Br
Ph
NMeMeN
Ph Ph
dl-255a
ON
Ph
Ph
ButO2C
PhBr
NHMeMeN
N CO2tBuPh
Ph Ph
dl-233
O
Br
Ph
 
In a flask (20 ml) equipped with a stir bar under argon atmosphere, a solution of dl-46 
(150.8 mg, 0.274 mmol, 1.26 Meq) in THF (0.75 ml) at room temperature was added TMG 
(0.04 ml, 0.319 mmol, 1.47 Meq). After being stirred at the same temperature for 5 min, the 
reaction was cooled to -40 oC. The solution of 228n (48.1 mg, 95% purity, 0.217 mmol, 1.00 
Meq) in THF (0.5 ml) was added and the reaction mixture was stirred at -40 oC for 2.5 h and an 
additional 3.5 h at -10 oC. Then, the solvent was concentrated under reduced pressure and the 
residue was purified by column chromatography (NH-silica gel 25 g, n-hexane/ AcOEt= 50 : 1 
to 5 : 1, AcOEt) to afford dl-255a as colorless solids* (108.0 mg, 73.1%, mp 150-153 oC), 
trans-aziridine dl-229n as a pale yellow oil (8.2 mg, 9.1%), and a mixture of dl-47 and dl-233 
as a pale yellow oil (40.0 mg, dl-47 : dl-233= 1 : 3.6, estimated by 1 H-NMR spectroscopy). 
*dl-255a (combined weight 175.2 mg) was recrystallized from n-hexane/ AcOEt to afford a 
colorless crystal (114.6 mg, 65.4%, mp= 160-161 oC) which was confirmed the structure by 
X-ray crystallography. 
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(1’Z,2R*,3R*,7S*,8S*)-4-Benzyl-3-tert-butoxycarbonyl-6,9-dimethyl-      
NMeMeN
Ph Ph
ONPh
O
O
Br Ph
14
69
 
7,8-diphenyl-2-(1-bromo-2-phenyl)vinyl-1-oxa-4,6,9-triazaspiro[4.4]nonane (dl-255a) 
colorless crystal, mp 160-161 oC; IR (ATR): nmax 1724 cm-1 (C=O); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 1.18 [9H, s, -CO2C(CH3)3], 2.38 (3H, s, -NCH3), 2.50 (3H, s, -NCH3), 3.83 
[1H, d, J= 7.9 Hz, -NCHCO2CH(CH3)3]; 3.95 (1H, d, J= 15.0 Hz, -NCHHPh), 4.02 (1H, d, J= 
7.9 Hz, -NCHPh), 4.03 (1H, d, J= 7.9 Hz, -NCHPh), 4.50 (1H, d, J= 15.0 Hz, -NCHHPh), 4.91 
[1H, d, J= 7.9 Hz, -OCHCBrCHPh], 7.01 (2H, m, PhH), 7.20-7.40 (15H, m, PhH, 
-OCHCBrCHPh), 7.46 (2H, d, J= 7.9 Hz, PhH), 7.64 (2H, d, J= 7.5 Hz, PhH); 13C-NMR (125 
MHz, CDCl3): d (ppm) 27.52 (CH3), 30.85 (CH3), 31.03 (CH3), 50.98 (CH2), 69.66 (CH), 
72.79 (CH), 74.13 (CH), 81.53 (CH), 81.58 (C), 122.26 (C), 124.13 (C), 126.72 (CH), 127.38 
(CH), 127.43 (CH), 127.50 (CH), 128.13 (CH), 128.187 (CH), 128.194 (CH), 128.21 (CH), 
128.45 (CH), 128.52 (CH), 128.61 (CH), 129.14 (CH), 135.02 (C), 139.82 (C), 139.97 (C), 
140.24 (C), 170.30 (C); HRFABMS m/z: 682.2458 (Calcd for C39H4381BrN3O3: 682.2467), 
680.2443 (Calcd for C39H4379BrN3O3: 680.2488). 
 
2. Synthesis of a Chiral Intermediate (2R,3R,7S,8S-255a) and fragmentation to 
aziridine 229n 
In a flask (20 ml) equipped with a stir bar under argon atmosphere, a solution of (S,S)-46 
(151.0 mg, 0.274 mmol, 1.24 Meq) in THF (0.75 ml) at room temperature was added TMG 
(0.04 ml, 0.319 mmol, 1.44 Meq). After being stirred at the same temperature for 10 min, the 
reaction was cooled to -20 oC. The solution of 228n (49.0 mg, 95% purity, 0.221 mmol, 1.00 
Meq) in THF (0.5 ml) was added and the reaction mixture was stirred at -20 oC for 30 min and 
an additional 1.5 h at 0 oC. Then, the solvent was concentrated under reduced pressure and the 
residue was purified by column chromatography (NH-silica gel 30 g, n-hexane/ AcOEt= 200: 3 
to 5: 1, AcOEt) to afford 225a as colorless solids (111.9 mg, 74.4%), trans-aziridine 229n as a 
pale yellow oil (10.1 mg, 11.0%, 35% ee), and a mixture of 47 and 233 as pale yellow solids 
(30.5 mg, 47 : 233= 1 : 1.2, estimated by 1 H-NMR spectroscopy). 
Next, the intermediate 255a (101.0 mg, 0.148 mmol) was dissolved in CHCl3 (2 ml) and 
slowly added into the suspension of SiO2 (2.98 g) in CHCl3 (6 ml) and stirred at room 
temperature for 20 h. The reaction mixture was filtered through a pad of celite® and washed 
with CHCl3 (50 ml). The filtrate was concentrated to afford the residue which was purified by 
column chromatography (NH-SiO2 15 g, n-hexane/ AcOEt= 50: 1 to 4: 1) to give 
trans-aziridine 229n as a pale yellow oil (38.3 mg, 63.1%, 98% ee), cis-aziridine 229n as 
colorless solids (7.1 mg, 11.5%, 94% ee) and 47 as colorless solids (38.1 mg, 96.5%). 
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(2R,3R,7S,8S,Z)-4-Benzyl-3-tert-butoxycarbonyl-6,9-dimethyl-7,8-        
NMeMeN
Ph Ph
ONPh
O
O
Br Ph
14
69
     
diphenyl-2-(1-bromo-2-phenyl)vinyl-1-oxa-4,6,9-triazaspiro[4.4]nonane (255a) 
colorless plates, mp 65-68 oC; [a]D22 -3.0 (1.3, CHCl3). 
 
tert-Butyl (2R,3S,Z)-trans-1-Benzyl-3-(1-bromo-2-phenyl)vinyl-         
N
O
O
Ph
Ph
1 2
3
1'
2'
Br
 
aziridine-2-carboxylate (229n)                                                        
a pale yellow oil; 98.0% ee, determined by chiral HPLC (Daicel CHIRALCEL OD-H, 0.46 cm 
x 25 cm); n-hexane/ 2-propanol= 450: 1; flow rate= 1.0 ml/ min; detection wavelength= 254 
nm; tR (minor)= 10.32 min, tR (major)= 12.31 min; [α]D22 +40.1 (c 1.4, CHCl3); Rf= 0.66 
(n-hexane/ AcOEt= 10: 1); IR (ATR): nmax 1720 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d 
(ppm) 1.42 [9H, s, -CO2C(CH3)3], 2.86 (1H, br s, C2-H), 3.15 (1H, br s, C3-H), 4.05 (1H, d, J= 
13.6 Hz, PhCHH); 4.20 (1H, d, J= 13.6 Hz, PhCHH), 7.08 (1H, s, C2’-H), 7.23-7.36 (6H, m, 
PhH), 7.40 (2H, d, J= 7.1 Hz, PhH), 7.59 (2H, d, J= 7.6 Hz, PhH); 13C-NMR (125 MHz, 
CDCl3): d (ppm) 27.96 (CH3), 43.85 (CH), 52.05 (CH), 54.42 (CH2), 82.15 (C), 122.45 (C), 
127.01 (CH), 128.06 (CH), 128.12 (CH), 128.30 (CH), 128.65 (CH), 129.01 (CH), 135.05 (C), 
138.77 (C), 167.18 (C); HREIMS m/z: 413.1018 (Calcd for C22H2479BrNO2: 413.0990) 
tert-Butyl (2R,3R,E)-cis-1-Benzyl-3-(1-bromo-2-phenyl)vinyl-        
N
O
O
Ph
Ph
1 2
3
1'
2'
Br
 
aziridine-2-carboxylate (229n)                               
colorless solids, mp 90-91 oC; 93.9% ee, determined by chiral HPLC (Daicel CHIRALCEL 
OD-H, 0.46 cm x 25 cm); n-hexane/ 2-propanol= 800: 1; flow rate= 1.0 ml/ min; detection 
wavelength= 254 nm; tR (major)= 34.09 min, tR (minor)= 40.64 min; [α]D23 +32.1 (c 0.3, 
CHCl3); Rf= 0.38 (n-hexane/ AcOEt= 10: 1); IR (ATR): nmax 1730 cm-1 (C=O); 1H-NMR (400 
MHz, CDCl3): d (ppm) 1.40 [9H, s, -CO2C(CH3)3], 2.56 (1H, br s, C2-H), 2.83 (1H, br s, C3-H), 
3.56 (1H, d, J= 13.6 Hz, PhCHH); 3.91 (1H, d, J= 13.6 Hz, PhCHH), 7.25 (1H, s, C2’-H), 
7.26-7.37 (6H, m, PhH), 7.43 (2H, d, J= 7.1 Hz, PhH), 7.56 (2H, d, J= 7.6 Hz, PhH); 13C-NMR 
(125 MHz, CDCl3): d (ppm) 28.00 (CH3), 46.49 (CH), 51.20 (CH), 62.74 (CH2), 81.57 (C), 
117.57 (C), 127.44 (CH), 127.87 (CH), 128.00 (CH), 128.05 (CH), 128.46 (CH), 129.01 (CH), 
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129.82 (CH), 135.12 (C), 137.30 (C), 166.26 (C); HREIMS m/z: 413.0970 (Calcd for 
C22H2479BrNO2: 413.0990). 
 
7.4 Aziridine Ring-opening reaction 
(dl)-anti-2-Benzylamino-3-hydroxy-3-(4-chlorophenyl)propanoic acid     
H
N
HO
Ph
O
O2
3
Cl     
tert-butyl ester (257a) (entry 1 in Table 5-10) 
colorless needles, mp 124-125 oC; Rf= 0.28 (n-hexane/ AcOEt = 5: 1); IR (KBr): nmax 3290 
cm-1 (NH), 3090 cm-1 (OH), 1726 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.34 [9H, 
s, -CO2C(CH3)3], 3.53 (1H, d, J= 5.1 Hz, C2-H), 3.67 (1H, d, J= 13.0 Hz, PhCHH), 3.87 (1H, d, 
J= 13.0 Hz, PhCHH), 4.91(1H, d, J= 5.1 Hz, C3-H), 7.21 (2H, d J= 8.4 Hz, PhH), 7.26-7.35 
(7H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 27.92 (CH3), 52.48 (CH2), 66.00 (CH), 
72.34 (CH), 82.17 (C), 127.31 (CH), 127.71 (CH), 128.11 (CH), 128.29 (CH), 128.49 (CH), 
133.33 (C), 138.91 (C), 139.14 (C), 171.13 (C); LRFABMS m/z: 364 (37ClMH+, 21%), 362 
(35ClMH+, 60%); Anal. Calcd for C20H24ClNO3: C, 66.38; H, 6.69; N, 3.87. Found: C, 66.43; H, 
6.58; N, 3.73. 
(dl)-anti-2-Benzylamino-3-hydroxy-3-phenylpropanoic acid tert-butyl     Ph
H
N
HO
Ph
O
O2
3
  
ester (257b) (entry 2 in Table 5-10) 
colorless needles, mp 95-96 oC; Rf= 0.49 (n-hexane/ AcOEt = 4: 1); IR (KBr): nmax 3290 cm-1 
(NH), 3064 cm-1 (OH), 1726 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.33 [9H, s, 
-CO2C(CH3)3], 2.08 (1H, br s, NH), 3.57 (1H, d, J= 5.1 Hz, C2-H), 3.68 (1H, d, J= 12.9 Hz, 
PhCHH), 3.880 (1H, br s, OH), 3.881 (1H, d, J= 12.9 Hz, PhCHH), 4.95 (1H, d, J= 5.1 Hz, 
C3-H), 7.23-7.35 (10H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 27.88 (CH3), 52.44 
(CH2), 66.16 (CH), 72.93 (CH), 81.91 (C), 126.27 (CH), 127.22 (CH), 127.62 (CH), 128.00 
(CH), 128.28 (CH), 128.44 (CH), 139.33 (C), 140.26 (C), 171.32 (C); LRFABMS m/z: 328 
(MH+, 42%); Anal. Calcd for C20H25NO3: C, 73.37; H, 7.70; N, 4.28. Found: C, 73.59; H, 7.68; 
N, 4.24. 
 
(dl)-anti-2-Benzylamino-3-hydroxy-3-(4-methoxyphenyl)propanoic acid 
H
N
HO
Ph
O
O2
3
OMe
2'
3'
4'
  
tert-butyl ester (257f) (entry 6 in Table 5-10) 
colorless needles, mp 97-98 oC; Rf= 0.45 (n-hexane/ AcOEt = 4: 1 x 3 times); IR (KBr): nmax 
3420 cm-1 (OH), 3298 cm-1 (NH), 1726 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.36 
[9H, s, -CO2C(CH3)3], 2.02 (1H, br s, OH), 3.54 (1H, d, J= 5.1 Hz, C2-H), 3.66 (1H, d, J= 12.9 
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Hz, PhCHH), 3.78 (3H, s, OCH3), 3.80 (1H, br s, NH), 3.87 (1H, d, J= 12.9 Hz, PhCHH), 4.90 
(1H, br d, J= 5.1 Hz, C3-H), 6.83 (2H, dif. d, J= 8.5 Hz, C3’,5’-H), 7.19 (2H, dif. d, J= 8.5 Hz, 
C2’,6’-H), 7.24-7.35 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 28.00 (CH3), 52.56 
(CH2), 55.23 (CH3), 66.26 (CH), 72.51 (CH), 81.94 (C), 113.46 (CH), 127.24 (CH), 127.50 
(CH), 128.32 (CH), 128.47 (CH), 132.38 (C), 139.42 (C), 159.14 (C), 171.44 (C); LREIMS 
m/z: 357 (M+, 0.2%), 339 [(M-H2O)+, 26%]; Anal. Calcd for C21H27NO4: C, 70.56; H, 7.61; N, 
3.92. Found: C, 70.59; H, 7.59; N, 3.87. 
(dl)-syn-2-Benzylamino-3-hydroxy-3-(4-methoxyphenyl)propanoic acid  
H
N
HO
Ph
O
O2
3
OMe
2'
3'
4'
  
tert-butyl ester (257f) (entry 6 in Table 5-10) 
colorless needles, mp 50-52 oC; Rf= 0.49 (n-hexane/ AcOEt = 4: 1 x 3 times); IR (ATR): nmax 
3427 cm-1 (OH), 3282 cm-1 (NH), 1720 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.23 
[9H, s, -CO2C(CH3)3], 2.18 (1H, br s, OH), 3.24 (1H, d, J= 8.1 Hz, C2-H), 3.68 (1H, d, J= 12.9 
Hz, PhCHH), 3.79 (3H, s, OCH3), 3.80 (1H, d, J= 12.9 Hz, PhCHH), 4.11 (1H, br s, NH), 4.45 
(1H, d, J= 8.1 Hz, C3-H), 6.86 (2H, dif. d, J= 8.8 Hz, C3’,5’-H), 7.24-7.35 (7H, m, PhH); 
13C-NMR (100 MHz, CDCl3): d (ppm) 27.78 (CH3), 52.44 (CH2), 55.28 (CH3), 68.48 (CH), 
74.31 (CH), 81.64 (C), 113.55 (CH), 127.29 (CH), 128.25 (CH), 128.37 (CH), 128.48 (CH), 
132.05 (C), 139.19 (C), 159.46 (C), 172.19 (C); HRFABMS m/z: 357.1914 (Calcd for 
C21H27NO4: 357.1940). 
(dl)-syn-2-Benzylamino-3-hydroxy-3-(4-chlorophenyl)propanoic acid     
H
N
HO
Ph
O
O2
3
Cl     
tert-butyl ester (257a) (entry 8 in Table 5-10) 
colorless needles, mp 86-87 oC; Rf= 0.34 (n-hexane/ AcOEt = 5: 1); IR (KBr): nmax 3420 cm-1 
(OH), 3281 cm-1 (NH), 1717 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.26 [9H, s, 
-CO2C(CH3)3], 2.25 (1H, br s, OH), 3.19 (1H, d, J= 7.8 Hz, C2-H), 3.67 (1H, d, J= 12.9 Hz, 
PhCHH), 3.78 (1H, d, J= 12.9 Hz, PhCHH), 4.16 (1H, br s, NH), 4.50 (1H, d, J= 7.8 Hz, C3-H), 
7.25-7.35 (9H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 27.81 (CH3), 52.45 (CH2), 
68.16 (CH), 73.88 (CH), 82.04 (C), 127.38 (CH), 128.23 (CH), 128.30 (CH), 128.47 (CH), 
128.52 (CH), 133.69 (C), 138.78 (C), 138.99 (C), 171.90 (C); LRFABMS m/z: 364 (37ClMH+, 
21%), 362 (35ClMH+, 60%); Anal. Calcd for C20H24ClNO3: C, 66.38; H, 6.69; N, 3.87. Found: C, 
66.50; H, 6.75; N, 3.81. 
(dl)-syn-2-Benzylamino-3-hydroxy-3-phenylpropanoic acid tert-butyl     
H
N
HO
Ph
O
O2
3
 
ester (257b) (entry 9 in Table 5-10) 
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colorless needles, mp 45-47 oC; Rf= 0.43 (n-hexane/ AcOEt = 4: 1); IR (KBr): nmax 3437 cm-1 
(OH), 3287 cm-1 (NH), 1720 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.22 [9H, s, 
-CO2C(CH3)3], 3.26 (1H, d, J= 8.1 Hz, C2-H), 3.67 (1H, d, J= 12.9 Hz, PhCHH), 3.78 (1H, d, 
J= 12.9 Hz, PhCHH), 4.51 (1H, d, J= 8.1 Hz, C3-H), 7.27-7.36 (10H, m, PhH); 13C-NMR (100 
MHz, CDCl3): d (ppm) 27.72 (CH3), 52.44 (CH2), 68.33 (CH), 74.66 (CH), 81.70 (C), 127.11 
(CH), 127.27 (CH), 127.99 (CH), 128.14 (CH), 128.22 (CH), 128.46 (CH), 139.16 (C), 140.06 
(C), 172.09 (C); LRFABMS m/z: 328 (MH+, 47%); Anal. Calcd for C20H25NO3: C, 73.37; H, 
7.70; N, 4.28. Found: C, 73.36; H, 7.54; N, 4.14. 
 
 
(dl)-3-Acetoxy-2-benzylamino-3-(4-methoxyphenyl)propanoic acid      
H
N
Ph
O
O2
3
OMe
2'
3'
4'
O
O      
tert-butyl ester (258f) (Table 5-11) 
a pale yellow oil; Rf= 0.15 (major), 0.36 (minor) (n-hexane/ AcOEt = 10: 1); IR (ATR): nmax 
3321 cm-1 (NH), 1720 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) diastereomeric ratio: 
1 : 0.14, major diastereomer: 1.44 [9H, s,-CO2C(CH3)3], 2.02 (3H, s, OCOCH3), 3.52 (1H, d, J= 
7.3 Hz, C2-H), 3.62 (1H, d, J= 13.6 Hz, PhCHH), 3.78 (3H, s, OCH3), 3.82 (1H, d, J= 13.6 Hz, 
PhCHH), 5.85 (1H, d, J= 7.3 Hz, C3-H), 6.85 (2H, dif. d, J= 8.6 Hz, C3’,5’-H), 7.17-7.32 (7H, m, 
C2’,6’-H, PhH), minor diastereomer: 1.35 [9H, s,-CO2C(CH3)3], 2.07 (3H, s, OCOCH3), 3.46 
(1H, d, J= 5.5 Hz, C2-H), 3.59 (1H, d, J= 13.0 Hz, PhCHH), 3.73 (1H, d, J= 13.0 Hz, PhCHH), 
3.75 (3H, s, OCH3), 5.99 (1H, d, J= 5.5 Hz, C3-H), 6.86 (2H, dif. d, J= 8.6 Hz, C3’,5’-H), 
7.17-7.32 (7H, m, C2’,6’-H, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) major diastereomer: 
20.93 (CH3), 27.90 (CH3), 51.71 (CH2), 55.10 (CH3), 64.88 (CH), 75.60 (CH), 81.50 (C), 
113.46 (CH), 126.88 (CH), 128.04, (CH), 128.12 (CH), 128.72 (CH), 129.23 (C), 139.38 (C), 
159.43 (C), 169.39 (C), 171.30 (C), observed minor diastereomer: 27.75 (CH3), 51.84 (CH2), 
55.13 (CH3), 65.29 (CH), 75.42 (CH), 81.53 (C), 113.35 (CH), 126.80 (CH), 127.93, (CH), 
129.26 (C), 139.62 (C), 169.76 (C), 171.16 (C); HREIMS m/z: 399.2010 (Calcd for C23H29NO5: 
399.2045). 
(2Z)-2-N-Acetylbenzylamino-3-(4-methoxyphenyl)-2-propenoicacid   
Ph
O
O2
3
MeO
2'
3'4'
N
O
    
tert-butyl ester (259) (Table 5-11) 
a pale yellow oil; Rf= 0.78 (n-hexane/ AcOEt = 4: 1 x 3 times); IR (ATR): nmax 1705, 1662 
cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.27 [9H, s, -CO2C(CH3)3], 2.00 (3H, s, 
-NCOCH3), 3.84 (3H, s, -OCH3), 4.07 (1H, d, J= 13.7 Hz, PhCHH), 5.21 (1H, d, J= 13.7 Hz, 
PhCHH), 6.89 (2H, dif. d, J= 8.5 Hz, C3’,5’-H), 7.18-7.22 (3H, m, PhH), 7.25-7.29 (2H, m, PhH), 
7.45 (2H, dif. d, J= 8.5 Hz, C2’,6’-H), 7.55 (1H, s, C3-H); 13C-NMR (100 MHz, CDCl3): d (ppm) 
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21.80 (CH3), 27.62 (CH3), 49.89 (CH2), 55.33 (CH3), 81.65 (C), 114.49 (CH), 124.95 (C), 
127.50 (CH), 128.05 (CH), 128.70 (C), 130.22 (CH), 132.07 (CH), 136.42 (CH), 136.44 (C), 
161.41 (C), 164.32 (C), 171.28 (C); HREIMS m/z: 381.1969 (Calcd for C23H27NO4: 381.1940) 
(2S,3S)-anti-2-Benzylamino-3-hydroxy-4-methyl-4-pentenoic acid        
H
N
HO
Ph
O
O2
3
4
5        
tert-butyl ester (260a) (entry 1 in Table 5-12) 
colorless needles, mp 115-116 oC; [α]D21 -18.0 (c 1.6, CHCl3); Rf= 0.37 (n-hexane/ AcOEt =   
4: 1); IR (KBr): nmax 3319 cm-1 (NH), 3104 cm-1 (OH), 1729 cm-1 (C=O); 1H-NMR (400 MHz, 
CDCl3): d (ppm) 1.46 [9H, s, -CO2C(CH3)3], 1.71 [s, 3H; C4-CH3], 2.16 (1H, br s, NH), 3.24 
(1H, br s, OH), 3.42 (1H, d, J= 5.1 Hz, C2-H), 3.68 (1H, d, J= 12.9 Hz, PhCHH), 3.87 (1H, d, 
J= 12.9 Hz, PhCHH), 4.26 (1H, br dd, J= 8.1, 5.1 Hz, C3-H), 4.91 (1H, br dd, J= 2.4, 1.5 Hz, 
C5-H), 5.00 (1H, br s, C5-H), 7.26-7.29 (1H, m, PhHpara), 7.32-7.34 (4H, m, PhHortho,meta); 
13C-NMR (100 MHz, CDCl3): d (ppm) 18.91 (CH3), 28.09 (CH3), 52.32 (CH2), 63.55 (CH), 
74.88 (CH), 82.10 (C), 112.57 (CH2), 127.19 (CH), 128.28 (CH), 128.42 (CH), 139.41 (C), 
143.95 (C), 172.02 (C); LRFABMS m/z: 292 (MH+, 86%); Anal. Calcd for C17H25NO3: C, 
70.07; H, 8.65; N, 4.81. Found: C, 70.04; H, 8.57; N, 4.81. 
 
Determination of Relative Configuration of Ring-opening Products 
(dl)-trans-3-Benzyl-5-isopropenyl-2-oxo-1,3-oxazolidine-4-carboxylic acid tert-butyl ester 
(262a) (Scheme 5-11) 
CO2tBuN
O
O
trans-262
2
3
4
5
1
Im2CO
CH2Cl2
35 oC, 3 d
CO2tBu
H
N
HO
syn-260
1'
2'
Ph
Ph
 
In a flask equipped with a stir bar under an argon atmosphere, a mixture of 260 (31.5 mg, 0.108 
mmol) and Im2CO (22.1 mg, 95% purity, 0.129 mmol, 1.19 Meq) in CH2Cl2 (1.0 ml) was 
stirred at 35 oC for 3 d. The reaction mixture was concentrated and the residue (56.8 mg, 108%) 
was purified by column chromatography (silica gel 5 g, n-hexane/ AcOEt= 10: 1, 4: 1) to afford 
262 as a colorless oil (30.7 mg, 89.5%). 
Rf= 0.45 (n-hexane/ AcOEt= 10: 1); IR (thin film): nmax 1763 and 1743 cm-1 (C=O); 1H-NMR 
(400 MHz, CDCl3): d (ppm) 1.48 [9H, s, -CO2C(CH3)3], 1.61 (3H, br s, C1’-CH3), 3.62 (1H, d, 
J= 5.1 Hz, C4-H), 4.18 (1H, d, J= 14.8 Hz, PhCHH), 4.78 (1H, d, J= 5.3 Hz, C5-H), 4.95 (1H, d, 
J= 14.8 Hz, PhCHH), 4.96 (1H, br s, C2’-H), 5.09 (1H, br s, C2’-H), 7.24 (2H, d, J= 1.8, PhH), 
7.29-7.37 (3H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 16.51 (CH3), 27.90 (CH3), 
47.11 (CH2), 60.61 (CH), 78.74 (CH), 83.43 (C), 114.41 (CH2), 128.14 (CH), 128.44 (CH), 
128.85 (CH), 134.98 (C), 140.50 (C), 157.21 (C), 168.35 (C); HRFABMS m/z: 318.1701 
(Calcd for C18H24NO4: 318.1705). 
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(4S,5S)-cis-3-Benzyl-5-isopropenyl-2-oxo-1,3-oxazolidine-4-carboxylic acid tert-butyl ester 
(262a) (Scheme 5-11) 
cis-262
Im2CO
CH2Cl2
rt, 12 h
CO2tBu
H
N
HO
anti-260
N
O
O
CO2tBu
Ph
Ph
 
87.3%; colorless needles, mp 83-84 oC; Rf= 0.49 (n-hexane/ AcOEt= 5: 1); IR (thin film): nmax 
1747 cm-1 (C=O); 1H-NMR (500 MHz, CDCl3): d (ppm) 1.42 [9H, s, -CO2C(CH3)3], 1.77 (3H, 
s, C1’-CH3), 3.97 (1H, d, J= 14.7 Hz, PhCHH), 4.00 (1H, d, J= 8.6 Hz, C4-H), 4.92 (1H, d, J= 
8.6 Hz, C5-H), 4.96 (1H, d, J= 14.7 Hz, PhCHH), 5.06 (1H, br d, J= 0.9 Hz, C2’-H), 5.22 (1H, 
br d, J= 0.9 Hz, C2’-H), 7.26 (2H, dif. d, J= 8.5, PhH), 7.32-7.38 (3H, m, PhH); 13C-NMR (100 
MHz, CDCl3): d (ppm) 18.96 (CH3), 27.88 (CH3), 47.55 (CH2), 61.11 (CH), 77.69 (CH), 83.16 
(C), 115.09 (CH2), 128.18 (CH), 128.63 (CH), 128.92 (CH), 135.17 (C), 137.44 (C), 157.62 (C), 
166.36 (C); LREIMS m/z: 317 (M+, 2%); Anal. Calcd for C18H23NO4: C, 68.12; H, 7.30; N, 
4.41. Found: C, 68.04; H, 7.31; N, 4.30. 
(dl)-trans-3-Benzyl-5-(4-chlorophenyl)-2-oxo-1,3-oxazolidine-4-carboxylic 
2
3
1
4
5
N
O
O
Ph
O
O
Cl 
acid tert-butyl ester 
colorless needles, mp 84-85 oC; Rf= 0.50 (n-hexane/ AcOEt=5: 1); IR (ATR): nmax 1759 cm-1 
(C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.45 [9H, s, -CO2C(CH3)3], 3.74 (1H, d, J= 5.4 
Hz, C4-H), 4.25 (1H, d, J= 14.8 Hz, PhCHH), 4.99 (1H, d, J= 14.8 Hz, PhCHH), 5.40 (1H, d, 
J= 5.4 Hz, C5-H), 7.18-7.20 (4H, m, PhH), 7.28-7.34 (5H, m, PhH); 13C-NMR (100 MHz, 
CDCl3): d (ppm) 27.94 (CH3), 47.25 (CH2), 63.89 (CH), 76.34 (CH), 83.88 (C), 126.66 (CH), 
128.22 (CH), 128.32 (CH), 128.90 (CH), 129.09 (CH), 134.79 (C), 134.92 (C), 136.66 (C), 
156.96 (C), 167.90 (C); LREIMS m/z: 389 [(37ClM)+, 1%], 387 [(35ClM)+, 3%]; Anal. Calcd for 
C21H22ClNO4: C, 65.03; H, 5.72; N, 3.61. Found: C, 64.97; H, 5.73; N, 3.54. 
(dl)-cis-3-Benzyl-5-(4-chlorophenyl)-2-oxo-1,3-oxazolidine-4-carboxylic   
2
3
1
4
5
N
O
O
Ph
O
O
Cl 
acid tert-butyl ester 
colorless needles, mp 100-101 oC; Rf= 0.45 (n-hexane/ AcOEt=5: 1); IR (ATR): nmax 1751 cm-1 
(C=O); 1H-NMR (500 MHz, CDCl3): d (ppm) 1.05 [9H, s, -CO2C(CH3)3], 4.03 (1H, d, J= 14.7 
Hz, PhCHH), 4.17 (1H, d, J= 9.2 Hz, C4-H), 5.00 (1H, d, J= 14.7 Hz, PhCHH), 5.58 (1H, d, J= 
9.2 Hz, C5-H), 7.25-7.28 (4H, m, PhH), 7.32-7.39 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): 
d (ppm) 27.32 (CH3), 47.55 (CH2), 62.18 (CH), 75.72 (CH), 83.02 (C), 128.08 (CH), 128.28 
(CH), 128.53 (CH), 128.68 (CH), 128.95 (CH), 132.71 (C), 134.91 (C), 134.98 (C), 157.29 (C), 
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165.86 (C); LREIMS m/z: 389 [(37ClM)+, 1%], 387 [(35ClM)+, 4%]; Anal. Calcd for 
C21H22ClNO4: C, 65.03; H, 5.72; N, 3.61. Found: C, 64.98; H, 5.76; N, 3.56. 
(dl)-trans-3-Benzyl-2-oxo-5-phenyl-1,3-oxazolidine-4-carboxylic acid      
2
3
1
4
5
N
O
O
Ph
O
O
 
tert-butyl ester 
colorless prisms, mp 89-90 oC; Rf= 0.49 (n-hexane/ AcOEt=5: 1); IR (ATR): nmax 1739 cm-1 
(C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.49 [9H, s, -CO2C(CH3)3], 3.81 (1H, d, J= 5.3 
Hz, C4-H), 4.26 (1H, d, J= 14.9 Hz, PhCHH), 4.99 (1H, d, J= 14.9 Hz, PhCHH), 5.43 (1H, d, 
J= 5.3 Hz, C5-H), 7.20 (2H, dif dd, J= 7.3, 1.4 Hz, PhHortho), 7.24-7.38 (8H, m, PhH); 13C-NMR 
(100 MHz, CDCl3): d (ppm) 27.93 (CH3), 47.21 (CH2), 64.05 (CH), 77.08 (CH), 83.63 (C), 
125.27 (CH), 128.11 (CH), 128.32 (CH), 128.83 (CH), 128.86 (CH), 128.97 (CH), 134.94 (C), 
138.13 (C), 157.23 (C), 168.12 (C); LREIMS m/z: 353 (M+, 7%); Anal. Calcd for C21H23NO4: 
C, 71.37; H, 6.56; N, 3.96. Found: C, 71.34; H, 6.54; N, 3.94. 
(dl)-cis-3-Benzyl-2-oxo-5-phenyl-1,3-oxazolidine-4-carboxylic acid        
2
3
1
4
5
N
O
O
Ph
O
O
 
tert-butyl ester 
colorless needles, mp 125-126 oC; Rf= 0.39 (n-hexane/ AcOEt=5: 1); IR (ATR): nmax 1759 and 
1716 cm-1 (C=O); 1H-NMR (500 MHz, CDCl3): d (ppm) 1.00 [9H, s, -CO2C(CH3)3], 4.04 (1H, 
d, J= 14.7 Hz, PhCHH), 4.18 (1H, d, J= 9.5 Hz, C4-H), 5.02 (1H, d, J= 14.7 Hz, PhCHH), 5.61 
(1H, d, J= 9.5 Hz, C5-H), 7.27 (2H, dif dd, J= 8.1, 1.4 Hz, PhHortho), 7.31-7.39 (8H, m, PhH); 
13C-NMR (100 MHz, CDCl3): d (ppm) 27.26 (CH3), 47.51 (CH2), 62.31 (CH), 76.44 (CH), 
82.71 (C), 126.64 (CH), 128.22 (CH), 128.33 (CH), 128.69 (CH), 128.92 (CH), 128.98 (CH), 
134.17 (C), 135.10 (C), 157.60 (C), 165.99 (C); LREIMS m/z: 353 (M+, 1%); Anal. Calcd for 
C21H23NO4: C, 71.37; H, 6.56; N, 3.96. Found: C, 71.26; H, 6.63; N, 3.88. 
dl)-trans-3-Benzyl-2-oxo-5-(4-methoxyphenyl)-1,3-oxazolidine-4-carboxy
2
3
1
4
5
N
O
O
Ph
O
O
OMe 
lic acid tert-butyl ester 
a colorless oil; Rf= 0.37 (n-hexane/ AcOEt=4: 1); IR (ATR): nmax 1757 cm-1 (C=O); 1H-NMR 
(400 MHz, CDCl3): d (ppm) 1.48 [9H, s, -CO2C(CH3)3], 3.77 (3H, s, OCH3), 3.81 (1H, d, J= 
5.5 Hz, C4-H), 4.26 (1H, d, J= 14.8 Hz, PhCHH), 4.99 (1H, d, J= 14.8 Hz, PhCHH), 5.36 (1H, 
d, J= 5.5 Hz, C5-H), 6.85 (2H, d, J= 8.8 Hz, ArH), 7.16 (2H, d, J= 8.6 Hz, ArH), 7.22-7.33 (5H, 
m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 27.82 (CH3), 47.13 (CH2), 55.18 (CH3), 63.99 
(CH), 76.99 (CH), 83.42 (C), 114.11 (CH), 126.82 (CH), 128.03 (CH), 128.29 (CH), 128.76 
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(CH), 129.91 (C), 134.93 (C), 157.17 (C), 160.00 (C), 168.06 (C); HRFABMS m/z: 384.1804 
(Calcd for C22H26NO5: 384.1811). 
dl)-cis-3-Benzyl-2-oxo-5-(4-methoxyphenyl)-1,3-oxazolidine-4-carboxy- 
2
3
1
4
5
N
O
O
Ph
O
O
OMe 
lic acid tert-butyl ester 
colorless needles, mp 117-118 oC; Rf= 0.30 (n-hexane/ AcOEt=4: 1); IR (ATR): nmax 1736 cm-1 
(C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.05 [9H, s, -CO2C(CH3)3], 3.77 (3H, s, OCH3), 
4.05 (1H, d, J= 14.6 Hz, PhCHH), 4.16 (1H, d, J= 9.2 Hz, C4-H), 5.01 (1H, d, J= 14.6 Hz, 
PhCHH), 5.56 (1H, d, J= 9.2 Hz, C5-H), 6.86 (2H, d, J= 9.0 Hz, ArH), 7.24 (2H, d, J= 8.4 Hz, 
ArH), 7.22-7.39 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 27.22 (CH3), 47.34 
(CH2), 55.21 (CH3), 62.23 (CH), 76.15 (CH), 82.49 (C), 113.59 (CH), 126.11 (C), 127.92 (CH), 
128.07 (CH), 128.54 (CH), 128.78 (CH), 134.97 (C), 157.55 (C),  160.04 (C), 166.01 (C); 
LRFABMS m/z: 384 (MH+, 21%); Anal. Calcd for C22H25NO5: C, 68.91; H, 6.57; N, 3.65. 
Found: C, 68.77; H, 6.57; N, 3.63. 
 
7.5 Application of vinylaziridines to the synthesis of vicinal amino alcohols 
7.5.1 Synthesis of tert-Butyl hydroxyleucinate 
(2R,3S)-syn-2-Benzylamino-3-hydroxy-4-methyl-4-pentenoic acid tert-butyl ester (260a) 
(Scheme 5-12) 
N
CO2tBu
p-TsOH H2O
CO2tBu
H
N
HO
229a 260a
50 oC, 20 h
.
THF-H2O (1 : 1)
1
2
3
4
5
Ph
Ph
 
In a flask equipped with a stir bar, a solution of 229a (144.6 mg, 0.529 mmol) in THF (2.0 ml) 
at RT was added a solution of p-TsOH.H2O (107.1 mg, 0.563 mmol, 1.06 Meq). After being 
stirred at room temperature for 30 min and heated to 50 0C for 20 h, the reaction was cooled to 
0 oC, diluted with H2O (10 ml), added with 15% NaOH aq (3.0 ml) and extracted with CH2Cl2 
(20 ml x 2). The organic layer was washed with H2O (10 ml x 2), brine (10 ml x 2), dried over 
NaSO4 and concentrated to afford a pale yellow oil (142.8 mg, 92.7%) which was used in the 
next step without purification. 1H-NMR analysis of the crude reaction mixture indicated the 
single diastereomer 260a. 
260a: [α]D21 +45.0 (c 1.2, CHCl3); Rf= 0.35 (n-hexane/ AcOEt = 4: 1); IR (thin film): nmax 3448 
cm-1 (OH), 3307 cm-1 (NH), 1726 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.43 [9H, 
s, -CO2C(CH3)3], 1.76 [3H, s, C4-CH3], 3.18 (1H, d, J= 8.1 Hz, C2-H), 3.71 (1H, d, J= 13.0 Hz, 
PhCHH), 3.83 (1H, d, J= 13.0 Hz, PhCHH), 3.93 (1H, d, J= 8.1 Hz, C3-H), 4.93 (1H, m, C5-H), 
4.99 (1H, m, C5-H), 7.26-7.34 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 16.80 
(CH3), 28.01 (CH3), 52.61 (CH2), 64.64 (CH), 76.54 (CH), 81.96 (C), 114.67 (CH2), 127.33 
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(CH), 128.25 (CH), 128.50 (CH), 139.24 (C), 143.48 (C), 172.16 (C); HRFABMS m/z: 
292.1934 (Calcd for C17H26NO3: 292.1913). 
ent-1: [α]D21 -45.1 (c 1.9, CHCl3); 
 
(2R,3S)-syn-2-Amino-3-hydroxy-4-methyl-pentanoic acid tert-butyl ester (175) (Scheme 
5-12) 
10% Pd/ C, H2
EtOH
rt, 9.5 h
CO2tBu
H
N
HO
260
CO2tBu
H
N
HO
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4
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Ph Ph
 
In a flask equipped with a stir bar under a hydrogen atmosphere, a mixture of 260 (123.6 mg, 
0.424 mmol) and 10% Pd/ C (92.8 mg, Pd 0.087 mmol, 0.21 Meq) in EtOH (10 ml) was stirred 
at room temperature for 9.5 h. The reaction mixture was filtered through a pad of celite. The 
celite was washed with EtOH and the filtrate was concentrated to afford the residue which was 
purified by column chromatography (silica gel 5 g, AcOEt) to afford 5 as a pale yellow oil 
(78.1 mg, 90.6%). 
175: [α]D23 -11.2 (c 1.4, CHCl3); Rf= 0.15 (AcOEt); IR (thin film): nmax 3371 cm-1 (OH and 
NH), 1728 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d(ppm) 0.96 (3H, d, J= 6.8 Hz, C4-CH3), 
1.01 (3H, d, J= 6.8 Hz, C5-H), 1.48 [9H, s, -CO2C(CH3)3], 1.68-1.80 (1H, m, C4-H), 2.06 (3H, 
br s, NH and OH), 3.40-3.43 (2H, m, C2-H and C3-H); 13C-NMR (100 MHz, CDCl3): d (ppm) 
17.58 (CH3), 19.45 (CH3), 27.98 (CH3), 30.82 (CH), 56.39 (CH), 77.05 (CH), 81.54 (C), 173.83 
(C); LRFABMS m/z: 204 (MH+, 48%). 
ent-175: [α]D23 +11.1 (c 1.4, CHCl3). 
 
[lit. 175: [α]D23 -11.6 (c 0.7, CHCl3), 92% ee*; ent-175: [α]D23 +11.9 (c 1.0, CHCl3), 95% ee*; 
1H-NMR (300 MHz, CDCl3): d (ppm) 0.94 (3H, d, J= 6.6 Hz), 0.98 (3H, d, J= 6.6 Hz), 1.46 
(9H, s), 1.71 (1H, m), 2.12 (3H, br s), 3.39 (2H, m); 13C-NMR (100 MHz, CDCl3): d (ppm) 
17.6 (CH3), 19.5 (CH3), 28.0 (CH3), 30.3 (CH), 56.4 (CH), 77.1 (CH), 81.6 (C), 173.8 (C), * 
*The enantiomeric excess of title compound was determined after conversion to thio- 
oxazolidinone derivative. 
 
(4R,5S)-trans-5-Isopropenyl-2-thio-1,3-oxazolidine-4-carboxylic acid tert-butyl ester (263) 
(Scheme 5-13) 
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In a tube equipped with a stir bar under an argon atmosphere, a mixture of 175 (20.3 mg, 0.100 
mmol) and Im2CS (20.3 mg, 95% purity, 0.103 mmol, 1.03 Meq) in CH2Cl2 (0.4 ml) was stirred 
at room temperature for 9 h. The reaction mixture was concentrated and the residue was 
purified by column chromatography (silica gel 5 g, n-hexane/ AcOEt= 10: 3) to afford 263 as 
pale brown plates (22.1 mg, 90.2%). 
263: mp 80-83 oC; 87.3% ee, determined by chiral HPLC (Daicel CHIRALPAK AD-H, 0.46 
cm x 25 cm); n-hexane/ 2-propanol= 9: 1; flow rate= 1.0 ml/ min; detection wavelength= 254 
nm; tR (minor)= 7.99 min, tR (major)= 11.47 min; Rf= 0.45 (n-hexane/ AcOEt= 10: 3); IR (thin 
film): nmax 3281 cm-1, (NH), 1734 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 1.03 (3H, 
d, J= 6.8 Hz, C1’-CH3), 1.05 (3H, d, J= 6.8 Hz, C1’-CH3), 1.50 [9H, s, -CO2C(CH3)3], 2.07 (1H, 
d-sept, J= 6.8, 6.8 Hz, C1’-H), 4.15 (1H, d, J= 6.0 Hz, C5-H), 4.73 (1H, t, J= 6.0 Hz, C4-H), 7.54 
(1H, br s, NH). 
ent-263: 80-83 oC; 86.7% ee, determined by chiral HPLC (Daicel CHIRALPAK AD-H, 0.46 
cm x 25 cm); n-hexane/ 2-propanol= 9: 1; flow rate= 1.0 ml/ min; detection wavelength= 254 
nm; tR (major)= 7.95 min, tR (minor)= 11.45 min; 
[lit. 263: 92% ee; ent-263: 95% ee; 1H-NMR (300 MHz, CDCl3): d (ppm) 1.01 (3H, d, J= 7.0 
Hz), 1.03 (3H, d, J= 7.0 Hz), 1.48 (9H, s), 2.06 (1H, d-sept, J= 7.0, 6.0 Hz), 4.16 (1H, d, J= 6.0 
Hz), 4.71 (1H, app.t, J= 6.0 Hz), 8.02 (1H, br s). 
 
7.5.2 Synthesis of D-erythro-sphingosine 
1. From trans-Aziridine 229c 
(2R,3R,4E)-anti-2-Benzylamino-3-acetoxy-4-octadecenoic acid tert-butyl ester (264) 
(Scheme 5-14) 
N
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C13H27
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H
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In a flask equipped with a stir bar under a CaCl2 tube, AcOH (0.60 ml, 10.5 mmol, 21.0 Meq) 
was added to 229c (221.8 mg, 0.50 mmol) at 2 oC and the reaction was allowed to warm to 
room temperature. After being stirred for 2.5 h, the reaction was concentrated. 1H-NMR 
analysis of the crude reaction mixture indicated the single diastereomer. The residue (256.0 mg, 
102%) was purified by column chromatography (silica gel 10 g, n-hexane/ AcOEt= 20: 1 and 
10: 1) to afford 264 as a pale yellow oil (251.8 mg, quant.). 
264: [α]D23 -6.2 (c 2.5, CHCl3); Rf= 0.45 (n-hexane/ AcOEt= 20: 1 x 2 times); IR (thin film): 
nmax 3332 cm-1 (NH), 1735 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 
7.0 Hz, -(CH2)12CH3], 1.25-1.36 [22H, br m, -CH2(CH2)11CH3], 1.46 [9H, s, -CO2C(CH3)3], 
2.00-2.05 [2H, m, -CH2(CH2)11CH3], 2.03 (3H, s, -OCOCH3), 3.35 (1H, d, J= 5.1 Hz, C2-H), 
3.70 (1H, d, J= 13.4 Hz, PhCHH), 3.88 (1H, d, J= 13.4 Hz, PhCHH), 5.40 (1H, dd, J= 7.7, 5.1 
Hz, C3-H), 5.46 (1H, br dd, J= 15.0, 7.7 Hz, C4-H), 5.76 (1H, dt, J= 15.0, 7.0 Hz, C5-H), 
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7.22-7.35 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 14.08 (CH3), 21.15 (CH3), 
22.65 (CH2), 28.06 (CH3), 28.77 (CH2), 29.12 (CH2), 29.32 (CH2), 29.43 (CH2), 29.55 (CH2), 
29.62 (CH2), 29.635 (CH2), 29.643 (CH2), 29.65 (CH2), 31.89 (CH2), 32.26 (CH2), 52.16 (CH2), 
64.07 (CH), 75.39 (CH), 81.59 (C), 124.27 (CH), 127.01 (CH), 128.24 (CH), 128.28 (CH), 
136.71 (CH), 139.69 (C), 169.73 (C), 171.04 (C); HRFABMS m/z: 502.3897 (Calcd for 
C31H52NO4: 502.3896). 
ent-264: [α]D19 +6.3 (c 3.0, CHCl3); Rf= 0.45 (n-hexane/ AcOEt= 20: 1 x 2 times); IR (ATR): 
nmax 3352 cm-1 (NH), 1736 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 
7.0 Hz, -(CH2)12CH3], 1.25-1.35 [22H, br m, -CH2(CH2)11CH3], 1.46 [9H, s, -CO2C(CH3)3], 
2.00-2.08 [2H, m, -CH2(CH2)11CH3], 2.03 (3H, s, -OCOCH3), 3.36 (1H, d, J= 5.1 Hz, C2-H), 
3.70 (1H, d, J= 13.2 Hz, PhCHH), 3.88 (1H, d, J= 13.2 Hz, PhCHH), 5.40 (1H, dd, J= 7.8, 5.1 
Hz, C3-H), 5.46 (1H, ddt, J= 14.9, 7.8, 1.2 Hz, C4-H), 5.76 (1H, dt, J= 14.9, 6.8 Hz, C5-H), 
7.23-7.34 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 14.07 (CH3), 21.13 (CH3), 
22.64 (CH2), 28.03 (CH3), 28.76 (CH2), 29.10 (CH2), 29.31 (CH2), 29.41 (CH2), 29.53 (CH2), 
29.61 (CH2), 29.62 (CH2), 29.63 (CH2), 29.64 (CH2), 31.87 (CH2), 32.24 (CH2), 52.11 (CH2), 
63.99 (CH), 75.34 (CH), 81.58 (C), 124.19 (CH), 127.01 (CH), 128.24 (CH), 128.27 (CH), 
136.71 (CH), 139.59 (C), 169.71 (C), 170.98 (C); HRFABMS m/z: 502.3896 (Calcd for 
C31H52NO4: 502.3896). 
 
(2R,3R,4E)-anti-2-Benzylamino-3-hydroxy-4-octadecenoic acid tert-butyl ester (260) 
3-Benzylamino-2-hydroxy-4-octadec-4-enoic acid tert-butyl ester (261c) (Scheme 5-14) 
Method 1: From aziridine 
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In a tube equipped with a stir bar, a solution of trans-229c (629.9 mg, 1.43 mmol) in THF (6.0 
ml) at room temperature was added a solution of p-TsOH.H2O (307.9 mg, 1.62 mmol, 1.13 
Meq). After being stirred for 35 h, the reaction was cooled to 0 oC, diluted with H2O (10 ml), 
neutralized with 15% NaOH aq (1.0 ml) and extracted with AcOEt (30 ml). The organic layer 
was washed with H2O (10 ml x 2), brine (10 ml x 2), dried over MgSO4 and concentrated. 1H 
NMR analysis of the crude reaction mixture indicated the ratio of anti-260, syn-260 and 261c to 
be 80.7: 1: 10.7. The residue (657.2 mg, 100%) was purified by column chromatography 
(NH-silica gel 100 g, n-hexane/ AcOEt = 10: 1, 5: 1 and 3: 1) to afford anti-260 as a pale 
yellow oil (465.5 mg, 70.8%) and 261c as a pale yellow oil (104.0 mg, 15.8%) which was 
confirmed the structure by HMQC and HMBC. 
anti-260: [α]D23 +14.8 (c 3.1, CHCl3); Rf= 0.62 (n-hexane/ AcOEt = 10: 1); IR (thin film): nmax 
3448 cm-1 (OH), 3317 cm-1 (NH), 1728 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 
[3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.24-1.32 [22H, br m, -CH2(CH2)11CH3], 1.46 [9H, s, 
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-CO2C(CH3)3], 1.99 [2H, br dt, J= 7.0, 7.0 Hz, -CH2(CH2)11CH3], 3.29 (1H, br s, OH), 3.37 (1H, 
d, J= 4.8 Hz, C2-H), 3.63 (1H, d, J= 12.6 Hz, PhCHH), 3.90 (1H, d, J= 12.6 Hz, PhCHH), 4.30 
(1H, br dd, J= 6.4, 4.8 Hz, C3-H), 5.30 (1H, ddt, J= 15.4, 6.4, 1.1 Hz, C4-H), 5.71 (1H, dtd, J= 
15.4, 7.0, 1.1 Hz, C5-H), 7.24-7.33 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 14.05 
(CH3), 22.62 (CH2), 28.07 (CH3), 28.96 (CH2), 29.14 (CH2), 29.29 (CH2), 29.42 (CH2), 29.51 
(CH2), 29.59 (CH2), 29.60 (CH2), 29.62 (CH2), 31.85 (CH2), 32.19 (CH2), 52.65 (CH2), 65.34 
(CH), 71.49 (CH), 81.58 (C), 127.15 (CH), 127.27 (CH), 128.32 (CH), 128.38 (CH), 133.66 
(CH), 139.49 (C), 171.50 (C); HRFABMS m/z: 460.3785 (Calcd for C29H50NO3: 460.3791). 
261c: Rf= 0.32 (n-hexane/ AcOEt= 4: 1); IR (thin film): nmax 3337 cm-1 (OH and NH), 1731 
cm-1 (C=O); 1H-NMR (500 MHz, CDCl3): d (ppm) diastereomer ratio= ca. 1:0.8, 0.88 [6H, t, 
J= 7.0 Hz, -(CH2)12CH3], 1.25-1.34 [44H, m, -CH2(CH2)11CH3], 1.46, 1.47 [each 9H, s, 
-CO2C(CH3)3], 1.49-1.59 [4H, m, -CH2(CH2)11CH3], 3.72, 3.77 (each 1H, d, J= 12.8 Hz, 
PhCH2), 3.72, 3.78 (each 1H, d, J= 13.1 Hz, PhCH2), 3.74-3.75 (2H, m, C2-H), 4.01-4.14 (2H, 
m, C3-H), 5.61 (1H, ddd, J= 15.6, 7.0, 0.9 Hz, C4-H), 5.66 (1H, ddd, J= 15.6, 6.7, 0.9 Hz, C4-H), 
5.76 (1H, ddd, J= 15.6, 6.7, 0.9 Hz, C5-H), 5.79 (1H, ddd, J= 15.6, 7.0, 0.9 Hz, C5-H), 
7.23-7.27 (2H, m, PhH), 7.30-7.35 (8H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 14.10 
(CH3), 22.66 (CH2), 25.30 (CH2), 25.31 (CH2), 28.04 (CH3), 28.05 (CH3), 29.33 (CH2), 29.53 
(CH2), 29.58 (CH2), 29.62 (CH2), 29.64 (CH2), 29.66 (CH2), 31.89 (CH2), 37.08 (CH2), 37.09 
(CH2), 51.49 (CH2), 51.51 (CH2), 62.58 (CH), 62.80 (CH), 72.22 (CH), 72.44 (CH), 81.53(C), 
127.05 (CH), 127.06 (CH), 127.44 (CH), 127.73 (CH), 128.26 (CH), 128.28 (CH), 128.38 (CH), 
136.41 (CH), 136.62 (CH), 139.66 (C), 139.68 (C), 172.186 (C), 172.193 (C); LRFABMS m/z: 
460 (MH+, 55%). 
 
Method 2: From acetyl aminoalcohol 
1) In a less protic condition (Scheme 5-14) 
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In a flask equipped with a stir bar under CaCl2 tube, a solution of anti-264 (388.0 mg, 0.77 
mmol) in THF (29 ml) at 0 oC was added a solution of KOH in MeOH (prepared from KOH, 
85% purity, 1.0230 g in MeOH 2.12 ml) (0.86 ml, 6.29 mmol, 8.1 Meq). After being stirred at 0 
oC for 15 min, the reaction was diluted with H2O (10 ml) and extracted with CHCl3 (30 ml x 2). 
The organic layer was washed with H2O (20 ml x 2), brine (30 ml x 2), dried over Na2SO4 and 
concentrated. 1H NMR analysis of the crude reaction mixture indicated the single diastereomer. 
The residue (365.1 mg, 103%) was purified by column chromatography (NH-silica gel 20 g, 
n-hexane/ AcOEt= 10: 1, 5: 1) to afford anti-260 as a pale yellow oil (351.0 mg, 98.9%), [α]D23 
+21.1 (c 3.0, CHCl3).  
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2) In a protic condition (Scheme 5-14) 
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In a flask equipped with a stir bar, a solution of anti-264 (30.1 mg, 0.060 mmol) in EtOH (2.0 
ml) at 2 oC was added a solution of KOH in H2O (prepared from KOH, 85% purity, 0.2150 g in 
H2O 2.10 ml) (0.20 ml, 0.31 mmol, 5.2 equiv). After being stirred at 2 oC for 15 min and room 
temperature for 2 h, the reaction was diluted with H2O (10 ml) and concentrated. Then, the 
mixture was extracted with AcOEt (15 ml x 2) and the organic layer was washed with H2O (10 
ml x 2), brine (10 ml x 1), dried over MgSO4 and concentrated. 1H-NMR analysis of the crude 
reaction mixture indicated ratio of anti-260: 265 is 0.27: 1. Next, the residue (25.5 mg, 92%) 
was purified by column chromatography (NH-silica gel 10 g, n-hexane/ AcOEt = 10: 1, 5: 1) to 
afford anti-260 as a pale yellow oil (5.0 mg, 18.1%) and 265 as a pale yellow oil (15.0 mg, 
51.7%) which was confirmed the structure by HMQC, HMBC and NOE.  
265: Rf= 0.57 (n-hexane/ AcOEt= 10: 1 x 2 times); IR (thin film): nmax 1735 and 1670 cm-1 
(C=O); 1H-NMR (500 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3]; 1.24-1.31 
[22H, m, -CH2(CH2)11CH3], 1.40 [9H, s, -CO2C(CH3)3], 1.90 (3H, s, -NCOCH3), 1.97, 2.02 
[each H, dddd, J= 14.0, 7.0 , 7.0, 7.0 Hz, -CH2(CH2)11CH3], 4.37 (1H, d, J= 14.0 Hz, PhCHH), 
4.90 (1H, d, J= 14.0 Hz, PhCHH), 5.72 (1H, dd, J= 15.3, 11.3 Hz, C4-H), 6.12 (1H, dt, J= 15.3, 
7.0 Hz, C5-H), 7.15 (1H, d, J= 11.3 Hz, C3-H), 7.20-7.31 (5H, m, PhH); 13C-NMR (125 MHz, 
CDCl3): d (ppm) 14.09 (CH3), 21.81 (CH3), 22.67 (CH2), 27.94 (CH3), 28.55 (CH2), 29.15 
(CH2), 29.33 (CH2), 29.41 (CH2), 29.54 (CH2), 29.64 (CH2), 29.66 (CH2), 29.68 (CH2), 31.90 
(CH2), 33.21 (CH2), 50.88 (CH2), 81.61 (C), 124.08 (CH), 127.47 (CH), 128.16 (CH), 129.29 
(C), 130.06 (CH), 136.90 (C), 139.85 (CH), 147.26 (CH), 163.84 (C), 170.81 (C); HRFABMS 
m/z: 484.3781 (Calcd for C31H50NO3: 484.3791). 
 
(2R,3R,4E)-anti-2-Benzylamino-3-(triisopropylsilanyloxy)-octadec-4-enoic acid tert-butyl 
ester (267) (Scheme 5-16) 
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In a flask equipped with a stir bar under an argon atmosphere, a solution of anti-260 (435.6 mg, 
0.95 mmol) in CH2Cl2 (4.4 ml) at 2 oC was treated with NEt3 (0.14 ml, 1.00 mmol, 1.05 equiv) 
and TIPSOTf (0.26 ml, 0.97 mmol, 1.02 Meq). After being stirred for 30 min, the reaction was 
diluted with H2O (20 ml), and extracted with CH2Cl2 (20 ml x 2). The organic layer was 
washed with 1 N HCl aq. (20 ml x 1), sat. NaHCO3 (20 ml x 1), H2O (20 ml x 1), brine (20 ml x 
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2), dried over Na2SO4 and concentrated. The residue (601.5 mg, 103%) was purified by column 
chromatography (silica gel 40 g, n-hexane/ AcOEt = 10: 1, 4: 1) to afford 267 as a colorless oil 
(556.7 mg, 95.3%).  
267: [α]D24 -1.5 (c 3.1, CHCl3); Rf= 0.70 (n-hexane/ AcOEt = 10: 1); IR (thin film): nmax 3333 
cm-1 (NH), 1736 and 1725 cm-1 (C=O); 1H-NMR (500 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 
7.0 Hz, -(CH2)12CH3], 1.00-1.06 [21H, br m, -OSi(CH(CH3)2)3], 1.25-1.34 [22H, m, 
-CH2(CH2)11 CH3], 1.47 [9H, s, -CO2C(CH3)3], 2.01 [2H, br dt, J= 6.7, 6.1 Hz, 
-CH2(CH2)11CH3], 3.29 (1H, d, J= 4.0 Hz, C2-H), 3.69 (1H, d, J= 13.4 Hz, PhCHH), 3.91 (1H, 
d, J= 13.4 Hz, PhCHH), 4.50 (1H, dd, J= 7.3, 4.0 Hz, C3-H), 5.52 (1H, dd, J= 15.3, 7.3 Hz, 
C4-H), 5.59 (1H, dt, J= 15.3, 6.1 Hz, C5-H), 7.21-7.24 (1H, dd, J= 7.0, 6.7 Hz, PhHpara), 
7.28-7.33 (4H, m, PhHortho,meta); 13C-NMR (100 MHz, CDCl3): d (ppm) 12.37 (CH), 14.06 
(CH3), 18.01 (CH3), 18.05 (CH3), 22.65 (CH2), 28.14 (CH3), 29.03 (CH2), 29.21 (CH2), 29.33 
(CH2), 29.49 (CH2), 29.58 (CH2), 29.62 (CH2), 29.64 (CH2), 29.66 (CH2), 31.89 (CH2), 32.15 
(CH2), 52.20 (CH2), 67.35 (CH), 76.01 (CH), 80.74 (C), 126.73 (CH), 128.16 (CH), 128.20 
(CH), 129.61 (CH), 133.12 (CH), 140.22 (C), 171.26 (C); HRFABMS m/z: 616.5150 (Calcd for 
C38H70NO3Si: 616.5125). 
 
(2S,3R,4E)-anti-2-Benzylamino-3-(triisopropylsilanyloxy)-octadec-4-en-1-ol (8) 
(2S,3R,4E)-anti-2-Benzylamino-3-hydroxy-octadec-4-en-1-ol (23) (Scheme 5-16) 
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In a flask equipped with a stir bar under an argon atmosphere, a suspension of LiAlH4 (52.3 mg, 
80% purity, 1.10 mmol, 2.09 Meq) in THF (1.0 ml) at room temperature was treated with a 
solution of 267 (324.5 mg, 0.53 mmol) in THF (6.0 ml) and the mixture was stirred at same 
temperature for 10 min. The reaction was cooled to 2 oC, diluted with THF 10 ml, quenched 
with H2O (0.5 ml) and dried over K2CO3. After filtering, the solvent was concentrated and the 
residue (285.3 mg, 99.2%) was purified by column chromatography (NH-silica gel 40 g, 
n-hexane/ AcOEt= 10: 1, 5: 1) to afford 268 as a colorless oil (235.1 mg, 81.7%) and 269 as 
colorless plates (37.1 mg, 18.1%). 
268: [α]D25 -12.7 (c 2.1, CHCl3); Rf= 0.64 (n-hexane/ AcOEt= 2: 1); IR (thin film): nmax 3448 
cm-1 (OH), 3324 cm-1 (NH); 1H-NMR (500 MHz, CDCl3): d (ppm) 0.88 [3H, t, J=7.0 Hz, 
-(CH2)12CH3], 1.00-1.11 [21H, m, -OSi(CH(CH3)2)3], 1.26-1.35 [22H, br m, -CH2(CH2)11CH3], 
2.03 [2H, br dt, J= 7.3, 7.0 Hz, -CH2(CH2)11CH3], 2.63 (1H, ddd, J= 5.5, 4.6, 4.6 Hz, C2-H), 
3.06 (1H, br s, OH), 3.61 (1H, dd, J= 10.7, 5.5 Hz, C1-H), 3.66 (1H, dd, J= 10.7, 4.6 Hz, C1-H), 
3.81 (1H, d, J= 13.1 Hz, PhCHH), 3.88 (1H, d, J= 13.1 Hz, PhCHH), 4.36 (1H, dd, J= 7.9, 4.6 
Hz, C3-H), 5.43 (1H, br dd, J= 15.6, 7.9 Hz, C4-H), 5.63 (1H, dt, J= 15.6, 7.0 Hz, C5-H), 
7.23-7.32 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 12.46 (CH), 14.10 (CH3), 
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18.06 (CH3), 18.12 (CH3), 22.67 (CH2), 29.01 (CH2), 29.23 (CH2), 29.34 (CH2), 29.48 (CH2), 
29.58 (CH2), 29.64 (CH2), 29.66 (CH2), 29.67 (CH2), 31.90 (CH2), 32.20 (CH2), 51.62 (CH2), 
59.89 (CH2), 63.40 (CH), 74.93 (CH), 126.99 (CH), 128.05 (CH), 128.39 (CH), 130.42 (CH), 
133.73 (CH), 140.33 (C); HRFABMS m/z: 546.4704 (Calcd for C34H64NO2Si: 546.4706). 
269: m.p. 45-47 oC; [α]D22 -7.0 (c 0.5, CHCl3); Rf= 0.23 (n-hexane/ AcOEt= 4: 1, NH-TLC); IR 
(KBr plates): nmax 3341 cm-1 (OH and NH); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, t, 
J= 7.0 Hz, -(CH2)12CH3], 1.25-1.38 [22H, br m, -CH2(CH2)11CH3], 1.97 (3H, br s, NH and OH), 
2.04 [2H, dt, J= 7.0, 7.0 Hz, -CH2(CH2)11CH3], 2.67 (1H, dt, J= 4.8, 4.8 Hz, C2-H), 3.70 (2H, d, 
J= 4.8 Hz, C1-H), 3.83 (1H, d, J= 13.2 Hz, PhCHH), 3.87 (1H, d, J= 13.2 Hz, PhCHH), 4.24 
(1H, dd, J= 6.8, 4.8 Hz, C3-H), 5.44 (1H, ddt, J= 15.4, 6.8, 1.5 Hz, C4-H), 5.75 (1H, dtd, J= 
15.4, 7.0, 0.9 Hz, C5-H); 7.24-7.36 (5H, m, PhH), 13C-NMR (100 MHz, CDCl3): d (ppm) 14.09 
(CH3), 22.66 (CH2), 29.10 (CH2), 29.20 (CH2), 29.33 (CH2), 29.46 (CH2), 29.57 (CH2), 29.62 
(CH2), 29.65 (CH2), 29.66 (CH2), 31.89 (CH2), 32.30 (CH2), 51.37 (CH2), 60.52 (CH2), 61.61 
(CH), 72.48 (CH), 127.14 (CH), 128.10 (CH), 128.48 (CH), 129.28 (CH), 134.03 (CH), 139.92 
(C); HRFABMS m/z: 390.3373 (Calcd for C25H44NO2: 390.3372). 
 
(1'R,2'E,4S)-anti-3-Benzyl-4-(1-triisopropylsilanyloxyhexadec-2-enyl)-1,3-oxazolidin-2-one 
(9) (Scheme 5-17) 
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In a flask equipped with a stir bar under an argon atmosphere, a mixture of 268 (233.0 mg, 0.43 
mmol) and Im2CO (73.1 mg, 95% purity, 0.43 mmol, 1.00 Meq) in CH2Cl2 (1.0 ml) was stirred 
at room temperature for 12 h. The reaction mixture was concentrated and the residue (301.0 mg, 
123%) was purified by column chromatography (silica gel 30 g, n-hexane/ AcOEt= 10: 1, 5: 1) 
to afford 270 as a colorless oil (237.4 mg, 97.2%). 
270: 92.1% ee, determined by chiral HPLC (Daicel CHIRALCEL OD-H, 0.46 cm x 25 cm); 
n-hexane/ 2-propanol= 100:1; flow rate= 1.0 ml/ min; detection wavelength= 254 nm; tR 
(minor)= 10.6 min, tR (major)= 13.0 min; [α]D25 -11.4 (c 2.4, CHCl3); Rf= 0.55 (n-hexane/ 
AcOEt= 5: 1); IR (thin film): nmax 1757 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 
0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.02-1.13 [21H, m, -OSi(CH(CH3)2)3], 1.22-1.36 [1H, 
22H, m, -CH2(CH2)11CH3], 2.01 [2H, br dt, J= 6.8, 6.8 Hz, -CH2(CH2)11CH3], 3.60 (1H, ddd, J= 
9.0, 5.3, 2.8 Hz, C4-H), 4.15 (1H, d, J= 15.2 Hz, PhCHH), 4.18 (1H, dd, J= 9.0, 8.8 Hz, C5-H), 
4.27 (1H, dd, J= 8.8, 5.3 Hz, C5-H), 4.34 (1H, dd, J= 7.7, 2.6 Hz, C1'-H), 4.96 (1H, d, J= 15.2 
Hz, PhCHH), 5.32 (1H, br dd, J= 15.6, 7.7 Hz, C2'-H), 5.66 (1H, dt, J= 15.6, 6.8 Hz, C3'-H), 
7.28-7.37 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 12.48 (CH), 14.09 (CH3), 
18.02 (CH3), 18.03 (CH3), 22.65 (CH2), 28.79 (CH2), 29.17 (CH2), 29.32 (CH2), 29.42 (CH2), 
29.57 (CH2), 29.62 (CH2), 29.64 (CH2), 29.65 (CH2), 31.89 (CH2), 32.22 (CH2), 46.31 (CH2), 
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59.05 (CH), 63.22 (CH2), 73.13 (CH), 127.77 (CH), 127.91 (CH), 128.01 (CH), 128.74 (CH), 
135.35 (CH), 136.03 (C), 158.85 (C); HRFABMS m/z: 572.4515 (Calcd for C35H62NO3Si: 
572.4499). 
 
(1'R,2'E,4S)-anti-4-(1-Triisopropylsilanyloxyhexadec-2-enyl)-1,3-oxazolidin-2-one (271) 
(Scheme 5-17) 
C13H27
TIPSO
O
N
O
Li/ liq NH3
Et2O
C13H27
TIPSO
O
HN
O
-70 oC, 5 min
270 271
12
3
4
5
1'
2'
3'
Ph
 
In a flask equipped with a stir bar under an argon atmosphere, freshly distilled liquid ammonia 
(12 ml) at -70 oC was added finely cut lithium (60 mg, 8.7 mmol, 41 Meq) in small portions. 
After 20 min, the mixture turned blue, the solution of 270 (117.9 mg, 0.21 mmol) in Et2O (3.2 
ml) was slowly added and stirring continued at same temperature for 5 min. The reaction 
mixture was quenched quickly with phosphate buffer (prepared from 0.5 M KH2PO4 and 0.5 M 
K2HPO4 in H2O, pH 6.8) (5.0 ml) and further stirred for 10 min until the blue color disappeared. 
The mixture was allowed to warm to room temperature. After being stirred for another 1 h, the 
reaction was diluted with H2O (30 ml), and extracted with AcOEt (50 ml). The organic layer 
was washed with H2O (30 ml x 3), brine (30 ml x 2), dried over MgSO4 and concentrated. 
1H-NMR analysis of the crude reaction mixture indicated the single product. The residue (98.3 
mg, 99.0%) was purified by column chromatography (silica gel 10 g, n-hexane/ AcOEt= 3: 1) 
to afford 271 as a colorless oil (88.3 mg, 88.9%). 
271: [α]D20 -13.3 (c 1.1, MeOH); Rf= 0.21 (n-hexane/ AcOEt= 5: 1); IR (thin film): nmax 3260 
cm-1 (NH), 1761 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 7.0 Hz, 
-(CH2)12CH3], 1.03-1.07 [21H, m, -OSi(CH(CH3)2)3], 1.26-1.37 [22H, m, -CH2(CH2)11CH3], 
2.05 [2H, br dt, J= 6.8, 6.8 Hz, -CH2(CH2)11CH3], 3.79 (1H, dt, J= 8.6, 5.3 Hz, C5-H), 4.08 (1H, 
dd, J= 7.9, 4.9 Hz, C5-H), 4.30 (1H, dd, J= 8.8, 4.9 Hz, C4-H), 4.43 (1H, t, J= 8.8 Hz, C1'-H), 
4.95 (1H, br s, NH), 5.36 (1H, br dd, J= 15.6, 8.1 Hz, C2'-H), 5.73 (1H, dt, J= 15.6, 7.0 Hz, 
C3'-H); 13C-NMR (100 MHz, CDCl3): d (ppm) 12.33 (CH), 14.08 (CH3), 17.96 (CH3), 18.02 
(CH3), 22.65 (CH2), 28.86 (CH2), 29.21 (CH2), 29.33 (CH2), 29.43 (CH2), 29.57 (CH2), 29.62 
(CH2), 29.64 (CH2), 29.65 (CH2), 31.89 (CH2), 32.21 (CH2), 57.16 (CH), 66.88 (CH2), 75.83 
(CH), 127.93 (CH), 136.24 (CH), 159.45 (C); HRFABMS m/z: 482.4045 (Calcd for 
C28H56NO3Si: 482.4029). 
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(1'R,2'E,4S)-anti-4-(1-hydroxyhexadec-2-enyl)-1,3-oxazolidin-2-one (271-TIPS) 
(2S,3R)-2-amino-octadec-4t-ene-1,3-diol or D-erythro-sphingosine (54) (Scheme 5-18) 
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In a flask equipped with a stir bar under a CaCl2 tube, TBAF (1.0 M in THF, 0.30 ml, 0.30 
mmol, 1.15 equiv) was added to 271 (127.0 mg, 0.26 mmol) at 2 oC and the reaction was 
allowed to warm to room temperature. After being stirred for 1.5 h, the reaction was 
concentrated to afford the residue (108.3 mg, 128%) as a pale yellow oil which was used in the 
next step without purification.  
The residue (108.3 mg, 0.26 mmol) in EtOH (2.1 ml) was treated with 2 N NaOH aq. (prepared 
from NaOH, 96% purity, 1.0730 g in H2O 13.4 ml) (2.1 ml, 4.0 mmol, 15 equiv) at room 
temperature and the reaction was allowed to 80 oC. After being stirred for 2.5 h, the reaction 
was concentrated, diluted with H2O (10 ml) and extracted with Et2O (30 ml). The organic layer 
was washed with H2O (10 ml x 2), brine (10 ml x 2), dried over Na2SO4 and concentrated to 
afford the residue (102.8 mg, 130%) as colorless solids which were used in the next step 
without purification.  
54: 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.26-1.47 [22H, 
m, -CH2(CH2)11CH3], 2.01 [2H, dt, J= 6.8, 6.8 Hz, -CH2(CH2)11CH3], 2.86 (1H, br dt, J= 5.8, 
4.7 Hz, C2-H), 3.62 (1H, dd, J= 10.7, 5.8 Hz, C1-H), 3.70 (1H, dd, J= 10.7, 4.7 Hz, C1-H), 4.04 
(1H, dd, J= 6.6, 6.6 Hz, C3-H), 5.48 (1H, ddt, J= 15.4, 7.1, 1.5 Hz, C4-H), 5.72 (1H, dtd, J= 
15.4, 7.0, 0.7 Hz, C5-H). 
[lit. 1H-NMR (CDCl3): d (ppm) 0.88 (3H, t, J= 7.0 Hz), 1.15-1.4 (22H, m), 2.06 (2H, q, J= 7.0 
Hz), 2.89 (1H, m), 3.67 (2H, m), 4.04 (1H, t, J= 6.3 Hz), 5.48 (1H, dd, J= 15.3, 7.1 Hz), 5.76 
(1H, dt, J= 15.3, 6.7 Hz)]. 
 
D-erythro-1,3-Diacetoxy-2-acetylamino-octadec-4t-ene (272) (Scheme 5-18) 
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In a flask equipped with a stir bar under a CaCl2, a mixture of crude solids 54 (102.8 mg, 0.26 
mmol) and DMAP (6.4 mg, 0.05 mmol, 0.20 Meq) in CH2Cl2 (3.5 ml) at 2 oC was treated with 
pyridine (0.35 ml, 4.33 mmol, 16.4 equiv) and Ac2O (0.16 ml, 1.70 mmol, 6.44 equiv). The 
reaction was allowed to warm to room temperature and stirring continued for 3 h. The reaction 
was diluted with H2O (10 ml), and extracted with AcOEt (15 ml x 2). The organic layer was 
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washed with sat. CuSO4 aq. (5 ml x 5), H2O (10 ml x 4), brine (10 ml x 2), dried over Na2SO4 
and concentrated. The residue (120.6 mg, 107%) was recrystallized 2 times from n-hexane/ 
AcOEt to afford 172 as colorless solids (104.7 mg, 93.2%). 
172: mp 100-102 oC; [α]D24 -13.0 (c 1.6, CHCl3); Rf= 0.66 (n-hexane/ AcOEt= 1: 2); IR (KBr 
plates): nmax 3288 cm-1 (NH), 1736 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, 
t, J= 7.0 Hz, -(CH2)12CH3], 1.25-1.36 [22H, m, -CH2(CH2)11CH3], 1.99, 2.07, 2.07 (each 3H, s, 
OCCH3), 2.01-2.06 [2H, m, -CH2(CH2)11CH3], 4.04 (1H, dd, J= 11.6, 3.8, Hz, C1-H), 4.31 (1H, 
dd, J= 11.6, 6.0 Hz, C1-H), 4.43 (1H, dddd, J= 9.0, 6.0, 6.0, 3.8 Hz, C2-H), 5.28 (1H, dd, J= 7.5, 
6.0 Hz, C3-H), 5.39 (1H, ddt, J= 15.3, 7.5, 1.1 Hz, C4-H), 5.66 (1H, d, J= 9.0 Hz, NH), 5.79 
(1H, dt, J= 15.3, 7.0 Hz, C5-H); 13C-NMR (100 MHz, CDCl3): d (ppm) 13.98 (CH3), 20.67 
(CH3), 20.99 (CH3), 22.55 (CH2), 23.15 (CH3), 28.77 (CH2), 29.04 (CH2), 29.22 (CH2), 29.32 
(CH2), 29.46 (CH2), 29.52 (CH2), 29.536 (CH2), 29.543 (CH2), 29.56 (CH2), 31.79 (CH2), 32.16 
(CH2), 50.55 (CH), 62.51 (CH2), 73.69 (CH), 124.07 (CH), 137.21 (CH), 169.67 (C), 169.85 
(C), 170.82 (C); HRFABMS m/z: 426.3208 (Calcd for C24H44NO5: 426.3219); Anal. Calcd for 
C24H43NO5: C, 67.73; H, 10.18; N, 3.29. Found: C, 67.99; H, 10.37; N, 3.31. 
(lit. m.p. 101-102 oC; [α]D25 -13.3 (c 1.4, CHCl3); 1H-NMR (CDCl3): d (ppm) 0.88 (t, J= 7.0 Hz, 
3H), 1.15-1.4 (m, 22H), 1.95-2.1 (11H, m, Me peaks at 1.98, 2.06, 2.07), 4.04 (1H, dd, J= 11.5, 
3.8, Hz), 4.30 (1H, dd, J= 11.5, 6.0 Hz), 4.38-4.48 (1H, m), 5.28 (1H, t, J= 7.0 Hz), 5.38 (1H, 
dd, J= 15.0, 7.4, 1.1 Hz), 5.68 (1H, d, J= 9.0 Hz NH), 5.79 (1H, dt, J= 15.0, 7.0 Hz); 13C-NMR 
(CDCl3): d (ppm) 14.1, 20.8, 21.1, 22.7, 23.3, 28.9, 29.1, 29.3, 29.4, 29.6, 31.9, 32.3, 50.6, 62.5, 
73.7, 124.0, 137.2, 169.6, 169.8, 170.7. 
 
2. From cis-aziridine 229c 
(2R,3S,4E)-syn-2-Benzylamino-3-hydroxy-4-octadecenoic acid tert-butyl ester (260) 
a pale yellow oil; [α]D22 +15.8 (c 3.0, CHCl3); Rf= 0.62 (n-hexane/ AcOEt= 10: 1); IR (thin 
film): nmax 3448 cm-1 (OH), 3332 cm-1 (NH), 1726 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): 
d (ppm) 0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.25-1.38 [22H, br m, -CH2(CH2)11CH3], 1.43 
[9H, s, -CO2C(CH3)3], 2.02 [2H, br dt, J= 7.0, 6.6 Hz, -CH2(CH2)11CH3], 3.03 (1H, d, J= 7.9 Hz, 
C2-H), 3.71 (1H, d, J= 13.0 Hz, PhCHH), 3.83 (1H, d, J= 13.0 Hz, PhCHH), 3.93 (1H, dd, J= 
7.5, 7.5 Hz, C3-H), 5.43 (1H, ddt, J= 15.2, 7.5, 1.0 Hz, C4-H), 5.74 (1H, dt, J= 15.2, 6.6 Hz, 
C5-H), 7.24-7.36 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 14.10 (CH3), 22.66 
(CH2), 28.07 (CH3), 28.89 (CH2), 29.24 (CH2), 29.33 (CH2), 29.48 (CH2), 29.54 (CH2), 29.62 
(CH2), 29.64 (CH2), 29.65 (CH2), 31.89 (CH2), 32.24 (CH2), 52.49 (CH2), 66.84 (CH), 73.35 
(CH), 81.73 (C), 127.27 (CH), 128.20 (CH), 128.28 (CH), 128.46 (CH), 135.01 (CH), 139.27 
(C), 172.33 (C); HRFABMS m/z: 460.3808 (Calcd for C29H50NO3: 460.3791). 
 
(2R,3S,4E)-syn-2-Benzylamino-3-acetoxy-4-octadecenoic acid tert-butyl ester (264) 
(Scheme 5-19) 
pale yellow oil; [α]D23 +7.4 (c 1.6, CHCl3); Rf= 0.55 (n-hexane/ AcOEt= 10: 1); IR (thin film): 
nmax 3347 cm-1 (NH), 1735 cm-1(C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 
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7.0 Hz, -(CH2)12CH3], 1.25-1.37 [22H, br m, -CH2(CH2)11CH3], 1.45 [9H, s, -CO2C(CH3)3], 
2.00-2.05 [2H, m, -CH2 (CH2)11CH3], 2.03 (3H, s, -OCOCH3), 3.27 (1H, d, J= 4.4 Hz, C2-H), 
3.64 (1H, d, J= 13.4 Hz, PhCHH), 3.89 (1H, d, J= 13.4 Hz, PhCHH), 5.48 (1H, dd, J= 7.9, 4.4 
Hz, C3-H), 5.57 (1H, ddt, J= 15.2, 7.9, 1.3 Hz, C4-H), 5.79 (1H, dt, J= 15.2, 7.0 Hz, C5-H), 
7.22-7.35 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 14.09 (CH3), 21.09 (CH3), 
22.67 (CH2), 28.01 (CH3), 28.76 (CH2), 29.18 (CH2), 29.33 (CH2), 29.46 (CH2), 29.57 (CH2), 
29.63 (CH2), 29.65 (CH2), 29.66 (CH2), 29.67 (CH2), 31.90 (CH2), 32.25 (CH2), 52.09 (CH2), 
63.90 (CH), 75.26 (CH), 81.59 (C), 124.76 (CH), 126.98 (CH), 128.22 (CH), 128.27 (CH), 
136.79 (CH), 139.82 (C), 169.83 (C), 171.50 (C); HRFABMS m/z: 502.3898 (Calcd for 
C31H52NO4: 502.3896). 
 
Trial for direct conversion of cis-aziridine 229c to oxazolidinine cis-262c(Scheme 5-20) 
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In a tube equipped with a stir bar under an argon atmosphere, a solution of cis-229c (32.8 mg, 
0.074 mmol) in MeCN (0.33 ml) at 0 oC was added methyl chloroformate (0.01 ml, 0.13 mmol, 
1.8 Meq) and the reaction was allowed to 80oC. After being stirred at for 7 h, the reaction was 
cooled to room temperature and concentrated. 1H-NMR analysis of the crude reaction mixture 
indicated the ratio of cis-262 and anti-262 to be 3.2: 1. The residue (40.1 mg, 111%) was 
purified by flash column chromatography (silica gel 25 g, n-hexane/ AcOEt= 10: 1) to afford 
cis-262 as colorless solid (9.0 mg, 24.9%, m.p. 51-52 oC) and anti-262 as a colorless oil (2.7 mg, 
7.5%). 
(1'E,4R,5R)-cis-3-Benzyl-2-oxo-5-(pentadec-1-enyl)-1,3-oxazolidine-4-carboxylic acid 
tert-butyl ester (262) 
mp 52-53 oC; 91.8% ee, determined by chiral HPLC (Daicel CHIRALCEL OD-H, 0.46 cm x 25 
cm); n-hexane/ 2-propanol= 100: 1; flow rate= 1.0 ml/ min; detection wavelength= 254 nm; tR 
(minor)= 18.6 min, tR (major)= 26.1 min; [α]D25 +34.3 (c 3.3, CHCl3); Rf= 0.38 (n-hexane/ 
AcOEt= 10:1); IR (thin film): nmax 1754 and 1718 cm-1 (C=O); 1H-NMR (500 MHz, CDCl3): 
d (ppm) 0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.25-1.38 [22H, br m, -CH2(CH2)11CH3], 1.44 
[9H, s, -CO2C(CH3)3], 2.04 [2H, br dt, J= 7.2, 7.2 Hz, -CH2(CH2)11CH3], 3.95 (1H, d, J= 9.2 Hz, 
C4-H), 4.00 (1H, d, J= 14.7 Hz, PhCHH), 4.93 (1H, dd, J= 9.2, 7.9 Hz, C5-H), 4.94 (1H, d, J= 
14.7 Hz, PhCHH), 5.42 (1H, ddt, J= 15.6, 7.9, 1.5 Hz, C1’-H), 5.89 (1H, dt, J= 15.6, 7.0 Hz, 
C2’-H), 7.24, 7.24 (each 1H, each d, J= 8.2, PhHortho), 7.30-7.37 (3H, m, PhH meta,para); 13C-NMR 
(100 MHz, CDCl3): d (ppm) 14.09 (CH3), 22.66 (CH2), 28.00 (CH3), 28.50 (CH2), 29.14 (CH2), 
29.32 (CH2), 29.40 (CH2), 29.50 (CH2), 29.605 (CH2), 29.612 (CH2), 29.63 (CH2), 29.64 (CH2), 
31.89 (CH2), 32.22 (CH2), 47.32 (CH2), 61.27 (CH), 75.96 (CH), 83.04 (C), 122.00 (CH), 
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128.13 (CH), 128.64 (CH), 128.87 (CH), 135.19 (C), 138.92 (CH), 157.57 (C), 166.67 (C); 
LRMS (FAB) m/z: 486 (MH+, 55%); Anal. Calcd for C30H47NO4: C, 74.19; H, 9.75; N, 2.88. 
Found: C, 74.25; H, 9.72; N, 2.91. 
(1'E,4R,5S)-trans-3-Benzyl-2-oxo-5-(pentadec-1-enyl)-1,3-oxazolidine-4-carboxylic acid 
tert-  
butyl ester (262) 
a colorless oil; [α]D21 +37.5 (c 2.0, CHCl3); Rf= 0.51 (n-hexane/ AcOEt= 10: 1); IR (thin film): 
nmax 1764 and 1740 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 7.0 Hz, 
-(CH2)12CH3], 1.25-1.36 [22H, br m, -CH2(CH2)11CH3], 1.46 [9H, s, -CO2C(CH3)3], 2.03 [2H, 
br dt, J= 6.8, 6.8 Hz, -CH2(CH2)11CH3], 3.61 (1H, d, J= 5.6 Hz, C4-H), 4.18 (1H, d, J= 14.9 Hz, 
PhCHH), 4.79 (1H, dd, J= 7.1, 5.6 Hz, C5-H), 4.93 (1H, d, J= 14.9 Hz, PhCHH), 5.39 (1H, ddt, 
J= 15.4, 7.1, 1.5 Hz, C1’-H), 5.83 (1H, dtd, J= 15.4, 6.8, 0.7 Hz, C2’-H), 7.23, 7.24 (each 1H, br 
d, J= 8.1 Hz, PhHortho), 7.29-7.37 (3H, m, PhHmeta,para); 13C-NMR (100 MHz, CDCl3): d (ppm) 
14.08 (CH3), 22.65 (CH2), 27.90 (CH3), 28.63 (CH2), 29.04 (CH2), 29.31 (CH2), 29.39 (CH2), 
29.51 (CH2), 29.61 (CH2), 29.62 (CH2), 29.64 (CH2), 31.88 (CH2), 32.00 (CH2), 47.04 (CH2), 
62.20 (CH), 76.92 (CH), 83.26 (C), 125.42 (CH), 128.04 (CH), 128.40 (CH), 128.82 (CH), 
135.14 (C), 137.07 (CH), 157.25 (C), 168.09 (C); HRFABMS m/z: 486.3582 (Calcd for 
C30H48NO4: 486.3583). 
 
Method 2: from syn-tert-butoxycarbonylamino alcohol 273 (Scheme 5-21) 
(2R,3S,4E)-syn-2-(Benzyl-tert-butoxycarbonylamino)-3-hydroxy-4-octadecenoic acid 
tert-butyl ester (273) (Scheme 5-21) 
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In a flask equipped with a stir bar under an argon atmosphere, a mixture of syn-260 (150.0 mg, 
0.33 mmol) and Boc2O (518.0 mg, 2.37 mmol, 7.27 Meq) was allowed to warm to 45 oC. After 
being stirred for 4 h, the residue (510.5 mg, 278%) was purified by column chromatography 
(silica gel 70 g, n-hexane/ AcOEt= 10: 1) to afford 273 as colorless solids (173.6 mg, 95.1%). 
273: mp 49-50 oC; [α]D22 +4.1 (c 3.3, CHCl3); Rf= 0.43 (n-hexane/ AcOEt= 10: 1); IR (thin 
film): nmax 3385 cm-1 (OH and NH), 1736 and 1686 cm-1 (C=O); 1H-NMR (400 MHz, CDCl3): 
d (ppm) 0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.26-1.35 [22H, br m, -CH2(CH2)11CH3], 1.39, 
1.46 [each 9H, s, -CO2C(CH3)3], 1.98 [2H, br dt, J= 6.8, 6.6 Hz, -CH2(CH2)11CH3], 3.91 (1H, br 
s, C2-H), 4.42 (2H, br s, PhCH2), 4.60 (1H, br s, C3-H), 4.85 (1H, br s, OH), 5.34 (1H, br d, J= 
13.5 Hz, C4-H), 5.71 (1H, dtd, J= 15.4, 6.8, 1.1 Hz, C5-H), 7.23-7.33 (5H, m, PhH); 13C-NMR 
(100 MHz, CDCl3): d (ppm) 14.09 (CH3), 22.66 (CH2), 27.91 (CH3), 28.27 (CH3), 29.09 (CH2), 
29.26 (CH2), 29.33 (CH2), 29.53 (CH2), 29.63 (CH2), 29.67 (CH2), 31.90 (CH2), 32.28 (CH2), 
53.78 (CH2), 66.60 (CH), 72.10 (CH), 81.10 (C), 81.91 (C), 127.28 (CH), 128.00 (CH), 128.25 
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(CH), 129.09 (CH), 132.54 (CH), 137.77 (C), 156.91 (C), 168.07 (C); HRFABMS m/z: 
560.4321 (Calcd for C34H58NO5: 560.4315). 
 
CO2tBu
C13H27
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In a flask equipped with a stir bar under an argon atmosphere, a solution of 273 (165.9 mg, 0.30 
mmol) in CH2Cl2 (1.7 ml) at 0 o C was treated with NEt3 (0.05 ml, 0.36 mmol, 1.2 equiv) and 
MsCl (0.03 ml, 0.39 mmol, 1.3 equiv). After being stirred at same temperature for 30 min, the 
reaction was diluted with H2O (10 ml), and extracted with CH2Cl2 (30 ml). The organic layer 
was washed with 1 N HCl aq. (10 ml x 1), sat. NaHCO3 (10 ml x 1), H2O (10 ml x 1), brine (10 
ml x 1), dried over Na2SO4 and concentrated. The residue (160.8 mg, 112%) was purified by 
column chromatography (silica gel 100 g, n-hexane/ AcOEt= 10: 1, 5: 1) to afford 262 as 
colorless prisms after recrystallization from n-hexane (138.6 mg, 96.4%), mp 52-53 oC, 93.7% 
ee: determined by chiral HPLC (Daicel CHIRALCEL OD-H, 0.46 cm x 25 cm); n-hexane/ 
2-propanol= 100:1; flow rate= 1.0 ml/min; detection wavelength= 254 nm; tR (minor)= 17.8 
min, tR (major)= 24.7 min; [α]D25 +34.9 (c 2.3, CHCl3). 
 
(1'E,4S,5R)-cis-3-Benzyl-4-hydroxymethyl-5-(pentadec-1-enyl)-1,3-oxazolidin-2-one (274) 
(Scheme 5-22) 
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In a flask equipped with a stir bar under an argon atmosphere, a suspension of LiBH4 (14.2 mg, 
95% purity, 0.62 mmol, 10.0 Meq) in THF (0.30 ml) at room temperature was treated with a 
solution of cis-262 (30.1 mg, 0.062 mmol) in THF (0.30 ml) and EtOH 0.04 ml and the reaction 
was allowed to 50 oC. After being stirred at same temperature for 2 d, the reaction was cooled 
to RT, diluted with THF (3 ml) and quenched with MeOH (1.0 ml). After being stirred for 
another 10 min, the reaction was diluted with H2O (10 ml), and extracted with AcOEt (20 ml). 
The organic layer was washed with 1 N HCl aq. (10 ml x 1), sat. NaHCO3 aq. (10 ml x 1), 
water (10 ml x 1), brine (10 ml x 2), dried over MgSO4 and concentrated. The residue (33.3 mg, 
129%) was purified by column chromatography (silica gel 20 g, n-hexane/ AcOEt= 3: 1) to 
afford 274 as colorless prisms after recrystallization from n-hexane/ Et2O (18.9 mg, 73.3%), 
and 262 as colorless solids (6.0 mg, 19.9%). 
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274: mp 51-53 oC; [α]D20 +3.9 (c 0.6, CHCl3), [α]D21 +18.3 (c 0.6, MeOH); Rf= 0.13 (n-hexane/ 
AcOEt= 5: 1); IR (KBr plates): nmax 3474 cm-1 (OH), 1718 cm-1 (C=O); 1H-NMR (500 MHz, 
CDCl3): d (ppm) 0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.25-1.39 [22H, br m, -CH2(CH2)11CH3], 
2.07 [2H, br dt, J= 7.3, 7.0 Hz, -CH2(CH2)11CH3], 3.62 (1H, ddd, J= 8.2, 4.0, 3.7 Hz, C4-H), 
3.65 (1H, ddd, J= 11.9, 4.0, 3.7 Hz, C4-CHH), 3.71 (1H, ddd, J= 11.9, 4.9, 4.0 Hz, C4-CHH) 
4.28 (1H, d, J= 15.3 Hz, PhCHH), 4.79 (1H, d, J= 15.3 Hz, PhCHH), 4.93 (1H, dd, J= 8.2, 7.9 
Hz, C5-H), 5.67 (1H, br dd, J= 15.6, 7.9 Hz, C1’-H), 5.90 (1H, dt, J= 15.6, 7.0 Hz, C2’-H), 
7.29-7.38 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 14.09 (CH3), 22.66 (CH2), 
28.78 (CH3), 29.11 (CH2), 29.32 (CH2), 29.40 (CH2), 29.55 (CH2), 29.62 (CH2), 29.63 (CH2), 
29.65 (CH2), 31.89 (CH2), 32.24 (CH2), 46.67 (CH2), 58.98 (CH), 59.31 (CH2), 77.72 (CH), 
122.73 (CH), 127.94 (CH), 128.04 (CH), 128.87 (CH), 136.42 (C), 138.89 (CH), 158.36 (C); 
LRFABMS m/z: 416 (MH+, 51%); Anal. Calcd for C26H41NO3: C, 75.14; H, 9.94; N, 3.37. 
Found: C, 75.44; H, 9.92; N, 3.44.  
(1'E,4S,5R)-cis-3-Benzyl-4-triisopropylsilanyloxymethyl-5-(pentadec-1-enyl)-1,3-oxazolidi
n-2-one (275) (Scheme 5-22) 
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In a flask equipped with a stir bar under an argon atmosphere, a solution of 274 (61.5 mg, 0.15 
mmol) in CH2Cl2 (0.6 ml) at 2 oC was treated with NEt3 (0.03 ml, 0.22 mmol, 1.47 Meq) and 
TIPSOTf (0.05 ml, 0.19 mmol, 1.27 Meq). After being stirred for 30 min, the reaction was 
diluted with H2O (10 ml), and extracted with CH2Cl2 (15 ml x 2). The organic layer was 
washed with 1 N HCl aq. (10 ml x 1), sat. NaHCO3 (10 ml x 1), H2O (10 ml x 1), brine (20 ml x 
2), dried over Na2SO4 and concentrated. The residue (110.1 mg, 130%) was purified by column 
chromatography (silica gel 20 g, n-hexane/ AcOEt = 10: 1, 4: 1) to afford 275 as a colorless oil 
(82.1 mg, 97.0%).  
275: [α]D20 +7.6 (c 1.6, CHCl3), [α]D21 +17.0 (c 1.6, MeOH); Rf= 0.43 (n-hexane/ AcOEt = 10: 
1 x 2 times); IR (ATR): nmax 1752 cm-1 (C=O); 1H-NMR (500 MHz, CDCl3): d (ppm) 0.88 [3H, 
t, J= 7.0 Hz, -(CH2)12CH3], 1.06-1.12 [21H, m, -OSi(CH(CH3)2)3], 1.25-1.38 [br m, 22H; 
-CH2(CH2)11CH3], 2.04, 2.09 [each H, dddd, J= 14.0, 7.0, 7.0, 7.0 Hz, -CH2(CH2)11CH3], 3.55 
(1H, ddd, J= 8.2, 4.3, 4.0 Hz, C4-H), 3.74 (1H, dd, J= 11.0, 4.0 Hz, C4-CHH), 3.82 (1H, dd, J= 
11.0, 4.3 Hz, C4-CHH), 4.11 (1H, d, J= 15.3 Hz, PhCHH), 4.89 (1H, dd, J= 8.2, 7.9 Hz, C5-H), 
4.94 (1H, d, J= 15.3 Hz, PhCHH), 5.68 (1H, br dd, J= 15.6, 7.9 Hz, C1’-H), 5.84 (1H, dt, J= 
15.6, 7.0 Hz, C2’-H), 7.28-7.36 (5H, m, PhH); 13C-NMR (100 MHz, CDCl3): d (ppm) 11.88 
(CH3), 14.09 (CH3), 17.95 (CH3), 22.66 (CH2), 28.77 (CH2), 29.12 (CH2), 29.33 (CH2), 29.45 
(CH2), 29.53 (CH2), 29.62 (CH2), 29.64 (CH2), 29.65 (CH2), 31.89 (CH2), 32.28 (CH2), 46.42 
(CH2), 58.90 (CH), 60.42 (CH2), 77.93 (CH), 123.00 (CH), 127.75 (CH), 127.98 (CH), 128.72 
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(CH), 136.42 (CH), 138.29 (C), 158.23 (C); HRFABMS m/z: 572.4509 (Calcd for 
C35H62NO3Si: 572.4499). 
 
(1'E,4S,5R)-cis-4-Triisopropylsilanyloxymethyl-5-(pentadec-1-enyl)-1,3-oxazolidin-2-one 
(276) (Scheme 5-22) 
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In a flask equipped with a stir bar under an argon atmosphere, freshly distilled liquid ammonia 
(10 ml) at -70 oC was added finely cut lithium (45 mg, 6.5 mmol, 46 Meq) in small portions. 
After 15 min, the mixture turned blue, the solution of 275 (80.5 mg, 0.14 mmol) in Et2O (1.5 
ml) was slowly added and stirring continued at same temperature for 5 min. The reaction 
mixture was quenched quickly with phosphate buffer (prepared from 0.5 M KH2PO4 and 0.5 M 
K2HPO4 in H2O, pH 6.8) (2.0 ml) and further stirred for 10 min until the blue color disappeared. 
The mixture was allowed to warm to room temperature. After being stirred for another 1 h, the 
reaction was diluted with H2O (20 ml), and extracted with AcOEt (20 ml x 2). The organic 
layer was washed with H2O (20 ml x 5), brine (20 ml x 2), dried over MgSO4 and concentrated. 
The residue (70.1 mg, 103%) was purified by column chromatography (silica gel 20 g, 
n-hexane/ AcOEt= 5:1, 4:1, 3:1) to afford 276 as a colorless oil (52.7 mg, 77.6%). 
276: [α]D19 -25.0 (c 1.4, MeOH); Rf= 0.26 (n-hexane/ AcOEt= 5: 1 x 2 times); IR (ATR): nmax 
3263 cm-1 (NH), 1755 cm-1 (C=O); 1H-NMR (500 MHz, CDCl3): d (ppm) 0.88 [3H, t, J= 7.0 
Hz, -(CH2)12CH3], 1.05-1.14 [21H, m, -OSi(CH(CH3)2)3], 1.26-1.39 [22H, br m, 
-CH2(CH2)11CH3], 2.08 [2H, br dt, J= 7.0, 6.7 Hz, -CH2(CH2)11CH3], 3.65 (1H, dd, J= 10.4, 7.6 
Hz, C4-CHH), 3.68 (1H, dd, J= 10.4, 4.3 Hz, C4-CHH), 3.87 (1H, ddd, J= 7.9, 7.6, 4.3 Hz, 
C4-H), 5.05 (1H, dd, J= 8.2, 7.9 Hz, C5-H), 5.12 (1H, br s, NH), 5.51 (1H, dd, J= 15.3, 8.2 Hz, 
C1’-H), 5.89 (1H, dt, J= 15.3, 7.0 Hz, C2’-H); 13C-NMR (100 MHz, CDCl3): d (ppm) 11.78 
(CH3), 14.10 (CH3), 17.90 (CH3), 22.67 (CH2), 28.71 (CH2), 29.09 (CH2), 29.33 (CH2), 29.45 
(CH2), 29.55 (CH2), 29.63 (CH2), 29.65 (CH2), 29.66 (CH2), 31.90 (CH2), 32.21 (CH2), 57.40 
(CH), 63.00 (CH2), 79.20 (CH), 122.06 (CH), 138.23 (CH), 158.97 (C); HRFABMS m/z: 
482.4038 (Calcd for C28H56NO3Si: 482.4029). 
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(1'E,4S,5R)-cis-4-Hydroxymethyl-5-(pentadec-1-enyl)-1,3-oxazolidin-2-one (276-TIPS) 
(2S,3R)-2-amino-octadec-4t-ene-1,3-diol or D-erythro-sphingosine (54) (Scheme 5-22) 
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In a flask equipped with a stir bar under a CaCl2 tube, TBAF (1.0 M in THF, 0.10 ml, 0.10 
mmol, 1.02 equiv) was added to 276 (47.0 mg, 0.098 mmol) at 2 oC and the reaction was 
allowed to warm to room temperature. After being stirred for 1.5 h, the reaction was 
concentrated to afford the residue (60.0 mg, 189%) as a pale yellow oil which was diluted with 
H2O (10 ml), and extracted with AcOEt (15 ml x 2). The organic layer was washed with H2O 
(10 ml x 5), brine (20 ml x 1), dried over Na2SO4 and concentrated. The residue (35.1 mg, 
111%) was recrystallized from n-hexane/ AcOEt / CHCl3 to afford 276-TIPS as colorless 
needles (22.1 mg, 69.7%) and the mixture of 271-TIPS and 276-TIPS as colorless needles (8.5 
mg, 26.8%). 
276-TIPS: mp 106-107 oC; [α]D21 -14.4 (c 0.6, MeOH); Rf= 0.17 (CHCl3/ MeOH= 30: 1); IR 
(ATR): nmax 3263 cm-1 (OH and NH), 1697 cm-1 (C=O); 1H-NMR (500 MHz, CDCl3): d (ppm) 
0.88 [3H, t, J= 7.0 Hz, -(CH2)12CH3], 1.24-1.40 [22H, br m, -CH2(CH2)11CH3], 2.09 [2H, br dt, 
J= 7.3, 7.0 Hz, -CH2(CH2)11CH3], 2.17 (1H, dd, J= 5.8, 4.9 Hz, -OH), 3.64 (1H, ddd, J= 11.0, 
7.0, 5.8 Hz, C4-CHH), 3.68 (1H, ddd, J= 11.0, 4.9, 4.0 Hz, C4-CHH), 3.89 (1H, ddd, J= 7.9, 7.0, 
4.0 Hz, C4-H), 5.09 (1H, dd, J= 8.2, 7.9 Hz, C5-H), 5.56 (1H, ddt, J= 15.3, 8.2, 1.5 Hz, C1’-H), 
5.68 (1H, br s, NH), 5.92 (1H, dtd, J= 15.3, 7.0, 0.6 Hz, C2’-H); 13C-NMR (100 MHz, CDCl3): 
d (ppm) 14.05 (CH3), 22.67 (CH2), 28.79 (CH2), 29.15 (CH2), 29.33 (CH2), 29.43 (CH2), 29.57 
(CH2), 29.64 (CH2), 29.65 (CH2), 29.68 (CH2), 31.92 (CH2), 32.23 (CH2), 57.29 (CH), 
61.97(CH2), 79.89 (CH), 122.06 (CH), 138.93 (CH), 159.83 (C); LRFABMS m/z: 326 (MH+, 
100%). 
[lit. mp 101-102 oC; [α]D26 -32.0 (c 0.5, no report); 1H-NMR (assigned with sphingosine 
numbering): d (ppm) 0.881 (br t, 7.0 Hz, H-18), 1.26 (20H, m), 1.39 (m, H-7), 2.09 (m, H-6), 
3.64 (br dd, 11.6, ?7 Hz, H-1), 3.68 (br dd, 11.6, 4.0 Hz, H-1), 3.893 (dddd, 8.1, 7.1, 4.0, 0.7 
Hz, H-2), 5.085 (td, 8.2, 1.0 Hz, H-3), 5.558 (ddt, 15.4, 8.1, 1.5 Hz, H-4), 5.65 (br s, NH), 5.923 
(dtd, 15.4, 6.8, 1.0 Hz, H-5); 13C-NMR: d (ppm) 14.11, 22.68, 28.76, 29.15, 29.35, 29.43, 29.58, 
29.64, 29.66 (2C), 29.68, 31.91, 32.24, 57.24, 61.91, 79.98, 121.92, 139.13, 159.95] 
 
Next, the solution of 276-TIPS (20.0 mg, 0.061 mmol) in EtOH (0.49 ml) was treated with 2 N 
NaOH (prepared from NaOH, 96% purity, 0.5125 g in H2O 12.3 ml) (0.49 ml, 0.93 mmol, 15 
equiv) at room temperature and the reaction was allowed to 80 oC. After being stirred for 2.5 h, 
the reaction was concentrated, diluted with H2O (5 ml) and extracted with Et2O (10 ml x 2). 
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The organic layer was washed with H2O (5 ml x 2), brine (5 ml x 2), dried over Na2SO4 and 
concentrated to afford the residue (19.0 mg, 103%) as colorless solids which was used in the 
next step without purification.  
 
D-erythro-1,3-Diacetoxy-2-acetylamino-octadec-4t-ene (172) (Scheme 5-22) 
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In a flask equipped with a stir bar under a CaCl2, a mixture of crude solids 54 (19.0 mg, 0.063 
mmol) and DMAP (1.5 mg, 0.012 mmol, 0.20 Meq) in CH2Cl2 (0.7 ml) at 2 oC was treated with 
pyridine (0.08 ml, 0.99 mmol, 15.7 Meq) and Ac2O (0.04 ml, 0.42 mmol, 6.7 Meq). The 
reaction was allowed to warm to room temperature and stirring continued for 3 h. The reaction 
was diluted with H2O (5 ml), and extracted with AcOEt (10 ml x 2). The organic layer was 
washed with sat. CuSO4 aq. (5 ml x 5), H2O (5 ml x 2), brine (5 ml x 2), dried over Na2SO4 and 
concentrated. The residue (29.7 mg, 110%) was recrystallized 2 times from n-hexane/ AcOEt to 
afford 172 as colorless plates (25.0 mg, 95.8%), mp 100-102 oC: [α]D24 -13.0 (c 1.6, CHCl3). 
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Crystal data and structure refinement for 1-oxa-4,6,9-triazaspiro[4.4]nonane derivative 
Identification code  DW08024-30 
Empirical formula  C39 H42 Br N3 O3 
Formula weight  680.67 
Temperature  150 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.1682(14) Å a= 103.742(2)°. 
 b = 13.934(2) Å b= 102.728(2)°. 
 c = 14.818(2) Å g = 103.863(2)°. 
Volume 1706.3(4) Å3 
Z 2 
Density (calculated) 1.325 Mg/m3 
Absorption coefficient 1.246 mm-1 
F(000) 712 
Crystal size 0.40 x 0.35 x 0.30 mm3 
Theta range for data collection 1.58 to 27.51°. 
Index ranges -11<=h<=11, -14<=k<=18, -19<=l<=19 
Reflections collected 10396 
Independent reflections 7511 [R(int) = 0.0466] 
Completeness to theta = 27.51° 95.8 %  
Absorption correction Empirical 
Max. and min. transmission 0.7062 and 0.6356 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7511 / 0 / 420 
Goodness-of-fit on F2 1.027 
Final R indices [I>2sigma(I)] R1 = 0.0468, wR2 = 0.1162 
R indices (all data) R1 = 0.0684, wR2 = 0.1279 
Largest diff. peak and hole 0.791 and -0.334 e.Å-3 
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